Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixturesText with EEA relevance.

Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 OJ L 353, 31.12.2008, p. 1. , and in particular Article 53(1) thereof, Whereas: (1) Tables 3.1 and 3.2 of Annex VI to Regulation (EC) No 1272/2008 contain the list of harmonised classification and labelling of hazardous substances but only in English for all language versions of that Regulation. (2) On 2 December 2008 Corrigendum to the position of the European Parliament adopted at first reading on 3 September 2008 with a view to the adoption of Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 — P6_TA(2008)0392 (COM (2007)0355 — C6-0197/2007 — 2007/0121 (COD)). the Commission committed itself to ensure that the chemical names corresponding to the International Chemical Identifications in Tables 3.1 and 3.2 of Annex VI to Regulation (EC) No 1272/2008 are published in the same language as the language versions in which that Regulation has been published. (3) Table 3.1 of Annex VI to Regulation (EC) No 1272/2008 has been amended several times to reflect technical and scientific progress, by adding, deleting or modifying substances or their classification. To take account of those changes and to ensure that all the chemical names in Table 3.1 of Annex VI to Regulation (EC) No 1272/2008 are in the same language as the language versions in which that Regulation has been published, Table 3.1 needs to be replaced partially. (4) In view of the derogation Council Regulation (EU) No 1257/2010 of 20 December 2010 extending the temporary derogation measures from Regulation No 1 of 15 April 1958 determining the languages to be used by the European Economic Community and Regulation No 1 of 15 April 1958 determining the languages to be used by the European Atomic Energy Community introduced by Regulation (EC) No 920/2005 (OJ L 343, 29.12.2010, p. 5). which applies to the translation into Irish of acts which are not adopted jointly by the European Parliament and the Council, the chemical names in Table 3.1 of Annex VI should not be translated into Irish. (5) Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC

Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ 196, 16.8.1967, p. 1). , which has been repealed with effect from 1 June 2015. As a consequence, Table 3.2 is to be deleted in accordance with Article 1(2) of Commission Regulation (EU) 2016/1179 Commission Regulation (EU) 2016/1179 of 19 July 2016 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 195 de 20.7.2016, p. 11). with effect from 1 June 2017. That table should therefore not be changed. As a result Table 3.1 has been renamed to Table 3 in accordance with Article 2(2) of Commission Regulation (EU) 2017/776 Commission Regulation (EU) 2017/776 of 4 May 2017 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 116, 5.5.2017, p. 1). with effect from 1 June 2017. (6) Suppliers should be given sufficient time to adapt the labelling and packaging of substances and mixtures to the new translation provisions and to sell existing stocks. (7) Suppliers should have the possibility of applying this Regulation before its date of application to ensure a high level of protection of human health and of the environment and to provide sufficient flexibility to suppliers. (8) The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1). , HAS ADOPTED THIS REGULATION:

Article 1

The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in the Annex to this Regulation are replaced by the entries set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. It shall apply from 1 December 2019. By way of derogation from the second subparagraph, substances and mixtures may before 1 December 2019 be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008, as amended by this Regulation.

This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 16 April 2018. For the Commission The President Jean-Claude Juncker

Annex

ANNEX Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingSpecific Conc. Limits, M-factorsNotes Hazard Class and Category Code(s) Hazard statement Code(s)Pictogram, Signal Word Code(s)Hazard statement Code(s)Suppl. Hazard statement Code(s)(1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)001-001-00-9hydrogen215-605-71333-74-0 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U001-002-00-4aluminium lithium hydride240-877-916853-85-3 Water-react. 1 Skin Corr. 1A H260 H314 GHS02 GHS05 Dgr H260 H314 001-003-00-Xsodium hydride231-587-37646-69-7Water-react. 1H260 GHS02 Dgr H260001-004-00-5calcium hydride232-189-27789-78-8Water-react. 1H260 GHS02 Dgr H260003-001-00-4lithium231-102-57439-93-2 Water-react. 1 Skin Corr. 1B H260 H314 GHS02 GHS05 Dgr H260 H314 EUH014003-002-00-Xn-hexyllithium404-950-021369-64-2 Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A H260 H250 H314 GHS02 GHS05 Dgr H260 H250 H314 EUH014 003-003-00-5(2-methylpropyl)lithium; isobutyllithium440-620-2920-36-5 Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H260 H250 H314 H336 H400 H410 GHS02 GHS05 GHS07 GHS09 Dgr H260 H250 H314 H336 H410 EUH014004-001-00-7beryllium231-150-77440-41-7 Carc. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H350i H330 H301 H372 H319 H335 H315 H317 GHS06 GHS08 Dgr H350i H330 H301 H372 H319 H335 H315 H317 004-002-00-2beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex—— Carc. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H350i H330 H301 H372 H319 H335 H315 H317 H411 GHS06 GHS08 GHS09 Dgr H350i H330 H301 H372 H319 H335 H315 H317 H411 A 004-003-00-8beryllium oxide215-133-11304-56-9 Carc. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H350i H330 H301 H372 H319 H335 H315 H317 GHS06 GHS08 Dgr H350i H330 H301 H372 H319 H335 H315 H317 005-001-00-Xboron trifluoride231-569-57637-07-2 Press. Gas Acute Tox. 2 Skin Corr. 1A H330 H314 GHS04 GHS06 GHS05 Dgr H330 H314 EUH014U005-002-00-5boron trichloride233-658-410294-34-5 Press. Gas Acute Tox. 2 Acute Tox. 2 Skin Corr. 1B H330 H300 H314 GHS04 GHS06 GHS05 Dgr H330 H300 H314 EUH014U005-003-00-0boron tribromide233-657-910294-33-4 Acute Tox. 2 Acute Tox. 2 Skin Corr. 1A H330 H300 H314 GHS06 GHS05 Dgr H330 H300 H314 EUH014005-004-00-6trialkylboranes, solid—— Pyr. Sol. 1 Skin Corr. 1B H250 H314 GHS02 GHS05 Dgr H250 H314 A005-004-01-3trialkylboranes, liquid—— Pyr. Liq. 1 Skin Corr. 1B H250 H314 GHS02 GHS05 Dgr H250 H314 A005-005-00-1trimethyl borate204-468-9121-43-7 Flam. Liq. 3 Acute Tox. 4 H226 H312 GHS02 GHS07 Wng H226 H312 005-006-00-7dibutyltin hydrogen borate401-040-575113-37-0

Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H360FD H341 H372 H312 H302 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H360FD H341 H372 H312 H302 H318 H317 H410 005-007-00-2 boric acid; [1] boric acid; [2] 233-139-2 [1] 234-343-4 [2] 10043-35-3 [1] 11113-50-1 [2] Repr. 1BH360FD GHS08 Dgr H360FD Repr.1B; H360FD: C ≥ 5,5 % 005-008-00-8 diboron trioxide; boric oxide 215-125-81303-86-2Repr. 1BH360FD GHS08 Dgr H360FD Repr.1B; H360FD:C ≥ 3,1 % 005-009-00-3tetrabutylammonium butyltriphenylborate418-080-4120307-06-4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 005-010-00-9N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate422-050-6118612-00-3 Carc. 2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 H351 H302 H315 H318 GHS08 GHS05 GHS07 Dgr H351 H302 H315 H318 005-011-00-4 disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2] orthoboric acid, sodium salt [3] 215-540-4 [1] 235-541-3 [2] 237-560-2 [3] 1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3] Repr. 1BH360FD GHS08 Dgr H360FDRepr. 1B; H360FD: C ≥4,5 % 005-011-01-1 disodium tetraborate decahydrate; borax decahydrate 215-540-41303-96-4Repr. 1BH360FD GHS08 Dgr H360FDRepr.1B; H360FD: C ≥ 8,5 %005-011-02-9 disodium tetraborate pentahydrate; borax pentahydrate 215-540-412179-04-3Repr. 1BH360FD GHS08 Dgr H360FDRepr.B; H360FD: C ≥ 6,5 %005-012-00-Xdiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate418-070-1141714-54-7 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 005-013-00-5diethylmethoxyborane425-380-97397-46-8 Pyr. Liq. 1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 H250 H332 H312 H302 H373 H314 H317 H413 GHS02 GHS05 GHS08 GHS07 Dgr H250 H332 H312 H302 H373 H314 H317 H413 005-014-00-04-formylphenylboronic acid438-670-587199-17-5Skin Sens. 1H317 GHS07 Wng H317005-015-00-61-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)414-380-4140681-55-6 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412 005-016-00-1tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate431-370-5—Aquatic Chronic 4H413—H413 005-017-00-7 sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 231-556-4 [2] 15120-21-5 [1] 7632-04-4 [2] Ox. Sol. 2 Repr. 1B Acute Tox. 4 STOT SE 3 Eye Dam. 1 H272 H360Df H302 H335 H318 GHS03 GHS05 GHS08 GHS07 Dgr H272 H360Df H302 H335 H318 Repr.1B; H360Df: C ≥9 % Repr.1B; H360 D: 6,5 % ≤ C <9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %005-017-01-4 sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

239-172-9 [1] 231-556-4 [2] 15120-21-5 [1] 7632-04-4 [2] Ox. Sol. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 H272 H360Df H331 H302 H335 H318 GHS03 GHS06 GHS05 GHS08 Dgr H272 H360Df H331 H302 H335 H318 Repr. 1B; H360Df: C ≥9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 234-390-0 [2] 231-556-4 [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. 1B STOT SE 3 Eye Dam. 1 H360Df H335 H318 GHS05 GHS08 GHS07 Dgr H360Df H335 H318 Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % 005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 239-172-9 [1] 234-390-0 [2] 231-556-4 [3] 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] Repr. 1B Acute Tox. 4 STOT SE 3 Eye Dam. 1 H360Df H332 H335 H318 GHS05 GHS08 GHS07 Dgr H360Df H332 H335 H318 Repr. 1B; H360 Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % 005-019-00-8 perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 234-390-0 [1] 234-390-0 [2] 231-556-4 [3] 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] Ox. Sol. 3 Repr. 1B Acute Tox. 4 STOT SE 3 Eye Dam. 1 H272 H360Df H302 H335 H318 GHS03 GHS05 GHS08 GHS07 Dgr H272 H360Df H302 H335 H318 Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % 005-019-01-5 perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate;[3] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] 234-390-0 [1] 234-390-0 [2] 231-556-4 [3] 11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] Ox. Sol. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 H272 H360Df H331 H302 H335 H318 GHS03 GHS06 GHS05 GHS08 Dgr H272 H360Df H331 H302 H335 H318 Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % 006-001-00-2carbon monoxide211-128-3630-08-0 Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3 STOT RE 1 H220 H360D H331 H372 GHS02 GHS04 GHS06 GHS08 Dgr H220 H360D H331 H372 U 006-002-00-8phosgene; carbonyl chloride200-870-375-44-5 Press. Gas Acute Tox. 2

Skin Corr. 1B H330 H314 GHS04 GHS06 GHS05 Dgr H330 H314 U006-003-00-3carbon disulphide200-843-675-15-0 Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 H225 H361fd H372 H319 H315 GHS02 GHS08 GHS07 Dgr H225 H361fd H372 H319 H315 Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % 006-004-00-9calcium carbide200-848-375-20-7Water-react. 1H260 GHS02 Dgr H260T006-005-00-4 thiram (ISO); tetramethylthiuram disulphide 205-286-2137-26-8 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H373 H319 H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H332 H302 H373 H319 H315 H317 H410 M = 10006-006-00-X hydrogen cyanide; hydrocyanic acid 200-821-674-90-8 Flam. Liq. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H224 H330 H400 H410 GHS02 GHS06 GHS09 Dgr H224 H330 H410 006-006-01-7 hydrogen cyanide … %; hydrocyanic acid … % 200-821-674-90-8 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 B 006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 EUH032A006-008-00-0 antu (ISO); 1-(1-naphthyl)-2-thiourea 201-706-386-88-4 Acute Tox. 2 Carc. 2 H300 H351 GHS06 GHS08 Dgr H300 H351 006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; isolan 204-318-2119-38-0 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 006-010-00-15,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; dimetan204-525-8122-15-6Acute Tox. 3 H301 GHS06 Dgr H301006-011-00-7 carbaryl (ISO); 1-naphthyl methylcarbamate 200-555-063-25-2 Carc. 2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H351 H332 H302 H400 GHS08 GHS07 GHS09 Wng H351 H332 H302 H400 M=100006-012-00-2 ziram (ISO); zinc bis dimethyldithiocarbamate 205-288-3137-30-4 Acute Tox. 2 Acute Tox. 4 STOT RE 2 STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H302 H373 H335 H318 H317 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H330 H302 H373 H335 H318 H317 H410 M = 100 006-013-00-8 metam-sodium (ISO); sodium methyldithiocarbamate 205-293-0137-42-8 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H317 H410 EUH031006-014-00-3 nabam (ISO); disodium ethylenebis(N, N'-dithiocarbamate) 205-547-0142-59-6 Acute Tox. 4 STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H335 H317 H410 GHS07 GHS09 Wng H302 H335 H317 H410 006-015-00-9 diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4330-54-1 Carc. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H373 H410

M = 10006-016-00-4 propoxur (ISO); 2-isopropyloxyphenyl N-methylcarbamate; 2-isopropoxyphenyl methylcarbamate 204-043-8114-26-1 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H410 006-017-00-X aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime 204-123-2116-06-3 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H311 H400 H410 GHS06 GHS09 Dgr H330 H300 H311 H410 006-018-00-5 aminocarb (ISO); 4-dimethylamino-3-tolyl methylcarbamate 217-990-72032-59-9 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 006-019-00-0 di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate 218-961-12303-16-4 Carc. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H410 006-020-00-6 barban (ISO); 4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate 202-930-4101-27-9 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 006-021-00-1 linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea 206-356-5330-55-2 Repr. 1B Carc. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H351 H302 H373 H400 H410 GHS08 GHS07 GHS09 Dgr H360Df H351 H302 H373 H410 006-022-00-7 decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate —1563-67-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 006-023-00-2 mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate 217-991-22032-65-7 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H410 006-024-00-8 proxan-sodium (ISO); sodium O-isopropyldithiocarbonate 205-443-5140-93-2 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H302 H315 H411 GHS07 GHS09 Wng H302 H315 H411 006-025-00-3 allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1] S-bioallethrin; [3] (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2] esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] 209-542-4 [1] 249-013-5 [2]-[3] 584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H400 H410 GHS07 GHS09 Wng H332 H302 H410 C006-026-00-9 carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate 216-353-01563-66-2 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H400 H410 GHS06 GHS09 Dgr H330 H300 H410 006-028-00-X dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate 213-546-1973-21-7 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1

H301 H400 H410 GHS06 GHS09 Dgr H301 H410 006-029-00-5 dioxacarb (ISO); 2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate 230-253-46988-21-2Acute Tox. 3 Aquatic Chronic 2 H301 H411 GHS06 GHS09 Dgr H301 H411 006-030-00-0 EPTC (ISO); S-ethyl dipropylthiocarbamate 212-073-8759-94-4Acute Tox. 4 H302 GHS07 Wng H302006-031-00-6 formetanate (ISO); 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate 244-879-022259-30-9 Acute Tox. 2 Acute Tox. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H317 H400 H410 GHS06 GHS09 Dgr H330 H300 H317 H410 006-032-00-1 monolinuron (ISO); 3-(4-chlorophenyl)-1-methoxy-1-methylurea 217-129-51746-81-2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H410 006-033-00-7 metoxuron (ISO); 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea 243-433-219937-59-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410006-034-00-2 pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate 214-215-41114-71-2 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 006-036-00-3 benzthiazuron (ISO); 1-benzothiazol-2-yl-3-methylurea 217-685-91929-88-0Acute Tox. 4 H302 GHS07 Wng H302006-037-00-9 promecarb (ISO); 3-isopropyl-5-methylphenyl N-methylcarbamate 220-113-02631-37-0 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H410 006-038-00-4 sulfallate (ISO); 2-chloroallyl N, N-dimethyldithiocarbamate 202-388-995-06-7 Carc. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 006-039-00-X tri-allate (ISO); S-2,3,3-trichloroallyl diisopropylthiocarbamate 218-962-72303-17-5 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 006-040-00-53-methylpyrazol-5-yl-dimethylcarbamate; monometilan—2532-43-6 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 006-041-00-0dimethylcarbamoyl chloride201-208-679-44-7 Carc. 1B Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H350 H331 H302 H319 H335 H315 GHS06 GHS08 Dgr H350 H331 H302 H319 H335 H315 Carc. 1B; H350: C ≥ 0,001 % 006-042-00-6 monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea 205-766-1150-68-5 Carc. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H410 006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA —140-41-0 Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H319 H315 H400 H410 GHS08 GHS07 GHS09 Wng H351 H319 H315 H410 006-044-00-7 isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea 251-835-434123-59-6 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 M = 10006-045-00-2 methomyl (ISO); 1-(methylthio)ethylideneamino N-methylcarbamate 240-815-016752-77-5 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H300 H400 H410 GHS06 GHS09 Dgr H300 H410 M=100006-047-00-3

bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate —8065-36-9 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 006-048-00-9 ethiofencarb (ISO); 2-(ethylthiomethyl)phenyl N-methylcarbamate 249-981-929973-13-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 006-049-00-4 dixanthogen; O, O-diethyl dithiobis(thioformate) 207-944-4502-55-6Acute Tox. 4 H302 GHS07 Wng H302006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate; fenuron-TCA —4482-55-7 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 006-051-00-5 ferbam (ISO); iron tris(dimethyldithiocarbamate) 238-484-214484-64-1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H319 H335 H315 H410 006-052-00-0 formetanate hydrochloride; 3-(N, N-dimethylaminomethyleneamino)phenyl N-methylcarbamate 245-656-023422-53-9 Acute Tox. 2 Acute Tox. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H317 H400 H410 GHS06 GHS09 Dgr H330 H300 H317 H410 006-053-00-6 isoprocarb (ISO); 2-isopropylphenyl N-methylcarbamate 220-114-62631-40-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 006-054-00-1 mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate 206-249-3315-18-4 Acute Tox. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H300 H312 H400 H410 GHS06 GHS09 Dgr H300 H312 H410 006-055-00-7 xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC 219-364-92425-10-7 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 006-056-00-2 metolcarb (ISO); m-tolyl methylcarbamate; MTMC 214-446-01129-41-5 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 006-057-00-8 nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine 217-682-21929-82-4 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 006-058-00-3 noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea —2163-79-3Acute Tox. 4 H302 GHS07 Wng H302006-059-00-9 oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; 245-445-323135-22-0 Acute Tox. 2 Acute Tox. 2 Acute Tox. 4 Aquatic Chronic 2 H330 H300 H312 H411 GHS06 GHS09 Dgr H330 H300 H312 H411 006-060-00-4 oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide 226-066-25259-88-1 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride 243-193-919622-19-6 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 006-062-00-5 methyl 3,4-dichlorophenylcarbanilate; SWEP. —1918-18-9Acute Tox. 4 H302 GHS07 Wng H302006-063-00-0 thiobencarb (ISO); S-4-chlorobenzyl diethylthiocarbamate 248-924-528249-77-6 Acute Tox. 4

Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 006-064-00-6 thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime 254-346-439196-18-4 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid —15271-41-7 Acute Tox. 2 Acute Tox. 3 Aquatic Chronic 2 H300 H311 H411 GHS06 GHS09 Dgr H300 H311 H411 006-066-00-7 vernolate (ISO); S-propyl dipropylthiocarbamate 217-681-71929-77-7 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 006-067-00-2 XMC; 3,5-xylyl methylcarbamate —2655-14-3Acute Tox. 4 H302 GHS07 Wng H302006-068-00-8diazomethane206-382-7334-88-3Carc. 1BH350 GHS08 Dgr H350006-069-00-3 thiophanate-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene 245-740-723564-05-8 Muta. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H332 H317 H400 H410 GHS08 GHS07 GHS09 Wng H341 H332 H317 H410 006-070-00-9 furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide 262-302-060568-05-0 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 006-071-00-4cyclooct-4-en-1-yl methyl carbonate401-620-887731-18-8Skin Sens. 1H317 GHS07 Wng H317006-072-00-X prosulfocarb (ISO); S-benzyl N, N-dipropylthiocarbamate 401-730-652888-80-9 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 006-073-00-53-(dimethylamino)propylurea401-950-231506-43-1Eye Dam. 1H318 GHS05 Dgr H318 006-074-00-02-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate402-440-22094-99-7 Acute Tox. 2 Skin Corr. 1B STOT RE 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H314 H373 H334 H317 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H330 H314 H373 H334 H317 H410 006-076-00-1 mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt —8018-01-7 Repr. 2 Skin Sens. 1 Aquatic Acute 1 H361d H317 H400 GHS08 GHS07 GHS09 Wng H361d H317 H400 M=10006-077-00-7 maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) 235-654-812427-38-2 Repr. 2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H332 H319 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361d H332 H319 H317 H410 M=10006-078-00-2 zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric) 235-180-112122-67-7 STOT SE 3 Skin Sens. 1 H335 H317 GHS07 Wng H335 H317 006-079-00-8 disulfiram; tetraethylthiuramdisulfide 202-607-897-77-8 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 006-080-00-3tetramethylthiuram monosulphide202-605-797-74-5 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 006-081-00-9zinc bis(dibutyldithiocarbamate)205-232-8136-23-2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H317

H400 H410 GHS07 GHS09 Wng H319 H335 H315 H317 H410 006-082-00-4zinc bis(diethyldithiocarbamate)238-270-914324-55-1 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H335 H315 H317 H400 H410 GHS07 GHS09 Wng H302 H319 H335 H315 H317 H410 006-083-00-X butocarboxim (ISO); 3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime 252-139-334681-10-2 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H226 H331 H311 H301 H319 H400 H410 GHS02 GHS06 GHS09 Dgr H226 H331 H311 H301 H319 H410 006-084-00-5 carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate 259-565-955285-14-8 Acute Tox. 2 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H301 H317 H400 H410 GHS06 GHS09 Dgr H330 H301 H317 H410 006-085-00-0 fenobucarb (ISO); 2-butylphenyl methylcarbamate 223-188-83766-81-2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 006-086-00-6 fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate 276-696-772490-01-8 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 M = 1 M = 10000 006-087-00-1 furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate 265-974-365907-30-4 Acute Tox. 2 Acute Tox. 3 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H301 H373 H319 H315 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H301 H373 H319 H315 H317 H410 M = 100006-088-00-7 benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate —82560-54-1 Repr. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H361f H331 H302 H400 H410 GHS06 GHS08 GHS09 Dgr H361f H331 H302 H410 006-090-00-82-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate408-010-088558-41-2 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H332 H318 H412 GHS05 GHS07 Dgr H332 H318 H412 006-091-00-3 propineb (ISO); polymeric zinc propylenebis(dithiocarbamate) —9016-72-2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 H332 H373 H317 H400 GHS08 GHS07 GHS09 Wng H332 H373 H317 H400 006-092-00-9tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate425-420-598737-29-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410006-093-00-42,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)427-180-7— Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 006-094-00-XO-isobutyl-N-ethoxy carbonylthiocarbamate434-350-4103122-66-3 Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H226 H350 H340 H302 H373 H317 H411 GHS02 GHS08 GHS07 GHS09 Dgr H226 H350 H340 H302 H373 H317 H411 006-095-00-5 fosetyl-aluminium (ISO); aluminium triethyl triphosphonate 254-320-239148-24-8Eye Dam. 1H318 GHS05 Dgr H318006-096-00-0 chlorpropham (ISO); isopropyl 3-chlorocarbanilate

202-925-7101-21-3 Carc. 2 STOT RE 2 Aquatic Chronic 2 H351 H373 H411 GHS08 GHS09 Wng H351 H373 H411 006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2 Acute Tox. 4 STOT RE 2 Aquatic Chronic 3 H302 H373 H412 GHS08 GHS07 Wng H302 H373 H412 006-098-00-1tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H302 H373 H318 H317 GHS05 GHS08 GHS07 Dgr H302 H373 H318 H317 006-099-00-7 N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-][(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl4-methylbenzenesulfonate 520-2232938-43-1Aquatic Chronic 2H411GHS09H411006-101-00-6 reaction mass of: N, N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N, N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea] 423-070-8—Aquatic Chronic 4H413—H413 006-102-00-1O-hexyl-N-ethoxycarbonylthiocarbamate432-750-3— Carc. 1B Muta. 1B Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H350 H340 H302 H373 H317 H411 GHS08 GHS07 GHS09 Dgr H350 H340 H302 H373 H317 H411 006-103-00-7N, N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea445-760-8— Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H334 H400 H410 GHS05 GHS08 GHS09 Dgr H318 H334 H410 M=100007-001-00-5ammonia, anhydrous231-635-37664-41-7 Flam. Gas 2 Press. Gas Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 H221 H331 H314 H400 GHS04 GHS06 GHS05 GHS09 Dgr H221 H331 H314 H400 U007-001-01-2ammonia ….%215-647-61336-21-6 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 STOT SE 3; H335: C ≥ 5 %B007-002-00-0 nitrogen dioxide; [1] dinitrogen tetraoxide [2] 233-272-6 [1] 234-126-4 [2] 10102-44-0 [1] 10544-72-6 [2] Press. Gas Ox. Gas 1 Acute Tox. 2 Skin Corr. 1B H270 H330 H314 GHS04 GHS03 GHS06 GHS05 Dgr H270 H330 H314

STOT SE 3; H335: C ≥0,5 % 5007-003-00-6 chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride 213-666-4999-81-5 Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 007-006-00-2ethyl nitrite203-722-6109-95-5 Flam. Gas 1 Press. Gas Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H220 H332 H312 H302 GHS02 GHS04 GHS07 Dgr H220 H332 H312 H302 U007-007-00-8ethyl nitrate210-903-3625-58-1Unst. Expl.H200 GHS01 Dgr H200007-008-00-3hydrazine206-114-9302-01-2 Flam. Liq. 3 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H350 H331 H311 H301 H314 H317 H400 H410 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H226 H350 H331 H311 H301 H314 H317 H410 Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 % 007-009-00-9dicyclohexylammonium nitrite221-515-93129-91-7 Acute Tox. 4 Acute Tox. 4 H332 H302 GHS07 Wng H332 H302 007-010-00-4sodium nitrite231-555-97632-00-0 Ox. Sol. 3 Acute Tox. 3 Aquatic Acute 1 H272 H301 H400 GHS03 GHS06 GHS09 Dgr H272 H301 H400 007-011-00-Xpotassium nitrite231-832-47758-09-0 Ox. Sol. 2 Acute Tox. 3

Aquatic Acute 1 H272 H301 H400 GHS03 GHS06 GHS09 Dgr H272 H301 H400

007-012-00-5N,N-dimethylhydrazine200-316-057-14-7 Flam. Liq. 2 Carc. 1B Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Aquatic Chronic 2 H225 H350 H331 H301 H314 H411 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H225 H350 H331 H301 H314 H411 007-013-00-01,2-dimethylhydrazine—540-73-8 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H350 H331 H311 H301 H411 GHS06 GHS08 GHS09 Dgr H350 H331 H311 H301 H411 Carc. 1B; H350: C ≥ 0,01 %007-014-00-6salts of hydrazine—— Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H331 H311 H301 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H331 H311 H301 H317 H410 A007-015-00-1O-ethylhydroxylamine402-030-3624-86-2 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H225 H331 H311 H301 H372 H319 H317 H400 GHS02 GHS06 GHS08 GHS09 Dgr H225 H331 H311 H301 H372 H319 H317 H400 007-016-00-7butyl nitrite208-862-1544-16-1 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 H225 H331 H301 GHS02 GHS06 Dgr H225 H331 H301 007-017-00-2isobutyl nitrite208-819-7542-56-3 Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 H225 H350 H341 H332 H302 GHS02 GHS08 GHS07 Dgr H225 H350 H341 H332 H302 007-018-00-8sec-butyl nitrite213-104-8924-43-6 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 H225 H332 H302 GHS02 GHS07 Dgr H225 H332 H302 007-019-00-3tert-butyl nitrite208-757-0540-80-7 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 H225 H332 H302 GHS02 GHS07 Dgr H225 H332 H302 007-020-00-9 pentyl nitrite; [1] ‘amyl nitrite’, mixed isomers [2] 207-332-7 [1] 203-770-8 [2] 463-04-7 [1] 110-46-3 [2] Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 H225 H332 H302 GHS02 GHS07 Dgr H225 H332 H302 007-021-00-4 hydrazobenzene; 1,2-diphenylhydrazine 204-563-5122-66-7 Carc. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 007-022-00-Xhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)405-030-1— Carc. 1B Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H350 H302 H314 H317 H412 GHS08 GHS05 GHS07 Dgr H350 H302 H314 H317 H412 007-023-00-5sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate405-510-0— Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 007-024-00-02-(decylthio)ethylammonium chloride405-640-836362-09-1 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H315 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H373 H315 H318 H410 007-025-00-6(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride406-090-181880-96-8 Muta. 2 Acute Tox. 3 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H301 H372 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H341 H301 H372 H317 H410 007-026-00-1oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide413-230-5122035-71-6 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 007-027-00-71,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane420-190-2771478-66-1

Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373 H314 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H312 H302 H373 H314 H317 H410 007-028-00-2hydroxylammonium nitrate236-691-213465-08-2 Expl. 1.1 Carc. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H201 H351 H311 H302 H373 H319 H315 H317 H400 GHS01 GHS06 GHS08 GHS09 Dgr H201 H351 H311 H302 H373 H319 H315 H317 H400 007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 008-001-00-8oxygen231-956-97782-44-7 Ox. Gas 1 Press. Gas H270 GHS03 GHS04 Dgr H270U 008-003-00-9hydrogen peroxide solution… %231-765-07722-84-1 Ox. Liq. 1 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H271 H332 H302 H314 GHS03 GHS05 GHS07 Dgr H271 H332 H302 H314 Ox. Liq. 1; H271: C ≥70 % Ox. Liq. 2; H272: 50 % ≤ C < 70 %

Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % B009-001-00-0fluorine231-954-87782-41-4 Press. Gas Ox. Gas 1 Acute Tox. 2 Skin Corr. 1A H270 H330 H314 GHS04 GHS03 GHS06 GHS05 Dgr H270 H330 H314 009-002-00-6hydrogen fluoride231-634-87664-39-3 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Skin Corr. 1A H330 H310 H300 H314 GHS06 GHS05 Dgr H330 H310 H300 H314 009-003-00-1hydrofluoric acid … %231-634-87664-39-3 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Skin Corr. 1A H330 H310 H300 H314 GHS06 GHS05 Dgr H330 H310 H300 H314 Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1 % ≤C < 1 %B009-004-00-7sodium fluoride231-667-87681-49-4 Acute Tox. 3 Eye Irrit. 2 Skin Irrit. 2 H301 H319 H315 GHS06 Dgr H301 H319 H315 EUH032009-005-00-2potassium fluoride232-151-57789-23-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 009-006-00-8ammonium fluoride235-185-912125-01-8 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 009-007-00-3 sodium bifluoride; sodium hydrogen difluoride 215-608-31333-83-1 Acute Tox. 3 Skin Corr. 1B H301 H314 GHS06 GHS05 Dgr H301 H314 Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 009-008-00-9 potassium bifluoride; potassium hydrogen difluoride 232-156-27789-29-9 Acute Tox. 3 Skin Corr. 1B H301 H314 GHS06 GHS05 Dgr H301 H314

Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 009-009-00-4 ammonium bifluoride; ammonium hydrogen difluoride 215-676-41341-49-7 Acute Tox. 3 Skin Corr. 1B H301 H314 GHS06 GHS05 Dgr H301 H314

Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 009-010-00-Xfluoroboric acid … %240-898-316872-11-0Skin Corr. 1BH314 GHS05 Dgr H314 Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 % B009-011-00-5fluorosilicic acid … %241-034-816961-83-4Skin Corr. 1BH314 GHS05 Dgr H314B009-012-00-0 alkali fluorosilicates(Na); [1] alkali fluorosilicates(K); [2] alkali fluorosilicates(NH4) [3] 240-934-8 [1] 240-896-2 [2] 240-968-3 [3] 16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 A009-013-00-6fluorosilicates, with the exception of those specified elsewhere in this Annex——Acute Tox. 4 H302 GHS07 Wng H302A009-014-00-1lead hexafluorosilicate247-278-125808-74-6 Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H332 H302 H373 H400 H410 GHS08 GHS07 GHS09 Dgr H360Df H332 H302 H373 H410 1 009-015-00-7sulphuryl difluoride220-281-52699-79-8 Press. Gas Acute Tox. 3 STOT RE 2 Aquatic Acute 1 H331 H373 H400 GHS04 GHS06 GHS08 GHS09 Dgr H331 H373 H400 U009-016-00-2 trisodium hexafluoroaluminate [1] trisodium hexafluoroaluminate(cryolite) [2] 237-410-6 [1] 239-148-8 [2] 13775-53-6 [1] 15096-52-3 [2] STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 H372 H332 H411 GHS07 GHS08 GHS09 Dgr H372 H332 H411 009-017-00-8potassium mu-fluoro-bis(triethylaluminium)400-040-212091-08-6 Flam. Sol. 1 Water-react. 1 Skin Corr. 1A Acute Tox. 4 H228 H270 H314 H332 GHS02 GHS05 GHS07 Dgr H228 H270 H314 H332 EUH014T009-018-00-3magnesium hexafluorosilicate241-022-216949-65-8Acute Tox. 3 H301 GHS06 Dgr H301011-001-00-0sodium231-132-97440-23-5 Water-react. 1 Skin Corr. 1B H260 H314 GHS02 GHS05 Dgr H260 H314 EUH014011-002-00-6 sodium hydroxide; caustic soda 215-185-51310-73-2Skin Corr. 1AH314 GHS05 Dgr H314Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit.2; H319: 0,5 % ≤ C < 2 % 011-003-00-1sodium peroxide215-209-41313-60-6 Ox. Sol. 1 Skin Corr. 1A H271 H314 GHS03 GHS05 Dgr H271 H314 011-004-00-7sodium azide247-852-126628-22-8 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H300 H400 H410 GHS06 GHS09 Dgr H300 H400 H410 EUH032011-005-00-2sodium carbonate207-838-8497-19-8Eye Irrit. 2H319 GHS07 Wng H319011-006-00-8sodium cyanate213-030-6917-61-3 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 011-007-00-3propoxycarbazone-sodium—181274-15-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M = 10012-001-00-3magnesium powder (pyrophoric)231-104-67439-95-4 Water-react. 1 Pyr. Sol. 1 H260 H250 GHS02 Dgr H260 H250 T012-002-00-9magnesium, powder or turnings231-104-6— Flam. Sol. 1 Water-react. 2 Self-heat. 1 H228 H261 H252 GHS02 Dgr H228 H261 H252 T012-003-00-4magnesium alkyls—— Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B H250 H260 H314 GHS02 GHS05 Dgr H250 H260 H314 EUH014A 012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410013-001-00-6aluminium powder (pyrophoric)231-072-37429-90-5 Water-react. 2 Pyr. Sol. 1 H261 H250 GHS02 Dgr H261 H250 T013-002-00-1aluminium powder (stabilised)231-072-37429-90-5

Water-react. 2 Flam. Sol. 1 H261 H228 GHS02 Dgr H261 H228 T013-003-00-7aluminium chloride, anhydrous231-208-17446-70-0Skin Corr. 1BH314 GHS05 Dgr H314013-004-00-2aluminium alkyls—— Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B H250 H260 H314 GHS02 GHS05 Dgr H250 H260 H314 EUH014A013-005-00-8diethyl(ethyldimethylsilanolato) aluminium401-160-855426-95-4 Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A H260 H250 H314 GHS02 GHS05 Dgr H260 H250 H314 EUH014013-006-00-3(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised402-370-2— Flam. Liq. 3 Eye Dam. 1 H226 H318 GHS02 GHS05 Dgr H226 H318 013-007-00-9poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)403-430-0—Eye Dam. 1H318 GHS05 Dgr H318013-008-00-4di-n-octylaluminium iodide408-190-07585-14-0 Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H250 H314 H400 H410 GHS02 GHS05 GHS09 Dgr H250 H314 H410 EUH014 013-009-00-Xsodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y =1,5418-720-2— Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 Skin Corr. 1A H228 H260 H250 H332 H314 GHS02 GHS05 GHS07 Dgr H228 H260 H250 H332 H314 EUH014T013-010-00-5hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d, g][1.3.2]dioxaphosphocin-6-oxide)430-650-4151841-65-5Aquatic Chronic 2H411GHS09H411014-001-00-9trichlorosilane233-042-510025-78-2 Flam. Liq. 1 Pyr. Liq. 1 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H224 H250 H332 H302 H314 GHS02 GHS05 GHS07 Dgr H224 H250 H332 H302 H314 EUH014 EUH029

STOT SE 3; H335: C ≥ 1 % T014-002-00-4silicon tetrachloride233-054-010026-04-7 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 EUH014014-003-00-Xdimethyldichlorosilane200-901-075-78-5 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H225 H319 H335 H315 GHS02 GHS07 Dgr H225 H319 H335 H315 014-004-00-5trichloro(methyl)silane; methyltrichlorosilane200-902-675-79-6 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H225 H319 H335 H315 GHS02 GHS07 Dgr H225 H319 H335 H315 EUH014Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %014-005-00-0 tetraethyl silicate; ethyl silicate 201-083-878-10-4 Flam. Liq. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H226 H332 H319 H335 GHS02 GHS07 Wng H226 H332 H319 H335 014-006-00-6bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride401-380-4— Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 014-007-00-1triethoxyisobutylsilane402-810-317980-47-1Skin Irrit. 2H315 GHS07 Wng H315014-008-00-7(chloromethyl)bis(4-fluorophenyl)methylsilane401-200-485491-26-5Aquatic Chronic 2H411GHS09H411014-009-00-2isobutylisopropyldimethoxysilane402-580-4111439-76-0 Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 H226 H332 H315 GHS02 GHS07 Wng H226 H332 H315 014-010-00-8disodium metasilicate229-912-96834-92-0 Skin Corr. 1B STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 014-011-00-3cyclohexyldimethoxymethylsilane402-140-117865-32-6 Skin Irrit. 2 Aquatic Chronic 2 H315 H411

GHS07 GHS09 Wng H315 H411 014-012-00-9bis(3-(trimethoxysilyl)propyl)amine403-480-3— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 014-013-00-4α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)404-920-7— Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H312 H302 H314 H411 GHS05 GHS07 GHS09 Dgr H312 H302 H314 H411 014-014-00-X etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane 253-704-737894-46-5 Repr. 1B Acute Tox. 4 STOT RE 2 H360D H302 H373 GHS08 GHS07 Dgr H360D H302 H373 014-015-00-5α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))406-420-469430-40-6Aquatic Chronic 4H413—H413014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane 406-490-6—Aquatic Chronic 2H411GHS09H411014-017-00-6 flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane —85509-19-9 Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2 H351 H360D H302 H411 GHS08 GHS07 GHS09 Dgr H351 H360D H302 H411 014-018-00-1octamethylcyclotetrasiloxane209-136-7556-67-2 Repr. 2 Aquatic Chronic 4 H361f H413 GHS08 Wng H361f H413014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole 403-250-2— Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2 H351 H360D H302 H411 GHS08 GHS07 GHS09 Dgr H351 H360D H302 H411 014-020-00-2bis(1,1-dimethyl-2-propynyloxy)dimethylsilane414-960-753863-99-3Acute Tox. 4 H332 GHS07 Wng H332014-021-00-8tris(isopropenyloxy)phenyl silane411-340-852301-18-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H400 H410 014-022-00-3reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)401-530-9— Flam. Sol. 1 STOT SE 1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H228 H370 H332 H312 H302 GHS02 GHS08 GHS07 Dgr H228 H370 H332 H312 H302 T 014-023-00-9α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole408-160-7125613-45-8Aquatic Chronic 2H411GHS09H411014-024-00-41-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene412-620-2121626-74-2Aquatic Chronic 2H411GHS09H411014-025-00-X4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine411-400-3102089-33-8 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H302 H373 H315 H318 H412 GHS08 GHS05 GHS07 Dgr H302 H373 H315 H318 H412 014-026-00-5dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane407-180-3770722-36-6Skin Corr. 1AH314 GHS05 Dgr H314014-027-00-0chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane410-270-5770722-46-8Skin Corr. 1AH314 GHS05 Dgr H314014-028-00-6α-[3-(1-oxoprop-2-enyl)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)415-290-8193159-06-7Skin Sens. 1H317

GHS07 Wng H317014-029-00-1O, O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]421-870-1156145-66-3 Repr. 2 Acute Tox. 4 STOT RE 2 H361f H302 H373 GHS08 GHS07 Wng H361f H302 H373 014-030-00-7[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium422-060-0137390-08-0Acute Tox. 2 H300 GHS06 Dgr H300014-031-00-2bis(1-methylethyl)-dimethoxysilane421-540-718230-61-0 Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H226 H315 H317 H412 GHS02 GHS07 Wng H226 H315 H317 H412 014-032-00-8dicyclopentyldimethoxysilane404-370-8126990-35-0 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 014-033-00-32-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica419-030-4125804-20-8 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 014-034-00-93-hexylheptamethyltrisiloxane428-700-51873-90-1 Acute Tox. 4 Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413 014-035-00-42-(3,4-epoxycyclohexyl)ethyltriethoxy silane425-050-410217-34-2 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360F H400 H410 GHS08 GHS09 Dgr H360F H410M=1000014-037-00-52-butanone-O, O',O''-(phenylsilylidyne)trioxime433-360-634036-80-1 STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H373 H317 H412 GHS08 GHS07 Wng H373 H317 H412 014-038-00-0S-(3-(triethoxysilyl)propyl)octanethioate436-690-9220727-26-4Skin Sens. 1H317 GHS07 Wng H317014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318 H412 014-041-00-7N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 014-042-00-2reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0—Eye Dam. 1H318 GHS05 Dgr H318014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2— STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H335 H315 H318 H412 GHS05 GHS07 Dgr H335 H315 H318 H412 014-044-00-33-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane433-050-0—Aquatic Chronic 2H411GHS09H411014-045-00-9magnesium sodium fluoride silicate442-650-1—STOT RE 2 H373 GHS08 Wng H373015-001-00-1white phosphorus231-768-712185-10-3 Pyr. Sol. 1 Acute Tox. 2 Acute Tox. 2 Skin Corr. 1A Aquatic Acute 1 H250 H330 H300 H314 H400 GHS02 GHS06 GHS05 GHS09 Dgr H250 H330 H300 H314 H400 015-002-00-7red phosphorus231-768-77723-14-0 Flam. Sol. 1 Aquatic Chronic 3 H228 H412 GHS02 Dgr H228 H412 015-004-00-8aluminium phosphide244-088-020859-73-8 Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 H260 H300 H311 H330 H400 GHS02 GHS06 GHS09 Dgr H260

H300 H311 H330 H400 EUH029 EUH032 M = 100015-005-00-3 magnesium phosphide; trimagnesium diphosphide 235-023-712057-74-8 Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 H260 H300 H311 H330 H400 GHS02 GHS06 GHS09 Dgr H260 H300 H311 H330 H400 EUH029 EUH032 M = 100 015-006-00-9 trizinc diphosphide; zinc phosphide 215-244-51314-84-7 Water-react. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H260 H300 H400 H410 GHS02 GHS06 GHS09 Dgr H260 H300 H410 EUH029 EUH032 M=100T015-007-00-4phosphorus trichloride231-749-37719-12-2 Acute Tox. 2 Acute Tox. 2 STOT RE 2 Skin Corr. 1A H330 H300 H373 H314 GHS06 GHS08 GHS05 Dgr H330 H300 H373 H314 EUH014 EUH029 015-008-00-Xphosphorus pentachloride233-060-310026-13-8 Acute Tox. 2 Acute Tox. 4 STOT RE 2 Skin Corr. 1B H330 H302 H373 H314 GHS06 GHS08 GHS05 Dgr H330 H302 H373 H314 EUH014 EUH029 015-009-00-5phosphoryl trichloride233-046-710025-87-3 Acute Tox. 2 STOT RE 1 Acute Tox. 4 Skin Corr. 1A H330 H372 H302 H314 GHS06 GHS08 GHS05 Dgr H330 H372 H302 H314 EUH014 EUH029 015-010-00-0phosphorus pentoxide215-236-11314-56-3Skin Corr. 1AH314 GHS05 Dgr H314015-011-00-6phosphoric acid . %, orthophosphoric acid . %231-633-27664-38-2Skin Corr. 1BH314 GHS05 Dgr H314Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 %B015-012-00-1 tetraphosphorus trisulphide; phosphorus sesquisulphid 215-245-01314-85-8 Flam. Sol. 2 Water-react. 1 Acute Tox. 4 Aquatic Acute 1 H228 H260 H302 H400 GHS02 GHS07 GHS09 Dgr H228 H260 H302 H400 T 015-013-00-7triethyl phosphate201-114-578-40-0Acute Tox. 4 H302 GHS07 Wng H302015-014-00-2tributyl phosphate204-800-2126-73-8 Carc. 2 Acute Tox. 4 Skin Irrit. 2 H351 H302 H315 GHS08 GHS07 Wng H351 H302 H315 015-015-00-8tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);201-103-578-30-8 STOT SE 1 Aquatic Chronic 2 H370 H411 GHS08 GHS09 Dgr H370 H411 STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 %C015-016-00-3 tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); 201-105-678-32-0 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H312 H302 H411 GHS07 GHS09 Wng H312 H302 H411 C015-019-00-X dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate 200-547-762-73-7 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 H330 H311 H301 H317 H400 GHS06 GHS09 Dgr H330 H311 H301 H317 H400 M=1000015-020-00-5 mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate 232-095-17786-34-7 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 M = 10000015-021-00-0 trichlorfon (ISO); dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 200-149-352-68-6 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H400 H410 M = 1000 015-022-00-6 phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate

236-116-513171-21-6 Muta. 2 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H341 H300 H311 H400 H410 GHS06 GHS08 GHS09 Dgr H341 H300 H311 H410 015-023-00-1 pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate —108-34-9 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 H330 H310 H300 GHS06 Dgr H330 H310 H300 015-024-00-7 triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphonic diamide —1031-47-6 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-025-00-2 TEPP (ISO); tetraethyl pyrophosphate 203-495-3107-49-3 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 H310 H300 H400 GHS06 GHS09 Dgr H310 H300 H400 015-026-00-8schradan (ISO); octamethylpyrophosphoramide205-801-0152-16-9 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-027-00-3 sulfotep (ISO); O, O,O, O-tetraethyl dithiopyrophosphate 222-995-23689-24-5 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 M = 1000015-028-00-9 demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate 206-053-8298-03-3 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 H310 H300 H400 GHS06 GHS09 Dgr H310 H300 H400 015-029-00-4 demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate 204-801-8126-75-0 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-030-00-X demeton-O-methyl (ISO); O-2-ethylthioethyl O,O-dimethyl phosphorothioate 212-758-1867-27-6Acute Tox. 3 H301 GHS06 Dgr H301015-031-00-5 demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate 213-052-6919-86-8 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H311 H301 H411 GHS06 GHS09 Dgr H311 H301 H411 015-032-00-0 prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate 218-893-22275-18-5 Acute Tox. 1 Acute Tox. 2 Aquatic Chronic 3 H310 H300 H412 GHS06 Dgr H310 H300 H412 015-033-00-6 phorate (ISO); O,O-diethyl ethylthiomethyl phosphorodithioate 206-052-2298-02-2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 M = 1000015-034-00-1 parathion (ISO); O,O-diethyl O-4-nitrophenyl phosphorothioate 200-271-756-38-2 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H311 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H300 H311 H372 H410 M = 100015-035-00-7 parathion — methyl (ISO); O,O-dimethyl O-4-nitrophenyl phosphorothioate 206-050-1298-00-0 Flam. Liq. 3 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H226 H330 H300 H311 H373 H400 H410 GHS02 GHS06 GHS08 GHS09 Dgr H226 H330 H300 H311 H373 H410 M = 100 015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate; EPN 218-276-82104-64-5 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 015-037-00-8 phenkapton (ISO); S-(2,5-dichlorophenylthiomethyl) O, O-diethyl phosphorodithioate 218-892-72275-14-1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1

H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 015-038-00-3 coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate 200-285-356-72-4 Acute Tox. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H300 H312 H400 H410 GHS06 GHS09 Dgr H300 H312 H410 015-039-00-9 azinphos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate 201-676-186-50-0 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H311 H317 H400 H410 GHS06 GHS09 Dgr H330 H300 H311 H317 H410 015-040-00-4 diazinon (ISO); O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate 206-373-8333-41-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H400 H410 015-041-00-X malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O, O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion] 204-497-7121-75-5 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M=1000 015-042-00-5chlorthion O-(3-chloro-4-nitrophenyl) O, O-dimethyl phosphorothioate207-902-5500-28-7 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 M = 100015-043-00-0 phosnichlor (ISO); O-4-chloro-3-nitrophenyl O, O-dimethyl phosphorothioate —5826-76-6 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H332 H312 H302 GHS07 Wng H332 H312 H302 015-044-00-6 carbophenothion (ISO); 4-chlorophenylthiomethyl O, O-diethyl phosphorodithioate 212-324-1786-19-6 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 015-045-00-1 mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl O, O-diethyl phosphorodithioate 219-993-92595-54-2 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H400 H410 015-046-00-7 oxydemeton-methyl; S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate 206-110-7301-12-2 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 H311 H301 H400 GHS06 GHS09 Dgr H311 H301 H400 015-047-00-2 ethion (ISO); O, O,O',O'-tetraethyl S, S'-methylenedi (phosphorodithioate); diethion 209-242-3563-12-2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H400 H410 GHS06 GHS09 Dgr H301 H312 H410 M = 10000 015-048-00-8 fenthion (ISO); O, O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate 200-231-955-38-9 Muta. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H331 H312 H302 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H341 H331 H312 H302 H372 H410 M=100015-049-00-3 endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate 220-472-32778-04-3 Acute Tox. 3 Acute Tox. 3 H311 H301 GHS06 Dgr H311 H301 015-050-00-9 thiometon (ISO); S-2-ethylthioethyl O,O-dimethyl phosphorodithioate 211-362-6640-15-3 Acute Tox. 3 Acute Tox. 4 H301 H312 GHS06 Dgr H301 H312 015-051-00-4 dimethoate (ISO); O, O-dimethyl methylcarbamoylmethyl phosphorodithioate

200-480-360-51-5 Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 015-052-00-X fenchlorphos (ISO); O, O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate 206-082-6299-84-3 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 015-053-00-5 menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate 201-123-478-57-9 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 015-054-00-0 fenitrothion (ISO); O, O-dimethyl O-4-nitro-m-tolyl phosphorothioate 204-524-2122-14-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 015-055-00-6 naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate 206-098-3300-76-5 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 H312 H302 H319 H315 H400 GHS07 GHS09 Wng H312 H302 H319 H315 H400 M = 1000015-056-00-1 azinphos-ethyl (ISO); O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate 220-147-62642-71-9 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 M=100015-057-00-7 formothion (ISO); N-formyl-N-methylcarbamoylmethyl O, O-dimethyl phosphorodithioate 219-818-62540-82-1 Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 015-058-00-2 morphothion (ISO); O, O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate 205-628-0144-41-2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 015-059-00-8 vamidothion (ISO); O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate 218-894-82275-23-2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 H301 H312 H400 GHS06 GHS09 Dgr H301 H312 H400 015-060-00-3 disulfoton (ISO); O,O-diethyl 2-ethylthioethyl phosphorodithioate 206-054-3298-04-4 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 015-061-00-9dimefox (ISO); tetramethylphosphorodiamidic fluoride204-076-8115-26-4 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-062-00-4 mipafox (ISO); N,N'-di-isopropylphosphorodiamidic fluoride 206-742-3371-86-8STOT SE 1H370 GHS08 Dgr H370 015-063-00-X dioxathion (ISO); 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) 201-107-778-34-2 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H311 H400 H410 GHS06 GHS09 Dgr H330 H300 H311 H410 M = 1000015-064-00-5 bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate 225-399-04824-78-6 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H400 H410 GHS06 GHS09 Dgr H301 H312 H410 015-065-00-0S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate—2703-37-9 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 015-066-00-6 omethoate (ISO); O, O-dimethyl S-methylcarbamoylmethyl phosphorothioate 214-197-81113-02-6

Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 H301 H312 H400 GHS06 GHS09 Dgr H301 H312 H400 015-067-00-1 phosalone (ISO); S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O, O-diethyl phosphorodithioate 218-996-22310-17-0 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H332 H312 H317 H400 H410 GHS06 GHS09 Dgr H301 H332 H312 H317 H410 M=1000 015-068-00-7 dichlofenthion (ISO); O—2,4-dichlorophenyl O,O-diethyl phosphorothioate 202-564-597-17-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H400 H410 015-069-00-2 methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate 213-449-4950-37-8 Acute Tox. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H300 H312 H400 H410 GHS06 GHS09 Dgr H300 H312 H410 015-070-00-8 cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate 223-099-43734-95-0 Acute Tox. 2 Acute Tox. 3 H300 H311 GHS06 Dgr H300 H311 015-071-00-3 chlorfenvinphos (ISO); 2-chloro-1-(2,4 dichlorophenyl)vinyl diethyl phosphate 207-432-0470-90-6 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 015-072-00-9 monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate 230-042-76923-22-4 Muta. 2 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H341 H330 H300 H311 H400 H410 GHS06 GHS08 GHS09 Dgr H341 H330 H300 H311 H410 015-073-00-4 dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate 205-494-3141-66-2 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 015-074-00-X crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate 206-083-1299-86-5 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 015-075-00-5S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate—2635-50-9 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 015-076-00-0 potasan; O, O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate —299-45-6 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 M = 1000015-077-00-62,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate—7076-53-1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 015-078-00-1 demeton-S-methylsulphon(ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate 241-109-517040-19-6 Acute Tox. 3 Acute Tox. 4 Aquatic Chronic 2 H301 H312 H411 GHS06 GHS09 Dgr H301 H312 H411 015-079-00-7 acephate (ISO); O, S-dimethyl acetylphosphoramidothioate 250-241-230560-19-1Acute Tox. 4 H302 GHS07 Wng H302015-080-00-2 amidithion (ISO); 2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate —919-76-6Acute Tox. 4 H302 GHS07 Wng H302015-081-00-8O,O,O',O'-tetrapropyl dithiopyrophosphate221-817-03244-90-4

Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 015-082-00-3 azothoate (ISO); O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate 227-419-35834-96-8 Acute Tox. 4 Acute Tox. 4 H332 H302 GHS07 Wng H332 H302 015-083-00-9 bensulide (ISO); O, O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate 212-010-4741-58-2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 015-084-00-4 chlorpyrifos (ISO); O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 220-864-42921-88-2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H400 H410 M = 10000015-085-00-X chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride 204-105-4115-78-6 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H301 H312 H319 H315 GHS06 Dgr H301 H312 H319 H315 015-086-00-5 coumithoate (ISO); O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate —572-48-5Acute Tox. 3 H301 GHS06 Dgr H301015-087-00-0 cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate 220-130-32636-26-2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 015-088-00-6 dialifos (ISO); 2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate 233-689-310311-84-9 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H400 H410 015-089-00-1ethoate-methyl (ISO); ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate204-121-1116-01-8 Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 015-090-00-7 fensulfothion (ISO); O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate 204-114-3115-90-2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 015-091-00-2 fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate 213-408-0944-22-9 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 015-092-00-8 phosacetim (ISO); O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate 223-874-74104-14-7 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 015-093-00-3 leptophos (ISO); O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate 244-472-821609-90-5 Acute Tox. 3 STOT SE 1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H370 H312 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H370 H312 H410 015-094-00-9 mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate 213-447-3950-10-7 Acute Tox. 1 Acute Tox. 2 Aquatic Chronic 2 H310 H300 H411 GHS06 GHS09 Dgr H310 H300 H411 015-095-00-4 methamidophos (ISO); O,S-dimethyl phosphoramidothioate 233-606-010265-92-6 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 H330 H300 H311 H400 GHS06 GHS09 Dgr H330 H300 H311 H400 015-096-00-X oxydisulfoton (ISO); O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate

219-679-12497-07-6 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 M = 10015-097-00-5 phenthoate (ISO); ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate 219-997-02597-03-7 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 M = 100 015-098-00-0 trichloronate (ISO); O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate 206-326-1327-98-0 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 015-099-00-6 pirimiphos-ethyl (ISO); O, O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate 245-704-023505-41-1 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H400 H410 GHS06 GHS09 Dgr H301 H312 H410 015-100-00-X phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-314816-18-3 Repr. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H302 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361f H302 H317 H410 M=1000015-101-00-5 phosmet (ISO); O, O-dimethyl phthalimidomethyl S-phosphorodithioate 211-987-4732-11-6 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 M = 100015-102-00-0tris(2-chloroethyl)phosphate204-118-5115-96-8 Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2 H351 H360F H302 H411 GHS08 GHS07 GHS09 Dgr H351 H360F H302 H411 015-103-00-6phosphorus tribromide232-178-27789-60-8 Skin Corr. 1B STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 EUH014 015-104-00-1 diphosphorus pentasulphide; phosphorus pentasulphide 215-242-41314-80-3 Flam. Sol. 1 Water-react. 1 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H228 H260 H332 H302 H400 GHS02 GHS07 GHS09 Dgr H228 H260 H332 H302 H400 EUH029T015-105-00-7triphenyl phosphite202-908-4101-02-0 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 %015-106-00-2hexamethylphosphoric triamide; hexamethylphosphoramide211-653-8680-31-9 Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 Carc. 1B; H350: C ≥ 0,01 % 015-107-00-8 ethoprophos (ISO); ethyl-S,S-dipropyl phosphorodithioate 236-152-113194-48-4 Acute Tox. 2 Acute Tox. 1 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H301 H317 H400 H410 GHS06 GHS09 Dgr H330 H310 H301 H317 H410 015-108-00-3 bromophos (ISO); O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate 218-277-32104-96-3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M = 100015-109-00-9 crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate 231-720-57700-17-6 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 M = 10 015-110-00-4 cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate —13067-93-1 Acute Tox. 3 STOT SE 1 Acute Tox. 4 Eye Irrit. 2

Aquatic Chronic 2 H301 H370 H312 H319 H411 GHS06 GHS08 GHS09 Dgr H301 H370 H312 H319 H411 015-111-00-X phosfolan (ISO); diethyl 1,3-dithiolan-2-ylidenephosphoramidate 213-423-2947-02-4 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-112-00-5 thionazin (ISO); O,O-diethyl O-pyrazin-2-yl phosphorothioate; 206-049-6297-97-2 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-113-00-0 tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate 260-515-357018-04-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 015-114-00-6 chlormephos (ISO); S-chloromethyl O,O-diethyl phosphorodithioate 246-538-124934-91-6 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 M = 10015-115-00-1 chlorthiophos (ISO); [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O, O-diethyl phosphorothioate predominates] 244-663-621923-23-9 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 M = 1000015-116-00-7 demephion-O (ISO); O, O-dimethyl O-2-methylthioethyl phosphorothioate 211-666-9682-80-4 Acute Tox. 2 Acute Tox. 3 H300 H311 GHS06 Dgr H300 H311 015-117-00-2 demephion-S (ISO); O, O-dimethyl S-2-methylthioethyl phosphorothioate 219-971-92587-90-8 Acute Tox. 2 Acute Tox. 3 H300 H311 GHS06 Dgr H300 H311 015-118-00-8demeton—8065-48-3 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 H310 H300 H400 GHS06 GHS09 Dgr H310 H300 H400 015-119-00-3dimethyl 4-(methylthio)phenyl phosphate—3254-63-5 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-120-00-9 ditalimfos (ISO); O, O-diethyl phthalimidophosphonothioate 225-875-85131-24-8 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 015-121-00-4 edifenphos (ISO); O-ethyl S, S-diphenyl phosphorodithioate 241-178-117109-49-8 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H312 H317 H400 H410 GHS06 GHS09 Dgr H331 H301 H312 H317 H410 015-122-00-X etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidin-4-yl O, O-dimethylphosphorothioate 253-855-938260-54-7 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M = 10015-123-00-5 fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-122224-92-6 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H300 H310 H330 H319 H400 H410 GHS06 GHS09 Dgr H300 H310 H330 H319 H410 M = 100 M = 100 015-124-00-0 fosthietan (ISO); diethyl 1,3-dithietan-2-ylidenephosphoramidate 244-437-721548-32-3 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 015-125-00-6 glyphosine (ISO); N,N-bis(phosphonomethyl)glycine 219-468-42439-99-8Eye Dam. 1H318 GHS05 Dgr H318015-126-00-1 heptenophos (ISO); 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate 245-737-023560-59-0 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301

H410 M = 100015-127-00-7 iprobenfos(ISO); S-benzyl diisopropyl phosphorothioate 247-449-026087-47-8 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 015-128-00-2 IPSP; S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate —5827-05-4 Acute Tox. 1 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H310 H301 H400 H410 GHS06 GHS09 Dgr H310 H301 H410 M = 100015-129-00-8 isofenphos (ISO); O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate 246-814-125311-71-1 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 M = 100015-130-00-3 isothioate (ISO); S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; —36614-38-7 Acute Tox. 3 Acute Tox. 3 H311 H301 GHS06 Dgr H311 H301 015-131-00-9 isoxathion (ISO); O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate 242-624-818854-01-8 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 015-132-00-4S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione—953-17-3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 M = 1000 015-133-00-X piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O, O-dipropyl phosphorodithioate —24151-93-7 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M = 10015-134-00-5 pirimiphos-methyl (ISO); O-(2-diethylamino-6-methylpyrimidin-4-yl) O, O-dimethyl phosphorothioate 249-528-529232-93-7 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 015-135-00-0profenofos (ISO)O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;255-255-241198-08-7 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 M = 1000015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO) 250-517-231218-83-4 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H410 M = 100015-137-00-1 pyrazophos (ISO); O, O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate 236-656-113457-18-6 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H400 H410 GHS07 GHS09 Wng H332 H302 H410 015-138-00-7 quinalphos (ISO); O, O-diethyl-O-quinoxalin-2-yl phosphorothioate 237-031-613593-03-8 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H400 H410 GHS06 GHS09 Dgr H301 H312 H410 M = 1000 015-139-00-2 terbufos (ISO); S-tert-butylthiomethyl O, O-diethylphosphorodithioate; 235-963-813071-79-9 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 M = 1000015-140-00-8 triazophos (ISO); O, O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate 245-986-524017-47-8 Acute Tox. 3 Acute Tox. 3

Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H312 H400 H410 GHS06 GHS09 Dgr H331 H301 H312 H410 M=100015-141-00-3ethylenediammonium O, O-bis(octyl) phosphorodithioate, mixed isomers400-520-1— Skin Corr. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H314 H302 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H302 H410 015-142-00-9butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate401-100-0— Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 H225 H319 H411 GHS02 GHS07 GHS09 Dgr H225 H319 H411 T015-143-00-4reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers401-740-0—Acute Tox. 4 H302 GHS07 Wng H302015-144-00-Xreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate402-090-087025-52-3Skin Corr. 1BH314 GHS05 Dgr H314015-145-00-5reaction mass of copper(I) O, O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O, O-bis(4-methylpent-2-yl) phosphorodithioate401-520-4— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 015-146-00-0S-(tricyclo(5.2.1.0 2,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate401-850-9— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410015-147-00-6reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)400-930-0— Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H315 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H411 015-148-00-12-(diphosphonomethyl)succinic acid403-070-451395-42-7 Skin Corr. 1B Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317 015-149-00-7reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide403-470-9— Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 015-150-00-2(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide404-940-686608-70-0 Acute Tox. 4 Eye Dam. 1 STOT RE 2 Aquatic Chronic 3 H302 H318 H373 H412 GHS08 GHS05 GHS07 Dgr H302 H318 H373 H412 015-151-00-8tris(isopropyl/tert-butylphenyl)phosphate405-010-2—Aquatic Chronic 2H411GHS09H411015-152-00-3 dioxabenzofos (ISO); 2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide 223-292-33811-49-2 Acute Tox. 3 Acute Tox. 3 STOT SE 1 Aquatic Chronic 2 H311 H301 H370 H411 GHS06 GHS08 GHS09 Dgr H311 H301 H370 H411 015-153-00-9 isazofos (ISO); O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O, O-diethyl phosphorothioate 255-863-842509-80-8 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H311 H301 H373 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H311 H301 H373 H317 H410 015-154-00-4 ethephon; 2-chloroethylphosphonic acid 240-718-316672-87-0 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 H311 H332 H302 H314 H411 GHS06 GHS05 GHS09 Dgr

H311 H332 H302 H314 H411 EUH071015-155-00-Xglufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate278-636-577182-82-2 Repr. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 H360Fd H332 H312 H302 H373 GHS08 GHS07 Dgr H360Fd H332 H312 H302 H373 015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] 250-366-9 [1]-[2] 30864-28-9 [1] 62610-77-9 [2] Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 015-157-00-0 phosphonic acid; [1] phosphorous acid [2] 237-066-7 [1] 233-663-1 [2] 13598-36-2 [1] 10294-56-1 [2] Acute Tox. 4 Skin Corr. 1A H302 H314 GHS05 GHS07 Dgr H302 H314 015-158-00-6(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)402-340-932760-80-8Aquatic Chronic 3H412—H412015-159-00-1hydroxyphosphonoacetic acid405-710-823783-26-8 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 H302 H373 H314 H317 GHS08 GHS05 GHS07 Dgr H302 H373 H314 H317 015-160-00-7vanadyl pyrophosphate406-260-558834-75-6 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H317 H412 GHS07 Wng H319 H317 H412 015-161-00-2divanadyl pyrophosphate407-130-065232-89-5 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 015-162-00-8vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped407-350-7— Acute Tox. 4 STOT RE 2 Eye Dam. 1 Aquatic Chronic 2 H332 H373 H318 H411 GHS08 GHS05 GHS07 GHS09 Dgr H332 H373 H318 H411 015-163-00-3bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide412-010-6145052-34-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 015-164-00-9calcium P, P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate400-480-536669-85-9Aquatic Chronic 3H412—H412015-165-00-4reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate404-986-7— Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 015-166-00-X3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane410-290-480693-00-1Aquatic Chronic 4H413—H413015-167-00-53-(hydroxyphenylphosphinyl)propanoic acid411-200-614657-64-8Eye Dam. 1H318 GHS05 Dgr H318015-168-00-0 fosthiazate (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate —98886-44-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H312 H317 H400 H410 GHS06 GHS09 Dgr H331 H301 H312 H317 H410 EUH070015-169-00-6tributyltetradecylphosphonium tetrafluoroborate413-520-1— Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H314 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H302 H373 H314 H317 H410 015-170-00-1reaction mass of: di-(1-octane-N, N,N-trimethylammonium) octylphosphate; 1-octane-N, N,N-trimethylammonium di-octylphosphate; 1-octane-N, N,N-trimethylammonium octylphosphate407-490-9—

Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 015-171-00-7O, O,O-tris(2(or 4)-C 9-10-isoalkylphenyl) phosphorothioate406-940-1—Aquatic Chronic 2H411GHS09H411015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate 406-240-6— Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 H226 H314 H411 GHS02 GHS05 GHS09 Dgr H226 H314 H411 015-173-00-8methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate414-080-3117291-73-3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 015-174-00-31-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine411-370-182857-68-9 Acute Tox. 3 Eye Dam. 1 Aquatic Chronic 2 H301 H318 H411 GHS06 GHS05 GHS09 Dgr H301 H318 H411 015-175-00-9tert-butyl (triphenylphosphoranylidene) acetate412-880-735000-38-5 Acute Tox. 3 STOT RE 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H301 H373 H319 H317 H411 GHS06 GHS08 GHS09 Dgr H301 H373 H319 H317 H411 015-176-00-4P, P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine413-430-2116163-96-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410015-177-00-X((4-phenylbutyl)hydroxyphosphoryl)acetic acid412-170-783623-61-4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H373 H318 H317 GHS08 GHS05 Dgr H373 H318 H317 015-178-00-5(R)-α-phenylethylammonium(-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate418-570-825383-07-7 Repr. 2 Aquatic Chronic 2 H361f H411 GHS08 GHS09 Wng H361f H411015-179-00-0UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine422-720-8166242-53-1 Carc. 2 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H373 H314 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H351 H302 H373 H314 H317 H410 015-180-00-6[R-(R,S)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt415-820-8137590-32-0 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 015-181-00-1phosphine232-260-87803-51-2 Flam. Gas 1 Press. Gas Acute Tox. 2 Skin Corr. 1B Aquatic Acute 1 H220 H330 H314 H400 GHS02 GHS04 GHS06 GHS05 GHS09 Dgr H220 H330 H314 H400 U015-182-00-7tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)430-630-510596-22-2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H302 H319 H317 GHS07 Wng H302 H319 H317 015-183-00-2(1-hydroxydodecylidene)diphosphonic acid425-230-216610-63-2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 015-184-00-8salts of glyphosate, with the exception of those specified elsewhere in this Annex——Aquatic Chronic 2H411GHS09H411A015-186-00-9chlorpyrifos-methyl (ISO) O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate227-011-55598-13-0 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317

H400 H410 GHS07 GHS09 Wng H317 H410 M = 10000015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide; trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide 417-540-1— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 015-189-00-5phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide423-340-5162881-26-7 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 015-190-00-0 bis(2,4-dicumylphenyl)neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 421-920-2154862-43-8Aquatic Chronic 4H413—H413015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412 015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3Skin Sens. 1H317 GHS07 Wng H317015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3 Acute Tox. 3 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H318 H400 H410 GHS05 GHS06 GHS09 Dgr H301 H318 H410 015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 015-195-00-8 reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate 433-860-4— Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H317 H412 GHS07 Wng H319 H317 H412 015-196-00-3 reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate 435-960-3— Carc. 1B Muta. 1B Skin Sens. 1 H350 H340 H317 GHS08 GHS07 Dgr H350 H340 H317 015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H226 H331 H302 H314 H411 GHS02 GHS06 GHS05 GHS09 Dgr H226 H331 H302 H314 H411 015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1 Carc. 2 Eye Dam. 1 H351 H318 GHS05 GHS08 Dgr H351 H318 015-199-00-Xtris[2-chloro-1-chloromethyl)ethyl] phosphate237-159-213674-87-8Carc. 2H351 GSH08 Wng H351015-200-00-3indium phosphide244-959-522398-80-7 Carc. 1B Repr. 2 STOT RE 1 H350 H361f H372 (lungs) GHS08 Dgr H350 H361f H372 (lungs) STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % 015-201-00-9trixylyl phosphate246-677-825155-23-1Repr. 1BH360F GHS08 Dgr H360F015-202-00-4tris(nonylphenyl) phosphite247-759-626523-78-4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 015-203-00-Xdiphenyl(2,4,6-trimethylbenzoyl)phosphine oxide278-355-875980-60-8Repr. 2H361f (causing atrophy of the testes) GHS08 Wng H361f (causing atrophy of the testes) 016-001-00-4hydrogen sulphide231-977-37783-06-4 Flam. Gas 1 Press. Gas Acute Tox. 2 Aquatic Acute 1 H220 H330 H400 GHS02 GHS04

GHS06 GHS09 Dgr H220 H330 H400 U016-002-00-Xbarium sulphide244-214-421109-95-5 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H332 H302 H400 GHS07 GHS09 Wng H332 H302 H400 EUH031016-003-00-5barium polysulphides256-814-350864-67-0 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H319 H335 H315 H400 GHS07 GHS09 Wng H319 H335 H315 H400 EUH031016-004-00-0calcium sulphide243-873-520548-54-3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H319 H335 H315 H400 GHS07 GHS09 Wng H319 H335 H315 H400 EUH031016-005-00-6calcium polysulphides215-709-21344-81-6 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H319 H335 H315 H400 GHS07 GHS09 Wng H319 H335 H315 H400 EUH031016-006-00-1 dipotassium sulphide; potassium sulphide 215-197-01312-73-8 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 EUH031016-007-00-7potassium polysulphides253-390-137199-66-9 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 EUH031 016-008-00-2ammonium polysulphides232-989-19080-17-5 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 EUH031EUH031: C ≥1 %016-009-00-8 disodium sulfide; sodium sulfide 215-211-51313-82-2 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 H311 H302 H314 H400 GHS06 GHS05 GHS09 Dgr H311 H302 H314 H400 016-010-00-3sodium polysulphides215-686-91344-08-7 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 H301 H314 H400 GHS06 GHS05 GHS09 Dgr H301 H314 H400 EUH031016-011-00-9sulphur dioxide231-195-27446-09-5 Press. Gas Acute Tox. 3 Skin Corr. 1B H331 H314 GHS04 GHS06 GHS05 Dgr H331 H314 U5016-012-00-4 disulphur dichloride; sulfur monochloride 233-036-210025-67-9 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Aquatic Acute 1 H301 H332 H314 H400 GHS06 GHS05 GHS09 Dgr H301 H332 H314 H400 EUH014 EUH029 STOT SE 3; H335: C ≥ 1 %016-013-00-Xsulphur dichloride234-129-010545-99-0 Skin Corr. 1B STOT SE 3 Aquatic Acute 1 H314 H335 H400 GHS05 GHS07 GHS09 Dgr H314 H335 H400 EUH014STOT SE 3; H335: C ≥ 5 %016-014-00-5sulphur tetrachloride—13451-08-6 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 EUH014STOT SE 3; H335: C ≥ 5 % 016-015-00-0 thionyl dichloride; thionyl chloride 231-748-87719-09-7 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H332 H302 H314 GHS05 GHS07 Dgr H332 H302 H314 EUH014 EUH029 STOT SE 3; H335: C ≥ 1 %016-016-00-6sulphuryl chloride232-245-67791-25-5 Skin Corr. 1B STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 EUH014016-017-00-1chlorosulphonic acid232-234-67790-94-5 Skin Corr. 1A STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 EUH014016-018-00-7fluorosulphonic acid232-149-47789-21-1 Acute Tox. 4 Skin Corr. 1A H332 H314 GHS05 GHS07 Dgr H332 H314 016-019-00-2oleum … % SO3—— Skin Corr. 1A STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 EUH014B016-020-00-8sulphuric acid … %231-639-57664-93-9Skin Corr. 1AH314 GHS05 Dgr H314 Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % B016-021-00-3 methanethiol; methyl mercaptan 200-822-174-93-1 Flam. Gas. 1 Press. Gas

Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H220 H331 H400 H410 GHS02 GHS04 GHS06 GHS09 Dgr H220 H331 H410 U 016-022-00-9 ethanethiol; ethyl mercaptan 200-837-375-08-1 Flam. Liq. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H225 H332 H400 H410 GHS02 GHS07 GHS09 Dgr H225 H332 H410 016-023-00-4dimethyl sulphate201-058-177-78-1 Carc. 1B Muta. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 H350 H341 H330 H301 H314 H317 GHS06 GHS08 GHS05 Dgr H350 H341 H330 H301 H314 H317 Carc. 1B; H350: C ≥ 0,01 % Muta. 2 H341: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 %016-024-00-Xdimexano(ISO); bis(methoxythiocarbonyl) disulphide215-993-81468-37-7 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 016-025-00-5 disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES 205-259-5149-26-8 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 H302 H315 H318 GHS05 GHS07 Dgr H302 H315 H318 016-026-00-0 sulphamidic acid; sulphamic acid; sulfamic acid 226-218-85329-14-6 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 H319 H315 H412 GHS07 Wng H319 H315 H412 016-027-00-6diethyl sulphate200-589-664-67-5 Carc. 1B Muta. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H350 H340 H332 H312 H302 H314 GHS05 GHS08 GHS07 Dgr H350 H340 H332 H312 H302 H314 016-028-00-1 sodium dithionite; sodium hydrosulphite 231-890-07775-14-6 Self-heat. 1 Acute Tox. 4 H251 H302 GHS02 GHS07 Dgr H251 H302 EUH031016-029-00-7p-toluenesulphonic acid, (containing more than 5 % H2SO4)——Skin Corr. 1BH314 GHS05 Dgr H314 Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % 016-030-00-2p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)203-180-0104-15-4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 STOT SE 3; H335: C ≥ 20 %016-031-00-8tetrahydrothiophene-1,1-dioxide; sulpholane204-783-1126-33-0Acute Tox. 4 H302 GHS07 Wng H302016-032-00-3 1,3-propanesultone; 1,2-oxathiolane 2,2-dioxide 214-317-91120-71-4 Carc. 1B Acute Tox. 4 Acute Tox. 4 H350 H312 H302 GHS08 GHS07 Dgr H350 H312 H302 Carc. 1B; H350: C ≥ 0,01 %016-033-00-9dimethylsulfamoylchloride236-412-413360-57-1 Carc. 1B Acute Tox. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H350 H330 H312 H302 H314 GHS06 GHS05 GHS08 Dgr H350 H330 H312 H302 H314 016-034-00-4tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)400-010-981898-60-4Skin Sens. 1H317 GHS07 Wng H317016-035-00-Xpentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate400-120-7—Eye Irrit. 2H319 GHS07 Wng H319 016-036-00-5tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate400-130-1— Resp. Sens. 1 Aquatic Chronic 2 H334 H411 GHS08 GHS09 Dgr H334 H411 016-037-00-0disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate400-350-885153-93-1

Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 016-038-00-6disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate400-380-186393-35-3Skin Sens. 1H317 GHS07 Wng H317016-039-00-1tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate400-430-2—Skin Sens. 1H317 GHS07 Wng H317016-040-00-7reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate400-570-4—Eye Irrit. 2H319 GHS07 Wng H319016-041-00-2calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate400-710-4—Acute Tox. 4 H332 GHS07 Wng H332016-042-00-8tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate400-790-085665-97-0 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 016-043-00-3dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl) phenylazo)naphthalene-2-sulphonate401-010-1—Skin Sens. 1H317 GHS07 Wng H317016-044-00-9disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate401-320-7— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 016-045-00-4lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate401-560-2108624-00-6Skin Sens. 1H317 GHS07 Wng H317016-046-00-Xsodium hydrogensulphate231-665-77681-38-1Eye Dam. 1H318 GHS05 Dgr H318016-047-00-5hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5-trisulphonate401-650-185665-96-9Skin Sens. 1H317 GHS07 Wng H317016-048-00-0sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate401-870-8— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 016-049-00-6calcium octadecylxylenesulphonate402-040-8— Skin Corr. 1B Aquatic Chronic 2 H314 H411 GHS05 GHS09 Dgr H314 H411 016-050-00-1potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat402-150-6— Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 016-051-00-7trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulphonate402-170-5106359-91-5Skin Sens. 1H317

GHS07 Wng H317016-052-00-2benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate402-240-5102561-46-6 Acute Tox. 4 Aquatic Chronic 2 H332 H411 GHS07 GHS09 Wng H332 H411 016-053-00-8(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate402-460-1— Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413 016-054-00-3sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate400-030-8— Acute Tox. 3 STOT RE 1 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Sens. 1 H331 H372 H302 H319 H335 H317 GHS06 GHS08 Dgr H331 H372 H302 H319 H335 H317 016-055-00-9tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)400-510-7— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 016-056-00-4potassium hydrogensulphate231-594-17646-93-7 Skin Corr. 1B STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 016-057-00-Xstyrene-4-sulfonyl chloride404-770-22633-67-2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H315 H318 H317 GHS05 GHS07 Dgr H315 H318 H317 016-058-00-5thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol andC 12-14-tert-alkylamine404-820-3— Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H315 H317 H412 GHS07 Wng H315 H317 H412 016-059-00-0N, N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride405-300-917339-60-5 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H317 H400 H410 GHS07 GHS09 Wng H302 H319 H317 H410 016-060-00-6diammonium peroxodisulphate; ammonium persulphate231-786-57727-54-0 Ox. Sol. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 H272 H302 H319 H335 H315 H334 H317 GHS03 GHS08 GHS07 Dgr H272 H302 H319 H335 H315 H334 H317 016-061-00-1dipotassium peroxodisulphate; potassium persulphate231-781-87727-21-1 Ox. Sol. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 H272 H302 H319 H335 H315 H334 H317 GHS03 GHS08 GHS07 Dgr H272 H302 H319 H335 H315 H334 H317 016-062-00-7 bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane —17606-31-4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 016-063-00-2sodium metabisulphite231-673-07681-57-4 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 EUH031016-064-00-8 sodium hydrogensulphite … %; sodium bisulphite . . . % 231-548-07631-90-5Acute Tox. 4 H302 GHS07 Wng H302EUH031B016-065-00-3sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate400-100-884057-97-6Aquatic Chronic 2H411GHS09H411016-066-00-9tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2-sulfonatobenzylidenehydrazino)benzoate]copper(II)404-070-7116912-62-0Aquatic Chronic 3H412—H412016-067-00-4(4-methylphenyl)mesitylene sulfonate407-530-567811-06-7Aquatic Chronic 4H413—H413016-068-00-Xsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate407-720-8155160-86-4

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 016-069-00-53,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid407-990-7141915-64-2 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 016-070-00-04-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone408-220-2—Aquatic Chronic 4H413—H413 016-071-00-6trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate410-130-3136248-03-8Skin Sens. 1H317 GHS07 Wng H317016-072-00-13-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide411-520-6112195-27-4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 016-073-00-7tetrakis(phenylmethyl)thioperoxydi(carbothioamide)404-310-010591-85-2Aquatic Chronic 4H413—H413016-074-00-26-fluoro-2-methyl-3-(4-methylthiobenzyl)indene405-410-7— Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H315 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H411 016-075-00-82,2'-diallyl-4,4'-sulfonyldiphenol411-570-941481-66-7 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 016-076-00-32,3-bis((2-mercaptoethyl)thio)-1-propanethiol411-290-7131538-00-6 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H410 016-077-00-92-chloro-p-toluenesulfochloride412-890-142413-03-6 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H314 H317 H412 GHS05 GHS07 Dgr H314 H317 H412 016-078-00-44-methyl-N, N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide413-300-556187-04-3Aquatic Chronic 4H413—016-079-00-XN, N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide412-920-316695-22-0 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 016-080-00-5sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate412-320-131361-99-6 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 016-081-00-0hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide418-350-1— Muta. 2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H341 H302 H319 H317 H411 GHS08 GHS07 GHS09 Wng H341 H302 H319 H317 H411 016-082-00-6 ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea —126801-58-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410016-083-00-1acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester420-050-0135158-54-2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H317 H400 H410 GHS07 GHS09 Wng H319 H335 H315 H317 H410 016-084-00-7 prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea —94125-34-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=100 016-085-00-2 flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea —104040-78-0 Aquatic Acute 1 Aquatic Chronic 1

H400 H410 GHS09 Wng H410016-086-00-8tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate402-590-9109125-56-6Eye Dam. 1H318 GHS05 Dgr H318016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate 403-490-8104558-95-4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H319 H317 H400 H410 GHS07 GHS09 Wng H319 H317 H410 016-088-00-94-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid407-280-771297-11-5Aquatic Chronic 3H412—H412016-089-00-4reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene413-840-1— Self-react. C Aquatic Chronic 4 H242 H413 GHS02 Dgr H242 H413 016-090-00-X4-methyl-N-(methylsulfonyl)benzenesulfonamide415-040-814653-91-9 Acute Tox. 4 STOT SE 3 Eye Dam. 1 H302 H335 H318 GHS05 GHS07 Dgr H302 H335 H318 016-091-00-5C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate414-110-5— Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 016-092-00-0 reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol 427-050-1— Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361f H315 H317 H410 016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) 414-770-4140698-96-0 Self-react. C Carc. 2 H242 H351 GHS02 GHS08 Dgr H242 H351 016-094-00-1sulfur231-722-67704-34-9Skin Irrit. 2H315 GHS07 Wng H315016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) 417-980-4— Self-react. C Carc. 2 H242 H351 GHS02 GHS08 Dgr H242 H351 016-096-00-2 thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate —79277-27-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H302 H314 H317 H412 GHS05 GHS07 Dgr H302 H314 H317 H412 017-001-00-7chlorine231-959-57782-50-5 Ox. Gas 1 Press. Gas Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H270 H331 H319 H335 H315 H400 GHS03 GHS04 GHS06

GHS09 Dgr H270 H331 H319 H335 H315 H400 M = 100U017-002-00-2hydrogen chloride231-595-77647-01-0 Press. Gas Acute Tox. 3 Skin Corr. 1A H331 H314 GHS04 GHS06 GHS05 Dgr H331 H314 U5017-002-01-Xhydrochloric acid … %231-595-7— Skin Corr. 1B STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % EyeIrrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % B017-003-00-8barium chlorate236-760-713477-00-4 Ox. Sol. 1 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H271 H332 H302 H411 GHS03 GHS07 GHS09 Dgr H271 H332 H302 H411 017-004-00-3potassium chlorate223-289-73811-04-9 Ox. Sol. 1 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H271 H332 H302 H411 GHS03 GHS07 GHS09 Dgr H271 H332 H302 H411 017-005-00-9sodium chlorate231-887-47775-09-9 Ox. Sol. 1 Acute Tox. 4 Aquatic Chronic 2 H271 H302 H411 GHS03 GHS07 GHS09 Dgr H271 H302 H411 017-006-00-4perchloric acid … %231-512-47601-90-3 Ox. Liq. 1 Skin Corr. 1A H271 H314 GHS03 GHS05 Dgr H271 H314 Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % Skin Irrit. 2; H315: 1 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 10 % Ox. Liq. 1; H271: C > 50 %: Ox. Liq. 2; H272: C ≤ 50 %: B017-007-00-Xbarium perchlorate236-710-413465-95-7 Ox. Sol. 1 Acute Tox. 4 Acute Tox. 4 H271 H332 H302 GHS03 GHS07 Dgr H271 H332 H302 017-008-00-5potassium perchlorate231-912-97778-74-7 Ox. Sol. 1 Acute Tox. 4 H271 H302 GHS03 GHS07 Dgr H271 H302 017-009-00-0ammonium perchlorate232-235-17790-98-9 Expl. 1.1 Ox. Sol. 1 H201 H271 GHS01 Dgr H201 H271 T017-010-00-6sodium perchlorate231-511-97601-89-0 Ox. Sol. 1 Acute Tox. 4 H271 H302 GHS03 GHS07 Dgr H271 H302 017-011-00-1sodium hypochlorite, solution… % Cl active231-668-37681-52-9 Skin Corr. 1B Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 EUH031EUH031: C ≥5 %B 017-012-00-7calcium hypochlorite231-908-77778-54-3 Ox. Sol. 2 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 H272 H302 H314 H400 GHS03 GHS05 GHS07 GHS09 Dgr H272 H302 H314 H400 EUH031 Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3 % M = 10 T017-013-00-2calcium chloride233-140-810043-52-4Eye Irrit. 2H319 GHS07 Wng H319017-014-00-8ammonium chloride235-186-412125-02-9 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 017-015-00-3(2-(aminomethyl)phenyl)acetylchloride hydrochloride417-410-461807-67-8 Acute Tox. 4 Skin Corr. 1A Skin Sens. 1 H302 H314 H317 GHS05 GHS07 Dgr H302 H314 H317 017-016-00-9methyltriphenylphosphonium chloride418-400-21031-15-8 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H312 H302 H315 H318 H411 GHS05 GHS07 GHS09 Dgr H312 H302 H315 H318 H411 017-017-00-4(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride426-210-6120086-58-0 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 017-018-00-XN, N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride405-660-7—Aquatic Chronic 2H411GHS09H411 017-019-00-5(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride415-110-854417-53-7

Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 017-020-00-0ethyl propoxy aluminium chloride421-790-713014-29-4 Water-react. 1 Skin Corr. 1A H260 H314 GHS02 GHS05 Dgr H260 H314 EUH014017-021-00-6behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride423-420-1136920-10-0 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410 017-023-00-7[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N, N-dimethyl-N-(C6-18)-alkyl] trichlorides425-520-9197179-61-6 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 017-026-00-3chlorine dioxide233-162-810049-04-4 Press. Gas Ox. Gas 1 Acute Tox. 2 Skin Corr. 1B Aquatic Acute 1 H270 H330 H314 H400 GHS04 GHS03 GHS06 GHS05 GHS09 Dgr H270 H330 H314 H400 M = 105017-026-01-0chlorine dioxide … %233-162-810049-04-4 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 H301 H314 H400 GHS06 GHS05 GHS09 Dgr H301 H314 H400 Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3 % STOT SE 3; H335: C ≥ 3 % M = 10 B 019-001-00-2potassium231-119-87440-09-7 Water-react. 1 Skin Corr. 1B H260 H314 GHS02 GHS05 Dgr H260 H314 EUH014019-002-00-8 potassium hydroxide; caustic potash 215-181-31310-58-3 Acute Tox. 4 Skin Corr. 1A H302 H314 GHS05 GHS07 Dgr H302 H314 Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 020-001-00-Xcalcium231-179-57440-70-2Water-react. 2H261 GHS02 Dgr H261020-002-00-5calcium cyanide209-740-0592-01-8 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H300 H400 H410 GHS06 GHS09 Dgr H300 H410 EUH032020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] 420-470-4— Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 022-001-00-5titanium tetrachloride231-441-97550-45-0Skin Corr. 1BH314 GHS05 Dgr H314EUH014022-002-00-0titanium(4+) oxalate403-260-7—Eye Dam. 1H318 GHS05 Dgr H318 022-003-00-6bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium412-000-1125051-32-3 Flam. Sol. 1 Repr. 2 STOT RE 2 Aquatic Chronic 2 H228 H361f H373 H411 GHS02 GHS08 GHS09 Dgr H228 H361f H373 H411 T022-004-00-1Potassium titanium oxide(K2Ti6O13)432-240-012056-51-8Carc. 2H351 GHS08 Wng H351022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6 Flam. Sol. 1 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 H228 H314 H317 H413 GHS02 GHS05 GHS07 Dgr H228 H314 H317 H413 023-001-00-8 divanadium pentaoxide; vanadium pentoxide 215-239-81314-62-1 Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 Acute Tox. 4 STOT SE 3

Aquatic Chronic 2 H341 H361d H372 H332 H302 H335 H411 GHS08 GHS07 GHS09 Dgr H341 H361d H372 H332 H302 H335 H411 024-001-00-0chromium (VI) trioxide215-607-81333-82-0 Ox. Sol. 1 Carc. 1A Muta. 1B Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H271 H350 H340 H361f H330 H311 H301 H372 H314 H334 H317 H400 H410 GHS03 GHS06 GHS08 GHS05 GHS09 Dgr H271 H350 H340 H361f H330 H311 H301 H372 H314 H334 H317 H410 STOT SE 3; H335: C ≥ 1 % 024-002-00-6potassium dichromate231-906-67778-50-9 Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H272 H350 H340 H360FD H330 H301 H372 H312 H314 H334 H317 H400 H410 GHS03 GHS06 GHS08 GHS05 GHS09 Dgr H272 H350 H340 H360FD H330 H301 H372 H312 H314 H334 H317 H410 STOT SE 3; H335: C ≥ 5 %3024-003-00-1ammonium dichromate232-143-17789-09-5 Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H272 H350 H340 H360FD H330 H301 H372 H312 H314 H334 H317 H400 H410 GHS03 GHS06 GHS08 GHS05 GHS09 Dgr H272 H350 H340 H360FD H330 H301 H372 H312 H314 H334 H317 H410 STOT SE 3; H335: C ≥ 5 % Resp. Sens.; H334: C ≥0,2 % Skin Sens.; H317:C ≥0,2 % G3 024-004-00-7sodium dichromate234-190-310588-01-9 Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H272 H350 H340 H360FD H330 H301 H312 H372 H314 H334 H317 H400 H410 GHS03 GHS06 GHS05 GHS08 GHS09 Dgr H272 H350 H340 H360FD H330 H301 H312 H372 H314 H334 H317 H410 Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317:C ≥0,2 % STOT SE 3; H335: C ≥ 5 % 3024-005-00-2 chromyl dichloride; chromic oxychloride 239-056-814977-61-8 Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H271 H350i H340 H314 H317 H400 H410 GHS03 GHS08 GHS05 GHS07 GHS09 Dgr H271 H350i H340 H314 H317 H410 Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: 0,5 % ≤ C < 5 % Skin Sens. 1; H317: C ≥ 0,5 % T3 024-006-00-8potassium chromate232-140-57789-00-6 Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H340 H319 H335 H315 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H340 H319 H335 H315 H317 H410 Skin Sens. 1; H317:C ≥ 0,5 %3024-007-00-3zinc chromates including zinc potassium chromate—— Carc. 1A Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H317 H410 A024-008-00-9calcium chromate237-366-813765-19-0 Carc. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 024-009-00-4strontium chromate232-142-67789-06-2

Carc. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H400 H410 024-010-00-X dichromium tris(chromate); chromium III chromate; chromic chromate 246-356-224613-89-6 Ox. Sol. 1 Carc. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H271 H350 H314 H317 H400 H410 GHS03 GHS08 GHS05 GHS07 GHS09 Dgr H271 H350 H314 H317 H410 T 024-011-00-5ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)400-110-2109125-51-1 Self-react. C Aquatic Acute 1 Aquatic Chronic 1 H242 H400 H410 GHS02 GHS09 Dgr H242 H410 024-012-00-0trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)400-810-8—Muta. 2H341 GHS08 Wng H341024-013-00-6trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)402-500-8— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 024-014-00-1trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)402-870-093952-24-0 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 024-015-00-7disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)404-930-1— Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H332 H318 H411 GHS05 GHS07 GHS09 Dgr H332 H318 H411 024-016-00-2tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)405-110-688377-66-6 STOT RE 2 Aquatic Chronic 4 H373 H413 GHS08 Wng H373 H413 024-017-00-8chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex—— Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H317 H410 A 024-018-00-3sodium chromate231-889-57775-11-3 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H360FD H330 H301 H372 H312 H314 H334 H317 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H350 H340 H360FD H330 H301 H372 H312 H314 H334 H317 H410 Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317:C ≥ 0,2 % 3024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfonyl)-3''-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III); by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III)

419-230-1— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 024-020-00-4trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)418-220-4— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 024-021-00-Xpotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)425-830-4—Eye Dam. 1H318 GHS05 Dgr H318025-001-00-3manganese dioxide215-202-61313-13-9 Acute Tox. 4 Acute Tox. 4 H332 H302 GHS07 Wng H332 H302 025-002-00-9potassium permanganate231-760-37722-64-7 Ox. Sol. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H272 H302 H400 H410 GHS03 GHS07 GHS09 Dgr H272 H302 H410 025-003-00-4manganese sulphate232-089-97785-87-7 STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411025-004-00-Xbis(N, N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate411-760-1116633-53-5Aquatic Chronic 2H411GHS09H411025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C, C,C-trisulfonato (6-)-N29, N30, N31, N32] manganate (3-); tetrasodium [29H, 31H-phthalocyanine-C, C,C, C-tetrasulfonato(6-)-N29, N30, N31, N32], manganate (3-); pentasodium [29H, 31H-phthalocyanine-C, C,C, C,C-pentasulfonato (6-)-N29, N30, N31, N32] manganate (3-) 417-660-4— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 026-001-00-6(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate407-840-0100011-37-8 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 026-002-00-1(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate407-880-9117549-13-0 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 026-003-00-7iron (II) sulfate231-753-57720-78-7 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315 026-003-01-4 iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate 231-753-57782-63-0 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315 Skin Irrit.2; H315: C ≥ 25 %026-004-00-2potassium ferrite430-010-412160-44-0 Skin Corr. 1B Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317 027-001-00-9cobalt231-158-07440-48-4 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 H334 H317 H413 GHS08 Dgr H334 H317 H413 027-002-00-4cobalt oxide215-154-61307-96-6 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M=10027-003-00-Xcobalt sulfide215-273-31317-42-6 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10 027-004-00-5cobalt dichloride231-589-47646-79-9 Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F H302 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360F H302 H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M=101027-005-00-0cobalt sulfate233-334-210124-43-3

Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F H302 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360F H302 H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M=101027-006-00-6cobalt di(acetate)200-755-871-48-7 Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360F H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M = 10 1027-007-00-1zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex425-240-7— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 027-008-00-7complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated(n H2O,2<n<3)427-390-9—Skin Sens. 1H317 GHS07 Wng H317027-009-00-2cobalt dinitrate233-402-110141-05-6 Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360F H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M = 10 1027-010-00-8cobalt carbonate208-169-4513-79-1 Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360F H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360F H334 H317 H410 Carc. 1B; H350i: C ≥ 0,01 % M=101028-001-00-1 tetracarbonylnickel; nickel tetracarbonyl 236-669-213463-39-3 Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H225 H351 H360D H330 H400 H410 GHS02 GHS06 GHS08 GHS09 Dgr H225 H351 H360D H330 H410 028-002-00-7nickel231-111-47440-02-0 Carc. 2 STOT RE 1 Skin Sens. 1 H351 H372 H317 GHS08 GHS07 Dgr H351 H372 H317 S7028-002-01-4 nickel powder; [particle diameter < 1mm] 231-111-47440-02-0 Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 H351 H372 H317 H412 GHS08 GHS07 Dgr H351 H372 H317 H412 028-003-00-2 nickel monoxide; [1] nickel oxide; [2] bunsenite [3] 215-215-7[1] 234-323-5[2]-[3] 1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 H350i H372 H317 H413 GHS08 GHS07 Dgr H350i H372 H317 H413 028-004-00-8nickel dioxide234-823-312035-36-8 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 H350i H372 H317 H413 GHS08 GHS07 Dgr H350i H372 H317 H413 028-005-00-3dinickel trioxide215-217-81314-06-3 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 H350i H372 H317 H413 GHS08 GHS07 Dgr H350i H372 H317 H413 028-006-00-9 nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] 240-841-2[1] 234-349-7[2]-[3] 16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H372 H317 H410 028-007-00-4 trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] 234-829-6[1] -[2] 12035-72-2 [1] 12035-71-1 [2] Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H372 H317

H410 028-008-00-X nickel dihydroxide; [1] nickel hydroxide [2] 235-008-5 [1] 234-348-1 [2] 12054-48-7 [1] 11113-74-9 [2] Carc. 1A Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H360D H341 H372 H332 H302 H315 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H360D H341 H372 H332 H302 H315 H334 H317 H410 028-009-00-5nickel sulfate232-104-97786-81-4 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H332 H302 H315 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D H372 H332 H302 H315 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 028-010-00-0 nickel carbonate; basic nickel carbonate; carbonic acid, nickel (2+) salt; [1] carbonic acid, nickel salt; [2] [μ-[carbonato(2-)-O:O']]dihydroxy trinickel; [3] [carbonato(2-)] tetrahydroxytrinickel [4] 222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] 3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H332 H302 H315 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D H372 H332 H302 H315 H334 H317 H410 028-011-00-6nickel dichloride231-743-07718-54-9 Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H331 H301 H372 H315 H334 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H350i H341 H360D H331 H301 H372 H315 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 028-012-00-1 nickel dinitrate; [1] nitric acid, nickel salt [2] 236-068-5 [1] 238-076-4 [2] 13138-45-9 [1] 14216-75-2 [2] Ox. Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H272 H350i H341 H360D H372 H332 H302 H315 H318 H334 H317 H400 H410 GHS03 GHS05 GHS08 GHS07 GHS09 Dgr H272 H350i H341 H360D H372 H332 H302 H315 H318 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317 C ≥0,01 % M = 1 028-013-00-7nickel matte273-749-669012-50-6 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate295-859-392129-57-2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H332 H302 H315 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D H372 H332 H302 H315 H334 H317 H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < % Skin Sens. 1; H317:C ≥ 0,01 % M=1 028-015-00-8slimes and sludges, copper electrolyte refining, decopperised305-433-194551-87-8 Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 028-016-00-3 nickel diperchlorate; perchloric acid, nickel(II) salt 237-124-113637-71-3 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H314 H334 H317 H400 H410 GHS05 GHS08 GHS09 Dgr H350i H341 H360D H372 H314 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 028-017-00-9 nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] 237-563-9 [1] 239-793-2 [2] 13842-46-1 [1] 15699-18-0 [2] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H332 H302 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D H372 H332 H302 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 028-018-00-4 nickel bis(sulfamidate); nickel sulfamate 237-396-113770-89-3 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 028-019-00-Xnickel bis(tetrafluoroborate)238-753-414708-14-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 028-021-00-0 nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] 222-101-0 [1] 239-946-6 [2] 268-755-0 [3] 3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 028-022-00-6 nickel di(acetate); [1] nickel acetate [2] 206-761-7 [1] 239-086-1 [2] 373-02-4 [1] 14998-37-9 [2] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H332 H302 H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D H372 H332 H302 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M = 1 028-024-00-7nickel dibenzoate209-046-8553-71-9 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1

Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M=1 028-025-00-2nickel bis(4-cyclohexylbutyrate)223-463-23906-55-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 028-026-00-8 nickel(II) stearate; nickel(II) octadecanoate 218-744-12223-95-2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C;≥0,01 % M=1 028-027-00-3nickel dilactate—16039-61-5 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 028-028-00-9nickel(II) octanoate225-656-74995-91-9 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H314 H334 H317 H400 H410 GHS05 GHS08 GHS09 Dgr H350i H341 H360D H372 H314 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 028-029-00-4 nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] 233-071-3 [1] 236-665-0 [2] 236-666-6 [3] -[4] 10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 028-030-00-Xnickel hexafluorosilicate247-430-726043-11-8 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 028-031-00-5nickel selenate239-125-215060-62-5 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 028-032-00-0 nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7]

diphosphoric acid, nickel(II) salt[8] 238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] -[7] -[8] 14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372 H334 H317 H410 028-033-00-6diammonium nickel hexacyanoferrate—74195-78-1 Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372 H334 H317 H410 028-034-00-1nickel dicyanide209-160-8557-19-7 Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372 H334 H317 H410 EUH032028-035-00-7nickel chromate238-766-514721-18-7 Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372 H334 H317 H410 028-036-00-2 nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] 244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] 21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-037-00-8dinickel hexacyanoferrate238-946-314874-78-3 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-038-00-3 trinickel bis(arsenate); nickel(II) arsenate 236-771-713477-70-8 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H372 H317 H410 028-039-00-9 nickel oxalate; [1] oxalic acid, nickel salt [2] 208-933-7 [1] 243-867-2 [2] 547-67-1 [1] 20543-06-0 [2] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-040-00-4nickel telluride235-260-612142-88-0 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-041-00-Xtrinickel tetrasulfide—12137-12-1 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-042-00-5trinickel bis(arsenite)—74646-29-0 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-043-00-0 cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] 269-051-6 [1] 261-346-8 [2] -[3] 68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372 H317 GHS08 GHS07 Dgr H350i H372 H317028-044-00-6 nickel tin trioxide;

nickel stannate 234-824-912035-38-0 Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372 H317 GHS08 GHS07 Dgr H350i H372 H317 028-045-00-1nickel triuranium decaoxide239-876-615780-33-3 Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372 H317 GHS08 GHS07 Dgr H350i H372 H317 028-046-00-7nickel dithiocyanate237-205-113689-92-4 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 EUH032 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 028-047-00-2nickel dichromate239-646-515586-38-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 028-048-00-8nickel(II) selenite233-263-710101-96-9 Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372 H334 H317 H410 028-049-00-3nickel selenide215-216-21314-05-2 Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-050-00-9silicic acid, lead nickel salt—68130-19-8 Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H360Df H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H360Df H372 H317 H410 028-051-00-4 nickel diarsenide; [1] nickel arsenide [2] 235-103-1 [1] 248-169-1 [2] 12068-61-0 [1] 27016-75-7 [2] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-052-00-X nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 271-853-668610-24-2 Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372 H317 GHS08 GHS07 Dgr H350i H372 H317 028-053-00-5 nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] 267-897-0 [1] 238-596-1 [2] 275-897-7 [3] 67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < % Skin Sens. 1; H317:C≥0,01%1 M=1 028-054-00-0 nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickelsalt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt;[16] nickel(II) neoundecanoate; [17] bis(d-gluconato-O1,O2)nickel; [18]

nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] (isononanoato-O)(isooctanoato-O)nickel; [22] (isooctanoato-O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] 2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] (isodecanoato-O)(isooctanoato-O)nickel; [26] (isodecanoato-O)(isononanoato-O)nickel; [27] (isononanoato-O)(neodecanoato-O)nickel; [28] fatty acids, C6-19-branched, nickel salts; [29] fatty acids, C 8-18 and C18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] 240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 294-302-1 [29] 283-972-0 [30] -[31] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H341 H360D H372 H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 028-055-00-6 nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] 231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] 7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H334 H317 H400 H410 GHS08 GHS09 Dgr H350i H372 H334 H317 H410 028-056-00-1 nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] 234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] -[8] 12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H372 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H372 H317 H410 028-057-00-7 dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6]

molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] 234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] -[10] -[11] 12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] Carc. 1A STOT RE 1 Skin Sens. 1 H350i H372 H317 GHS08 GHS07 Dgr H350i H372 H317 028-058-00-2cobalt lithium nickel oxide442-750-5— Carc. 1A Acute Tox. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H330 H372 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H350i H330 H372 H317 H410 029-001-00-4 copper chloride; copper (I) chloride; cuprous chloride 231-842-97758-89-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H400 H410 029-003-00-5 naphthenic acids, copper salts; copper naphthenate 215-657-01338-02-9 Flam. Liq. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H226 H302 H400 H410 GHS02 GHS07 GHS09 Wng H226 H302 H410 029-004-00-0copper sulphate231-847-67758-98-7 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H315 H410 029-005-00-6(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid401-260-1—Eye Irrit. 2H319 GHS07 Wng H319029-006-00-1tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)403-210-4— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 029-007-00-7(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide404-670-989797-01-3Skin Sens. 1H317 GHS07 Wng H317G029-008-00-2copper(II) methanesulfonate405-400-254253-62-2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410 029-009-00-8phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex413-650-993971-95-0Aquatic Chronic 3H412—H412029-010-00-3reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II)to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)407-700-9101408-30-4Skin Sens. 1H317 GHS07 Wng H317029-011-00-9sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex412-730-0150522-10-4Skin Corr. 1BH314 GHS05 Dgr H314029-012-00-4sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)407-340-2124719-24-0Eye Dam. 1H318 GHS05 Dgr H318 029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Eye Dam. 1H318 GHS05 Dgr H318029-014-00-5reaction mass of: 2,2'-[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]N, N',O, O'-copper complex;2,2'-[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]N, N',O, O'-copper complex419-610-7171866-24-3

STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411 030-001-00-1zinc powder — zinc dust (pyrophoric)231-175-37440-66-6 Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 H260 H250 H400 H410 GHS02 GHS09 Dgr H260 H250 H410 T030-001-01-9zinc powder — zinc dust (stabilised)231-175-37440-66-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410030-003-00-2zinc chloride231-592-07646-85-7 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H410 STOT SE 3; H335: C ≥ 5 %030-004-00-8 dimethylzinc; [1] diethylzinc [2] 208-884-1 [1] 209-161-3 [2] 544-97-8 [1] 557-20-0 [2] Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H250 H260 H314 H400 H410 GHS02 GHS05 GHS09 Dgr H250 H260 H314 H410 EUH014030-005-00-3diamminediisocyanatozinc401-610-3— Acute Tox. 4 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 H302 H318 H334 H317 H400 GHS05 GHS08 GHS07 GHS09 Dgr H302 H318 H334 H317 H400 030-006-00-9 zinc sulphate (hydrous) (mono-, hexa-and hepta hydrate); [1] zinc sulphate (anhydrous) [2] 231-793-3 [1] 231-793-3 [2] 7446-19-7 [1] 7733-02-0 [2] Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410 030-007-00-4bis(3,5-di-tert-butylsalicylato-O1,O2)zinc403-360-042405-40-3 Flam. Sol. 1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H228 H302 H400 H410 GHS02 GHS07 GHS09 Dgr H228 H302 H410 T030-008-00-Xhydroxo(2-(benzenesulfonamido)benzoato)zinc(II)403-750-0113036-91-2 Acute Tox. 4 Aquatic Chronic 2 H332 H411 GHS07 GHS09 Wng H332 H411 030-009-00-5zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate417-130-2— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 030-010-00-02-dodec-1-enylbutanedioic acid,4-methyl ester zinc salt430-740-3—Aquatic Chronic 2H411GHS09H411030-011-00-6trizinc bis(orthophosphate)231-944-37779-90-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9Aquatic Chronic 4H413H413030-013-00-7zinc oxide215-222-51314-13-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9—Aquatic Chronic 2H411GHS09H411 033-001-00-Xarsenic231-148-67440-38-2 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H400 H410 GHS06 GHS09 Dgr H331 H301 H410 033-002-00-5arsenic compounds, with the exception of those specified elsewhere in this Annex—— Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H400 H410 GHS06 GHS09 Dgr H331 H301 H410 A1033-003-00-0 diarsenic trioxide; arsenic trioxide 215-481-41327-53-3 Carc. 1A Acute Tox. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H300 H314 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H350 H300 H314 H410 033-004-00-6 diarsenic pentaoxide; arsenic pentoxide; arsenic oxide 215-116-91303-28-2 Carc. 1A Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1

H350 H331 H301 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H331 H301 H410 033-005-00-1arsenic acid and it salts with the exception of those specified elsewhere in this Annex—— Carc. 1A Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H350 H331 H301 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H331 H301 H410 A033-006-00-7arsine232-066-37784-42-1 Flam. Gas 1 Press. Gas Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H220 H330 H373 H400 H410 GHS02 GHS04 GHS06 GHS08 GHS09 Dgr H220 H330 H373 H410 U 033-007-00-2tert-butylarsine423-320-64262-43-5 Pyr. Liq. 1 Acute Tox. 2 H250 H330 GHS02 GHS06 Dgr H250 H330 034-001-00-2selenium231-957-47782-49-2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 4 H331 H301 H373 H413 GHS06 GHS08 Dgr H331 H301 H373 H413 034-002-00-8selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex—— Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H301 H373 H410 A034-003-00-3sodium selenite233-267-910102-18-8 Acute Tox. 2 Acute Tox. 3 Skin Sens. 1 Aquatic Chronic 2 H300 H331 H317 H411 GHS06 GHS09 Dgr H300 H331 H317 H411 EUH031035-001-00-5bromine231-778-17726-95-6 Acute Tox. 2 Skin Corr. 1A Aquatic Acute 1 H330 H314 H400 GHS06 GHS05 GHS09 Dgr H330 H314 H400 035-002-00-0hydrogen bromide233-113-010035-10-6 Press. Gas Skin Corr. 1A STOT SE 3 H314 H335 GHS04 GHS05 GHS07 Dgr H314 H335 U 035-002-01-8hydrobromic acid … %—— Skin Corr. 1B STOT SE 3 H314 H335 GHS05 GHS07 Dgr H314 H335 Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40 % STOT SE 3; H335: C ≥ 10 % B035-003-00-6potassium bromate231-829-87758-01-2 Ox. Sol. 1 Carc. 1B Acute Tox. 3 H271 H350 H301 GHS03 GHS06 GHS08 Dgr H271 H350 H301 035-004-00-12-hydroxyethylammonium perbromide407-440-6— Ox. Sol. 2 Acute Tox. 4 Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 H272 H302 H314 H317 H400 GHS03 GHS05 GHS07 GHS09 Dgr H272 H302 H314 H317 H400 040-001-00-3zirconium powder (pyrophoric)231-176-97440-67-7 Water-react. 1 Pyr. Sol. 1 H260 H250 GHS02 Dgr H260 H250 T040-002-00-9zirconium powder, dry (non pyrophoric)——Self-heat. 1H251 GHS02 Dgr H251T040-003-00-4reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS= 1.0:1.0 to 1.0: 1.5430-610-6226996-19-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410042-001-00-9molybdenum trioxide215-204-71313-27-5 Carc. 2 Eye Irrit. 2 STOT SE 3 H351 H319 H335 GHS08 GHS07 Wng H351 H319 H335 042-002-00-4tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)404-760-8117342-25-3 Acute Tox. 3 Eye Dam. 1 H331 H318 GHS06 GHS05 Dgr H331 H318 042-003-00-Xtetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)404-860-1116810-46-9 Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H228 H318 H400 H410 GHS02 GHS05 GHS09 Dgr H228

H318 H410 T042-004-00-5reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)412-780-3— Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H315 H317 H411 GHS07 GHS09 Wng H315 H317 H411 042-005-00-0 reaction mass of: mono-and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl]; N, N-diorgano dithiocarbamate molybdenum complex 434-240-6— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 046-001-00-Xtetraammine palladium (II)hydrogen carbonate425-270-0134620-00-1 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H302 H373 H318 H317 H410 047-001-00-2silver nitrate231-853-97761-88-8 Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H272 H314 H400 H410 GHS03 GHS05 GHS09 Dgr H272 H314 H410 047-002-00-8polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt416-850-4— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 048-001-00-5cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 A1048-002-00-0 cadmium (non-pyrophoric); [1] cadmium oxide (non-pyrophoric) [2] 231-152-8 [1] 215-146-2 [2] 7440-43-9 [1] 1306-19-0 [2] Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H341 H361fd H330 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H341 H361fd H330 H372 H410 048-003-00-6 cadmium diformate; cadmiumformate 224-729-04464-23-7 Acute Tox. 3 Acute Tox. 3 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H351 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H301 H351 H373 H410

STOT RE 2; H373: C ≥0,25 % 048-004-00-1cadmium cyanide208-829-1542-83-6 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H351 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H351 H373 H410 EUH032 STOT RE 2; H373: C ≥0,1 % EUH032:C≥1 % 048-005-00-7 cadmiumhexafluorosilicate(2-); cadmium fluorosilica 241-084-017010-21-8 Acute Tox. 3 Acute Tox. 3 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H351 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H301 H351 H373 H410

STOT RE 2; H373: C ≥0,1 % 048-006-00-2cadmium fluoride232-222-07790-79-6 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H360FD H330 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H340 H360FD H330 H301 H372 H410 Carc. 1B; H350: C ≥ 0,01 % oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C <7 % 048-007-00-8cadmium iodide232-223-67790-80-9 Acute Tox. 3 Acute Tox. 3 Carc. 2 STOT RE 2 Aquatic Acute 1

Aquatic Chronic 1 H331 H301 H351 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H301 H351 H373 H410

STOT RE 2; H373: C ≥ 0,1 % 048-008-00-3cadmium chloride233-296-710108-64-2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H360FD H330 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H340 H360FD H330 H301 H372 H410 Carc. 1B; H350: C ≥ 0,01 % oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % 048-009-00-9cadmium sulphate233-331-610124-36-4 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H360FD H330 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H340 H360FD H330 H301 H372 H410 Carc. 1B; H350: C ≥ 0,01 % oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1 % ≤ C < 7 % 048-010-00-4cadmium sulphide215-147-81306-23-6 Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 Aquatic Chronic 4 H350 H341 H361fd H372 H302 H413 GHS08 GHS07 Dgr H350 H341 H361fd H372 H302 H413

STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 % 1048-011-00-Xcadmium (pyrophoric)231-152-87440-43-9 Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H250 H350 H341 H361fd H330 H372 H400 H410 GHS02 GHS06 GHS08 GHS09 Dgr H250 H350 H341 H361fd H330 H372 H410 050-001-00-5 tin tetrachloride; stannic chloride 231-588-97646-78-8 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412 STOT SE 3; H335:C≥5 % 050-002-00-0cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide236-049-113121-70-5 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 M=1000050-003-00-6 fentin acetate (ISO); triphenyltin acetate 212-984-0900-95-8 Carc. 2 Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361d H330 H311 H301 H372 H335 H315 H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H351 H361d H330 H311 H301 H372 H335 H315 H318 H410 M=10050-004-00-1 fentin hydroxide (ISO); triphenyltin hydroxide 200-990-676-87-9 Carc. 2 Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361d H330 H311 H301 H372 H335 H315 H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H351 H361d H330 H311 H301 H372 H335 H315 H318 H410 M=10 050-005-00-7trimethyltin compounds, with the exception of those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 A1050-006-00-2triethyltin compounds, with the exception of those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 A1050-007-00-8tripropyltin compounds, with the exception of those specified elsewhere in this Annex—— Acute Tox. 3

Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 A1050-009-00-9 fluorotripentylstannane;[1] hexapentyldistannoxane [2] 243-546-7 [1] 247-143-7 [2] 20153-49-5 [1] 25637-27-8 [2] Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 1050-010-00-4fluorotrihexylstannane243-547-220153-50-8 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 1 050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this Annex—— Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 M=100A1050-012-00-5tetracyclohexylstannane; [1] chlorotricyclohexylstannane; [2] butyltricyclohexylstannane [3] 215-910-5 [1] 221-437-5 [2] 230-358-5 [3] 1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 A1050-013-00-0trioctyltin compounds, with the exception of those specified elsewhere in this Annex—— Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 H319 H335 H315 H413 GHS07 Wng H319 H335 H315 H413 Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %A1050-017-00-2 fenbutatin oxide (ISO); bis(tris(2-methyl-2-phenylpropyl)tin)oxide 236-407-713356-08-6 Acute Tox. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H319 H315 H400 H410 GHS06 GHS09 Dgr H330 H319 H315 H410 050-018-00-8tin(II) methanesulphonate401-640-753408-94-9 Skin Corr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H314 H302 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H302 H317 H411 050-019-00-3 azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H-1,2,4-triazole 255-209-141083-11-8 Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H301 H335 H315 H318 H400 H410 GHS06 GHS05 GHS09 Dgr H330 H301 H335 H315 H318 H410 050-020-00-9trioctylstannane413-320-4869-59-0 STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 H372 H315 H413 GHS08 GHS07 Dgr H372 H315 H413 050-021-00-4dichlorodioctyl stannane222-583-23542-36-7 Acute Tox. 3 STOT RE 1 Aquatic Chronic 3 H331 H372 H412 GHS06 GHS08 Dgr H331 H372 H412 050-022-00-X dibutyltin dichloride; (DBTC) 211-670-0683-18-1 Muta. 2 Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H341 H360FD H330 H301 H312 H372 H314 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H341 H360FD H330 H301 H312 H372 H314 H410 Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10 050-023-00-5 reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane 422-920-5— STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410 M=10 050-024-00-0reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane432-230-6— STOT RE 1 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H372 H302 H315 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H372 H302 H315 H318 H317 H410 050-025-00-6trichloromethylstannane213-608-8993-16-8Repr. 2H361d GHS08 Wng H361d050-026-00-12-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-828-557583-34-3Repr. 2H361d GHS08 Wng H361d050-027-00-72-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate239-622-415571-58-1Repr. 1BH360D GHS08 Dgr H360D050-028-00-22-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-829-057583-35-4 Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A H361d H302 H372 (nervous system, immune system) H317 GHS08 GHS07 Dgr H361d H302 H372 (nervous system, immune system) H317 050-029-00-8dimethyltin dichloride212-039-2753-73-1 Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B H361d H330 H301 H311 H372 (nervous system, immune system) H314 GHS08 GHS06 GHS05 Dgr H361d H330 H301 H311 H372 (nervous system, immune system) H314 EUH071 051-001-00-8antimony trichloride233-047-210025-91-9 Skin Corr. 1B Aquatic Chronic 2 H314 H411 GHS05 GHS09 Dgr H314 H411 STOT SE3; H335: C ≥ 5 %051-002-00-3antimony pentachloride231-601-87647-18-9 Skin Corr. 1B Aquatic Chronic 2 H314 H411 GHS05 GHS09 Dgr H314 H411 STOT SE 3; H335: C ≥ 5 %051-003-00-9antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H332 H302 H411 GHS07 GHS09 Wng H332 H302 H411 A1051-004-00-4antimony trifluoride232-009-27783-56-4 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H331 H311 H301 H411 GHS06 GHS09 Dgr H331 H311 H301 H411 051-005-00-Xantimony trioxide215-175-01309-64-4Carc. 2H351 GHS08 Wng H351051-006-00-5diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate403-500-0— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 051-007-00-0bis(4-dodecylphenyl)iodonium hexafluoroantimonate404-420-971786-70-4 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 053-001-00-3iodine231-442-47553-56-2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H332 H312 H400 GHS07 GHS09 Wng H332 H312 H400 053-002-00-9hydrogen iodide233-109-910034-85-2 Press. Gas Skin Corr. 1A H314 GHS04 GHS05 Dgr H314 Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥0,02 % U5053-002-01-6hydriodic acid … %——Skin Corr. 1BH314 GHS05 Dgr Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 % B053-003-00-4iodoxybenzene—696-33-3Expl. 053-004-00-Xcalcium iodoxybenzoate——Expl. C053-005-00-5(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate(1-)422-960-3178233-72-2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H312 H302 H373 H410 056-001-00-1barium peroxide215-128-41304-29-6 Ox. Sol. 2 Acute Tox. 4 Acute Tox. 4 H272 H332 H302 GHS03 GHS07 Dgr H272 H332 H302 056-002-00-7barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 H332 H302 GHS07 Wng H332 H302 A1 056-003-00-2barium carbonate208-167-3513-77-9Acute Tox. 4 H302 GHS07 Wng H302056-004-00-8barium chloride233-788-110361-37-2 Acute Tox. 3 Acute Tox. 4 H301 H332 GHS06 Dgr H301 H332 064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5Aquatic Chronic 2H411GHS09H411072-001-00-4hafnium tetra-n-butoxide411-740-222411-22-9 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 074-001-00-Xhexasodium tungstate hydrate412-770-912141-67-2 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 074-002-00-5reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione408-250-6— Flam. Liq. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H225 H332 H314 H317 H400 H410 GHS02 GHS05 GHS07 GHS09 Dgr H225 H332 H314 H317 H410 076-001-00-5 osmium tetraoxide; osmic acid 244-058-720816-12-0 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Skin Corr. 1B H330 H310 H300 H314 GHS06 GHS05 Dgr H330 H310 H300 H314 078-001-00-0tetrachloroplatinates with the exception of those specified elsewhere in this Annex—— Acute Tox. 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H318 H334 H317 A 078-002-00-6diammonium tetrachloroplatinate237-499-113820-41-2 Acute Tox. 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H315 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H315 H318 H334 H317 078-003-00-1disodium tetrachloroplatinate233-051-410026-00-3 Acute Tox. 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H315 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H315 H318 H334 H317 078-004-00-7dipotassium tetrachloroplatinate233-050-910025-99-7 Acute Tox. 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H315 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H315 H318 H334 H317 078-005-00-2hexachloroplatinates with the exception of those specified elsewhere in this Annex—— Acute Tox. 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H318 H334 H317 A078-006-00-8disodium hexachloroplatinate240-983-516923-58-3 Acute Tox. 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H318 H334 H317 078-007-00-3dipotassium hexachloroplatinate240-979-316921-30-5

Acute Tox. 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H318 H334 H317 078-008-00-9diammonium hexachloroplatinate240-973-016919-58-7 Acute Tox. 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H301 H318 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H318 H334 H317 078-009-00-4hexachloroplatinic acid241-010-716941-12-1 Acute Tox. 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 H301 H314 H334 H317 GHS06 GHS05 GHS08 Dgr H301 H314 H334 H317 078-010-00-X tetraammine platinum (II) hydrogen carbonate 426-730-3123439-82-7 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 078-011-00-5hydroxydisulfito platinum(II)acid423-310-161420-92-6 Acute Tox. 4 STOT RE 2 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H373 H314 H334 H317 H412 GHS05 GHS08 GHS07 Dgr H302 H373 H314 H334 H317 H412 078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1— Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 080-001-00-0mercury231-106-77439-97-6 Repr. 1B Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H360D H330 H372 H410 080-002-00-6Inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H410

STOT RE 2; H373: C ≥ 0,1 % A1080-003-00-1 dimercury dichloride; mercurous chloride; calomel 233-307-510112-91-1 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H335 H315 H410 080-004-00-7organic compounds of mercury with the exception of those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H410

STOT RE 2; H373: C ≥0,1 % A1080-005-00-2 mercury difulminate; mercuric fulminate; fulminate of mercury 211-057-8628-86-4 Unst. Expl. Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H200 H331 H311 H301 H373 H400 H410 GHS01 GHS06 GHS08 GHS09 Dgr H200 H331 H311 H301 H373 H400 H410 080-005-01-X mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser] 211-057-8628-86-4 Expl. 1.1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H331 H311 H301 H373 H400 H410 GHS01 GHS06 GHS08 GHS09 Dgr H201 H331 H311 H301 H373 H400 H410 080-006-00-8 dimercury dicyanide oxide; mercuric oxycyanide 215-629-81335-31-5 Expl. 1.1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H331 H311 H301 H373 H400 H410 GHS01 GHS06 GHS08 GHS09 Dgr H201 H331 H311 H301 H373 H410 080-007-00-3 dimethylmercury; [1] diethylmercury [2] 209-805-3 [1] 211-000-7 [2]

593-74-8 [1] 627-44-1 [2] Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H410

STOT RE 2; H373: C ≥0,05 % 1080-008-00-9 phenylmercury nitrate; [1] phenylmercury hydroxide; [2] basic phenylmercury nitrate [3] 200-242-9 [1] 202-866-7 [2] -[3] 55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] Acute Tox. 3 STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H301 H372 H314 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H301 H372 H314 H410 080-009-00-42-methoxyethylmercury chloride204-659-7123-88-6 Acute Tox. 3 STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H301 H372 H314 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H301 H372 H314 H410 080-010-00-X mercury dichloride; mercuric chloride 231-299-87487-94-7 Muta. 2 Repr. 2 Acute Tox. 2 STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H341 H361f H300 H372 H314 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H341 H361f H300 H372 H314 H410 080-011-00-5phenylmercury acetate200-532-562-38-4 Acute Tox. 3 STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H301 H372 H314 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H301 H372 H314 H410 081-001-00-3thallium231-138-17440-28-0 Acute Tox. 2 Acute Tox. 2 STOT RE 2 Aquatic Chronic 4 H330 H300 H373 H413 GHS06 GHS08 Dgr H330 H300 H373 H413 081-002-00-9thallium compounds, with the exception of those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H330 H300 H373 H411 GHS06 GHS08 GHS09 Dgr H330 H300 H373 H411 A 081-003-00-4 dithallium sulphate; thallic sulphate 231-201-37446-18-6 Acute Tox. 2 STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 H300 H372 H315 H411 GHS06 GHS08 GHS09 Dgr H300 H372 H315 H411 082-001-00-6lead compounds with the exception of those specified elsewhere in this Annex—— Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H332 H302 H373 H400 H410 GHS08 GHS07 GHS09 Dgr H360Df H332 H302 H373 H410 Repr.2 H361f: C ≥ 2,5 %

STOT RE 2; H373: C ≥0,5 % A1082-002-00-1lead alkyls—— Repr. 1A Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H330 H310 H300 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H360Df H330 H310 H300 H373 H410 Repr.1A; H360D: C≥ 0,1 %

STOT RE 2; H373: C ≥0,05 % A1082-003-00-7 lead diazide; lead azide 236-542-113424-46-9 Unst. Expl. Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H200 H360Df H332 H302 H373 H400 H410 GHS01 GHS08 GHS07 GHS09 Dgr H200 H360Df H332 H302 H373 H410 1 082-003-01-4 lead diazide; lead azide [≥ 20 % phlegmatiser] 236-542-113424-46-9 Expl. 1.1 Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H360Df H332 H302 H373 H400 H410 GHS01 GHS08 GHS07 GHS09 Dgr H201 H360Df H332 H302 H373 H410 1082-004-00-2lead chromate231-846-07758-97-6 Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H360Df H373 H400 H410 GHS08

GHS09 Dgr H350 H360Df H373 H410 1082-005-00-8lead di(acetate)206-104-4301-04-2 Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H373 H400 H410 GHS08 GHS09 Dgr H360Df H373 H410 1082-006-00-3trilead bis(orthophosphate)231-205-57446-27-7 Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H373 H400 H410 GHS08 GHS09 Dgr H360Df H373 H410 1082-007-00-9lead acetate, basic215-630-31335-32-6 Carc. 2 Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H360Df H373 H400 H410 GHS08 GHS09 Dgr H351 H360Df H373 H410 1 082-008-00-4lead(II) methanesulphonate401-750-517570-76-2 Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 H360Df H332 H302 H373 H315 H318 GHS08 GHS05 GHS07 Dgr H360Df H332 H302 H373 H315 H318 1082-009-00-X lead sulfochromate yellow; C.I. Pigment Yellow 34; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] 215-693-71344-37-2 Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H360Df H373 H400 H410 GHS08 GHS09 Dgr H350 H360Df H373 H410 1082-010-00-5 lead chromate molybdate sulfate red; C.I. Pigment Red 104; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] 235-759-912656-85-8 Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H360Df H373 H400 H410 GHS08 GHS09 Dgr H350 H360Df H373 H410 1082-011-00-0lead hydrogen arsenate232-064-27784-40-9 Carc. 1A Repr. 1A Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H360Df H331 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H360Df H331 H301 H373 H410 1082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H302 H373 H411 GHS08 GHS07 GHS09 Wng H302 H373 H411 092-001-00-8uranium231-170-67440-61-1 Acute Tox. 2 Acute Tox. 2 STOT RE 2 Aquatic Chronic 4 H330 H300 H373 H413 GHS06 GHS08 Dgr H330 H300 H373 H413 092-002-00-3uranium compounds with the exception of those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H330 H300 H373 H411 GHS06 GHS08 GHS09 Dgr H330 H300 H373 H411 A601-001-00-4methane200-812-774-82-8 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U601-002-00-Xethane200-814-874-84-0 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U601-003-00-5propane200-827-974-98-6 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U601-004-00-0butane; [1] and isobutane [2] 203-448-7 [1] 200-857-2 [2] 106-97-8 [1] 75-28-5 [2] Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220C U601-004-01-8 butane (containing ≥ 0,1 % butadiene (203-450-8)); [1] isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2] 203-448-7 [1] 200-857-2 [2] 106-97-8 [1] 75-28-5 [2] Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B H220 H350 H340 GHS02 GHS04 GHS08 Dgr H220 H350 H340 C S U 601-005-00-6 2,2-dimethylpropane; neopentane 207-343-7463-82-1 Flam. Gas 1 Press. Gas Aquatic Chronic 2 H220

H411 GHS02 GHS04 GHS09 Dgr H220 H411 U601-006-00-1pentane203-692-4109-66-0 Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 H225 H304 H336 H411 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H336 H411 EUH066C601-007-00-7 hexane (containing < 5 % n-hexane (203-777-6)); 2-methylpentane;[1] 3-methylpentane; [2] 2,2-dimethylbutane; [3] 2,3-dimethylbutane [4] 203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] 107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 H225 H304 H315 H336 H411 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H315 H336 H411 C601-008-00-2 heptane; n-heptane; [1] 2,4-dimethylpentane; [2] 2,2,3-trimethylbutane; [3] 3,3-dimethylpentane; [4] 2,3-dimethylpentane; [5] 3-methylhexane; [6] 2,2-dimethylpentane; [7] 2-methylhexane; [8] 3-ethylpentane; [9] isoheptane; [10] 205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] 142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H225 H304 H315 H336 H400 H410 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H315 H336 H410 C 601-009-00-8 octane; n-octane; [1] 2,2,4-trimethylpentane; [2] 2,3,3-trimethylpentane; [3] 3,3-dimethylhexane; [4] 2,2,3-trimethylpentane; [5] 2,3,4-trimethylpentane; [6] 3,4-dimethylhexane; [7] 2,3-dimethylhexane; [8] 2,4-dimethylhexane; [9] 4-methylheptane; [10] 3-methylheptane; [11] 2,2-dimethylhexane; [12] 2,5-dimethylhexane; [13] 2-methylheptane; [14] 2,2,3,3-tetramethylbutane; [15] 3-ethyl-2-methylpentane; [16] 3-ethylhexane; [17] 3-ethyl-3-methylpentane; [18] isooctane; [19] 203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] 111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H225 H304 H315 H336 H400 H410 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H315 H336 H410 C601-010-00-3ethylene200-815-374-85-1 Flam. Gas 1 Press. Gas STOT SE 3 H220 H336 GHS02 GHS04 GHS07 Dgr H220 H336 U601-011-00-9 propene; propylene 204-062-1115-07-1 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U 601-012-00-4 but-1-ene; [1] butene, mixed-1-and-2-isomers; [2] 2-methylpropene; [3] (Z)-but-2-ene; [4] (E)-but-2-ene [5] 203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] 106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220C U601-013-00-X

1,3-butadiene; buta-1,3-diene 203-450-8106-99-0 Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B H220 H350 H340 GHS02 GHS04 GHS08 Dgr H220 H350 H340 D U601-014-00-5 isoprene (stabilised) 2-methyl-1,3-butadiene 201-143-378-79-5 Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 H224 H350 H341 H412 GHS02 GHS08 Dgr H224 H350 H341 H412 D601-016-00-6cyclopropane200-847-875-19-4 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U601-017-00-1cyclohexane203-806-2110-82-7 Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H225 H304 H315 H336 H400 H410 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H315 H336 H410 601-018-00-7methylcyclohexane203-624-3108-87-2 Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 H225 H304 H315 H336 H411 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H315 H336 H411 601-019-00-21,4-dimethylcyclohexane209-663-2589-90-2 Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 H225 H304 H315 H336 H411 GHS02 GHS08 GHS07 GHS09 Dgr H225 H304 H315 H336 H411 601-020-00-8benzene200-753-771-43-2 Flam. Liq. 2 Carc. 1a Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 H225 H350 H340 H372 H304 H319 H315 GHS02 GHS08 GHS07 Dgr H225 H350 H340 H372 H304 H319 H315 E601-021-00-3toluene203-625-9108-88-3 Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 Skin Irrit. 2 STOT SE 3 H225 H361d H304 H373 H315 H336 GHS02 GHS08 GHS07 Dgr H225 H361d H304 H373 H315 H336 601-022-00-9 o-xylene; [1] p-xylene; [2] m-xylene; [3] xylene [4] 202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] 95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 H226 H332 H312 H315 GHS02 GHS07 Wng H226 H332 H312 H315 C601-023-00-4ethylbenzene202-849-4100-41-4 Flam. Liq. 2 Acute Tox. 4 STOT RE 2 Asp. Tox. 1 H225 H332 H373 (hearing organs) H304 GHS02 GHS07 GHS08 Dgr H225 H332 H373 (hearing organs) H304 601-024-00-X cumene; [1] propylbenzene [2] 202-704-5 [1] 203-132-9 [2] 98-82-8 [1] 103-65-1 [2] Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 H226 H304 H335 H411 GHS02 GHS08 GHS07 GHS09 Dgr H226 H304 H335 H411 C601-025-00-5 mesitylene; 1,3,5-trimethylbenzene 203-604-4108-67-8 Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 H226 H335 H411 GHS02 GHS07 GHS09 Wng H226 H335 H411 STOT SE 3; H335: C ≥ 25 %601-026-00-0styrene202-851-5100-42-5 Flam. Liq. 3 Repr. 2 Acute Tox. 4 STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 H226 H361d H332 H372 (hearing organs) H315 H319 GHS02 GHS08 GHS07 Dgr H226 H361d H332 H372 (hearing organs) H315 H319 D601-027-00-6 2-phenylpropene; α-methylstyrene 202-705-098-83-9 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 H226 H319 H335 H411 GHS02 GHS07 GHS09 Wng H226 H319 H335 H411 STOT SE 3; H335: C ≥ 25 %601-028-00-1 2-methylstyrene; 2-vinyltoluene 210-256-7611-15-4 Acute Tox. 4 Aquatic Chronic 2 H332 H411 GHS07 GHS09 Wng H332 H411 601-029-00-7 dipentene; limonene;[1] (R)-p-mentha-1,8-diene; d-limonene; [2] (S)-p-mentha-1,8-diene; l-limonene; [3] trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]

(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] 205-341-0 [1] 227-813-5 [2] 227-815-6 [3] 229-977-3 [4] 231-732-0 [5] 138-86-3 [1] 5989-27-5 [2] 5989-54-8 [3] 6876-12-6 [4] 7705-14-8 [5] Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H315 H317 H400 H410 GHS02 GHS07 GHS09 Wng H226 H315 H317 H410 C601-030-00-2cyclopentane206-016-6287-92-3 Flam. Liq. 2 Aquatic Chronic 3 H225 H412 GHS02 Dgr H225 H412 601-031-00-82,4,4-trimethylpent-1-ene203-486-4107-39-1 Flam. Liq. 2 Aquatic Chronic 2 H225 H411 GHS02 GHS09 Dgr H225 H411 601-032-00-3 benzo[a]pyrene; benzo[def]chrysene 200-028-550-32-8 Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H340 H360FD H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H340 H360FD H317 H410 Carc. 1B; H350: C ≥ 0,01 %601-033-00-9benz[a]anthracene200-280-656-55-3 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 M=100601-034-00-4benz[e]acephenanthrylene205-911-9205-99-2 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 601-035-00-Xbenzo[j]fluoranthene205-910-3205-82-3 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 601-036-00-5benzo[k]fluoranthene205-916-6207-08-9 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 601-037-00-0n-hexane203-777-6110-54-3 Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 H225 H361f H304 H373 H315 H336 H411 GHS02 GHS08 GHS07 GHS09 Dgr H225 H361f H304 H373 H315 H336 H411 STOT RE 2; H373: C ≥ 5 %601-041-00-2dibenz[a,h]anthracene200-181-853-70-3 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 Carc. 1B; H350: C ≥ 0,01 % M=100601-042-00-8 biphenyl; diphenyl 202-163-592-52-4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H319 H335 H315 H410 601-043-00-31,2,4-trimethylbenzene202-436-995-63-6 Flam. Liq. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H226 H332 H319 H335 H315 H411 GHS02 GHS07 GHS09 Wng H226 H332 H319 H335 H315 H411 601-044-00-93a,4,7,7a-tetrahydro-4,7-methanoindene201-052-977-73-6 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H225 H332 H302 H319 H335 H315 H411 GHS02 GHS07 GHS09 Dgr H225 H332 H302 H319 H335 H315 H411 601-045-00-41,2,3,4-tetrahydronaphthalene204-340-2119-64-2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H319 H315 H411 GHS07 GHS09 Wng H319 H315 H411 EUH019601-046-00-X7-methylocta-1,6-diene404-210-742152-47-6 Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 H226 H400 H410 GHS02 GHS09 Wng H226 H410 601-047-00-5m-mentha-1,3(8)-diene404-150-117092-80-7 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 601-048-00-0chrysene205-923-4218-01-9 Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H341 H400 H410 GHS08 GHS09 Dgr H350 H341 H410 601-049-00-6benzo[e]pyrene205-892-7192-97-2

Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 601-051-00-74-phenylbut-1-ene405-980-7768-56-9 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 601-052-00-2naphthalene202-049-591-20-3 Carc. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H400 H410 GHS07 GHS08 GHS09 Wng H351 H302 H410 601-053-00-8 nonylphenol; [1] 4-nonylphenol, branched [2] 246-672-0 [1] 284-325-5 [2] 25154-52-3 [1] 84852-15-3 [2] Repr. 2 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H361fd H302 H314 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H361fd H302 H314 H410 601-054-00-3reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene405-570-8— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410601-055-00-9reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes410-190-0132983-41-6 Eye Irrit. 2 Aquatic Chronic 4 H319 H413 GHS07 Wng H319 H413 601-056-00-4reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane405-470-473807-39-3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 601-057-00-XN-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate421-130-8156679-41-3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410 601-058-00-5di-L-para-menthene417-870-683648-84-4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 601-059-00-0methyl 2-benzylidene-3-oxobutyrate420-940-915768-07-7 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H319 H315 H411 GHS07 GHS09 Wng H319 H315 H411 601-060-00-6 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y =0,245 417-610-1155522-09-1Skin Sens. 1H317 GHS07 Wng H317601-061-00-1(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)418-960-8— Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H317 H411 601-062-00-7 reaction mass of: branched triacontane; branched dotriacontane; branched tetratriacontane; branched hexatriacontane 417-030-9151006-59-6Aquatic Chronic 4H413—H413601-063-00-2reaction mass of isomers of branched tetracosane417-060-2151006-61-0 Acute Tox. 4 Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413 601-064-00-8branched hexatriacontane417-070-7151006-62-1Aquatic Chronic 4H413—H413601-065-00-3 reaction mass of: (1'α, 3'α, 6'α)-2,2,3' ,7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) 416-930-9— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 601-066-00-91-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone426-820-278531-60-9

Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 601-067-00-4triethyl arsenate427-700-215606-95-8 Carc. 1A Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H350 H331 H301 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H331 H301 H410 601-068-00-X1,2-diacetoxybut-3-ene421-720-518085-02-4Acute Tox. 4 H302 GHS07 Wng H302601-069-00-52-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide422-680-1287933-44-2Aquatic Chronic 3H412—H412601-070-00-0reaction mass of: branched icosane; branched docosane; branched tetracosane417-050-8151006-58-5 Acute Tox. 4 Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413 601-071-00-61-dimethoxymethyl-2-nitro-benzene423-830-920627-73-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 601-072-00-1 reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane 430-690-252783-21-8 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 601-073-00-71-bromo-3,5-difluorobenzene416-710-2461-96-1 Flam. Liq. 3 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H302 H373 H315 H317 H400 H410 GHS02 GHS08 GHS07 GHS09 Wng H226 H302 H373 H315 H317 H410 601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] 422-040-1— Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H319 H315 H411 GHS07 GHS09 Wng H319 H315 H411 601-075-00-84,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane418-770-5151882-81-4Carc. 2H351 GHS08 Wng H351601-076-00-3ethynyl cyclopropane425-430-16746-94-7 Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H225 H315 H318 H412 GHS02 GHS05 Dgr H225 H315 H318 H412 601-077-00-9 reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane 426-510-7196965-91-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410601-078-00-4 reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane 427-040-5— Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 601-079-00-X reaction mass of: trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene 429-620-3— Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413 601-080-00-5 reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers 431-100-6— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9

Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413 601-082-00-6 reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane 434-420-4— Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3 Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 H304 H315 H413 GHS08 GHS07 Dgr H304 H315 H413 601-084-00-7 reaction mass of:5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) 435-180-3— Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H304 H315 H400 H410 GHS08 GHS07 GHS09 Dgr H304 H315 H410 601-085-00-2 isopentane; 2-methylbutane 201-142-878-78-4 Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 H224 H304 H336 H411 GHS02 GHS08 GHS07 GHS09 Dgr H224 H304 H336 H411 EUH066601-087-00-32,4,4-trimethylpentene246-690-925167-70-8 Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 H225 H304 H336 GHS02 GHS07 GHS08 Dgr H225 H304 H336 D 601-088-00-94-vinylcyclohexene202-848-9100-40-3Carc. 2H351 GHS08 Wng H351601-089-00-4muscalure; cis-tricos-9-ene248-505-727519-02-4Skin Sens. 1BH317 GHS07 Wng H317602-001-00-7 chloromethane; methyl chloride 200-817-474-87-3 Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2 H220 H351 H373 GHS02 GHS04 GHS08 Dgr H220 H351 H373 U602-002-00-2 bromomethane; methylbromide 200-813-274-83-9 Press. Gas Muta. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 H341 H331 H301 H373 H319 H335 H315 H400 H420 GHS04 GHS06 GHS08 GHS09 Dgr H341 H331 H301 H373 H319 H335 H315 H400 H420 U602-003-00-8dibromomethane200-824-274-95-3 Acute Tox. 4 Aquatic Chronic 3 H332 H412 GHS07 Wng H332 H412 602-004-00-3 dichloromethane; methylene chloride 200-838-975-09-2Carc. 2H351 GHS08 Wng H351602-005-00-9 methyl iodide; iodomethane 200-819-574-88-4 Carc. 2 Acute Tox. 4 Acute Tox. 3 Acute Tox. 3 STOT SE 3 Skin Irrit. 2 H351 H312 H331 H301 H335 H315 GHS06 GHS08 Dgr H351 H312 H331 H301 H335 H315 602-006-00-4 chloroform; trichloromethane 200-663-867-66-3 Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 H351 H361d H331 H302 H372 H319 H315 GHS06 GHS08 Dgr H351 H361d H331 H302 H372 H319 H315 602-007-00-X bromoform; tribromomethane 200-854-675-25-2 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H331 H302 H319 H315 H411 GHS06 GHS09 Dgr H331 H302 H319 H315 H411 602-008-00-5 carbon tetrachloride; tetrachloromethane 200-262-856-23-5 Carc. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Aquatic Chronic 3 Ozone 1 H351 H331 H311 H301 H372 H412 H420 GHS06 GHS08 Dgr H351 H331 H311 H301 H372 H412 H420

STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2 % ≤C < 1 % 602-009-00-0chloroethane200-830-575-00-3 Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3

H220 H351 H412 GHS02 GHS04 GHS08 Dgr H220 H351 H412 U 602-010-00-61,2-dibromoethane203-444-5106-93-4 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H350 H331 H311 H301 H319 H335 H315 H411 GHS06 GHS08 GHS09 Dgr H350 H331 H311 H301 H319 H335 H315 H411 602-011-00-11,1-dichloroethane200-863-575-34-3 Flam. Liq. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 H225 H302 H319 H335 H412 GHS02 GHS07 Dgr H225 H302 H319 H335 H412 602-012-00-7 1,2-dichloroethane; ethylene dichloride 203-458-1107-06-2 Flam. Liq. 2 Carc. 1B Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H225 H350 H302 H319 H335 H315 GHS02 GHS08 GHS07 Dgr H225 H350 H302 H319 H335 H315 602-013-00-2 1,1,1-trichloroethane; methyl chloroform 200-756-371-55-6 Acute Tox. 4 Ozone 1 H332 H420 GHS07 Wng H332 H420 F602-014-00-81,1,2-trichloroethane201-166-979-00-5 Carc. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H351 H332 H312 H302 GHS08 GHS07 Wng H351 H332 H312 H302 EUH066 602-015-00-31,1,2,2-tetrachloroethane201-197-879-34-5 Acute Tox. 2 Acute Tox. 1 Aquatic Chronic 2 H330 H310 H411 GHS06 GHS09 Dgr H330 H310 H411 602-016-00-91,1,2,2-tetrabromoethane201-191-579-27-6 Acute Tox. 2 Eye Irrit. 2 Aquatic Chronic 3 H330 H319 H412 GHS06 Dgr H330 H319 H412 602-017-00-4pentachloroethane200-925-176-01-7 Carc. 2 STOT RE 1 Aquatic Chronic 2 H351 H372 H411 GHS08 GHS09 Dgr H351 H372 H411 STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 %602-018-00-X 1-chloropropane; [1] 2-chloropropane [2] 208-749-7 [1] 200-858-8 [2] 540-54-5 [1] 75-29-6 [2] Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H225 H332 H312 H302 GHS02 GHS07 Dgr H225 H332 H312 H302 C602-019-00-5 1-bromopropane; n-propyl bromide 203-445-0106-94-5 Flam. Liq. 2 Repr. 1B STOT RE 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 H225 H360FD H373 H319 H335 H315 H336 GHS02 GHS08 GHS07 Dgr H225 H360FD H373 H319 H335 H315 H336 602-021-00-61,2-dibromo-3-chloropropane202-479-396-12-8 Carc. 1B Muta. 1B Repr. 1A Acute Tox. 3 STOT RE 2 Aquatic Chronic 3 H350 H340 H360F H301 H373 H412 GHS06 GHS08 Dgr H350 H340 H360F H301 H373 H412 602-022-00-1 1-chloropentane; [1] 2-chloropentane; [2] 3-chloropentane [3] 208-846-4 [1] 210-885-7 [2] 210-467-4 [3] 543-59-9 [1] 625-29-6 [2] 616-20-6 [3] Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H225 H332 H312 H302 GHS02 GHS07 Dgr H225 H332 H312 H302 C602-023-00-7 vinyl chloride; chloroethylene 200-831-075-01-4 Press. Gas Flam. Gas 1 Carc. 1A H220 H350 GHS02 GHS08 Dgr H220 H350 D U602-024-00-2bromoethylene209-800-6593-60-2 Press. Gas Flam. Gas 1 Carc. 1B H220 H350 GHS02 GHS08 Dgr H220 H350 U602-025-00-8 1,1-dichloroethylene; vinylidene chloride 200-864-075-35-4 Flam. Liq. 1 Carc. 2 Acute Tox. 4 H224 H351 H332 GHS02 GHS08 GHS07 Dgr H224 H351 H332 D602-026-00-3 1,2-dichloroethylene; [1] cis-dichloroethylene; [2] trans-dichloroethylene [3] 208-750-2 [1] 205-859-7 [2] 205-860-2 [3] 540-59-0 [1] 156-59-2 [2] 156-60-5 [3] Flam. Liq. 2 Acute Tox. 4

Aquatic Chronic 3 H225 H332 H412 GHS02 GHS07 Dgr H225 H332 H412 C602-027-00-9 trichloroethylene; trichloroethene 201-167-479-01-6 Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 H350 H341 H319 H315 H336 H412 GHS08 GHS07 Dgr H350 H341 H319 H315 H336 H412 602-028-00-4tetrachloroethylene204-825-9127-18-4 Carc. 2 Aquatic Chronic 2 H351 H411 GHS08 GHS09 Wng H351 H411 602-029-00-X 3-chloropropene; allyl chloride 203-457-6107-05-1 Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H225 H351 H341 H332 H312 H302 H373 H319 H335 H315 H400 GHS02 GHS08 GHS07 GHS09 Dgr H225 H351 H341 H332 H312 H302 H373 H319 H335 H315 H400 D602-030-00-5 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] 208-826-5 [1] 233-195-8 [2] 542-75-6 [1] 10061-01-5 [2] Flam. Liq. 3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 GHS02 GHS06 GHS08 GHS09 Dgr H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 C D602-031-00-01,1-dichloropropene209-253-3563-58-6 Flam. Liq. 2 Acute Tox. 3 Aquatic Chronic 3 H225 H301 H412 GHS02 GHS06 Dgr H225 H301 H412 602-032-00-63-chloro-2-methylpropene209-251-2563-47-3 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H225 H332 H302 H314 H317 H411 GHS02 GHS05 GHS07 GHS09 Dgr H225 H332 H302 H314 H317 H411 602-034-00-7 1,2-dichlorobenzene; o-dichlorobenzene 202-425-995-50-1 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H335 H315 H410 602-035-00-2 1,4-dichlorobenzene; p-dichlorobenzene 203-400-5106-46-7 Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H319 H400 H410 GHS08 GHS09 Wng H351 H319 H410 602-036-00-8 chloroprene (stabilised); 2-chlorobuta-1,3-diene (stabilised) 204-818-0126-99-8 Flam. Liq. 2 Carc. 1B Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H225 H350 H332 H302 H373 H319 H335 H315 GHS02 GHS08 GHS07 Dgr H225 H350 H332 H302 H373 H319 H335 H315 D 602-037-00-3 α-chlorotoluene; benzyl chloride 202-853-6100-44-7 Carc. 1B Acute Tox. 3 Acute Tox. 4 STOT RE 2 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H350 H331 H302 H373 H335 H315 H318 GHS06 GHS08 GHS05 Dgr H350 H331 H302 H373 H335 H315 H318 602-038-00-9 α, α, α-trichlorotoluene; benzotrichloride 202-634-598-07-7 Carc. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H350 H331 H302 H335 H315 H318 GHS06 GHS08 GHS05 Dgr H350 H331 H302 H335 H315 H318 602-039-00-4 polychlorobiphenyls; PCB 215-648-11336-36-3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410STOT RE 2; H373: C ≥ 0,005 %C602-040-00-X 2-chlorotoluene; [1] 3-chlorotoluene; [2] 4-chlorotoluene; [3] chlorotoluene [4] 202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] 95-49-8 [1]

108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] Acute Tox. 4 Aquatic Chronic 2 H332 H411 GHS07 GHS09 Wng H332 H411 C602-041-00-5penthachloronaphthalene215-320-81321-64-8 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H319 H315 H400 H410 GHS07 GHS09 Wng H312 H302 H319 H315 H410 C 602-042-00-01,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex—— Carc. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H301 H312 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H301 H312 H410 A C602-043-00-6 lindane (ISO); γ-HCH or γ-BHC; γ-1,2,3,4,5,6-hexachlorocyclohexane 200-401-258-89-9 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Lact. Aquatic Acute 1 Aquatic Chronic 1 H301 H332 H312 H373 H362 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H332 H312 H373 H362 H410 M=10602-044-00-1 camphechlor (ISO); toxaphene; 232-283-38001-35-2 Carc. 2 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H301 H312 H335 H315 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H301 H312 H335 H315 H410 602-045-00-7 DDT (ISO); clofenotane (INN); dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane 200-024-350-29-3 Carc. 2 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H301 H372 H410 602-046-00-2 heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene 200-962-376-44-8 Carc. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H311 H301 H373 H410 602-047-00-8 chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan 200-349-057-74-9 Carc. 2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H312 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H312 H302 H410 602-048-00-3aldrin (ISO)206-215-8309-00-2 Carc. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H311 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H311 H301 H372 H410 602-049-00-9dieldrin (ISO)200-484-560-57-1 Carc. 2 Acute Tox. 1 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H310 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H310 H301 H372 H410 602-050-00-4 isodrin; (1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene 207-366-2465-73-6 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 M=100 602-051-00-X endrin (ISO); 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene 200-775-772-20-8 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H311 H400 H410 GHS06 GHS09 Dgr H300 H311 H410 602-052-00-5 endosulfan (ISO); 1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite; 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite

204-079-4115-29-7 Acute Tox. 2 Acute Tox. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H312 H400 H410 GHS06 GHS09 Dgr H330 H300 H312 H410 602-053-00-0 isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran 206-045-4297-78-9 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 H310 H300 H400 GHS06 GHS09 Dgr H310 H300 H400 602-054-00-6 3-iodpropene; allyl iodide 209-130-4556-56-9 Flam. Liq. 2 Skin Corr. 1B H225 H314 GHS02 GHS05 Dgr H225 H314 602-055-00-1 bromoethane; ethyl bromide 200-825-874-96-4 Flam. Liq. 2 Carc. 2 Acute Tox. 4 Acute Tox. 4 H225 H351 H332 H302 GHS02 GHS08 GHS07 Dgr H225 H351 H332 H302 602-056-00-7 α, α, α-trifluorotoluene; benzotrifluoride 202-635-098-08-8 Flam. Liq. 2 Aquatic Chronic 2 H225 H411 GHS02 GHS09 Dgr H225 H411 602-057-00-2 α-bromotoluene; benzyl bromide 202-847-3100-39-0 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 602-058-00-8 α, α-dichlorotoluene; benzylidene chloride; benzal chloride 202-709-298-87-3 Carc. 2 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H351 H331 H302 H335 H315 H318 GHS06 GHS08 GHS05 Dgr H351 H331 H302 H335 H315 H318 602-059-00-3 1-chlorobutane; butyl chloride 203-696-6109-69-3Flam. Liq. 2H225 GHS02 Dgr H225602-060-00-9bromobenzene203-623-8108-86-1 Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 H226 H315 H411 GHS02 GHS07 GHS09 Wng H226 H315 H411 602-061-00-4 hexafluoropropene; hexafluoropropylene 204-127-4116-15-4 Press. Gas Acute Tox. 4 STOT SE 3 H332 H335 GHS07 Wng H332 H335 U602-062-00-X1,2,3-trichloropropane202-486-196-18-4 Carc. 1B Repr. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H350 H360F H332 H312 H302 GHS08 GHS07 Dgr H350 H360F H332 H312 H302 D602-063-00-5 heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane 213-831-01024-57-3 Carc. 2 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H301 H373 H410 602-064-00-01,3-dichloro-2-propanol202-491-996-23-1 Carc. 1B Acute Tox. 3 Acute Tox. 4 H350 H301 H312 GHS06 GHS08 Dgr H350 H301 H312 602-065-00-6hexachlorobenzene204-273-9118-74-1 Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H372 H400 H410 GHS08 GHS09 Dgr H350 H372 H410 602-066-00-1tetrachloro-p-benzoquinone204-274-4118-75-2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 602-067-00-71,3-dichlorbenzene208-792-1541-73-1 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 602-068-00-2ethylene bis(trichloroacetate)219-732-92514-53-6Skin Irrit. 2H315 GHS07 Wng H315602-069-00-8dichloroacetylene—7572-29-4 Unst. Expl. Carc. 2 STOT RE 2 H200 H351 H373 GHS01 GHS08 Wng H200 H351 H373 602-070-00-33-chloro-4,5,α, α, α-pentafluorotoluene401-930-377227-99-7 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H226 H332 H302 H400 GHS02 GHS07 GHS09 Wng H226 H332 H302 H400 602-071-00-9bromobenzylbromotoluene, reaction mass of isomers402-210-199688-47-8

STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 H317 H410 602-072-00-4dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)278-404-376253-60-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 602-073-00-X1,4-dichlorobut-2-ene212-121-8764-41-0 Carc. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H330 H311 H301 H314 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H350 H330 H311 H301 H314 H410 Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5 %602-074-00-5pentachlorobenzene210-172-0608-93-5 Flam. Sol. 1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H228 H302 H400 H410 GHS02 GHS07 GHS09 Dgr H228 H302 H410 T602-075-00-04,4,5,5-tetrachloro-1,3-dioxolan-2-one404-060-222432-68-4 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B H330 H302 H314 GHS06 GHS05 Dgr H330 H302 H314 602-076-00-62,3,4-trichlorobut-1-ene219-397-92431-50-7 Carc. 2 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H302 H319 H335 H315 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H331 H302 H319 H335 H315 H410 Carc. 2; H351: C ≥ 0,1 % 602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex 219-196-62385-85-5 Carc. 2 Repr. 2 Lact. Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H361fd H362 H312 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361fd H362 H312 H302 H410 602-078-00-7hexachlorocyclopentadiene201-029-377-47-4 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H330 H311 H302 H314 H400 H410 GHS06 GHS05 GHS09 Dgr H330 H311 H302 H314 H410 602-079-00-2 2,3-dichloropropene; 2,3-dichloropropylene 201-153-878-88-6 Flam. Liq. 2 Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H225 H341 H332 H312 H302 H335 H315 H318 H412 GHS02 GHS08 GHS05 GHS07 Dgr H225 H341 H332 H312 H302 H335 H315 H318 H412 602-080-00-8alkanes, C10-13, chloro; chlorinated paraffins, C10-13287-476-585535-84-8 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 EUH066602-081-00-32-chloro-4,5-difluorobenzoic acid405-380-5— Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H312 H302 H318 H317 GHS05 GHS07 Dgr H312 H302 H318 H317 602-082-00-92,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol408-020-5109678-33-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 602-083-00-4diphenyl ether, pentabromo derivative pentabromodiphenyl ether251-084-232534-81-9 STOT RE 2 Lact. Aquatic Acute 1 Aquatic Chronic 1 H373 H362 H400 H410 GHS08 GHS09 Wng H373 H362 H410 602-084-00-X1,1-dichloro-1-fluoroethane404-080-11717-00-6 Aquatic Chronic 3 Ozone 1 H412 H420 GHS07 Wng H412 H420 602-085-00-52-bromopropane200-855-175-26-3 Flam. Liq. 2 Repr. 1a STOT RE 2 H225 H360F H373 GHS02 GHS08 Dgr H225 H360F H373 EUH066602-086-00-0 trifluoroiodomethane;

trifluoromethyl iodide 219-014-52314-97-8Muta. 2H341 GHS08 Wng H341602-087-00-61,2,4-trichlorobenzene204-428-0120-82-1 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H400 H410 GHS07 GHS09 Wng H302 H315 H410 602-088-00-1 2,3-dibromopropan-1-ol; 2,3-dibromo-1-propanol 202-480-996-13-9 Carc. 1B Repr. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H350 H361f H311 H332 H302 H412 GHS08 GHS07 Dgr H350 H361f H311 H332 H302 H412 602-089-00-74-bromo-2-chlorofluorobenzene405-580-260811-21-4 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H400 H410 GHS07 GHS09 Wng H302 H315 H410 602-090-00-21-allyl-3-chloro-4-fluorobenzene406-630-6121626-73-1 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 602-091-00-81,3-dichloro-4-fluorobenzene406-160-11435-48-9 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 H302 H373 H315 H411 GHS08 GHS07 Wng H302 H373 H315 H411 602-092-00-31-bromo-3,4,5-trifluorobenzene418-480-9138526-69-9 Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H226 H351 H315 H318 H411 GHS02 GHS08 GHS05 GHS09 Dgr H226 H351 H315 H318 H411 602-093-00-9 α, α, α,4-tetrachlorotoluene; p-chlorobenzotrichloride 226-009-15216-25-1 Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 H350 H361f H372 H312 H302 H335 H315 GHS08 GHS07 Dgr H350 H361f H372 H312 H302 H335 H315 602-094-00-4 diphenylether; octabromo derivate 251-087-932536-52-0Repr. 1BH360Df GHS08 Dgr H360Df602-095-00-X alkanes, C14-17, chloro; chlorinated paraffins, C14-17 287-477-085535-85-9 Lact. Aquatic Acute 1 Aquatic Chronic 1 H362 H400 H410 GHS09 Wng H362 H410 EUH066602-096-00-5 malachite green hydrochloride; [1] malachite green oxalate [2] 209-322-8 [1] 219-441-7 [2] 569-64-2 [1] 2437-29-8 [2] Repr. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H302 H318 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H361d H302 H318 H410 602-097-00-01-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane422-850-5148757-89-5 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 602-098-00-62-(3-bromophenoxy)tetrahydro-2H-pyran429-030-657999-49-2 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 602-099-00-13-(4-fluorophenyl)-2-methylpropionylchloride426-370-7— Skin Corr. 1A Acute Tox. 4 Aquatic Chronic 3 H314 H302 H412 GHS05 GHS07 Dgr H314 H302 H412 EUH014 EUH029 602-100-00-5 reaction mass of: (R, R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; (S, S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane 420-640-8—Aquatic Chronic 3H412—H412602-101-00-02-chloro-4-fluoro-5-nitrophenyl(isobutyl)carbonate427-020-6141772-37-4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 H317 H410 602-102-00-61,1,1,3,3-pentafluorobutane430-250-1406-58-6Flam. Liq. 2H225 GHS02 Dgr H225602-103-00-11-(chlorophenylmethyl)-2-methylbenzene431-450-141870-52-4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng

H315 H410 602-104-00-71,1,2,2,3,3,4-heptafluorocyclopentane430-710-115290-77-4Aquatic Chronic 3H412—H412602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H302 H315 H411 GHS07 GHS09 Wng H302 H315 H411 602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H302 H319 H317 GHS07 Wng H302 H319 H317 602-109-00-4 hexabromocyclododecane [1] 1,2,5,6,9,10-hexabromocyclododecane [2] 247-148-4 [1] 221-695-9[2] 25637-99-4[1] 3194-55-6[2] Repr. 2 Lact. H361 H362 GHS08 Wng H361 H362 603-001-00-Xmethanol200-659-667-56-1 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT SE 1 H225 H331 H311 H301 H370 GHS02 GHS06 GHS08 Dgr H225 H331 H311 H301 H370

STOT SE 1; H370: C≥10 % STOT SE 2; H371: 3 % ≤ C<10 % 603-002-00-5 ethanol; ethyl alcohol 200-578-664-17-5Flam. Liq. 2H225 GHS02 Dgr H225603-003-00-0 propan-1-ol; n-propanol 200-746-971-23-8 Flam. Liq. 2 Eye Dam. 1 STOT SE 3 H225 H318 H336 GHS02 GHS05 GHS07 Dgr H225 H318 H336 603-004-00-6 butan-1-ol; n-butanol 200-751-671-36-3 Flam. Liq. 3 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 H226 H302 H335 H315 H318 H336 GHS02 GHS05 GHS07 Dgr H226 H302 H335 H315 H318 H336 603-005-00-1 2-methylpropan-2-ol; tert-butyl alcohol 200-889-775-65-0 Flam. Liq. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H225 H332 H319 H335 GHS02 GHS07 Dgr H225 H332 H319 H335 603-006-00-7pentanol isomers, with the exception of those specified elsewhere in this Annex250-378-8 Flam. Liq. 3 Acute Tox. 4 STOT SE 3 H226 H332 H335 GHS02 GHS07 Wng H226 H332 H335 EUH066C603-007-00-2 2-methylbutan-2-ol; tert-pentanol 200-908-975-85-4 Flam. Liq. 2 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 H225 H332 H335 H315 GHS02 GHS07 Dgr H225 H332 H335 H315 603-008-00-8 4-methylpentan-2-ol; methyl isobutyl carbinol 203-551-7108-11-2 Flam. Liq. 3 STOT SE 3 H226 H335 GHS02 GHS07 Wng H226 H335 STOT SE 3; H335: C ≥ 25 %603-009-00-3cyclohexanol203-630-6108-93-0 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 H332 H302 H335 H315 GHS07 Wng H332 H302 H335 H315 603-010-00-9 2-methylcyclohexanol, mixed isomers; [1] cis-2-methylcyclohexanol; [2] trans-2-methylcyclohexanol [3] 209-512-0 [1] 231-187-9 [2] 231-186-3 [3] 583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] Acute Tox. 4 H332 GHS07 Wng H332C603-011-00-4 2-methoxyethanol; ethylene glycol monomethyl ether 203-713-7109-86-4 Flam. Liq. 3 Repr. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H226 H360FD H332 H312 H302 GHS02 GHS08 GHS07 Dgr H226 H360FD H332 H312 H302 603-012-00-X 2-ethoxyethanol; ethylene glycol monoethyl ether 203-804-1110-80-5 Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 H226 H360FD H331 H302 GHS02 GHS08 GHS06 Dgr H226 H360FD H331

H302 603-013-00-5 2-isopropoxyethanol; ethylene glycol monoisopropyl ether 203-685-6109-59-1 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 H332 H312 H319 GHS07 Wng H332 H312 H319 603-014-00-0 2-butoxyethanol; ethyleneglycol monobutyl ether; butyl cellosolve 203-905-0111-76-2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H332 H312 H302 H319 H315 GHS07 Wng H332 H312 H302 H319 H315 603-015-00-6allyl alcohol203-470-7107-18-6 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H225 H331 H311 H301 H319 H335 H315 H400 GHS02 GHS06 GHS09 Dgr H225 H331 H311 H301 H319 H335 H315 H400 603-016-00-14-hydroxy-4-methylpentan-2-one; diacetone alcohol204-626-7123-42-2Eye Irrit. 2H319 GHS07 Wng H319Eye Irrit. 2; H319: C≥ 10 %603-018-00-2furfuryl alcohol202-626-198-00-0 Carc. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 STOT SE 3 H351 H331 H312 H302 H373 H319 H335 GHS06 GHS08 Dgr H351 H331 H312 H302 H373 H319 H335 603-019-00-8dimethyl ether204-065-8115-10-6 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U603-020-00-3ethyl methyl ether—540-67-0 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220U603-021-00-9methyl vinyl ether203-475-4107-25-5 Flam. Gas 1 Press. Gas H220 GHS02 GHS04 Dgr H220D U603-022-00-4 diethyl ether; ether 200-467-260-29-7 Flam. Liq. 1 Acute Tox. 4 STOT SE 3 H224 H302 H336 GHS02 GHS07 Dgr H224 H302 H336 EUH019 EUH066 603-023-00-X ethylene oxide; oxirane 200-849-975-21-8 Press. Gas Flam. Gas 1 Carc. 1B Muta. 1B Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H220 H350 H340 H331 H319 H335 H315 GHS02 GHS04 GHS06 GHS08 Dgr H220 H350 H340 H331 H319 H335 H315 U603-024-00-51,4-dioxane204-661-8123-91-1 Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 H225 H351 H319 H335 GHS02 GHS08 GHS07 Dgr H225 H351 H319 H335 EUH019 EUH066 D603-025-00-0tetrahydrofuran203-726-8109-99-9 Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 H225 H351 H319 H335 GHS02 GHS07 GHS08 Dgr H225 H351 H319 H335 EUH019 STOT SE 3; H335: C≥25 % Eye Irrit.2; H319: C ≥ 25 % 603-026-00-61-chloro-2,3-epoxypropane; epichlorhydrin203-439-8106-89-8 Flam. Liq. 3 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 H226 H350 H331 H311 H301 H314 H317 GHS02 GHS06 GHS08 GHS05 Dgr H226 H350 H331 H311 H301 H314 H317 603-027-00-1 ethanediol; ethylene glycol 203-473-3107-21-1Acute Tox. 4 H302 GHS07 Wng H302603-028-00-7 2-chloroethanol; ethylene chlorohydrin 203-459-7107-07-3 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 H330 H310 H300 GHS06 Dgr H330 H310 H300 603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4 Carc. 2 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 H351 H330 H310 H300 GHS06 GHS08 Dgr H351 H330 H310 H300 603-030-00-8 2-aminoethanol; ethanolamine 205-483-3141-43-5 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H332 H312 H302 H314 GHS05 GHS07 Dgr H332 H312 H302 H314 STOT SE 3; H335: C ≥ 5 %603-031-00-3 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME 203-794-9110-71-4 Flam. Liq. 2

Repr. 1B Acute Tox. 4 H225 H360FD H332 GHS02 GHS08 GHS07 Dgr H225 H360FD H332 EUH019 603-032-00-9 ethylene dinitrate; ethylene glycol dinitrate 211-063-0628-96-6 Unst. Expl. Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 H200 H330 H310 H300 H373 GHS01 GHS06 GHS08 Dgr H200 H330 H310 H300 H373 603-033-00-4 oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate 211-745-8693-21-0 Unst. Expl Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 3 H200 H330 H310 H300 H373 H412 GHS01 GHS06 GHS08 Dgr H200 H330 H310 H300 H373 H412 603-033-01-1 oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate; [>25 % phlegmatiser] 211-745-8693-21-0 Expl. 1.1 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 3 H201 H330 H310 H300 H373 H412 GHS01 GHS06 GHS08 Dgr H201 H330 H310 H300 H373 H412 603-034-00-Xglycerol trinitrate; nitroglycerine200-240-855-63-0 Unst. Expl. Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H200 H330 H310 H300 H373 H411 GHS01 GHS06 GHS08 GHS09 Dgr H200 H330 H310 H300 H373 H411 603-034-01-7glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser]200-240-855-63-0 Expl. 1.1 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H201 H330 H310 H300 H373 H411 GHS01 GHS06 GHS08 GHS09 Dgr H201 H330 H310 H300 H373 H411 603-035-00-5pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.201-084-378-11-5Unst. Expl.H200 GHS01 Dgr H200603-035-01-2pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.;[>20 % phlegmatiser]201-084-378-11-5Expl. 1.1H201 GHS01 Dgr H201T603-036-00-0mannitol hexanitrate; nitromannite239-924-615825-70-4Unst. Expl.H200 GHS01 Dgr H200603-036-01-8mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]239-924-615825-70-4Expl. 1.1H201 GHS01 Dgr H201603-037-00-6cellulose nitrate; nitrocellulose——Expl. 1.1H201 GHS01 Dgr H201T603-038-00-1allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether203-442-4106-92-3 Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H226 H351 H341 H361f H332 H302 H335 H315 H318 H317 H412 GHS02 GHS08 GHS05 GHS07 Dgr H226 H351 H341 H361f H332 H302 H335 H315 H318 H317 H412 603-039-00-7butyl glycidyl ether; butyl 2,3-epoxypropyl ether219-376-42426-08-6 Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 H226 H351 H341 H332 H302 H335 H317 H412 GHS02 GHS08 GHS07 Wng H226 H351 H341 H332 H302 H335 H317 H412 603-040-00-2sodium methanolate; sodium methoxide; [1] potassium methanolate; potassium methoxide; [2] lithium methanolate; lithium methoxide [3] 204-699-5 [1] 212-736-1 [2] 212-737-7 [3] 124-41-4 [1] 865-33-8 [2] 865-34-9 [3] Self-heat 1 Skin Corr. 1B H251 H314 GHS02 GHS05 Dgr H251 H314 EUH014T603-041-00-8potassium ethanolate; potassium ethoxide; [1] sodium ethanolate; sodium ethoxide [2] 213-029-0 [1] 205-487-5 [2] 917-58-8 [1] 141-52-6 [2]

Self-heat 1 Skin Corr. 1B H251 H314 GHS02 GHS05 Dgr H251 H314 EUH014T603-042-00-3aluminium-tri-isopropoxide209-090-8555-31-7Flam. Sol. 1H228 GHS02 Dgr H228T603-043-00-9triarimol (ISO); 2,4-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol—26766-27-8Acute Tox. 4 H302 GHS07 Wng H302603-044-00-4dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol204-082-0115-32-2 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H315 H317 H400 H410 GHS07 GHS09 Wng H312 H302 H315 H317 H410 603-045-00-Xdiisopropyl ether; [1] dipropyl ether [2] 203-560-6 [1] 203-869-6 [2] 108-20-3 [1] 111-43-3 [2] Flam. Liq. 2 STOT SE 3 H225 H336 GHS02 GHS07 Dgr H225 H336 EUH019 EUH066 C 603-046-00-5bis(chloromethyl) ether; oxybis(chloromethane)208-832-8542-88-1 Flam. Liq. 2 Carc. 1A Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 H225 H350 H330 H311 H302 GHS02 GHS06 GHS08 Dgr H225 H350 H330 H311 H302 Carc. 1A; H350: C ≥ 0,001 %603-047-00-02-dimethylaminoethanol; N,N-dimethylethanolamine203-542-8108-01-0 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H226 H332 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H226 H332 H312 H302 H314 STOT SE 3; H335: C≥5 %603-048-00-62-diethylaminoethanol; N,N-diethylethanolamine202-845-2100-37-8 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H226 H332 H312 H302 H314 GHS02 GHS05 GHS07 GHS09 Dgr H226 H332 H312 H302 H314 STOT SE 3; H335: C≥5 %603-049-00-1chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol201-246-380-06-8 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 603-050-00-71-(2-butoxypropoxy)propan-2-ol246-011-624083-03-2Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 603-051-00-22-ethylbutan-1-ol202-621-497-95-0Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 603-052-00-83-butoxypropan-2-ol; propylene glycol monobutyl ether225-878-45131-66-8 Eye Irrit. 2 Skin Irrit. 2 H319 H315 GHS07 Wng H319 H315 603-053-00-32-methylpentane-2,4-diol203-489-0107-41-5 Eye Irrit. 2 Skin Irrit. 2 H319 H315 GHS07 Wng H319 H315 603-054-00-9di-n-butyl ether; dibutyl ether205-575-3142-96-1 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 H226 H319 H335 H315 H412 GHS02 GHS07 Wng H226 H319 H335 H315 H412 STOT SE 3; H335: C≥10 %603-056-00-X[(p-tolyloxy)methyl]oxirane; [1] [(m-tolyloxy)methyl]oxirane; [2]2,3-epoxypropyl o-tolyl ether; [3] [(tolyloxy)methyl]oxirane; cresyl glycidyl ether [4] 218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] 2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H341 H315 H317 H411 GHS08 GHS07 GHS09 Wng H341 H315 H317 H411 C603-057-00-5benzyl alcohol202-859-9100-51-6Acute Tox. 4 Acute Tox. 4 H332 H302 GHS07 Wng H332 H302 603-058-00-01,3-propylene oxide207-964-3503-30-0 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H225 H332 H312 H302 GHS02 GHS07 Dgr H225 H332 H312 H302 603-059-00-6hexan-1-ol203-852-3111-27-3Acute Tox. 4 H302 GHS07 Wng H302603-060-00-12,2'-bioxirane; 1,2:3,4-diepoxybutane215-979-11464-53-5

Carc. 1B Muta. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B H350 H340 H330 H311 H301 H314 GHS06 GHS08 GHS05 Dgr H350 H340 H330 H311 H301 H314 603-061-00-7tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol202-625-697-99-4Repr. 1B Eye Irrit. 2 H360Df H319 GHS08 GHS07 Dgr H360Df H319 603-062-00-2tetrahydrofuran-2,5-diyldimethanol203-239-0104-80-3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 STOT SE 3; H335: C ≥10 %603-063-00-82,3-epoxypropan-1-ol; glycidol; oxiranemethanol209-128-3556-52-5 Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H350 H341 H360F H331 H312 H302 H319 H335 H315 GHS06 GHS08 Dgr H350 H341 H360F H331 H312 H302 H319 H335 H315 603-064-00-31-methoxy-2-propanol; monopropylene glycol methyl ether203-539-1107-98-2 Flam. Liq. 3 STOT SE 3 H226 H336 GHS02 GHS07 Wng H226 H336 603-065-00-9resorcinol diglycidyl ether;1,3-bis(2,3-epoxypropoxy)benzene202-987-5101-90-6 Carc. 2 Muta. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H351 H341 H312 H302 H319 H315 H317 H412 GHS08 GHS07 Wng H351 H341 H312 H302 H319 H315 H317 H412 603-066-00-41,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide203-437-7106-87-6 Carc. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H351 H331 H311 H301 GHS06 GHS08 Dgr H351 H331 H311 H301

603-067-00-Xphenyl glycidyl ether; 2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane204-557-2122-60-1 Carc. 1B Muta. 2 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H350 H341 H332 H335 H315 H317 H412 GHS08 GHS07 Dgr H350 H341 H332 H335 H315 H317 H412 603-068-00-52,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether—130014-35-6 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 603-069-00-02,4,6-tris(dimethylaminomethyl)phenol202-013-990-72-2 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315 603-070-00-62-amino-2-methylpropanol204-709-8124-68-5 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 H319 H315 H412 GHS07 Wng H319 H315 H412 603-071-00-12,2'-iminodiethanol; diethanolamine203-868-0111-42-2 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 H302 H373 H315 H318 GHS08 GHS05 GHS07 Dgr H302 H373 H315 H318 603-072-00-71,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether219-371-72425-79-8 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H332 H312 H319 H315 H317 GHS07 Wng H332 H312 H319 H315 H317 603-073-00-2bis-[4-(2,3-epoxipropoxi)phenyl]propane216-823-51675-54-3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 % 603-074-00-8reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ≤ 700)500-033-525068-38-6 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H319 H315 H317 H411 GHS07 GHS09 Wng H319 H315 H317 H411 Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 %603-075-00-3chlormethyl methyl ether; chlorodimethyl ether203-480-1107-30-2

Flam. Liq. 2 Carc. 1A Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H225 H350 H332 H312 H302 GHS02 GHS08 GHS07 Dgr H225 H350 H332 H312 H302 603-076-00-9but-2-yne-1,4-diol; 2-butyne-1,4-diol203-788-6110-65-6 Skin Corr. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Sens. 1 H314 H331 H301 H312 H373 H317 GHS06 GHS05 GHS08 Dgr H314 H331 H301 H312 H373 H317 Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 % Eye Irrit. 2; H319: 25 %≤ C<50 % D603-077-00-41-dimethylaminopropan-2-ol; dimepranol (INN)203-556-4108-16-7 Flam. Liq. 3 Acute Tox. 4 Skin Corr. 1B H226 H302 H314 GHS02 GHS05 GHS07 Dgr H226 H302 H314 603-078-00-Xprop-2-yn-1-ol; propargyl alcohol203-471-2107-19-7 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Aquatic Chronic 2 H226 H331 H311 H301 H314 H411 GHS02 GHS06 GHS05 GHS09 Dgr H226 H331 H311 H301 H314 H411 603-079-00-52,2'-(methylimino)diethanol; N-methyldiethanolamine203-312-7105-59-9Eye Irrit. 2H319 GHS07 Wng H319 603-080-00-02-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol203-710-0109-83-1 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 STOT SE 3; H335: C≥5 %603-081-00-62,2'-thiodiethanol; thiodiglycol203-874-3111-48-8Eye Irrit. 2H319 GHS07 Wng H319603-082-00-11-aminopropan-2-ol; isopropanolamine201-162-778-96-6Skin Corr. 1BH314 GHS05 Dgr H314603-083-00-71,1'-iminodipropan-2-ol; di-isopropanolamine203-820-9110-97-4Eye Irrit. 2H319 GHS07 Wng H319603-084-00-2styrene oxide;(epoxyethyl)benzene; phenyloxirane202-476-796-09-3 Carc. 1B Acute Tox. 4 Eye Irrit. 2 H350 H312 H319 GHS08 GHS07 Dgr H350 H312 H319 603-085-00-8bronopol (INN); 2-bromo-2-nitropropane-1,3-diol200-143-052-51-7 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 H312 H302 H335 H315 H318 H400 GHS05 GHS07 GHS09 Dgr H312 H302 H335 H315 H318 H400 M=10603-086-00-3ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol245-949-323947-60-6Acute Tox. 4 H312 GHS07 Wng H312603-087-00-92-ethylhexane-1,3-diol; octylene glycol; ethoexadiol202-377-994-96-2Eye Dam. 1H318 GHS05 Dgr H318603-088-00-42-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide222-598-43547-33-9Eye Dam. 1H318 GHS05 Dgr H318 603-089-00-X7,7-dimethyl-3-oxa-6-azaoctan-1-ol400-390-6— Skin Corr. 1A Acute Tox. 4 H314 H302 GHS05 GHS07 Dgr H314 H302 603-090-00-52-(2-bromoethoxy)anisole402-010-44463-59-6 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 603-091-00-0exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol402-470-687172-89-2 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 603-092-00-62-methyl-4-phenylpentanol402-770-792585-24-5 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 603-093-00-1cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane402-410-987818-31-3 Acute Tox. 4 Aquatic Chronic 2 H332 H411 GHS07 GHS09 Dgr H332 H411 603-094-00-71,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane241-536-717557-23-2

Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 603-095-00-22-(propyloxy)ethanol; EGPE220-548-62807-30-9 Acute Tox. 4 Eye Irrit. 2 H312 H319 GHS07 Wng H312 H319 603-096-00-82-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether203-961-6112-34-5Eye Irrit. 2H319 GHS07 Wng H319603-097-00-31,1’,1’-nitrilotripropan-2-ol; triisopropanolamine204-528-4122-20-3Eye Irrit. 2H319 GHS07 Wng H319603-098-00-92-phenoxyethanol204-589-7122-99-6 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 603-099-00-43-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride403-440-593633-79-5 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 603-100-00-81,2-dimethoxypropane404-630-07778-85-0Flam. Liq. 2H225 GHS02 Dgr H225EUH019603-101-00-3tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)405-040-6—Eye Irrit. 2H319 GHS07 Wng H319603-103-00-4oxirane, mono[(C12-14-alkyloxy)methyl] derivs.271-846-868609-97-2 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 603-104-00-Xfenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol262-095-760168-88-9 Repr. 2 Lact. Aquatic Chronic 2 H361fd H362 H411 GHS08 GHS09 Wng H361fd H362 H411 603-105-00-5furan203-727-3110-00-9 Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Aquatic Chronic 3 H224 H350 H341 H332 H302 H373 H315 H412 GHS02 GHS08 GHS07 Dgr H224 H350 H341 H332 H302 H373 H315 H412 EUH019603-106-00-02-methoxypropanol216-455-51589-47-5 Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H226 H360D H335 H315 H318 GHS02 GHS08 GHS05 GHS07 Dgr H226 H360D H335 H315 H318 603-107-00-62-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether203-906-6111-77-3Repr. 2H361d GHS08 Wng H361d 603-108-00-12-methylpropan-1-ol; iso-butanol201-148-078-83-1 Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 H226 H335 H315 H318 H336 GHS02 GHS05 GHS07 Dgr H226 H335 H315 H318 H336 603-109-00-7reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane425-340-0—Aquatic Chronic 4H413—H413603-110-00-2reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane426-130-1166301-21-9 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412 603-111-00-8reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane426-530-6— Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 603-112-00-3cyclopentyl 2-phenylethyl ether428-340-9— Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 603-113-00-96-glycidyloxynapht-1-yl oxymethyloxirane429-960-227610-48-6 Muta. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H341 H312 H315 H317 H412 GHS08 GHS07 Wng H341 H312 H315 H317 H412 603-114-00-49-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene430-830-226912-64-1 Skin Irrit. 2 Aquatic Chronic 2 H315

H411 GHS07 GHS09 Wng H315 H411 603-115-00-Xreaction mass of: O, O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)423-580-0— STOT RE 2 Aquatic Chronic 4 H373 H413 GHS08 Wng H373 H413603-116-00-5(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride424-740-2138271-16-6 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 603-117-00-0propan-2-ol; isopropyl alcohol; isopropanol200-661-767-63-0 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 603-118-00-66-dimethylaminohexan-1-ol404-680-31862-07-3 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 3 H302 H314 H412 GHS05 GHS07 Dgr H302 H314 H412 603-119-00-11,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)405-840-5— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 603-120-00-72-methyl-5-phenylpentanol405-890-825634-93-9 Eye Irrit. 2 Skin Irrit. 2 H319 H315 GHS07 Wng H319 H315 603-121-00-24-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone406-057-1114565-66-1 Carc. 2 Skin Sens. 1 Aquatic Chronic 4 H351 H317 H413 GHS08 GHS07 Wng H351 H317 H413 603-122-00-8sodium 2-ethylhexanolate406-150-738411-13-1 Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 H228 H314 H412 GHS02 GHS05 Dgr H228 H314 H412 T603-123-00-34-methyl-8-methylenetricyclo[3.3.1.1 3,7]decan-2-ol406-330-5122760-84-3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H315 H317 H411 GHS07 GHS09 Wng H315 H317 H411 603-124-00-91,4-bis[2-(vinyloxy)ethoxy]benzene406-900-384563-49-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410603-125-00-42-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol407-850-589544-40-1 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 603-126-00-X2-((4-methyl-2-nitrophenyl)amino)ethanol408-090-7100418-33-5 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 603-127-00-5butan-2-ol; 1-butan-2-ol; [2] (R)-butan-2-ol; 3-butan-2-ol [4] 201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] 78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 H226 H319 H335 H336 GHS02 GHS07 Wng H226 H319 H335 H336 C603-128-00-02-(phenylmethoxy)naphthalene405-490-3613-62-7Aquatic Chronic 4H413—H413603-129-00-61-tert-butoxypropan-2-ol406-180-057018-52-7 Flam. Liq. 3 Eye Dam. 1 H226 H318 GHS02 GHS05 Dgr H226 H318 603-130-00-1reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)406-325-8— Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 603-131-00-7reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)407-290-1—Eye Dam. 1H318 GHS05 Dgr H318603-132-00-22-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane408-200-363187-91-7 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318

H412 603-133-00-8reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)408-240-1— Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 603-134-00-3reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produce by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6 Linear C12 and C14, 50/50 used.410-450-3—Aquatic Chronic 4H413—H413603-135-00-9bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium410-500-4— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 603-136-00-43-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol410-910-3104226-19-9 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 603-137-00-Xreaction mass of:1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol411-130-6—Eye Dam. 1H318 GHS05 Dgr H318603-138-00-53-(2,2-dimethyl-3-hydroxypropyl)toluene;(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol403-140-4103694-68-4Aquatic Chronic 3H412—H412603-139-00-0bis(2-methoxyethyl) ether203-924-4111-96-6 Flam. Liq. 3 Repr. 1B H226 H360FD GHS02 GHS08 Dgr H226 H360FD EUH019603-140-00-62,2' -oxybisethanol; diethylene glycol203-872-2111-46-6Acute Tox. 4 H302 GHS07 Wng H302 603-141-00-1reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane413-780-6—Aquatic Chronic 3H412—H412603-142-00-72-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane407-360-1116230-20-7 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 H312 H302 H373 H315 H318 GHS06 GHS08 GHS05 Dgr H312 H302 H373 H315 H318 603-143-00-2R—2,3-epoxy-1-propanol404-660-457044-25-4 Self-react. C Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H242 H350 H341 H360F H331 H312 H302 H314 GHS02 GHS06 GHS08 GHS05 Dgr H242 H350 H341 H360F H331 H312 H302 H314 603-144-00-8Reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol413-530-6111850-00-1Aquatic Chronic 2H411GHS09H411603-145-00-32-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane406-970-5129228-11-1 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 603-146-00-92-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol406-080-783016-70-0 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 3 H302 H314 H412 GHS05 GHS07 Dgr H302 H314 H412 603-147-00-4(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine406-030-4105812-81-5 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 603-148-00-X1,4-bis[(vinyloxy)methyl]cyclohexane413-370-717351-75-6 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 603-149-00-5reaction mass of: diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane407-640-363767-86-2

Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H319 H315 H411 GHS07 GHS09 Wng H319 H315 H411 603-150-00-0(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol411-580-3107898-54-4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 603-151-00-6(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol413-570-4—Aquatic Chronic 3H412—H412603-152-00-12-(4-tert-butylphenyl)ethanol410-020-55406-86-0 Repr. 2 STOT RE 2 Eye Dam. 1 Aquatic Chronic 2 H361f H373 H318 H411 GHS08 GHS05 GHS09 Dgr H361f H373 H318 H411 603-153-00-73-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol410-010-0104333-00-8 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 603-154-00-21-[(2-tert-butyl)cyclohexyloxy]-2-butanol412-300-2139504-68-0Aquatic Chronic 2H411GHS09H411603-156-00-32-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane411-210-089544-48-9 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 603-157-00-96,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol411-450-6143747-72-2Aquatic Chronic 4H413—H413 603-158-00-4reaction mass of: 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene412-460-3— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 603-159-00-X2-cyclododecylpropan-1-ol411-410-8118562-73-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410603-160-00-51,2-diethoxypropane412-180-110221-57-5Flam. Liq. 2H225 GHS02 Dgr H225EUH019603-161-00-01,3-diethoxypropane413-140-63459-83-4Flam. Liq. 3H226 GHS02 Wng H226603-162-00-6α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]413-420-8144736-29-8 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H317 H411 603-163-00-12-phenyl-1,3-propanediol411-810-21570-95-2Eye Dam. 1H318 GHS05 Dgr H318603-164-00-72-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole412-420-5133909-99-6Aquatic Chronic 4H413—H413603-165-00-2reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol417-470-1— Muta. 2 Skin Sens. 1 H341 H317 GHS08 GHS07 Wng H341 H317 603-166-00-8R-1-chloro-2,3-epoxypropane424-280-251594-55-9 Flam. Liq. 3 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 H226 H350 H331 H311 H301 H314 H317 GHS02 GHS06 GHS08 GHS05 Dgr H226 H350 H331 H311 H301 H314 H317 603-167-00-33,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol407-920-56390-69-8Aquatic Chronic 4H413

GHS05 Dgr H413603-168-00-93-(2-ethylhexyloxy)propane-1,2-diol408-080-270445-33-9 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 603-169-00-4(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine415-550-0109887-53-8 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 603-170-00-Xreaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol415-990-367739-11-1 Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 603-171-00-55-thiazolylmethanol414-780-938585-74-9 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 603-172-00-0mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate415-180-1773058-82-5 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 603-173-00-64,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane421-750-957280-22-5 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 603-174-00-14-cyclohexyl-2-methyl-2-butanol420-630-383926-73-2 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 603-175-00-72-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol203-988-3112-59-4 Acute Tox. 4 Eye Dam. 1 H312 H318 GHS05 GHS07 Dgr H312 H318 603-176-00-21,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme203-977-3112-49-2Repr. 1BH360Df GHS08 Dgr H360DfEUH019603-177-00-81-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether; [1] 2-ethoxy-1-methylethyl acetate; 2PG1EEA [2] 216-374-5 [1] 259-370-9 [2] 1569-02-4 [1] 54839-24-6 [2] Flam. Liq. 3 STOT SE 3 H226 H336 GHS02 GHS07 Wng H226 H336 603-178-00-32-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol203-951-1112-25-4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 603-179-00-9ergocalciferol (ISO); Vitamin D2200-014-950-14-6Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 H330 H311 H301 H372 GHS06 GHS08 Dgr H330 H311 H301 H372 603-180-00-4colecalciferol; Vitamin D3200-673-267-97-0Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 H330 H311 H301 H372 GHS06 GHS08 Dgr H330 H311 H301 H372 603-181-00-Xtert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane216-653-11634-04-4 Flam. Liq. 2 Skin Irrit. 2 H225 H315 GHS02 GHS07 Dgr H225 H315 603-182-00-5reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O, O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide428-630-5—Skin Sens. 1H317 GHS07 Wng H317603-183-00-02-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutylether; butoxytriethylene glycol205-592-6143-22-6Eye Dam. 1H318

GHS05 Dgr H318Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 %603-184-00-62-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol416-380-1146925-83-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410603-185-00-12,4-dichloro-3-ethyl-6-nitrophenol420-740-199817-36-4 Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H301 H318 H317 H410 603-186-00-7trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol419-050-379944-37-9Skin Sens. 1H317 GHS07 Wng H317603-187-00-22-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride419-360-9163661-77-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410603-188-00-8reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene426-970-9— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 603-189-00-3reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol405-250-8—Aquatic Chronic 2H411GHS09H411603-190-00-98,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane424-030-262406-73-9 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412 603-191-00-42-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol419-740-4137658-79-8Aquatic Chronic 4H413—H413603-192-00-X(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol423-240-1125474-34-2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 603-193-00-5disodium 9,10-anthracenedioxide426-030-846492-07-3Skin Corr. 1AH314 GHS05 Dgr H314603-194-00-02-(2-aminoethylamino)ethanol; (AEEA)203-867-5111-41-1 Repr. 1B Skin Corr. 1B Skin Sens. 1 H360Df H314 H317 GHS05 GHS08 GHS07 Dgr H360Df H314 H317 STOT SE 3; H335: C≥5 %603-195-00-62-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol430-810-3154825-62-4Aquatic Chronic 3H412—H412603-196-00-12-(7-ethyl-1H-indol-3-yl)ethanol431-020-141340-36-7 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H302 H373 H411 GHS08 GHS07 GHS09 Wng H302 H373 H411 603-199-00-8etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole—153233-91-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M = 100 603-200-00-11-pentanol; [1] 3-pentanol [2] 200-752-1 [1] 209-526-7 [2] 71-41-0 [1] 584-02-1 [2] Flam. Liq. 3 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 H226 H332 H335 H315 GHS02 GHS07 Wng H226 H332 H335 H315 603-201-00-7(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol416-120-5— Skin Irrit. 2 Aquatic Chronic 4 H315 H413 GHS07 Wng H315 H413 603-202-00-24,4,5,5,5-pentafluoropentan-1-ol421-360-9148043-73-6 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 603-203-00-8(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane427-580-1—Skin Irrit. 2H315

GHS07 Wng H315603-204-00-3reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane428-110-8—Aquatic Chronic 3H412—H412603-205-00-9(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride426-200-1172015-79-1 STOT RE 1 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H372 H302 H318 H317 H412 GHS05 GHS08 GHS07 Dgr H372 H302 H318 H317 H412 603-206-00-42,2-dichloro-1,3-benzodioxol426-850-62032-75-9 Flam. Liq. 3 Skin Corr. 1A Acute Tox. 4 Skin Sens. 1 H226 H314 H302 H317 GHS02 GHS05 GHS07 Dgr H226 H314 H302 H317 EUH014603-207-00-X2-isobutyl-2-isopropyl-1,3-dimethoxypropane430-800-9129228-21-3 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 603-208-00-51,2-diethoxyethane211-076-1629-14-1 Flam. Liq. 2 Repr. 1A Eye Irrit. 2 H225 H360Df H319 GHS02 GHS08 GHS07 Dgr H225 H360Df H319 EUH019603-209-00-0spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S,14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS,5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1] spinosyn A; [2] spinosyn D [3] -[1] -[2] -[3] -[1] 131929-60-7 [2] 131929-63-0 [3] Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=10603-210-00-62,4-diethyl-1,5-pentanediol429-310-857987-55-0Eye Dam. 1H318 GHS05 Dgr H318603-211-00-12,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … %221-221-03033-77-0 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H350 H341 H361f H312 H302 H373 H318 H317 H412 GHS05 GHS08 GHS07 Dgr H350 H341 H361f H312 H302 H373 H318 H317 H412 B 603-212-00-71,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide;(HHCB)214-946-91222-05-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410603-213-00-22-methoxy-2-methylbutane; tert-amyl methyl ether213-611-4994-05-8 Flam. Liq. 2 Acute Tox. 4 STOT SE 3 H225 H302 H336 GHS02 GHS07 Dgr H225 H302 H336 603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2Skin Corr. 1BH314 GHS05 Dgr H314603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0 Expl. 1.1 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H201 H302 H373 H318 H317 H400 H410 GHS01 GHS05 GHS08 GHS07 GHS09 Dgr H201 H302 H373 H318 H317 H410 603-216-00-9cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3

H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 603-220-00-01-{]benzyl[}2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3Aquatic Chronic 4H413—H413603-221-00-61-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]433-580-2214353-17-0 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H302 H314 H411 GHS05 GHS07 GHS09 Dgr H302 H314 H411 603-221-01-31-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]433-580-2214353-17-0 Carc. 1B Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H350 H302 H314 H411 GHS05 GHS08 GHS07 GHS09 Dgr H350 H302 H314 H411 603-222-00-1(2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Eye Irrit. 2H319 GHS07 Wng H319603-223-00-72-cyclopentylidene cyclopentanol 1,1'-bi(cyclopentyliden)-2-ol434-270-16261-30-9 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318 H412 603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9Aquatic Chronic 4H413—H413603-225-00-8erythromycin A9-oxime (E);(3R, 4S, 5S, 6R, 7R, 9R, 11R,12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)437-070-013127-18-9Aquatic Chronic 2H411GHS09H411603-226-00-34,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2Aquatic Chronic 3H412—H412603-227-00-9α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate445-060-2203574-04-3

Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 603-228-00-4(+/–)-(R,R)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane419-620-1— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7— Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5— Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 H315 H318 H413 GHS05 Dgr H315 H318 H413 603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6—Aquatic Chronic 3H412—H412603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6—Aquatic Chronic 4H413—H413603-233-00-1reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol444-430-0—Aquatic Chronic 2H411GHS09H411603-234-00-7(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3—

Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 604-001-00-2phenol; carbolic acid; monohydroxybenzene; phenylalcohol203-632-7108-95-2 Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Corr. 1B H341 H331 H311 H301 H373 H314 GHS06 GHS08 GHS05 Dgr H341 H331 H311 H301 H373 H314

Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315 1 % ≤ C<3 % Eye Irrit. 2; H319:1 % ≤C<3 % 604-002-00-8pentachlorophenol201-778-687-86-5 Carc. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H311 H301 H319 H335 H315 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H330 H311 H301 H319 H335 H315 H410 604-003-00-3sodiumpentachlorophenolate; [1] potassium pentachlorophenolate[2] 205-025-2 [1] 231-911-3 [2] 131-52-2 [1] 7778-73-6 [2] Carc. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H311 H301 H319 H335 H315 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H330 H311 H301 H319 H335 H315 H410 604-004-00-9m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] 203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] 108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B H311 H301 H314 GHS06 GHS05 Dgr H311 H301 H314 C 604-005-00-41,4-dihydroxybenzene; hydroquinone; quinol204-617-8123-31-9 Carc. 2 Muta. 2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H351 H341 H302 H318 H317 H400 GHS05 GHS08 GHS07 GHS09 Dgr H351 H341 H302 H318 H317 H400 M=10604-006-00-X3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(or 2,5)-xylenol [7] 202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] 95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Aquatic Chronic 2 H311 H301 H314 H411 GHS06 GHS05 GHS09 Dgr H311 H301 H314 H411 C604-007-00-52-naphthol205-182-7135-19-3 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H332 H302 H400 GHS07 GHS09 Wng H332 H302 H400 604-008-00-02-chlorophenol; [1] 4-chlorophenol; [2] 3-chlorophenol; [3] chlorophenol [4] 202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] 95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H332 H312 H302 H411 GHS07 GHS09 Wng H332 H312 H302 H411 C604-009-00-6pyrogallol; 1,2,3-trihydroxybenzene201-762-987-66-1 Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H341 H332 H312 H302 H412 GHS08 GHS07 Wng H341 H332 H312 H302 H412 604-010-00-1resorcinol; 1,3-benzenediol203-585-2108-46-3 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 H302 H319 H315 H400 GHS07 GHS09 Wng H302 H319 H315 H400

604-011-00-72,4-dichlorophenol204-429-6120-83-2 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H311 H302 H314 H411 GHS06 GHS05 GHS09 Dgr H311 H302 H314 H411 604-012-00-24-chloro-o-cresol; 4-chloro-2-methylphenol216-381-31570-64-5

Acute Tox. 3 Skin Corr. 1A Aquatic Acute 1 H331 H314 H400 GHS06 GHS05 GHS09 Dgr H331 H314 H400 STOT SE 3; H335: C≥1 %604-013-00-82,3,4,6-tetrachlorophenol200-402-858-90-2 Acute Tox. 3 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H301 H319 H315 H400 H410 GHS06 GHS09 Dgr H301 H319 H315 H410

Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; H315: C≥5 % 604-014-00-3chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol200-431-659-50-7 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H312 H302 H318 H317 H400 GHS05 GHS07 GHS09 Dgr H312 H302 H318 H317 H400 604-015-00-92,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene200-733-870-30-4 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H311 H301 H400 H410 GHS06 GHS09 Dgr H311 H301 H410 604-016-00-41,2-dihydroxybenzene; pyrocatechol204-427-5120-80-9 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H312 H302 H319 H315 GHS07 Wng H312 H302 H319 H315 604-017-00-X2,4,5-trichlorophenol202-467-895-95-4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H315 H410

Eye Irrit. 2; H319: C≥5 % Skin Irrit.2; H315: C ≥5 % 604-018-00-52,4,6-trichlorophenol201-795-988-06-2 Carc. 2 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H319 H315 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H319 H315 H410 604-019-00-0dichlorophen (ISO)202-567-197-23-4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H400 H410 GHS07 GHS09 Wng H302 H319 H410 604-020-00-62-phenylphenol (ISO)biphenyl-2-ol; 2-hydroxybiphenyl;201-993-590-43-7 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H319 H335 H315 H400 GHS07 GHS09 Wng H319 H335 H315 H400 604-021-00-1sodium 2-biphenylate; 2-phenylphenol, sodium salt205-055-6132-27-4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 H302 H335 H315 H318 H400 GHS05 GHS07 GHS09 Wng H302 H335 H315 H318 H400 604-022-00-72,2-dimethyl-1,3-benzodioxol-4-ol400-900-722961-82-6Eye Dam. 1H318 GHS05 Dgr H318 604-023-00-22,4-dichloro-3-ethylphenol401-060-4— Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 604-024-00-84,4-isobutylethylidenediphenol401-720-16807-17-6 Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H360F H319 H400 H410 GHS08 GHS09 Dgr H360F H319 H410 604-025-00-32,5-bis(1,1-dimethylbutyl)hydroquinone400-220-0—Aquatic Chronic 2H411GHS09H411604-026-00-92,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)400-270-3—Aquatic Chronic 2H411GHS09H411604-027-00-42-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone400-530-6— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 604-028-00-X4-amino-3-fluorophenol402-230-0399-95-1 Carc. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H350 H302 H317 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H317 H411 604-029-00-51-naphtol201-969-490-15-3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H312

H302 H335 H315 H318 GHS05 GHS07 Dgr H312 H302 H335 H315 H318 604-031-00-6guaiacol201-964-790-05-1 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315 604-032-00-1thymol201-944-889-83-8 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H302 H314 H411 GHS05 GHS07 GHS09 Dgr H302 H314 H411 604-033-00-7isobutyl but-3-enoate401-170-224342-03-8Flam. Liq. 3H226 GHS02 Wng H226604-034-00-24,4'-thiodi-o-cresol403-330-724197-34-0 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 604-035-00-84-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol404-160-6— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 604-036-00-34,4'-oxybis(ethylenethio)diphenol404-590-490884-29-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 604-037-00-93,5-xylenol; 3,5-dimethylphenol203-606-5108-68-9 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B H311 H301 H314 GHS06 GHS05 Dgr H311 H301 H314 604-038-00-44-chloro-3,5-dimethylphenol; [1] chloroxylenol [2] 201-793-8 [1] 215-316-6 [2] 88-04-0 [1] 1321-23-9 [2] Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H302 H319 H315 H317 GHS07 Wng H302 H319 H315 H317 604-039-00-Xethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl266-362-966441-23-4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 604-040-00-5fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide276-439-972178-02-0Acute Tox. 4 H302 GHS07 Wng H302 604-041-00-0acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1] sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium [2] 256-634-5 [1] 263-560-7 [2] 50594-66-6 [1] 62476-59-9 [2] Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H315 H318 H410 604-042-00-64-nitrosophenol203-251-6104-91-6 Muta. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H341 H302 H318 H411 GHS08 GHS05 GHS07 GHS09 Dgr H341 H302 H318 H411 604-043-00-1monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether203-083-3103-16-2 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 604-044-00-7mequinol; 4-methoxyphenol; hydroquinone monomethyl ether205-769-8150-76-5 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H302 H319 H317 GHS07 Wng H302 H319 H317 604-045-00-22,3,5-trimethylhydroquinone211-838-3700-13-0 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H335 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H332 H335 H315 H318 H317 H410 604-046-00-84-(4-isopropoxyphenylsulfonyl)phenol405-520-595235-30-6Aquatic Chronic 2H411GHS09H411604-047-00-34-(4-tolyloxy)biphenyl405-730-751601-57-1 STOT RE 2 Aquatic Chronic 4 H373 H413 GHS08 Wng H373 H413604-048-00-94,4',4''-(ethan-1,1,1-triyl)triphenol405-800-727955-94-8Aquatic Chronic 2H411GHS09H411 604-049-00-44-4'-methylenebis(oxyethylenethio)diphenol407-480-493589-69-6Aquatic Chronic 2H411GHS09H411604-051-00-53,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol401-110-587113-78-8Aquatic Chronic 3H412—H412604-052-00-02,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)403-800-1103597-45-1Aquatic Chronic 4H413—H413604-053-00-62-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol410-760-9157661-93-3

Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 604-054-00-1reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol412-020-0— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 604-055-00-72,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane413-900-785954-11-6 Carc. 2 Skin Sens. 1 H351 H317 GHS08 GHS07 Wng H351 H317 604-056-00-22-(2-hydroxy-3,5-dinitroanilino)ethanol412-520-999610-72-7 Flam. Sol. 2 Repr. 2 Acute Tox. 4 H228 H361f H302 GHS02 GHS07 GHS08 Dgr H228 H361f H302 604-058-00-31,2-bis(3-methylphenoxy)ethane402-730-954914-85-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410604-059-00-92-n-hexadecylhydroquinone406-400-5— STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H373 H315 H317 H413 GHS08 GHS07 Wng H373 H315 H317 H413 604-060-00-49,9-bis(4-hydroxyphenyl)fluorene406-950-63236-71-3 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 604-061-00-Xreaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl407-740-7— Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H315 H317 H412 GHS07 Wng H315 H317 H412 604-062-00-52,4-dimethyl-6-(1-methyl-pentadecyl)phenol411-220-5— Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 604-063-00-05,6-dihydroxyindole412-130-93131-52-0 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 604-064-00-62-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol411-380-6147315-50-2Aquatic Chronic 4H413—H413604-065-00-14,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)407-460-5111850-25-0Aquatic Chronic 2H411GHS09H411604-066-00-7reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]-(C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol414-550-8— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 604-067-00-2reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)414-520-4— Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 604-068-00-8(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride415-170-590274-24-1

Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 H332 H302 H317 GHS07 Wng H332 H302 H317 604-069-00-32-(1-methylpropyl)-4-tert-butylphenol421-740-451390-14-8 Skin Corr. 1B Aquatic Chronic 2 H314 H411 GHS05 GHS09 Dgr H314 H411 604-070-00-9triclosan;2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol222-182-23380-34-5 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 M = 100604-071-00-44,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol425-600-3110726-28-8Aquatic Chronic 4H413—H413604-072-00-X1,2-bis(phenoxymethyl)benzene428-620-010403-74-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410604-073-00-5(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol428-010-482413-20-5 Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H360F H317 H400 H410 GHS08 GHS07 GHS09 Dgr H351 H360F H317 H410 604-074-00-0tetrabromobisphenol-A; 2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol201-236-979-94-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 604-075-00-64-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol205-426-2140-66-9 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 M=10604-076-00-1phenolphthalein201-004-777-09-8 Carc. 1B Muta. 2 Repr. 2 H350 H341 H361f GHS08 Dgr H350 H341 H361f Carc. 1B; H350: C ≥1 %604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6Aquatic Chronic 4H413—H413604-079-00-84,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0 Repr. 2 Skin Sens. 1 Aquatic Chronic 2 H361f H317 H411 GHS08 GHS07 GHS09 Wng H361f H317 H411 604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1 Acute Tox. 4 Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 H332 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H332 H314 H317 H411 604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410604-082-00-42-chloro-6-fluoro-phenol433-890-82040-90-6 Muta. 1B Repr. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H340 H361f H302 H314 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H340 H361f H302 H314 H317 H411 604-083-00-X4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol439-270-3260408-02-4Aquatic Chronic 4H413—H413 604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 604-087-00-1reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride(or sulfonicacid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol433-640-8—

Pyr. Sol. 1 Aquatic Chronic 4 H250 H413 GHS02 Dgr H250 H413 EUH044604-089-00-22-methyl-5-tert-butylthiophenol444-970-7— Flam. Liq. 3 Repr. 2 STOT RE 2 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H226 H361d H373 H304 H319 H315 H317 H336 H400 H410 GHS02 GHS08 GHS07 GHS09 Dgr H226 H361d H373 H304 H319 H315 H317 H336 H410 604-090-00-84-tert-butylphenol202-679-098-54-4 Repr. 2 Skin Irrit. 2 Eye Dam. 1 H361f H315 H318 GHS08 GHS05 Dgr H361f H315 H318 604-091-00-3etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether407-980-280844-07-1 Lact. Aquatic Acute 1 Aquatic Chronic 1 H362 H400 H410 GHS09 Wng H362 H410 M = 100 M = 1000 605-001-00-5formaldehyde …%200-001-850-00-0 Carc. 1B Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 H350 H341 H301 H311 H331 H314 H317 GHS08 GHS06 GHS05 Dgr H350 H341 H301 H311 H331 H314 H317

Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤C < 25 % Eye Irrit. 2; H319: 5 % ≤ C <25 % STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2 % B, D605-002-00-01,3,5-trioxan; trioxymethylene203-812-5110-88-3 Flam. Sol. 1 Repr. 2 STOT SE 3 H228 H361d H335 GHS02 GHS08 GHS07 Dgr H228 H361d H335 T605-003-00-6acetaldehyde; ethanal200-836-875-07-0 Flam. Liq. 1 Carc. 2 Eye Irrit. 2 STOT SE 3 H224 H351 H319 H335 GHS02 GHS08 GHS07 Dgr H224 H351 H319 H335 605-004-00-12,4,6-trimethyl-1,3,5-trioxane; paraldehyde204-639-8123-63-7Flam. Liq. 3H226 GHS02 Wng H226605-005-00-72,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde203-600-2108-62-3 Flam. Sol. 2 Acute Tox. 4 H228 H302 GHS02 GHS07 Wng H228 H302 605-006-00-2butyraldehyde204-646-6123-72-8Flam. Liq. 2H225 GHS02 Dgr H225605-007-00-81,1-dimethoxyethane; dimethyl acetal208-589-8534-15-6Flam. Liq. 2H225 GHS02 Dgr H225 605-008-00-3acrolein; prop-2-enal; acrylaldehyde203-453-4107-02-8 Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H225 H330 H300 H311 H314 H400 H410 GHS02 GHS06 GHS05 GHS09 Dgr H225 H330 H300 H311 H314 H410 EUH071 Skin Corr. 1B; H314:C≥ 0,1 % M = 100 M = 1 D605-009-00-9crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] 224-030-0 [1] 204-647-1 [2] 4170-30-3 [1] 123-73-9 [2] Flam. Liq. 2 Muta. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 H225 H341 H330 H311 H301 H373 H335 H315 H318 H400 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H225 H341 H330 H311 H301 H373 H335 H315 H318 H400 605-010-00-42-furaldehyde202-627-798-01-1 Carc. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H351 H331 H301 H312 H319 H335 H315 GHS06 GHS08 Dgr H351 H331 H301 H312 H319 H335 H315 605-011-00-X2-chlorobenzaldehyde; o-chlorobenzaldehyde201-956-389-98-5Skin Corr. 1BH314 GHS05 Dgr H314605-012-00-5benzaldehyde202-860-4100-52-7Acute Tox. 4 H302 GHS07 Wng H302 605-014-00-6chloral hydrate; 2,2,2-trichloroethane-1,1-diol206-117-5302-17-0 Acute Tox. 3 Eye Irrit. 2

Skin Irrit. 2 H301 H319 H315 GHS06 Dgr H301 H319 H315 605-015-00-11,1-diethoxyethane; acetal203-310-6105-57-7 Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 H225 H319 H315 GHS02 GHS07 Dgr H225 H319 H315 605-016-00-7glyoxal…%; ethandial…%203-474-9107-22-2 Muta. 2 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H341 H332 H319 H315 H317 GHS07 GHS08 Wng H341 H332 H319 H315 H317 B605-017-00-21,3-dioxolane211-463-5646-06-0Flam. Liq. 2H225 GHS02 Dgr H225605-018-00-8propanal; propionaldehyde204-623-0123-38-6 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H225 H319 H335 H315 GHS02 GHS07 Dgr H225 H319 H335 H315 605-019-00-3citral226-394-65392-40-5 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 605-020-00-9safrole; 5-allyl-1,3-benzodioxole202-345-494-59-7 Carc. 1B Muta. 2 Acute Tox. 4 H350 H341 H302 GHS08 GHS07 Dgr H350 H341 H302 605-021-00-4formaldehyde, reaction products with butylphenol294-145-991673-30-2Skin Sens. 1H317 GHS07 Wng H317605-024-00-02-bromo-5-hydroxy-4-methoxybenzaldehyde426-540-02973-59-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 605-025-00-6chloroacetaldehyde203-472-8107-20-0 Carc. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 H351 H330 H311 H301 H314 H400 GHS06 GHS08 GHS05 GHS09 Dgr H351 H330 H311 H301 H314 H400 STOT SE 3; H335: C≥ 5 %605-026-00-12,5,7,7-tetramethyloctanal405-690-0114119-97-0 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H315 H317 H411 GHS07 GHS09 Wng H315 H317 H411 605-027-00-7reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde410-480-7— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 605-028-00-2β-methyl-3-(1-methylethyl)-benzenepropanal412-050-4125109-85-5Aquatic Chronic 2H411GHS09H411605-029-00-82-cyclohexylpropanal412-270-02109-22-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 605-030-00-31-(p-methoxyphenyl)acetaldehyde oxime411-510-13353-51-3Skin Sens. 1H317 GHS07 Wng H317605-031-00-9reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate; water (Including free water and water in hydrated 2,2-dimethoxyethanal)]421-890-0—Skin Sens. 1H317 GHS07 Wng H317605-032-00-43-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal425-370-493957-50-7 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 605-033-00-XReaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal425-910-932480-08-3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 605-034-00-5reaction mass of: (1RS, 2RS,3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde429-860-9—

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 605-035-00-0(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal426-330-9177964-68-0 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H319 H317 H413 GHS07 Wng H319 H317 H413 605-036-00-62-bromomalonaldehyde430-470-62065-75-0 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 605-037-00-1trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde421-800-1120578-03-2Aquatic Chronic 4H413—H413605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H302 H315 H317 H411 GHS07 GHS09 Wng H302 H315 H317 H411 605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317 606-001-00-8acetone; propan-2-one; propanone200-662-267-64-1 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 EUH066 606-002-00-3butanone; ethyl methyl ketone201-159-078-93-3 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 EUH066606-003-00-9heptan-3-one; butyl ethyl ketone203-388-1106-35-4 Flam. Liq. 3 Acute Tox. 4 Eye Irrit. 2 H226 H332 H319 GHS02 GHS07 Wng H226 H332 H319 606-004-00-44-methylpentan-2-one; isobutyl methyl ketone203-550-1108-10-1 Flam. Liq. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H225 H332 H319 H335 GHS02 GHS07 Dgr H225 H332 H319 H335 EUH066606-005-00-X2,6-dimethylheptan-4-one; di-isobutyl ketone203-620-1108-83-8 Flam. Liq. 3 STOT SE 3 H226 H335 GHS02 GHS07 Wng H226 H335 STOT SE 3; H335: C ≥ 10 %606-006-00-5pentan-3-one; diethyl ketone202-490-396-22-0 Flam. Liq. 2 STOT SE 3 STOT SE 3 H225 H335 H336 GHS02 GHS07 Dgr H225 H335 H336 EUH066606-007-00-03-methylbutan-2-one; methyl isopropyl ketone209-264-3563-80-4Flam. Liq. 2H225 GHS02 Dgr H225606-009-00-14-methylpent-3-en-2-one; mesityl oxide205-502-5141-79-7 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H226 H332 H312 H302 GHS02 GHS07 Wng H226 H332 H312 H302 606-010-00-7cyclohexanone203-631-1108-94-1 Flam. Liq. 3 Acute Tox. 4 H226 H332 GHS02 GHS07 Wng H226 H332 606-011-00-22-methylcyclohexanone209-513-6583-60-8 Flam. Liq. 3 Acute Tox. 4 H226 H332 GHS02 GHS07 Wng H226 H332 606-012-00-83,5,5-trimethylcyclohex-2-enone; isophorone201-126-078-59-1 Carc. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H351 H312 H302 H319 H335 GHS08 GHS07 Wng H351 H312 H302 H319 H335 STOT SE 3; H335: C ≥10 %606-013-00-3p-benzoquinone; quinone203-405-2106-51-4 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 H331 H301 H319 H335 H315 H400 GHS06 GHS09 Dgr H331 H301 H319 H335 H315 H400 M=10606-016-00-Xpindone (ISO); 2-pivaloylindan-1,3-dione201-462-883-26-1 Acute Tox. 3 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H372 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H372 H410 606-017-00-5diketene; diketen211-617-1674-82-8 Flam. Liq. 3 Acute Tox. 4 H226

H332 GHS02 GHS07 Wng H226 H332 D606-018-00-0dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone204-210-5117-80-6 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H315 H410 606-019-00-6chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,0 4,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one205-601-3143-50-0 Carc. 2 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H351 H311 H301 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H311 H301 H410 606-020-00-15-methylheptan-3-one208-793-7541-85-5 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 H226 H319 H335 GHS02 GHS07 Wng H226 H319 H335 STOT SE 3; H335: C≥10 %606-022-00-21-phenyl-3-pyrazolidone202-155-192-43-3 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 606-023-00-84-methoxy-4-methylpentan-2-one203-512-4107-70-0 Flam. Liq. 3 Acute Tox. 4 H226 H332 GHS02 GHS07 Wng H226 H332 606-024-00-3heptan-2-one; methyl amyl ketone203-767-1110-43-0 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 H226 H332 H302 GHS02 GHS07 Wng H226 H332 H302 606-025-00-9cyclopentanone204-435-9120-92-3 Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 H226 H319 H315 GHS02 GHS07 Wng H226 H319 H315 606-026-00-45-methylhexan-2-one; isoamyl methyl ketone203-737-8110-12-3 Flam. Liq. 3 Acute Tox. 4 H226 H332 GHS02 GHS07 Wng H226 H332 606-027-00-Xheptan-4-one; di-n-propyl ketone204-608-9123-19-3 Flam. Liq. 3 Acute Tox. 4 H226 H332 GHS02 GHS07 Wng H226 H332 606-028-00-52,4-dimethylpentan-3-one; di-isopropyl ketone209-294-7565-80-0 Flam. Liq. 2 Acute Tox. 4 H225 H332 GHS02 GHS07 Dgr H225 H332 606-029-00-0pentane-2,4-dione; acetylacetone204-634-0123-54-6 Flam. Liq. 3 Acute Tox. 4 H226 H302 GHS02 GHS07 Wng H226 H302 606-030-00-6hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone209-731-1591-78-6 Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 H226 H361f H372 H336 GHS02 GHS08 GHS07 Dgr H226 H361f H372 H336 606-031-00-13-propanolide;1,3-propiolactone200-340-157-57-8 Carc. 1B Acute Tox. 2 Eye Irrit. 2 Skin Irrit. 2 H350 H330 H319 H315 GHS06 GHS08 Dgr H350 H330 H319 H315 606-032-00-7hexachloroacetone204-129-5116-16-5 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 606-033-00-22-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole243-761-620354-26-1 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H312 H302 H319 H315 H411 GHS07 GHS09 Wng H312 H302 H319 H315 H411 606-034-00-8metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one244-209-721087-64-9 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=10 606-035-00-3chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon216-920-21698-60-8 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 606-036-00-9quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one219-455-32439-01-2

Repr. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H332 H312 H302 H373 H319 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361f H332 H312 H302 H373 H319 H317 H410 606-037-00-4triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone256-103-843121-43-3 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 606-038-00-Xdiphacinone (ISO); 2-diphenylacetylindan-1,3-dione201-434-582-66-6Acute Tox. 2 STOT RE 1 H300 H372 GHS06 GHS08 Dgr H300 H372 606-039-00-55(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one400-680-2— Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H400 H410 GHS07 GHS09 Wng H332 H410 606-040-00-0(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride401-840-455845-90-4 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 606-042-00-1acetophenone202-708-798-86-2 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 606-043-00-72,4-di-tert-butylcyclohexanone405-340-713019-04-0 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 606-044-00-22,4,6-trimethylbenzophenone403-150-9954-16-5 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H400 H410 GHS07 GHS09 Wng H302 H319 H410 606-045-00-8oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one243-215-719666-30-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-046-00-3reaction mass of cis-and trans-cyclohexadec-8-en-1-one401-700-23100-36-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-047-00-92-benzyl-2-dimethylamino-4-morpholinobutyrophenone404-360-3119313-12-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-048-00-42'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one406-480-1—Aquatic Chronic 4H413—H413606-049-00-X4-(trans-4-propylcyclohexyl)acetophenone406-700-678531-61-0 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 606-050-00-56-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione412-480-272453-58-8Aquatic Chronic 2H411GHS09H411606-051-00-04-pentylcyclohexanone406-670-461203-83-6Aquatic Chronic 2H411GHS09H411606-052-00-64-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone410-410-554574-82-2Aquatic Chronic 3H412—H412606-053-00-1flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one—96525-23-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 606-055-00-21-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone411-180-992836-10-7 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H302 H373 H411 GHS08 GHS07 GHS09 Wng H302 H373 H411 606-056-00-84-chloro-3',4'-dimethoxybenzophenone404-610-1116412-83-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-057-00-34-propylcyclohexanone406-810-440649-36-3 Skin Irrit. 2 Aquatic Chronic 3

H315 H412 GHS07 Wng H315 H412 606-058-00-94'-fluoro-2,2-dimethoxyacetophenone407-500-121983-80-2 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 606-059-00-42,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride412-390-386386-75-6 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317 606-060-00-XReaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane412-950-7— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-061-00-5(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone423-290-466938-41-8 Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 H341 H400 H410 GHS08 GHS09 Wng H341 H410 606-062-00-0tetrahydrothiopyran-3-carboxaldehyde407-330-861571-06-0 Repr. 1B Eye Dam. 1 Aquatic Chronic 3 H360D H318 H412 GHS08 GHS05 Dgr H360D H318 H412 606-063-00-6(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal410-980-5112704-51-5 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 606-064-00-1pregn-5-ene-3,20-dione bis(ethylene ketal)407-450-07093-55-2Aquatic Chronic 4H413—H413606-065-00-71-(4-morpholinophenyl)butan-1-one413-790-0—Aquatic Chronic 2H411GHS09H411606-066-00-2(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone410-440-9164058-20-2Aquatic Chronic 2H411GHS09H411606-067-00-8reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone414-870-896792-67-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-068-00-32,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al415-770-71638-05-7 STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H373 H317 H412 GHS08 GHS07 Wng H373 H317 H412 606-069-00-9spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]415-460-1154171-76-3Aquatic Chronic 2H411GHS09H411606-070-00-4butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one414-790-3138164-12-2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H361fd H302 H315 H400 H410 GHS08 GHS07 GHS09 Wng H361fd H302 H315 H410 606-071-00-X17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one421-050-313258-43-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-072-00-53-acetyl-1-phenyl-pyrrolidine-2,4-dione421-600-2719-86-8 STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411 606-073-00-04,4'-bis(dimethylamino)benzophenone; Michler's ketone202-027-590-94-8 Carc. 1B Muta. 2 Eye Dam. 1 H350 H341 H318 GHS08 GHS05 Dgr H350 H341 H318 606-074-00-6reaction mass of: (1R, 2S)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R,3S)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene425-570-1—

Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-075-00-11-benzyl-5-ethoxyimidazolidine-2,4-dione417-340-465855-02-9Acute Tox. 4 H302 GHS07 Wng H302606-076-00-71-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione418-630-3136465-99-1 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 606-077-00-2(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone418-650-2104872-06-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-078-00-81-octylazepin-2-one420-040-659227-88-2 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H317 H411 606-079-00-32-n-butyl-benzo[d]isothiazol-3-one420-590-74299-07-4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410 606-081-00-4(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one419-790-74229-69-0 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 606-082-00-Xreaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane406-930-7 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 H372 H317 H412 GHS08 GHS07 Dgr H372 H317 H412 606-083-00-52-chloro-5-sec-hexadecylhydroquinone407-750-1137193-60-3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H315 H317 H412 GHS07 Wng H319 H315 H317 H412 606-084-00-01-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione414-540-3484-33-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-085-00-6(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one418-530-179200-56-9 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317 606-086-00-11-(3,3-dimethylcyclohexyl)pent-4-en-1-one422-330-856973-87-6Aquatic Chronic 2H411GHS09H411606-087-00-76-ethyl-5-fluoro-4(3H)-pyrimidone422-460-5137234-87-8 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 606-088-00-22,4,4,7-tetramethyl-6-octen-3-one422-520-074338-72-0 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 606-089-00-8reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone423-220-212223-77-7Aquatic Chronic 4H413—H413606-090-00-31-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone430-920-173096-98-7 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 606-091-00-96-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one421-320-0118289-55-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 606-092-00-4reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one422-320-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-093-00-X5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one414-470-395885-13-5 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 606-094-00-5N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one417-460-7—Aquatic Chronic 4H413—H413606-095-00-0(R, S)-2-azabicyclo[2.2.1]hept-5-en-3-one421-830-349805-30-3

Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 606-096-00-63-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one424-170-4130603-71-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 606-097-00-12,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone424-210-023911-85-5Aquatic Chronic 4H413—H413606-098-00-71-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione431-220-9158574-65-3Aquatic Chronic 4H413—H413606-099-00-25-methoxy-4'-(trifluoromethyl)valerophenone425-000-161718-80-7Aquatic Chronic 2H411GHS09H411606-100-00-62-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one425-150-894723-86-1 Repr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H360F H302 H317 H412 GHS08 GHS07 Dgr H360F H302 H317 H412 606-101-00-1reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione426-050-7165038-51-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410606-102-00-74-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone431-490-879876-59-8Aquatic Chronic 2H411GHS09H411606-103-00-21-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone426-460-6—Skin Sens. 1H317 GHS07 Wng H317606-104-00-81-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone426-830-778531-59-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 606-105-00-33,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione431-500-0226065-73-2 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 606-106-00-91-(4-(trans-4-butylcyclohexyl)phenyl)ethanone427-320-783626-30-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 606-107-00-48-azaspiro[4.5]decane-7,9-dione427-770-41075-89-4 Acute Tox. 3 Aquatic Chronic 2 H301 H411 GHS06 GHS09 Dgr H301 H411 606-108-00-X1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone436-710-6756-13-8Aquatic Chronic 3H412—H412606-109-00-52-(4-methyl-3-pentenyl)anthraquinone428-320-171308-16-2 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 4 H302 H317 H413 GHS07 Wng H302 H317 H413 606-110-00-05-ethoxy-5H-furan-2-one428-330-42833-30-9 Skin Corr. 1B Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Sens. 1 H314 H312 H302 H373 H317 GHS05 GHS08 GHS07 Dgr H314 H312 H302 H373 H317 606-111-00-65-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one428-410-967014-36-2 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 606-112-00-1(4aR,8aR)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one428-690-21668-86-6 Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 3 H302 H319 H412 GHS07 Wng H302 H319 H412 606-113-00-71-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one429-040-0272460-97-6

Eye Dam. 1 Aquatic Chronic 4 H318 H413 GHS05 Dgr H318 H413 606-114-00-24,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone429-150-967887-47-2Aquatic Chronic 4H413—H413606-115-00-8profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one—139001-49-3 Carc. 2 Repr. 2 Skin Sens. 1 H351 H361d H317 GHS08 GHS07 Wng H351 H361d H317 606-116-00-3tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one—149979-41-9 Carc. 2 Repr. 2 H351 H361fd GHS08 Wng H351 H361fd 606-117-00-92,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one429-460-47078-98-0 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 606-118-00-4N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine429-640-252870-46-9 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H400 H410 GHS07 GHS09 Wng H319 H410 606-119-00-X(E)-3-methyl-5-cyclopentadecen-1-one429-900-5— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 606-120-00-52,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one430-170-5114625-74-0 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 606-121-00-0(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)430-460-1133636-82-5 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410 606-122-00-63-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one430-820-8114341-88-7 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H315 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H302 H373 H315 H318 H317 H410 606-123-00-14-hexadecyl-1-phenylpyrazolidin-3-one430-840-7— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Acute Tox. 4 H302 GHS07 Wng H302606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7Aquatic Chronic 2H411GHS09H411606-128-00-92,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8Aquatic Chronic 4H413—H413 606-129-00-45-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one423-090-7156732-13-7Aquatic Chronic 4H413—H413606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione427-230-85571-36-8 Repr. 1B STOT RE 2 Aquatic Chronic 2 H360F H373 H411 GHS08 GHS09 Dgr H360F H373 H411606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3 Skin Sens. 1 Aquatic Chronic 3 H317

H412 GHS07 Wng H317 H412 606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. 2H361f GHS08 Wng H361f606-135-00-7cyclohexadecanone438-930-82550-52-9Aquatic Chronic 4H413—H413606-136-00-2(3S, 6R, 9S, 12R, 15S, 18R, 21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4 Eye Irrit. 2 Aquatic Chronic 4 H319 H413 GHS07 Wng H319 H413 606-137-00-8trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione444-750-0211387-26-7Aquatic Chronic 4H413—H413606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0 Flam. Liq. 3 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H302 H373 H315 H318 H317 H400 H410 GHS02 GHS05 GHS08 GHS07 GHS09 Dgr H226 H302 H373 H315 H318 H317 H410 M=10 606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9Aquatic Chronic 4H413—H413606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wn H373 H410606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7—Eye Irrit. 2H319 GHS07 Wng H319606-142-00-5reaction mass of: (1RS, 2SR,7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one434-290-9— Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 606-143-00-0abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] avermectin B1a (purity ≥ 80 %); [2] _ [1] 265-610-3 [2] 71751-41-2 [1] 65195-55-3 [2] Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H300 H330 H372 (nervous system) H400 H410 GHS06 GHS08 GHS09 Dgr H361d H300 H330 H372 (nervous system) H410 STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C< 5 % M = 10000 606-144-00-6acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate—57960-19-7 Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H317 H370 (lung) (inhalation) H373 (blood system) H400 H410 GHS07 GHS08 GHS09 Dgr H317 H370 (lung) (inhalation) H373 (blood system) H410 M = 1000 606-145-00-1sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione99105-77-8 Repr. 2 STOT RE 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H361d H373 (kidneys) H317 H400 H410 GHS08 GHS07 GHS09 Wng H361d H373 (kidneys) H317 H410 M = 1 M = 10 606-146-00-7tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one—87820-88-0 Carc. 2 Acute Tox. 4 Aquatic Chronic 2 H351 H302 H411 GHS08 GHS07 GHS09 Wng H351 H302 H411 606-147-00-2cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one405-230-9101205-02-1Repr. 2H361d

GHS08 Wng H361d607-001-00-0formic acid … %200-579-164-18-6Skin Corr. 1AH314 GHS05 Dgr H314 Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤C < 10 % Eye Irrit. 2; H319: 2 %≤ <10 % B607-002-00-6acetic acid … %200-580-764-19-7 Flam. Liq. 3 Skin Corr. 1A H226 H314 GHS02 GHS05 Dgr H226 H314 Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 % Skin Irrit. 2; H315: 10 % ≤C <25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % B 607-003-00-1chloroacetic acid201-178-479-11-8 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 H331 H311 H301 H314 H400 GHS06 GHS05 GHS09 Dgr H331 H311 H301 H314 H400 STOT SE 3; H335: C≥ 5 %607-004-00-7TCA (ISO); trichloroacetic acid200-927-276-03-9 Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 STOT SE 3; H335: C ≥ 1 %607-005-00-2TCA-sodium (ISO); sodium trichloroacetate211-479-2650-51-1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H335 H400 H410 GHS07 GHS09 Wng H335 H410 607-006-00-8oxalic acid205-634-3144-62-7Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 607-007-00-3salts of oxalic acid (with the exception of those specified elsewhere in this Annex)——Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 A607-008-00-9acetic anhydride203-564-8108-24-7 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H226 H332 H302 H314 GHS02 GHS05 GHS07 Dgr H226 H332 H302 H314 Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C < 25 % Eye Dam. 1; H318: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 1 % ≤C < 5 % STOT SE 3; H335: C ≥ 5 % 607-009-00-4phthalic anhydride201-607-585-44-9 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H302 H335 H315 H318 H334 H317 GHS08 GHS05 GHS07 Dgr H302 H335 H315 H318 H334 H317 607-010-00-Xpropionic anhydride204-638-2123-62-6Skin Corr. 1BH314 GHS05 Dgr H314 Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % 607-011-00-5acetyl chloride200-865-675-36-5 Flam. Liq. 2 Skin Corr. 1B H225 H314 GHS02 GHS05 Dgr H225 H314 EUH014607-012-00-0benzoyl chloride202-710-898-88-4 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H332 H312 H302 H314 H317 GHS05 GHS07 Dgr H332 H312 H302 H314 H317 607-013-00-6dimethyl carbonate210-478-4616-38-6Flam. Liq. 2H225 GHS02 Dgr H225607-014-00-1methyl formate203-481-7107-31-3 Flam. Liq. 1 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H224 H332 H302 H319 H335 GHS02 GHS07 Dgr H224 H332 H302 H319 H335 607-015-00-7ethyl formate203-721-0109-94-4 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H225 H332 H302 H319 H335 GHS02 GHS07 Dgr H225 H332 H302 H319 H335 607-016-00-2propyl formate; [1] isopropyl formate [2] 203-798-0 [1] 210-901-2 [2] 110-74-7 [1] 625-55-8 [2] Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 H225 H319 H335 H336 GHS02 GHS07 Dgr H225 H319 H335 H336 C607-017-00-8butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] 209-772-5 [1] 212-105-0 [2]

208-818-1 [3] 592-84-7 [1] 762-75-4 [2] 542-55-2 [3] Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H335 GHS02 GHS07 Dgr H225 H319 H335 C607-018-00-3isopentyl formate; [1] 2-methylbutyl formate [2] 203-769-2 [1] 252-343-2 [2] 110-45-2 [1] 35073-27-9 [2] Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H335 GHS02 GHS07 Dgr H225 H319 H335 C607-019-00-9methyl chloroformate201-187-379-22-1 Flam. Liq. 2 Acute Tox. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H225 H330 H312 H302 H314 GHS02 GHS06 GHS05 Dgr H225 H330 H312 H302 H314 607-020-00-4ethyl chloroformate208-778-5541-41-3 Flam. Liq. 2 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B H225 H330 H302 H314 GHS02 GHS06 GHS05 Dgr H225 H330 H302 H314 607-021-00-Xmethyl acetate201-185-279-20-9 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 EUH066 607-022-00-5ethyl acetate205-500-4141-78-6 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 EUH066607-023-00-0vinyl acetate203-545-4108-05-4 Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 H225 H351 H332 H335 GHS02 GHS08 GHS07 Dgr H225 H351 H332 H335 D607-024-00-6propyl acetate; [1] isopropyl acetate [2] 203-686-1 [1] 203-561-1 [2] 109-60-4 [1] 108-21-4 [2] Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 H225 H319 H336 GHS02 GHS07 Dgr H225 H319 H336 EUH066C607-025-00-1n-butyl acetate204-658-1123-86-4 Flam. Liq. 3 STOT SE 3 H226 H336 GHS02 GHS07 Wng H226 H336 EUH066607-026-00-7sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] 203-300-1 [1] 203-745-1 [2] 208-760-7 [3] 105-46-4 [1] 110-19-0 [2] 540-88-5 [3] Flam. Liq. 2H225 GHS02 Dgr H225EUH066C607-027-00-2methyl propionate209-060-4554-12-1 Flam. Liq. 2 Acute Tox. 4 H225 H332 GHS02 GHS07 Dgr H225 H332 607-028-00-8ethyl propionate203-291-4105-37-3Flam. Liq. 2H225 GHS02 Dgr H225607-029-00-3n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3] 209-669-5 [1] -[2] 208-746-0 [3] 590-01-2 [1] 591-34-4 [2] 540-42-1 [3] Flam. Liq. 3H226 GHS02 Wng H226C607-030-00-9propyl propionate203-389-7106-36-5 Flam. Liq. 3 Acute Tox. 4 H226 H332 GHS02 GHS07 Wng H226 H332 607-031-00-4butyl butyrate203-656-8109-21-7Flam. Liq. 3H226 GHS02 Wng H226C607-032-00-Xethyl acrylate205-438-8140-88-5 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H225 H332 H312 H302 H319 H335 H315 H317 GHS02 GHS07 Dgr H225 H332 H312 H302 H319 H335 H315 H317 Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 %D607-033-00-5n-butyl methacrylate202-615-197-88-1 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H226 H319 H335 H315 H317 GHS02 GHS07 Wng H226 H319 H335 H315 H317 D607-034-00-0methyl acrylate; methyl propenoate202-500-696-33-3 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H225 H332 H312 H302 H319 H335 H315 H317 GHS02 GHS07 Dgr H225 H332 H312 H302 H319 H335 H315 H317 D607-035-00-6methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate201-297-180-62-6

Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H225 H335 H315 H317 GHS02 GHS07 Dgr H225 H335 H315 H317 D 607-036-00-12-methoxyethyl acetate; methylglycol acetate203-772-9110-49-6 Repr. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H360FD H332 H312 H302 GHS08 GHS07 Dgr H360FD H332 H312 H302 607-037-00-72-ethoxyethyl acetate; ethylglycol acetate203-839-2111-15-9 Flam. Liq. 3 Repr. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H226 H360FD H332 H312 H302 GHS02 GHS08 GHS07 Dgr H226 H360FD H332 H312 H302 607-038-00-22-butoxyethyl acetate; butylglycol acetate203-933-3112-07-2Acute Tox. 4 Acute Tox. 4 H332 H312 GHS07 Wng H332 H312 607-039-00-82,4-D (ISO); 2,4-dichlorophenoxyacetic acid202-361-194-75-7 Acute Tox. 4 STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H335 H318 H317 H412 GHS05 GHS07 Dgr H302 H335 H318 H317 H412 607-040-00-3salts of 2,4-D—— Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 A607-041-00-92,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid202-273-393-76-5 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H335 H315 H410 607-042-00-4salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid—— Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H335 H315 H410 A607-043-00-Xdicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid217-635-61918-00-9 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 607-044-00-53,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate[2] 218-951-7 [1] 233-002-7 [2] 2300-66-5 [1] 10007-85-9 [2] Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 607-045-00-0dichlorprop (ISO); 2-(2,4-dichlorophenoxy)propionic acid204-390-5120-36-5 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 H312 H302 H315 H318 GHS05 GHS07 Dgr H312 H302 H315 H318 607-046-00-6salts of dichlorprop——Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H332 H312 H302 GHS07 Wng H332 H312 H302 A607-047-00-1fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid202-271-293-72-1 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H400 H410 GHS07 GHS09 Wng H302 H315 H410 607-048-00-7salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid—— Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 A 607-049-00-2mecoprop (ISO); 2-(4-chloro-o-tolyloxy)propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] 230-386-8 [1] 202-264-4 [2] 7085-19-0 [1] 708519-0 [2] Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H315 H318 H410

M=100607-050-00-8salts of mecoprop—— Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H315 H318 H410 A607-051-00-3MCPA (ISO); 4-chloro-o-tolyloxyacetic acid202-360-694-74-6 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H315 H318 H410 607-052-00-9salts and esters of MCPA—— Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 A607-053-00-4MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid202-365-394-81-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-054-00-Xsalts and esters of MCPB——Acute Tox. 4 H302 GHS07 Wng H302A 607-055-00-5endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate204-959-8129-67-9 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H301 H312 H319 H335 H315 GHS06 Dgr H301 H312 H319 H335 H315 607-057-00-6coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin201-378-181-82-3 STOT RE 2 Aquatic Chronic 3 H373 H412 GHS08 Wng H373 H412607-058-00-1coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]coumarin204-195-5117-52-2 Acute Tox. 3 STOT RE 1 Aquatic Chronic 3 H301 H372 H412 GHS06 GHS08 Dgr H301 H372 H412 607-060-00-2dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)200-632-966-76-2 STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 H372 H302 H411 GHS08 GHS07 GHS09 Dgr H372 H302 H411 607-061-00-8acrylic acid; prop-2-enoic acid201-177-979-10-7 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A Aquatic Acute 1 H226 H332 H312 H302 H314 H400 GHS02 GHS05 GHS07 GHS09 Dgr H226 H332 H312 H302 H314 H400 STOT SE 3; H335: C ≥ 1 %D607-062-00-3n-butyl acrylate205-480-7141-32-2 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H226 H319 H335 H315 H317 GHS02 GHS07 Wng H226 H319 H335 H315 H317 D607-063-00-9isobutyric acid201-195-779-31-2Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 607-064-00-4benzyl chloroformate207-925-0501-53-1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H314 H400 H410 GHS05 GHS09 Dgr H314 H410 STOT SE 3; H335: C ≥ 5 %607-065-00-Xbromoacetic acid201-175-879-08-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 H331 H311 H301 H314 H317 H400 GHS06 GHS05 GHS09 Dgr H331 H311 H301 H314 H317 H400 607-066-00-5dichloroacetic acid201-207-079-43-6Skin Corr. 1A Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 607-067-00-0dichloroacetyl chloride201-199-979-36-7Skin Corr. 1A Aquatic Acute 1 H314 H400 GHS05 GHS09 Dgr H314 H400 607-068-00-6iodoacetic acid200-590-164-69-7 Acute Tox. 3 Skin Corr. 1A H301 H314 GHS06 GHS05 Dgr H301 H314 607-069-00-1ethyl bromoacetate203-290-9105-36-2 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 H330 H310 H300 GHS06 Dgr H330 H310 H300 607-070-00-7ethyl chloroacetate203-294-0105-39-5

Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 H331 H311 H301 H400 GHS06 GHS09 Dgr H331 H311 H301 H400 607-071-00-2ethyl methacrylate202-597-597-63-2 Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H225 H319 H335 H315 H317 GHS02 GHS07 Dgr H225 H319 H335 H315 H317 D607-072-00-82-hydroxyethyl acrylate212-454-9818-61-1 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 H311 H314 H317 H400 GHS06 GHS05 GHS09 Dgr H311 H314 H317 H400

Skin Sens. 1; H317: C ≥ 0,2 % D607-073-00-34-CPA (ISO); 4-chlorophenoxyacetic acid204-581-3122-88-3Acute Tox. 4 H302 GHS07 Wng H302607-074-00-9chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid201-599-385-34-7 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-075-00-4chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate238-413-514437-17-3 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 607-076-00-Xdodine(ISO); dodecylguanidinium acetate219-459-52439-10-3 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H315 H400 H410 GHS07 GHS09 Wng H302 H319 H315 H410 607-077-00-5erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl2,2-dichloropropionate—136-25-4 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-078-00-0fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate—4301-50-2 Acute Tox. 1 Acute Tox. 2 H310 H300 GHS06 Dgr H310 H300 607-079-00-6kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate—4234-79-1 Acute Tox. 3 Acute Tox. 4 Aquatic Chronic 2 H311 H302 H411 GHS06 GHS09 Dgr H311 H302 H411 607-080-00-1chloroacetyl chloride201-171-679-04-9 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1A Aquatic Acute 1 H331 H311 H301 H372 H314 H400 GHS06 GHS08 GHS05 GHS09 Dgr H331 H311 H301 H372 H314 H400 EUH014 EUH029 607-081-00-7fluoroacetic acid205-631-7144-49-0Acute Tox. 2 Aquatic Acute 1 H300 H400 GHS06 GHS09 Dgr H300 H400 607-082-00-2fluoroacetates, soluble——Acute Tox. 2 Aquatic Acute 1 H300 H400 GHS06 GHS09 Dgr H300 H400 A607-083-00-82,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid202-366-994-82-6 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-084-00-3salts of 2,4-DB—— Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 A607-085-00-9benzyl benzoate204-402-9120-51-4 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-086-00-4diallyl phthalate205-016-3131-17-9 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 607-088-00-5methacrylic acid; 2-methylpropenoic acid201-204-479-41-4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 STOT SE 3; H335: C ≥ 1 %D607-089-00-0propionic acid … %201-176-379-09-4Skin Corr. 1BH314 GHS05 Dgr H314

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % B607-090-00-6thioglycolic acid200-677-468-11-1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B H331 H311 H301 H314 GHS06 GHS05 Dgr H331 H311 H301 H314 607-091-00-1trifluoroacetic acid . . . %200-929-376-05-1 Acute Tox. 4 Skin Corr. 1A Aquatic Chronic 3 H332 H314 H412 GHS05 GHS07 Dgr H332 H314 H412 B607-092-00-7methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] 208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] 547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 H226 H319 H335 GHS02 GHS07 Wng H226 H319 H335 C607-093-00-2propionyl chloride201-170-079-03-8 Flam. Liq. 2 Skin Corr. 1B H225 H314 GHS02 GHS05 Dgr H225 H314 EUH014B D 607-094-00-8peracetic acid . . . %201-186-879-21-0 Flam. Liq. 3 Org. Perox. D Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A Aquatic Acute 1 H226 H242 H332 H312 H302 H314 H400 GHS02 GHS05 GHS07 GHS09 Dgr H226 H242 H332 H312 H302 H314 H400

STOT SE 3; H335: C ≥ 1 % B D607-095-00-3maleic acid203-742-5110-16-7 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H302 H319 H335 H315 H317 GHS07 Wng H302 H319 H335 H315 H317 Skin Sens. 1; H317: C ≥0,1 %607-096-00-9maleic anhydride203-571-6108-31-6 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 H302 H314 H334 H317 GHS08 GHS05 GHS07 Dgr H302 H314 H334 H317 607-097-00-4benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride209-008-0552-30-7 STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H335 H318 H334 H317 GHS08 GHS05 GHS07 Dgr H335 H318 H334 H317 607-098-00-Xbenzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride201-898-989-32-7 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H318 H334 H317 GHS08 GHS05 Dgr H318 H334 H317 607-099-00-51,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalicanhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] 201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] 85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H334 H317 H412 GHS08 GHS05 Dgr H318 H334 H317 H412 C 607-100-00-9benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride)219-348-12421-28-5 Eye Irrit. 2 STOT SE 3 H319 H335 GHS07 Wng H319 H335 Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %607-101-00-41,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylicanhydride chlorendic anhydride204-077-3115-27-5 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %607-102-00-Xcyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylicanhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] 201-604-9 [1] 236-086-3 [2]

238-009-9 [3] 85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H318 H334 H317 GHS08 GHS05 Dgr H318 H334 H317 C607-103-00-5succinic anhydride203-570-0108-30-5 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H302 H319 H335 GHS07 Wng H302 H319 H335

Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % 607-104-00-0cyclopentane-1,2,3,4-tetracarboxylic dianhydride227-964-76053-68-5 Eye Irrit. 2 STOT SE 3 H319 H335 GHS07 Wng H319 H335 Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %607-105-00-68,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] 204-957-7 [1] 212-557-9 [2] 220-384-5 [3] 129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H318 H334 H317 GHS08 GHS05 Dgr H318 H334 H317 C607-106-00-18,9-dinorborn-5-ene-2,3-dicarboxylic anhydride—123748-85-6 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H302 H319 H335 H315 H334 GHS08 GHS07 Dgr H302 H319 H335 H315 H334 STOT SE 3; H335: C ≥ 10 %C 607-107-00-72-ethylhexyl acrylate203-080-7103-11-7 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H335 H315 H317 GHS07 Wng H335 H315 H317 D607-108-00-22-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2-diol [3] 220-852-9 [1] 213-663-8 [2] 247-118-0 [3] 2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 H331 H311 H301 H314 H317 GHS06 GHS05 Dgr H331 H311 H301 H314 H317

Skin Sens. 1; H317:C ≥0,2 % C D607-109-00-8hexamethylene diacrylate; hexane-1,6-diol diacrylate235-921-913048-33-4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-110-00-3pentaerythritol triacrylate222-540-83524-68-3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-111-00-92,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate239-701-315625-89-5 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-112-00-42,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate218-741-52223-82-7 Acute Tox. 3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H311 H319 H315 H317 GHS06 Dgr H311 H319 H315 H317 D607-113-00-Xisobutyl methacrylate202-613-097-86-9 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H226 H319 H335 H315 H317 H400 GHS02 GHS07 GHS09 Wng H226 H319 H335 H315 H317 H400 D 607-114-00-5ethylene dimethacrylate202-617-297-90-5 STOT SE 3 Skin Sens. 1 H335 H317 GHS07 Wng H335 H317 STOT SE 3; H335: C ≥ 10 %D607-115-00-0isobutyl acrylate203-417-8106-63-8 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 H226 H332 H312 H315 H317 GHS02 GHS07 Wng H226 H332 H312 H315 H317 D607-116-00-6cyclohexyl acrylate221-319-33066-71-5 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H335 H315 H411 GHS07 GHS09 Wng H335 H315 H411 STOT SE 3; H335: C ≥ 10 %D607-117-00-12,3-epoxypropyl acrylate; glycidyl acrylate203-440-3106-90-1

Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 H331 H311 H301 H314 H317 GHS06 GHS05 Dgr H331 H311 H301 H314 H317

Skin Sens. 1; H317:C ≥0,2 % D607-118-00-71-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate243-105-919485-03-1 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H312 H314 H317 GHS05 GHS07 Dgr H312 H314 H317 D607-119-00-2tetramethylene diacrylate; 1,4-butyleneglycol diacrylate213-979-61070-70-8 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H312 H314 H317 GHS05 GHS07 Dgr H312 H314 H317 D607-120-00-82,2'-oxydiethyl diacrylate; diethylene glycol diacrylate223-791-64074-88-8 Acute Tox. 3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H311 H319 H315 H317 GHS06 Dgr H311 H319 H315 H317

Skin Sens. 1; H317:C≥0,2 % D607-121-00-38,9,10-trinorborn-2-yl acrylate—10027-06-2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 H312 H315 H317 GHS07 Wng H312 H315 H317 D 607-122-00-9pentaerythritol tetraacrylate225-644-14986-89-4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-124-00-X2-hydroxyethyl methacrylate212-782-2868-77-9 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-125-00-52-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate[2] 213-090-3 [1] 220-426-2 [2] 923-26-2 [1] 2761-09-3 [2] Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 C D607-126-00-02,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate216-853-91680-21-3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-127-00-62-diethylaminoethyl methacrylate203-275-7105-16-8 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H332 H319 H315 H317 GHS07 Wng H332 H319 H315 H317 D607-128-00-12-tert-butylaminoethyl methacrylate223-228-43775-90-4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 D607-129-00-7ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] 202-598-0 [1] 211-694-1 [2] 97-64-3 [1] 687-47-8 [2] Flam. Liq. 3 STOT SE 3 Eye Dam. 1 H226 H335 H318 GHS02 GHS05 GHS07 Dgr H226 H335 H318 C607-130-00-2pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] 211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] 628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] Flam. Liq. 3H226 GHS02 Wng H226EUH066C 607-131-00-8isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] 203-322-1 [1] 210-852-7 [2] 219-449-0 [3] 105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] Flam. Liq. 3H226 GHS02 Wng H226C607-132-00-32-dimethylaminoethyl methacrylate220-688-82867-47-2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H312 H302 H319 H315 H317 GHS07 Wng H312 H302 H319 H315 H317 D607-133-00-9monoalkylor monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex—— Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2

H319 H335 H315 H411 GHS07 GHS09 Wng H319 H335 H315 H411 STOT SE 3; H335: C ≥ 10 %A607-134-00-4monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex—— Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 STOTSE 3; H335: C ≥ 10 %A607-135-00-Xbutyric acid203-532-3107-92-6Skin Corr. 1BH314 GHS05 Dgr H314607-136-00-5butyryl chloride205-498-5141-75-3 Flam. Liq. 2 Skin Corr. 1B H225 H314 GHS02 GHS05 Dgr H225 H314 607-137-00-0methyl acetoacetate203-299-8105-45-3Eye Irrit. 2H319 GHS07 Wng H319607-138-00-6butyl chloroformate; chloroformic acid butyl ester209-750-5592-34-7 Flam. Liq. 3 Acute Tox. 3 Skin Corr. 1B H226 H331 H314 GHS02 GHS06 GHS05 Dgr H226 H331 H314 607-139-00-12-chloropropionic acid209-952-3598-78-7 Acute Tox. 4 Skin Corr. 1A H302 H314 GHS05 GHS07 Dgr H302 H314 607-140-00-7isobutyryl chloride201-194-179-30-1 Flam. Liq. 2 Skin Corr. 1A H225 H314 GHS02 GHS05 Dgr H225 H314 607-141-00-2oxydiethylene bis(chloroformate)203-430-9106-75-2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H302 H315 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H315 H318 H411 607-142-00-8propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate203-687-7109-61-5 Flam. Liq. 2 Acute Tox. 3 Skin Corr. 1B H225 H331 H314 GHS02 GHS06 GHS05 Dgr H225 H331 H314 607-143-00-3valeric acid203-677-2109-52-4 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412 607-144-00-9adipic acid204-673-3124-04-9Eye Irrit. 2H319 GHS07 Wng H319607-145-00-4methanesulphonic acid200-898-675-75-2Skin Corr. 1BH314 GHS05 Dgr H314607-146-00-Xfumaric acid203-743-0110-17-8Eye Irrit. 2H319 GHS07 Wng H319607-147-00-5oxalic acid diethylester; diethyl oxalate202-464-195-92-1 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 607-148-00-0guanidinium chloride; guanadine hydrochloride200-002-350-01-1 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 H302 H319 H315 GHS07 Wng H302 H319 H315 607-149-00-6urethane (INN); ethyl carbamate200-123-151-79-6Carc. 1BH350 GHS08 Dgr H350607-150-00-1endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid205-660-5145-73-3 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H301 H312 H319 H335 H315 GHS06 Dgr H301 H312 H319 H335 H315 607-151-00-7propargite (ISO); 2-(4-tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite219-006-12312-35-8 Carc. 2 Acute Tox. 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H315 H318 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H351 H331 H315 H318 H410 M = 10607-152-00-22,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid200-026-450-31-7 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-153-00-8benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid223-297-03813-05-6 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 H319 H315 H412 GHS07 Wng H319 H315 H412 607-154-00-3ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO)244-845-522212-55-1 Acute Tox. 4 Aquatic Acute 1

Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 607-155-00-93-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s—2079-00-7Acute Tox. 2 H300 GHS06 Dgr H300 607-156-00-4chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate201-270-480-33-1 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H400 H410 GHS07 GHS09 Wng H302 H315 H410 607-158-00-5sodium salt of chloroacetic acid; sodium chloroacetate223-498-33926-62-3 Acute Tox. 3 Skin Irrit. 2 Aquatic Acute 1 H301 H315 H400 GHS06 GHS09 Dgr H301 H315 H400 607-159-00-0chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate208-110-2510-15-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 607-160-00-6isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO)—51337-71-4Acute Tox. 4 H302 GHS07 Wng H302607-161-00-1diethanolamine salt of 4-CPA——Acute Tox. 4 H302 GHS07 Wng H302607-162-00-7dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate[2] 200-923-0 [1] 204-828-5 [2] 75-99-0 [1] 127-20-8 [2] Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318 H412 607-163-00-23-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid208-293-9520-45-6Acute Tox. 4 H302 GHS07 Wng H302607-164-00-8sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate224-580-14418-26-2Acute Tox. 4 H302 GHS07 Wng H302607-165-00-3diclofop-methyl (ISO)methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;257-141-851338-27-3 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 607-166-00-9medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate219-634-62487-01-6Acute Tox. 3 Acute Tox. 4 H301 H312 GHS06 Dgr H301 H312 607-167-00-4sodium 3-chloroacrylate—4312-97-4Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 607-168-00-Xdipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome—83-59-0 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H311 H302 H400 H410 GHS06 GHS09 Dgr H311 H302 H410 607-169-00-5sodium fluoroacetate200-548-262-74-8 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 H330 H310 H300 H400 GHS06 GHS09 Dgr H330 H310 H300 H400 607-170-00-0bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate250-859-231895-22-4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 607-173-00-7dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate400-460-6— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-174-00-2reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate400-580-9—

Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 607-175-00-8methyl 2-(2-nitrobenzylidene)acetoacetate400-650-939562-27-1 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-176-00-3reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)400-830-7— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-177-00-9tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester; methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate401-190-1101200-48-0 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 100607-178-00-4methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate401-340-683055-99-6 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-179-00-X(benzothiazol-2-ylthio)succinic acid401-450-495154-01-1Skin Sens. 1H317 GHS07 Wng H317607-180-00-5potassium 2-hydroxycarbazole-1-carboxylate401-630-296566-70-0 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 H302 H319 H335 H412 GHS07 Wng H302 H319 H335 H412 607-181-00-03,5-dichloro-2,4-difluorobenzoyl fluoride401-800-6101513-70-6 Acute Tox. 3 Skin Corr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H331 H314 H302 H317 H412 GHS06 GHS05 Dgr H331 H314 H302 H317 H412 EUH029607-182-00-6methyl 3-sulphamoyl-2-thenoate402-050-2—Skin Sens. 1H317 GHS07 Wng H317607-183-00-1zinc 2-hydroxy-5-C13-18 alkylbenzoate402-280-3— Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H319 H315 H411 GHS07 GHS09 Wng H319 H315 H411 607-184-00-7S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate402-290-885702-90-5 Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 H226 H334 H317 GHS02 GHS08 Dgr H226 H334 H317 607-185-00-2ethyl trans-3-dimethylaminoacrylate402-650-41117-37-9Skin Sens. 1H317 GHS07 Wng H317607-186-00-8quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid402-780-184087-01-4Skin Sens. 1H317 GHS07 Wng H317607-187-00-3bis(2,2,6,6-tetramethyl-4-piperidyl) succinate402-940-062782-03-0 Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 607-188-00-9hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate402-970-4— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-189-00-4trimethylenediaminetetraacetic acid400-400-91939-36-2 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 607-190-00-Xmethyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)401-890-777402-03-0 Carc. 1B Muta. 1B Acute Tox. 4 Eye Irrit. 2 H350 H340 H302 H319 GHS08 GHS07 Dgr H350 H340 H302 H319 607-191-00-5isobutyl 3,4-epoxybutyrate401-920-9100181-71-3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09

Wng H315 H317 H410 607-192-00-0disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate402-360-892511-22-3Eye Dam. 1H318 GHS05 Dgr H318 607-194-00-1propylene carbonate203-572-1108-32-7Eye Irrit. 2H319 GHS07 Wng H319607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6Flam. Liq. 3H226 GHS02 Wng H226607-196-00-2heptanoic acid203-838-7111-14-8Skin Corr. 1BH314 GHS05 Dgr H314607-198-00-3propyl 3,4,5-trihydroxybenzoate204-498-2121-79-9 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 607-199-00-9octyl 3,4,5-trihydroxybenzoate213-853-01034-01-1 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 607-200-00-2dodecyl 3,4,5-trihydroxybenzoate214-620-61166-52-5Skin Sens. 1H317 GHS07 Wng H317607-201-00-8thiocarbonyl chloride207-341-6463-71-8 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H331 H302 H319 H335 H315 GHS06 Dgr H331 H302 H319 H335 H315 607-203-00-92-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate279-452-880387-97-9 Repr. 1B Skin Sens. 1 Aquatic Chronic 3 H360D H317 H412 GHS08 GHS07 Dgr H360D H317 H412 607-204-00-4(chlorophenyl)(chlorotolyl)methane, mixed isomers400-140-6— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 607-205-00-Xmethyl chloroacetate202-501-196-34-4 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H226 H331 H301 H335 H315 H318 GHS02 GHS06 GHS05 Dgr H226 H331 H301 H335 H315 H318 607-206-00-5isopropyl chloroacetate203-301-7105-48-6 Flam. Liq. 3 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H226 H301 H319 H335 H315 GHS02 GHS06 Dgr H226 H301 H319 H335 H315 607-207-00-0haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl)402-560-587237-48-7 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 607-208-00-64,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers403-000-291853-67-7 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 607-209-00-1reaction mass of O, O'-diisopropyl (pentathio)dithioformate and O, O'-diisopropyl (trithio)dithioformate and O, O'-diisopropyl (tetrathio)dithioformate403-030-6— Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 607-210-00-7methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)403-230-377402-05-2 Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 H350 H340 H314 H317 GHS08 GHS05 GHS07 Dgr H350 H340 H314 H317 607-211-00-2methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate403-270-16386-39-6 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-212-00-8poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate403-300-3—Skin Sens. 1H317 GHS07 Wng H317607-213-00-3ethyl 3,3-bis(tert-pentylperoxy)butyrate403-320-267567-23-1 Org. Perox. D Flam. Liq. 3 Aquatic Chronic 2 H242 H226 H411 GHS02 GHS09 Dgr H242 H226 H411 607-214-00-9N, N-hydrazinodiacetic acid403-510-519247-05-3

Acute Tox. 3 STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H301 H373 H317 H412 GHS06 GHS08 Dgr H301 H373 H317 H412 607-215-00-43-(3-tert-butyl-4-hydroxyphenyl)propionic acid403-920-4107551-67-7 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 607-216-00-Xglutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine403-950-8— Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 H330 H302 H314 H400 GHS06 GHS05 GHS09 Dgr H330 H302 H314 H400 607-217-00-52-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate403-960-2— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-218-00-0dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid403-980-115165-67-0 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317 607-219-00-6bis(2-ethylhexyl) dithiodiacetate404-510-862268-47-7 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 607-221-00-76-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid404-550-6— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-222-00-26-(2,3-dimethylmaleimido)hexyl methacrylate404-870-663740-41-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-223-00-8transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate405-060-5118712-89-3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 607-224-00-3methyl 2-(3-nitrobenzylidene)acetoacetate405-270-739562-17-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-225-00-93-azidosulfonylbenzoic acid405-310-315980-11-7 Self-React. C STOT RE 2 Eye Dam. 1 Skin Sens. 1 H241 H373 H318 H317 GHS02 GHS08 GHS05 GHS07 Dgr H241 H373 H318 H317 607-226-00-4reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate405-360-6— Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H315 H318 H317 H412 GHS05 GHS07 Dgr H315 H318 H317 H412 607-227-00-Xpotassium 2-amino-2-methylpropionate octahydrate405-560-3120447-91-8 Acute Tox. 4 Skin Corr. 1A H302 H314 GHS05 GHS07 Dgr H302 H314 607-228-00-5bis(2-methoxyethyl) phthalate204-212-6117-82-8Repr. 1BH360Df GHS08 Dgr H360Df 607-229-00-0diethylcarbamoyl chloride201-798-588-10-8 Carc. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H351 H332 H302 H319 H335 H315 GHS08 GHS07 Wng H351 H332 H302 H319 H335 H315 607-230-00-62-ethylhexanoic acid205-743-6149-57-5Repr. 2H361d GHS08 Wng H361d 607-231-00-1clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid216-935-41702-17-6Eye Dam. 1H318 GHS05 Dgr H318607-232-00-7pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate259-686-755512-33-9 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410

GHS07 GHS09 Wng H315 H317 H410 607-233-00-2hexyl acrylate219-698-52499-95-8 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H319 H335 H315 H317 H411 GHS07 GHS09 Wng H319 H335 H315 H317 H411 607-234-00-8flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid207-397-1467-69-6Aquatic Chronic 2H411GHS09H411607-235-00-3mecrilate; methyl 2-cyanoacrylate205-275-2137-05-3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 STOT SE 3; H335: C ≥ 10 % 607-236-00-9ethyl 2-cyanoacrylate230-391-57085-85-0 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 STOT SE 3; H335: C ≥ 10 %607-237-00-4benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole276-942-372850-64-7Aquatic Chronic 2H411GHS09H411607-238-00-Xtau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate—102851-06-9 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H315 H400 H410 GHS07 GHS09 Wng H302 H315 H410 607-239-00-5fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate254-485-039515-41-8 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H330 H301 H312 H400 H410 GHS06 GHS09 Dgr H330 H301 H312 H410 607-240-00-0cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalicanhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalicanhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] 216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] 1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H318 H334 H317 GHS08 GHS05 Dgr H318 H334 H317 C607-241-00-6hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalicanhydride [4] 243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] 19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H318 H334 H317 GHS08 GHS05 Dgr H318 H334 H317 C 607-242-00-1tetrachlorophthalic anhydride204-171-4117-08-8 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H334 H317 H400 H410 GHS08 GHS05 GHS09 Dgr H318 H334 H317 H410 607-243-00-7sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] 217-846-3 [1] 246-590-5 [2] 258-527-9 [3] 1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] Aquatic Chronic 3H412—H412607-244-00-2isooctyl acrylate249-707-829590-42-9 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H319 H335 H315 H410 STOT SE 3; H335: C ≥ 10 %607-245-00-8tert-butyl acrylate216-768-71663-39-4

Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H225 H332 H312 H302 H335 H315 H317 H411 GHS02 GHS07 GHS09 Dgr H225 H332 H312 H302 H335 H315 H317 H411 D607-246-00-3allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester202-473-096-05-9 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 H226 H331 H312 H302 H400 GHS02 GHS06 GHS09 Dgr H226 H331 H312 H302 H400 607-247-00-9dodecyl methacrylate205-570-6142-90-5 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H319 H335 H315 H410 STOT SE 3; H335: C ≥ 10 %607-248-00-4naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate205-073-4132-67-2Acute Tox. 4 H302 GHS07 Wng H302607-249-00-X(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate256-032-242978-66-5 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H319 H335 H315 H317 H411 GHS07 GHS09 Wng H319 H335 H315 H317 H411 STOT SE 3; H335: C ≥ 10 %607-250-00-54H-3,1-benzoxazine-2,4(1H)-dione204-255-0118-48-9 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 607-251-00-02-methoxypropyl acetate274-724-270657-70-4 Flam. Liq. 3 Repr. 1B STOT SE 3 H226 H360D H335 GHS02 GHS08 GHS07 Dgr H226 H360D H335 607-252-00-6lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)415-130-791465-08-6 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H330 H301 H312 H400 H410 GHS06 GHS09 Dgr H330 H301 H312 H410 M=10000 607-253-00-1cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate269-855-768359-37-5 Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H300 H331 H400 H410 GHS06 GHS09 Dgr H300 H331 H410 M=1000607-254-00-7α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin269-855-768359-37-5 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H400 H410 GHS06 GHS09 Dgr H330 H300 H410 607-255-00-2fluroxypyr (ISO);4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid—69377-81-7Aquatic Chronic 3H412—H412607-256-00-8azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate—131860-33-8 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H400 H410 GHS06 GHS09 Dgr H331 H410 607-257-00-3isopropyl propionate211-300-8637-78-5Flam. Liq. 2H225 GHS02 Dgr H225607-258-00-9dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate403-990-670950-45-7Aquatic Chronic 4H413—H413607-259-00-4methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate404-130-2105560-93-8 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412

607-260-00-Xethyl 2-(3-nitrobenzylidene)acetoacetate404-490-039562-16-8 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 607-261-00-5iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate404-800-4118832-72-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-262-00-07-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid405-050-086393-33-1 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 607-263-00-6potassium iron(III) 1,3-propanediamine-N, N,N',N'-tetraacetate hemihydrate405-680-6—Self-heat. 2 Aquatic Chronic 2 H252 H411 GHS02 GHS09 Wng H252 H411 607-264-00-12-chloro-4-(methylsulfonyl)benzoic acid406-520-853250-83-2Eye Dam. 1H318 GHS05 Dgr H318607-265-00-7ethyl-2-chloro-2,2-diphenylacetate406-580-552460-86-3 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412 607-266-00-2reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid406-890-0130296-87-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 607-267-00-8tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate407-620-433610-13-8 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H334 H317 H412 GHS08 Dgr H334 H317 H412 607-268-00-32-methylpropyl (R)-2-hydroxypropanoate407-770-061597-96-4Eye Irrit. 2H319 GHS07 Wng H319607-269-00-9(R)-2-(4-hydroxyphenoxy)propanoic acid407-960-394050-90-5Eye Dam. 1H318 GHS05 Dgr H318607-270-00-43,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane410-730-590498-90-1Acute Tox. 4 H312 GHS07 Wng H312 607-271-00-X2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane417-420-9156324-82-2 Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 607-272-00-5fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] 279-752-9 [1] -[2] 81406-37-3 [1] 154486-27-8 [2] Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-273-00-0ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate404-520-2—Aquatic Chronic 3H412—H412607-274-00-62-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate405-350-154527-73-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-275-00-1sodium benzoyloxybenzene-4-sulfonate405-450-566531-87-1Skin Sens. 1H317 GHS07 Wng H317607-276-00-7bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex405-635-0— Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 607-277-00-2reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate405-720-2— Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07

GHS09 Dgr H302 H318 H317 H411 607-278-00-8reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate405-760-0— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 607-279-00-3reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate405-960-8— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-280-00-9sodium 4-chloro-1-hydroxybutane-1-sulfonate406-190-554322-20-2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H302 H319 H317 GHS07 Wng H302 H319 H317 607-281-00-4reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates407-000-3127519-17-9Aquatic Chronic 2H411GHS09H411607-282-00-X2-acetoxymethyl-4-benzyloxybut-1-yl acetate407-140-5131266-10-9Aquatic Chronic 3H412—H412607-283-00-5E-ethyl-4-oxo-4-phenylcrotonate408-040-415121-89-8 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H312 H302 H315 H318 H317 H410 607-284-00-0reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)410-040-4136213-76-8Aquatic Chronic 2H411GHS09H411607-285-00-6reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate410-065-0—Skin Sens. 1H317 GHS07 Wng 607-286-00-1reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate410-070-8141880-36-6 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-287-00-7O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate410-140-8—Aquatic Chronic 3H412—H412607-288-00-2tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a, b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively410-160-7148732-74-5 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H317 H412 GHS07 Wng H319 H317 H412 607-289-00-83-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid410-370-9105488-33-3Aquatic Chronic 4H413—H413607-290-00-3reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate410-540-2—

Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 607-291-00-9dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate410-630-1104051-92-5Aquatic Chronic 4H413—H413607-292-00-4reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid410-640-6— Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 607-293-00-Xreaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate410-650-0— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 607-294-00-5sodium 2-benzoyloxy-1-hydroxyethane-sulfonate410-680-4—Skin Sens. 1H317 GHS07 Wng H317607-295-00-0reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate410-800-5— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-296-00-6reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid410-830-9—Aquatic Chronic 4H413—H413607-297-00-1(E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)410-960-692761-26-7Eye Dam. 1H318 GHS05 Dgr H318607-298-00-72-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate411-010-3—Skin Sens. 1H317 GHS07 Wng H317607-299-00-2methyl 3-(acetylthio)-2-methyl-propanoate411-040-797101-46-7 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 607-300-00-6trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4, N29, N30, N31, N32-sulfonylamino)benzoato(5-)]cuprate(II) where a =1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25411-430-7— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-301-00-1reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid411-860-5— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-302-00-7reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid411-910-6— Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H315 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H411 607-303-00-21-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid413-760-793107-30-3 Repr. 2 Aquatic Chronic 3 H361f H412 GHS08 Wng H361f H412607-304-00-8fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate274-125-669806-50-4 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410607-305-00-3fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate—79241-46-6 Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 H361d H400 H410 GHS08 GHS09 Wng H361d H410607-306-00-9chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate282-714-484332-86-5

Carc. 2 Aquatic Chronic 2 H351 H411 GHS08 GHS09 Wng H351 H411 607-307-00-4vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione256-599-650471-44-8 Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 H351 H360FD H317 H411 GHS08 GHS07 GHS09 Dgr H351 H360FD H317 H411 607-308-00-Xesters of 2,4-D—— Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 A 607-309-00-5carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate—128639-02-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-310-00-0kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate—143390-89-0 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 607-311-00-6benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate246-591-025059-80-7Aquatic Chronic 2H411GHS09H411607-312-00-1methoxyacetic acid210-894-6625-45-6 Repr. 1B Acute Tox. 4 Skin Corr. 1B H360FD H302 H314 GHS08 GHS05 GHS07 Dgr H360FD H302 H314 STOT SE 3; H335: C ≥ 5 %607-313-00-7neodecanoyl chloride254-875-040292-82-8 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B H330 H302 H314 GHS06 GHS06 Dgr H330 H302 H314 STOT SE 3; H335: C ≥ 5 %607-314-00-2ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-ylmethanesulfonate247-525-326225-79-6Aquatic Chronic 2H411GHS09H411607-315-00-8glyphosate (ISO); N-(phosphonomethyl)glycine213-997-41071-83-6 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 607-316-00-3glyphosate-trimesium; glyphosate-trimethylsulfonium—81591-81-3 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-317-00-9bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP204-211-0117-81-7Repr. 1BH360FD GHS08 Dgr H360FD607-318-00-4dibutyl phthalate; DBP201-557-484-74-2 Repr. 1B Aquatic Acute 1 H360Df H400 GHS08 GHS09 Dgr H360Df H400 607-319-00-Xdeltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate258-256-652918-63-5 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H400 H410 GHS06 GHS09 Dgr H331 H301 H410 M=1000000607-320-00-5bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate413-930-0130066-57-8 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-321-00-0(S)-methyl-2-chloropropionate412-470-873246-45-4 Flam. Liq. 3 STOT RE 2 Eye Irrit. 2 H226 H373 H319 GHS02 GHS08 Wng H226 H373 H319 607-322-00-64-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid413-120-7107144-30-9 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-323-00-12-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate413-850-6123968-25-2Aquatic Chronic 4H413—H413607-324-00-7reaction mass of: N, N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine413-800-3—Aquatic Chronic 4H413—H413

607-325-00-2(S)-2-chloropropionic acid411-150-529617-66-1 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 607-326-00-8reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate410-720-0141847-13-4 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 607-327-00-32-(2-iodoethyl)-1,3-propanediol diacetate411-780-0127047-77-2 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-328-00-9methyl 4-bromomethyl-3-methoxybenzoate410-310-170264-94-7 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 607-329-00-4reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate411-250-9—Skin Sens. 1H317 GHS07 Wng H317607-330-00-X(S)-2,3-dihydro-1H-indole-2-carboxylic acid410-860-279815-20-6 Repr. 2 STOT RE 2 Skin Sens. 1 H361f H373 H317 GHS08 GHS07 Wng H361f H373 H317607-331-00-5reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane406-750-9—Aquatic Chronic 4H413—H413 607-332-00-0cyclopentyl chloroformate411-460-050715-28-1 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H226 H331 H302 H373 H318 H317 GHS02 GHS06 GHS08 GHS05 Dgr H226 H331 H302 H373 H318 H317 607-333-00-6reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate405-670-1— Acute Tox. 4 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H314 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H302 H373 H314 H410 607-334-00-1ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate405-880-3100501-62-0 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-335-00-7methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate406-250-072619-32-0 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 607-336-00-24-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate406-560-6122760-85-4 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H315 H317 H411 GHS07 GHS09 Wng H315 H317 H411 607-337-00-8di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate406-052-4125078-60-6 Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H226 H302 H315 H318 H411 GHS02 GHS05 GHS07 GHS09 Dgr H226 H302 H315 H318 H411 607-338-00-32-methylpropyl 2-hydroxy-2-methylbut-3-enoate406-235-972531-53-4 Eye Irrit. 2 Skin Irrit. 2 H319 H315 GHS07 Wng H319 H315 607-339-00-92,3,4,5-tetrachlorobenzoylchloride406-760-342221-52-3 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H302 H314 H317 GHS05 GHS07 Dgr H302 H314 H317 607-340-00-41,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate406-990-4—Aquatic Chronic 2H411GHS09H411607-341-00-X(9S)-9-amino-9-deoxyerythromycin406-790-726116-56-3

Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 607-342-00-54-chlorobutyl veratrate410-950-169788-75-6 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-343-00-04,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)407-410-2—Aquatic Chronic 4H413—H413607-344-00-6reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate407-810-7—STOT RE 2 H373 GHS08 Wng H373 607-345-00-1potassium 2-(2,4-dichlorophenoxy)-(R)-propionate413-580-9113963-87-4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317 607-346-00-73-icosyl-4-henicosylidene-2-oxetanone401-210-983708-14-9Aquatic Chronic 4H413—H413607-347-00-2sodium (R)-2-(2,4-dichlorophenoxy)propionate413-340-3119299-10-4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317 607-348-00-8magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)413-360-2— Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317 607-349-00-3mono-(tetrapropylammonium)hydrogen 2,2'-dithiobisbenzoate411-270-8—Aquatic Chronic 3H412H412607-350-00-9bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane412-060-9136210-32-7 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-351-00-4methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate407-550-469184-17-4Aquatic Chronic 2H411GHS09H411607-352-00-X4,4'-oxydiphthalic anhydride412-830-41823-59-2Aquatic Chronic 3H412—H412607-353-00-5reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate407-520-080657-64-3 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 607-354-00-0ethyl 2-cyclohexylpropionate412-280-52511-00-4Aquatic Chronic 2H411GHS09H411607-355-00-6p-tolyl 4-chlorobenzoate411-530-015024-10-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-356-00-1ethyl trans-2,2,6-trimethylcyclohexanecarboxylate412-540-8— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 607-357-00-7reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran412-450-9131766-73-9Skin Sens. 1H317 GHS07 Wng H317607-358-00-2(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate412-670-554275-93-3Resp. Sens. 1H334 GHS08 Dgr H334607-359-00-8(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate412-800-076109-32-5Resp. Sens. 1H334 GHS08 Dgr H334607-360-00-3sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate411-680-7133167-77-8Skin Sens. 1H317 GHS07 Wng H317607-361-00-9methyl (R)-2-(4-hydroxyphenoxy)propionate411-950-496562-58-2

Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-362-00-4reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate413-500-2— Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H315 H318 H411 GHS05 GHS09 Dgr H315 H318 H411 607-363-00-Xmethyl-3-methoxyacrylate412-900-45788-17-0Skin Sens. 1H317 GHS07 Wng H317 607-364-00-53-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione413-330-9134724-55-3Aquatic Chronic 4H413H413607-365-00-02-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride410-620-7119154-86-8 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H302 H314 H317 GHS05 GHS07 Dgr H302 H314 H317 607-366-00-63,5-dimethylbenzoyl chloride413-010-96613-44-1 Skin Corr. 1B Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317 607-367-00-1potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrate-(1-)monohydrate411-640-9153352-59-1Acute Tox. 4 H302 GHS07 Wng H302607-368-00-71-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole411-650-3110895-43-7 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H400 H410 GHS06 GHS09 Dgr H331 H301 H410 607-369-00-2reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid411-660-8147027-04-1 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317 607-370-00-82-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol412-210-341620-33-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-371-00-33-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate413-410-388150-62-3Aquatic Chronic 4H413—H413 607-372-00-9ethoxylated bisphenol A di-(norbornene carboxylate)412-410-0—Aquatic Chronic 3H412—H412607-373-00-4(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate414-200-4119738-06-6 Muta. 2 Repr. 1B Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H341 H360Df H302 H373 H400 H410 GHS08 GHS07 GHS09 Dgr H341 H360Df H302 H373 H410 607-374-00-X5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride417-220-137441-29-5 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-376-00-0benzyl 2,4-dibromobutanoate420-710-823085-60-1 Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361f H315 H317 H410 607-377-00-6trans-4-cyclohexyl-L-proline monohydrochloride419-160-190657-55-9

Repr. 2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H361f H302 H315 H318 H317 GHS08 GHS05 GHS07 Dgr H361f H302 H315 H318 H317 607-378-00-1ammonium (Z)-α-methoxyimino-2-furylacetate405-990-197148-39-5Flam. Sol. 2H228 GHS02 Dgr H228T 607-379-00-7reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N, N-bis(2-hydroxyethyl)stearamide401-230-8Aquatic Chronic 3H412—H412607-380-00-2reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate407-320-3— Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H315 H318 H412 GHS05 Dgr H315 H318 H412 607-381-00-8reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid413-710-4—Aquatic Chronic 4H413—H413607-382-00-32-((4-amino-2-nitrophenyl)amino)benzoic acid411-260-3117907-43-4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 607-383-00-9reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate415-430-886403-32-9 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410 607-384-00-4reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate413-750-2171090-93-0Aquatic Chronic 4H413—H413 607-385-00-Xcopolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate414-590-6125229-74-5Aquatic Chronic 2H411GHS09H411607-386-00-5reaction mass of: tetradecanoic acid (42,5-47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5-57,5 %)412-580-6174591-51-6 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 607-387-00-0reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %)412-590-058856-63-6 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 607-388-00-64-ethylamino-3-nitrobenzoic acid412-090-22788-74-1 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 607-389-00-1trisodium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionate414-130-4119710-96-2Acute Tox. 4 H302 GHS07 Wng H302607-390-00-71,2,3,4-tetrahydro-6-nitro-quinoxaline414-270-641959-35-7 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-391-00-2dimethylcyclopropane-1,1-dicarboxylate414-240-26914-71-2Aquatic Chronic 3H412—H412607-392-00-82-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate414-260-188938-37-8Aquatic Chronic 4H413—H413

607-393-00-33-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid415-750-8106447-44-3Skin Sens. 1H317 GHS07 Wng H317607-394-00-95-methylpyrazine-2-carboxylic acid413-260-95521-55-1Eye Dam. 1H318 GHS05 Dgr H318607-395-00-4reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate410-230-7— Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H317 H411 607-396-00-Xbis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate414-840-4147783-69-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-397-00-5reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates(branched C10-14 and C18-30 alkylated)415-930-6— Repr. 2 Skin Sens. 1 H361f H317 GHS08 GHS07 Wng H361f H317607-398-00-0ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate414-820-5125630-94-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-399-00-62,2-dimethyl 3-methyl-3-butenyl propanoate415-610-6104468-21-5 Skin Irrit. 2 Aquatic Chronic 3 H315 H412 GHS07 Wng H315 H412 607-400-00-Xmethyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate414-400-132750-89-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-401-00-5ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate414-450-488805-65-6 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H315 H318 H317 GHS05 GHS07 Dgr H315 H318 H317 607-402-00-0methyl N-(phenoxycarbonyl)-L-valinate414-500-5153441-77-1Aquatic Chronic 3H412—H412607-403-00-6reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol414-810-0— STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H373 H318 H410 607-404-00-1reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid415-190-4—Skin Sens. 1H317 GHS07 Wng H317607-405-00-72-hexyldecyl-p-hydroxybenzoate415-380-7148348-12-3Aquatic Chronic 2H411GHS09H411607-406-00-2potassium 2,5-dichlorobenzoate415-700-5184637-62-5 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 607-407-00-8ethyl 2-carboxy-3-(2-thienyl)propionate415-680-8143468-96-6 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H315 H318 H317 GHS05 GHS07 Dgr H315 H318 H317 607-408-00-3potassium N-(4-fluorophenyl)glycinate415-710-1184637-63-6 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H373 H318 H317 H412 GHS08 GHS05 GHS07 Dgr H373 H318 H317 H412 607-409-00-9reaction mass of: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus415-840-7—

Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-410-00-4mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate415-880-5779343-34-9 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 607-411-00-Xoxiranemethanol, 4-methylbenzene-sulfonate, (S)-417-210-770987-78-9 Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H350 H341 H318 H317 H411 GHS08 GHS05 GHS07 GHS09 Dgr H350 H341 H318 H317 H411 607-412-00-5ethyl 2-(1-cyanocyclohexyl)acetate415-970-4133481-10-4 Acute Tox. 4 STOT RE 2 Aquatic Chronic 3 H302 H373 H412 GHS08 GHS07 Wng H302 H373 H412 607-413-00-0trans-4-phenyl-L-proline416-020-196314-26-0 Repr. 2 Skin Sens. 1 H361f H317 GHS08 GHS07 Wng H361f H317607-414-00-6tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate402-070-188122-99-0Aquatic Chronic 4H413—H413607-415-00-1poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride)419-590-1— Flam. Sol. 1 Skin Sens. 1 H228 H317 GHS02 GHS07 Dgr H228 H317 T 607-416-00-74-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide420-730-7— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-417-00-23-chloropropyl chloroformiate425-770-9628-11-5 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H331 H302 H373 H315 H318 H317 GHS06 GHS05 GHS08 Dgr H331 H302 H373 H315 H318 H317 607-418-00-82-ethylhexyl 4-aminobenzoate420-170-326218-04-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-419-00-3(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid422-240-9166596-68-5 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-420-00-92,2-bis(hydroxymethyl)butanoic acid424-090-110097-02-6 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-421-00-4cypermethrin cis/trans +/-40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate257-842-952315-07-8 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H335 H400 H410 GHS07 GHS09 Wng H332 H302 H335 H410 607-422-00-Xα-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate257-842-967375-30-8 Acute Tox. 3 STOT RE 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H373 H335 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H373 H335 H410 M=1000 607-423-00-5esters of mecoprop and of mecoprop-P—— Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 A607-424-00-0trifloxystrobin (ISO); (E, E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester—141517-21-7

Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-425-00-6metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate260-979-757837-19-1 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 607-426-00-11,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] 284-032-2 [1] -[2] 205-017-9 [3] 210-088-4 [4] 84777-06-0 [1] -[2] 131-18-0 [3] 605-50-5 [4] Repr. 1B Aquatic Acute 1 H360FD H400 GHS08 GHS09 Dgr H360FD H400607-427-00-7bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate260-300-456634-95-8 Repr. 2 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H332 H302 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361d H332 H302 H317 H410 607-428-00-2tetrasodium ethylene diamine tetraacetate200-573-964-02-8 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 607-429-00-8edetic acid; (EDTA)200-449-460-00-4Eye Irrit. 2H319 GHS07 Wng H319607-430-00-3BBP; benzyl butyl phthalate e201-622-785-68-7 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360Df H400 H410 GHS08 GHS09 Dgr H360Df H410 607-431-00-9prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate245-387-923031-36-9 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H331 H302 H400 H410 GHS06 GHS09 Dgr H331 H302 H410 607-432-00-4S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] -[1] -[2] 87392-12-9 [1] 178961-20-1 [2] Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-433-00-Xcypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate257-842-952315-07-8 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H335 H315 H317 H400 H410 GHS07 GHS09 Wng H302 H335 H315 H317 H410 607-434-00-5mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid240-539-016484-77-8 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 607-435-00-02S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate416-810-6111969-64-3 STOT RE 2 Eye Dam. 1 Aquatic Chronic 2 H373 H318 H411 GHS08 GHS05 GHS09 Dgr H373 H318 H411 607-436-00-62-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate417-350-9— Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 607-437-00-13-(4-aminophenyl)-2-cyano-2-propenoic acid417-480-6252977-62-1Skin Sens. 1H317 GHS07 Wng H317 607-438-00-7methyl-2-[(aminosulfonyl)methyl]benzoate419-010-5112941-26-1 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319

607-439-00-2methyl tetrahydro-2-furancarboxylate420-670-137443-42-8Eye Dam. 1H318 GHS05 Dgr H318607-440-00-8methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate421-220-7144740-59-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-441-00-33-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid421-490-6167684-63-1Aquatic Chronic 4H413—H413607-442-00-9benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate416-050-587460-09-1Eye Dam. 1H318 GHS05 Dgr H318607-444-00-Xreaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate416-230-335541-81-2Aquatic Chronic 4H413—H413607-445-00-5Iron (III) tris(4-methylbenzenesulfonate)420-960-877214-82-5Eye Dam. 1H318 GHS05 Dgr H318607-446-00-0methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate416-240-8155522-12-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-447-00-6sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate416-370-5156738-27-1 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-448-00-12,3,5,6-tetrafluorobenzoic acid416-800-1652-18-6 Skin Irrit. 2 Eye Dam. 1 H315 H318 GHS05 Dgr H315 H318 607-449-00-7reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]417-080-1— Self-react. D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H242 H317 H400 H410 GHS02 GHS07 GHS09 Dgr H242 H317 H410 607-450-00-22-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate419-040-989604-92-2Aquatic Chronic 4H413—H413607-451-00-84-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt417-640-5161935-19-9 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-453-00-94-benzyl-2,6-dihydroxy-4-aza-heptylene bis (2,2-dimethyloctanoate)418-100-1172964-15-7 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-454-00-4reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid418-170-3116193-72-7 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-455-00-X1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt419-520-8172890-93-6Skin Sens. 1H317 GHS07 Wng H317 607-456-00-53-amino-4-chlorobenzoic acid, hexadecyl ester419-700-6143269-74-3Aquatic Chronic 2H411GHS09H411607-457-00-0tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)420-350-1172277-97-3

Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 607-458-00-6reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]420-850-1—Aquatic Chronic 2H411GHS09H411607-459-00-1isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate418-930-4—Aquatic Chronic 4H413—H413607-460-00-73-tridecyloxy-propyl-ammonium 9-octadecenoate418-990-1778577-53-0 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H319 H315 H400 H410 GHS08 GHS07 GHS09 Wng H373 H319 H315 H410 607-461-00-2reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate421-160-1—Aquatic Chronic 3H412—H412 607-462-00-8reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates421-230-188230-35-7Aquatic Chronic 2H411GHS09H411607-463-00-33-(phenothiazin-10-yl)propionic acid421-260-5362-03-8Aquatic Chronic 2H411GHS09H411607-464-00-9reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid421-280-4Aquatic Chronic 3H412—H412607-465-00-4tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate421-440-3778583-04-3Aquatic Chronic 3H412—H412607-466-00-Xreaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate421-480-1—Aquatic Chronic 2H411GHS09H411607-467-00-51,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate419-430-956533-00-7 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373 H314 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H312 H302 H373 H314 H410 607-468-00-0reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate419-450-8—Skin Sens. 1H317

GHS07 Wng H317607-469-00-6disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate419-460-2120029-06-3Aquatic Chronic 3H412—H412607-470-00-1potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate414-100-0154336-20-6 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-471-00-71,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane429-280-6151900-44-6Aquatic Chronic 4H413—H413607-473-00-8pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid426-590-3187412-41-5Skin Sens. 1H317 GHS07 Wng H317 607-474-00-3(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid410-430-4117573-89-4Aquatic Chronic 4H413—H413607-475-00-9reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)412-940-2148878-18-6Skin Sens. 1H317 GHS07 Wng H317607-476-00-4trisodium N, N-bis(carboxymethyl)-β-alanine414-070-9129050-62-0 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412 607-477-00-X(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt426-740-8— Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 607-478-00-5tetramethylammonium hydrogen phthalate416-900-579723-02-7Acute Tox. 3 STOT RE 2 Aquatic Acute 1 H301 H373 H400 GHS06 GHS08 GHS09 Dgr H301 H373 H400 607-479-00-0hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate418-550-9168689-49-4Aquatic Chronic 4H413—H413607-480-00-61,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters271-084-668515-42-4Repr. 1BH360Df GHS08 Dgr H360Df607-481-00-1reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate430-290-8—Aquatic Chronic 4H413—H413 607-482-00-7N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride430-360-884793-24-8 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-483-00-21,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich276-158-171888-89-6Repr. 1BH360D GHS08 Dgr H360D607-484-00-8ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate430-480-0221452-67-1Aquatic Chronic 4H413—H413607-485-00-3(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate430-510-2—Aquatic Chronic 4H413—H413607-486-00-9potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate402-110-8110081-40-8Aquatic Chronic 3H412—H412607-487-00-4reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate402-660-9—

Repr. 1B Aquatic Chronic 3 H360D H412 GHS08 Dgr H360D H412607-488-00-Xethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate414-210-9147379-38-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-489-00-5reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate414-890-771302-79-9Skin Sens. 1H317 GHS07 Wng H317 607-490-00-0N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate415-060-7— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-491-00-6reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)427-140-9—Carc. 2H351 GHS08 Wng H351607-492-00-12-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate415-490-5141773-73-1Aquatic Chronic 2H411GHS09H411607-493-00-7methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate415-670-378850-37-0Eye Dam. 1H318 GHS05 Dgr H318607-494-00-2bis(2-ethylhexyl)octylphosphonate417-170-052894-02-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-495-00-8sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate417-550-6168151-92-6Skin Sens. 1H317 GHS07 Wng H317607-496-00-32,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite418-310-3126050-54-2Aquatic Chronic 4H413—H413607-497-00-9cerium oxide isostearate419-760-3—Aquatic Chronic 4H413—H413607-498-00-4(E)-3,7-dimethyl-2,6-octadienylhexadecanoate421-370-33681-73-0 Skin Irrit. 2 Aquatic Chronic 4 H315 H413 GHS07 Wng H315 H413 607-499-00-Xbis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)421-660-1— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 607-500-00-3calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate421-670-4— Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H315 H400 H410 GHS07 GHS09 Wng H315 H410 607-501-00-9reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives421-820-9192268-65-8Aquatic Chronic 4H413—H413607-502-00-4(N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzenesulfonate422-200-0178277-55-9 Skin Corr. 1B Acute Tox. 4 Aquatic Chronic 2 H314 H302 H411 GHS05 GHS07 GHS09 Dgr H314 H302 H411 607-503-00-X2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane422-210-568957-94-8Skin Corr. 1BH314 GHS05 Dgr H314607-504-00-5diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate422-670-7— Repr. 2 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H361f H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H361f H301 H373 H410 607-505-00-0pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate422-930-1Aquatic Chronic 3H412—H412607-506-00-6reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate422-970-8Aquatic Chronic 2H411GHS09H411607-507-00-1potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate422-980-2187026-95-5Eye Dam. 1H318

GHS05 Dgr H318607-508-00-7disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]423-110-4—Eye Dam. 1H318 GHS05 Dgr H318607-509-00-22-phenoxyethyl 4-aminobenzoate430-880-588938-23-2Aquatic Chronic 2H411GHS09H411607-510-00-8(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide427-200-476646-91-8 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 H302 H315 H318 H317 GHS05 GHS07 Dgr H302 H315 H318 H317 607-511-00-3reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid423-750-4— Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 607-512-00-9trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate423-970-0182926-43-8Aquatic Chronic 3H412—H412607-513-00-4reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid423-200-3— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 607-514-00-Xpotassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate427-240-2134841-35-3Skin Sens. 1H317 GHS07 Wng H317607-515-00-5reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate429-650-7147732-60-3 Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 607-516-00-0N, N'-bis(trifluoroacetyl)-S, S'-bis-L-homocysteine429-670-6105996-54-1 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-517-00-6(S)-α-(acetylthio)benzenepropanoic acid430-300-076932-17-7 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317 607-518-00-13-oxoandrost-4-ene-17-β-carboxylic acid414-990-0302-97-6 Repr. 2 Aquatic Chronic 4 H361f H413 GHS08 Wng H361f H413 607-519-00-7poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]427-280-0176429-27-9 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H335 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H335 H315 H318 H410 607-520-00-2reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate427-740-0— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-521-00-8tetraethyl N, N'-(methylenedicyclohexane-4,1-diyl)bis-DL-aspartate429-270-1136210-30-5

Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-522-00-3sodium salt of the polymer of:sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate429-720-7184246-86-4Aquatic Chronic 3H412—H412607-523-00-9reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate430-200-7— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-524-00-4tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters430-310-5—Aquatic Chronic 4H413H413607-525-00-X(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid431-520-164485-90-1 Flam. Sol. 1 Carc. 2 Aquatic Chronic 3 H228 H351 H412 GHS02 GHS08 Dgr H228 H351 H412 607-526-00-5cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane—15263-53-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-527-00-0Reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate423-180-6—STOT RE 2 H373 GHS08 Wng H373 607-528-00-6(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid430-900-2192725-50-1Eye Dam. 1H318 GHS05 Dgr H318607-529-00-1benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate426-070-667299-45-0Aquatic Chronic 3H412—H412607-530-00-7reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate406-040-9125643-61-0Aquatic Chronic 4H413—H413 607-531-00-2methyl 3-amino-4,6-dibromo-2-methyl-benzoate425-190-6119916-05-1 STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09

Wng H373 H411607-532-00-8(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt425-510-4167944-94-7Aquatic Chronic 3H412—H412607-533-00-3pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate414-910-4— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-534-00-9ethyl 2-(3-benzoylphenyl)propanoate414-920-960658-04-0 Acute Tox. 3 STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 H301 H372 H317 H411 GHS06 GHS08 GHS09 Dgr H301 H372 H317 H411 607-535-00-4potassium 4-iodo-2-sulfonato-benzoic acid426-620-5— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-536-00-X(2,6-xylyloxy) acetic acid430-910-713335-71-2 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 607-537-00-5isopropylammonium 2-(3-benzoylphenyl)propionate417-970-1— Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H372 H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H301 H312 H372 H318 H410 607-539-00-6propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate431-000-2198705-81-6Aquatic Chronic 4H413—H413607-540-00-11-(mercaptomethyl)cyclopropylacetic acid420-240-3162515-68-6 Skin Corr. 1B Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H314 H312 H302 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H312 H302 H317 H411 607-541-00-7[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)421-940-128698-31-9 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 607-542-00-2methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate422-110-1— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-543-00-8poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]427-480-8176429-22-4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H335 H315 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H335 H315 H318 H410 607-544-00-3ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate427-490-2158585-86-5Aquatic Chronic 3H412—H412607-545-00-91,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate424-070-094346-09-5 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 607-546-00-4reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate424-290-7188070-47-5Skin Sens. 1H317 GHS07 Wng H317607-547-00-X18-methylnonadecyl 2,2-dimethylpropanoate424-370-1125496-22-2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413 607-548-00-51-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate431-010-7154486-26-7

Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 607-549-00-0methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate424-430-7125778-19-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-550-00-62-amino-4-bromo-5-chlorobenzoic acid424-700-4— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-551-00-1tetrabutylammonium 2-amino-6-iodopurinate424-710-9156126-48-6 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H312 H302 H373 H315 H318 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H312 H302 H373 H315 H318 H317 H411 607-552-00-7hexadecyl -amino-4-isopropoxybenzoate424-830-1—Aquatic Chronic 4H413—H413607-553-00-27-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt424-850-0—Eye Dam. 1H318 GHS05 Dgr H318607-554-00-82,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid424-870-127624-67-5 Expl. 1.1 Eye Dam. 1 Aquatic Chronic 3 H201 H318 H412 GHS01 GHS05 Dgr H201 H318 H412 607-555-00-31,1,3,3-tetramethylbutylperoxypivalate424-980-822288-41-1 Flam. Liq. 2 Org. Perox. D Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H225 H242 H315 H317 H411 GHS02 GHS07 GHS09 Dgr H225 H242 H315 H317 H411 607-556-00-92-acetoxymethylene-4-acetylphenylacetate425-160-224085-06-1 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H302 H373 H318 H317 H410 607-557-00-4salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[RR]]-2,3-dihydroxybutanedioic acid425-210-3169939-84-8Skin Sens. 1H317 GHS07 Wng H317607-558-00-X2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate425-250-1147027-10-9Aquatic Chronic 2H411GHS09H411 607-559-00-5coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid425-400-6179986-09-5Aquatic Chronic 4H413—H413607-560-00-0(R, S)-2-butyloctanedioic acid431-210-450905-10-7Eye Dam. 1H318 GHS05 Dgr H318607-561-00-6sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate425-460-3— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-562-00-1reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate425-530-398769-75-6 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 607-563-00-75,7-dichloro-4-hydroxyquinoline-3-carboxylic acid431-250-2171850-30-9Aquatic Chronic 2H411GHS09H411607-564-00-21,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate425-730-051178-75-7Skin Sens. 1H317 GHS07 Wng H317607-565-00-83-ethyl 5 methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate425-820-188150-42-9

Acute Tox. 3 STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H373 H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H301 H373 H318 H410 607-566-00-3reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate426-140-6—Aquatic Chronic 4H413—H413 607-567-00-9potassium 3-iodo-6-methylbenzenesulfonate426-300-5—Eye Dam. 1H318 GHS05 Dgr H318607-568-00-4potassium 2-chloro-3-(benzyloxy)propionate426-350-8138666-92-9 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H302 H373 H318 H317 GHS05 GHS08 GHS07 Dgr H302 H373 H318 H317 607-569-00-Xreaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate426-470-0—Skin Sens. 1H317 GHS07 Wng H317607-570-00-5sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate426-520-171420-85-4Skin Sens. 1H317 GHS07 Wng H317607-571-00-02-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate431-400-757374-49-9 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-572-00-6diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate426-790-0162208-27-7 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H312 H302 H373 H317 H410 607-573-00-1reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium; 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate426-840-1—Eye Dam. 1H318 GHS05 Dgr H318 607-574-00-7[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate426-890-477341-67-4Eye Dam. 1H318 GHS05 Dgr H318607-575-00-24-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt426-900-7— STOT SE 3 Aquatic Chronic 3 H335 H412 GHS07 Wng H335 H412 607-576-00-8branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate427-030-0— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-577-00-3(2R, 3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate427-100-0— Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412 607-578-00-9ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate427-110-5— Acute Tox. 4 STOT RE 2 Aquatic Chronic 4 H302 H373 H413 GHS08 GHS07 Wng H302 H373 H413 607-579-00-4diethyl[(p-ethoxyanilino)methylene]malonate431-430-0103976-28-9 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-581-00-5ethyl 2-ethoxy-4-carboxymethylbenzoate427-630-299469-99-5Eye Dam. 1H318 GHS05 Dgr H318607-582-00-0reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate427-650-1—Aquatic Chronic 3H412—H412607-583-00-64-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid427-680-5188907-52-0 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 607-584-00-1trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate427-710-7215612-56-9 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 607-585-00-7strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate427-930-3—Skin Sens. 1H317 GHS07 Wng H317607-586-00-2dodecyl 3-amino-4-chlorobenzoate428-020-96195-20-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-587-00-8ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate428-030-367914-69-6 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H410 607-588-00-3reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate428-050-2— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-589-00-9tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate428-070-191788-83-9 STOT RE 1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H372 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H372 H302 H410 607-590-00-4hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate428-140-1210706-50-6Aquatic Chronic 4H413—H413607-591-00-Xreaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate428-400-4—Eye Dam. 1H318 GHS05 Dgr H318607-592-00-5di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate428-870-0—Aquatic Chronic 4H413—H413607-593-00-04-(2-methylacryloyloxy)phenyl4-allyloxybenzoate429-000-2159235-16-2 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-594-00-6ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate429-020-1204254-96-6 STOT RE 2 Skin Sens. 1 H373 H317 GHS08 GHS07 Wng H373 H317607-595-00-1N-amidino-N-methylglycine-2-oxopropionate429-120-5208535-04-0Eye Dam. 1H318 GHS05 Dgr H318 607-596-00-7ethyl 2-(4-phenoxyphenyl)lactate429-220-9132584-17-9

Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-597-00-2tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate429-230-3—Eye Dam. 1H318 GHS05 Dgr H318607-598-00-8trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate429-240-8212652-59-0Eye Dam. 1H318 GHS05 Dgr H318607-599-00-31,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate431-610-968860-54-8 Org. Perox. D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H242 H317 H400 H410 GHS02 GHS07 GHS09 Dgr H242 H317 H410 607-600-00-7(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate431-700-8—Aquatic Chronic 2H411GHS09H411607-601-00-21,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate429-370-5220410-74-2Acute Tox. 4 H302 GHS07 Wng H302607-602-00-8ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate429-680-0122665-86-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-603-00-3lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate429-730-1193562-37-7 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-604-00-9guanidinium benzoate429-820-026739-54-8Acute Tox. 4 H302 GHS07 Wng H302 607-605-00-4methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate429-890-2144550-06-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-606-00-X(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid430-100-386978-24-7Acute Tox. 4 H302 GHS07 Wng H302607-607-00-5reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol430-180-1— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 607-608-00-0pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate430-210-1— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-609-00-6ethyl (3R)-4-cyano-3-hydroxybutanoate430-220-6141942-85-0Eye Irrit. 2H319 GHS07 Wng H319607-610-00-1trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate430-280-3—Skin Sens. 1H317 GHS07 Wng H317607-611-00-7methyl 3-amino-2,2,3-trimethylbutyrate431-720-790886-53-6 Skin Corr. 1B Acute Tox. 4 Aquatic Chronic 3 H314 H302 H412 GHS05 GHS07 Dgr H314 H302 H412 607-612-00-2Reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate432-190-1182176-52-9

Acute Tox. 4 STOT RE 2 Eye Dam. 1 H302 H373 H318 GHS05 GHS08 GHS07 Dgr H302 H373 H318 607-613-00-8reaction mass of: succinic acid; monopersuccinic acid; dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic aciddimethyl adipate hydrogen peroxide methanolwater432-790-1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B STOT SE 2 H332 H312 H302 H314 H371 (eyes) GHS07 GHS05 GHS08 Dgr H332 H312 H302 H314 H371 (eyes) 607-614-00-32-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid426-480-563562-33-4 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 607-615-00-9reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance431-120-5— Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H331 H302 H319 H317 GHS06 Dgr H331 H302 H319 H317 607-616-00-42,4-dichloro-5-fluorobenzoylchloride428-390-186393-34-2 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H335 H315 H318 H317 H412 GHS05 GHS07 Dgr H335 H315 H318 H317 H412 607-617-00-Xbis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate430-700-510138-36-0Skin Sens. 1H317 GHS07 Wng H317607-618-00-5menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt204-987-0130-37-0 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 607-619-00-0menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonicacid, compound with nicotin-3-amide (1:1)277-543-773581-79-0 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3 Carc. 2 Acute Tox. 4 Eye Irrit. 2 H351 H302 H319 GHS08 GHS07 Wng H351 H302 H319 Carc. 2; H351: C ≥ 5 % 607-621-00-1milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]—— Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H400 H410 GHS07 GHS09 Wng H332 H302 H410 M=100607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. 2H361d GHS08 Wng H361d 607-624-00-8perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctanesulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4]

29457-72-5 [5] Carc. 2 Repr. 1B STOT RE 1 Acute Tox. 4 Acute Tox. 4 Lact. Aquatic Chronic 2 H351 H360D H372 H332 H302 H362 H411 GHS08 GHS07 GHS09 Dgr H351 H360D H372 H332 H302 H362 H411 607-625-00-3clodinafop-propargyl (ISO)—105512-06-9 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 Skin Sens. 1; H317: C ≥ 0,001 % M=1 607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 607-627-00-4[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5Skin Sens. 1H317 GHS07 Wng H317607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Eye Dam. 1H318 GHS05 Dgr H318607-629-00-5[2-methyl-1-(1-oxopropoxy)propoxyphosphinyl] acetic acid419-270-1123599-82-6Eye Irrit. 2H319 GHS07 Wng H319607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H332 H314 H317 H412 GHS05 GHS07 Dgr H332 H314 H317 H412 607-631-00-6reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl)oxo(phenyl)acetate442-300-8—Skin Sens. 1H317 GHS07 Wng H317607-632-00-1N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5Aquatic Chronic 4H413—H413607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-634-00-2(S)-(–)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate420-610-436394-75-9 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H302 H314 H317 GHS05 GHS07 Dgr H302 H314 H317 607-635-00-8trisodium N-(3-propionato)-l-aspartate422-090-4172737-80-3Eye Dam. 1H318 GHS05 Dgr H318607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8 Flam. Liq. 3 Carc. 2 Skin Corr. 1B Skin Sens. 1 H226 H351 H314 H317 GHS02 GHS05 GHS08 GHS07 Dgr H226 H351 H314 H317 607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate423-730-5250688-43-8Eye Dam. 1H318 GHS05 Dgr H318607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7Aquatic Chronic 4H413—H413 607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6Aquatic Chronic 4H413—H413607-641-00-02-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid431-930-943028-69-9 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0

Flam. Liq. 3 Eye Dam. 1 Skin Sens. 1 H226 H318 H317 GHS02 GHS05 GHS07 Dgr H226 H318 H317 607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Skin Irrit. 2H315 GHS07 Wng H315607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Eye Dam. 1H318 GHS05 Dgr H318607-646-00-8D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate432-960-5124655-09-0Acute Tox. 4 H302 GHS07 Wng H302607-647-00-35-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 H302 H317 H400 GHS07 GHS09 Wng H302 H317 H400 607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8 Skin Corr. 1A Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317 607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2Skin Sens. 1H317 GHS07 Wng H317607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-652-00-0ethyl N2-dodecanoyl-l-argininate hydrochloride434-630-660372-77-2 Eye Dam. 1 Aquatic Acute 1 H318 H400 GHS05 GHS09 Dgr H318 H400 607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4Aquatic Chronic 2H411GHS09H411607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4Skin Sens. 1H317 GHS07 Wng H317607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Eye Dam. 1H318 GHS05 Dgr H318607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Eye Dam. 1H318 GHS05 Dgr H318607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazophenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Eye Dam. 1H318

GHS05 Dgr H318607-661-00-X1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3Aquatic Chronic 4H413—H413607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 607-665-00-1trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1Flam. Liq. 3H226 GHS02 Wng H226607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Eye Irrit. 2H319 GHS07 Wng H319607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2 Muta. 2 Skin Sens. 1 H341 H317 GHS08 GHS07 Wng H341 H317 607-668-00-8trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 607-670-00-9dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate448-700-9500791-70-8 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H373 H318 H317 H410 M=10 607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6Aquatic Chronic 2H411GHS09H411607-672-00-Xreaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate419-000-0— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0— Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 607-675-00-6reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid422-260-8— Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 607-676-00-1reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid423-670-1— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 607-677-00-72,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazoly]methyl]amino]carbonyl}-L-Valinate424-660-8— STOT RE 2 Eye Dam. 1 Skin Sens. 1 H373 H318 H317 GHS05 GHS08 GHS07 Dgr H373 H318 H317 607-678-00-2reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate427-090-8—

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-679-00-8reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo[}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetate)431-440-5— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 607-680-00-3tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-ylvinyl}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9—Aquatic Chronic 4H413—H413607-681-00-9reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate432-910-2—Aquatic Chronic 4H413—H413607-682-00-4complex reaction mass of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9Aquatic Chronic 4H413—H413 607-683-00-Xreaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)435-450-0— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7— Skin Irrit. 2 Eye Dam. 1 H315 H318 GHS05 Dgr H315 H318 607-686-00-66,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5—Self-react. C Carc. 2 H242 H351 GHS02 GHS08 Dgr H242 H351 607-687-00-1reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)442-800-6—

Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2—Acute Tox. 4 H302 GHS07 Wng H302607-689-00-2reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis-and trans-isomers); methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’including cis-and trans-isomers)444-920-4—Aquatic Chronic 3H412—H412607-690-00-8dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3Skin Sens. 1H317 GHS07 Wng H317607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6—Aquatic Chronic 4H413—H413607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4—Aquatic Chronic 4H413—H413607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7Aquatic Chronic 4H413—H413607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 607-696-00-0pentyl formate211-340-6638-49-3 Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 H226 H319 H335 GHS02 GHS07 Dgr H226 H319 H335 C 607-697-00-6tert-butyl propionate—20487-40-5Flam. Liq. 2H225 GHS02 Dgr H225C607-698-00-14-tert-butylbenzoic acid202-696-398-73-7 Repr. 1B STOT RE 1 Acute Tox. 4 H360F H372 H302 GHS07 GHS08 Dgr H360F H372 H302 607-699-00-7bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate82657-04-3 Carc. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H300 H372 (nervous system) H317 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H331 H300 H372 (nervous system) H317 H410 M = 10000 M = 100000 607-700-00-0indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] 173584-44-6 [1] 144171-61-9 [2] Acute Tox. 3 Acute Tox. 4 STOT RE 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H301 H332 H372 (blood, nervous system, heart) H317 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H332 H372 (blood, nervous system, heart) H317 H410 M = 1 M = 1 607-702-00-1dihexyl phthalate201-559-584-75-3Repr. 1BH360FD GHS08 Dgr H360FD 607-703-00-7ammoniumpentadeca-fluorooctanoate223-320-43825-26-1 Carc. 2 Repr. 1B Lact. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam.1 H351 H360D H362 H332 H302 H372 (liver) H318 GHS08 GHS07 GHS05 Dgr H351 H360D H362 H332 H302 H372 (liver) H318 607-704-00-2perfluorooctanoic acid206-397-9335-67-1 Carc. 2 Repr. 1B Lact. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam. 1 H351 H360D H362 H332

H302 H372 (liver) H318 GHS08 GHS07 GHS05 Dgr H351 H360D H362 H332 H302 H372 (liver) H318 607-705-00-8benzoic acid200-618-265-85-0 STOT RE 1 Skin Irrit. 2 Eye Dam. 1 H372 (lungs) (inhalation) H315 H318 GHS08 GHS05 Dgr H372 (lungs) (inhalation) H315 H318 607-706-00-3methyl 2,5-dichlorobenzoate220-815-72905-69-3 Acute Tox. 4 STOT SE 3 Aquatic Chronic 2 H302 H336 H411 GHS07 GHS09 Wng H302 H336 H411 608-001-00-3acetonitrile; cyanomethane200-835-275-05-8 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 H225 H332 H312 H302 H319 GHS02 GHS07 Dgr H225 H332 H312 H302 H319 608-002-00-9trichloroacetonitrile208-885-7545-06-2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H331 H311 H301 H411 GHS06 GHS09 Dgr H331 H311 H301 H411 608-003-00-4acrylonitrile203-466-5107-13-1 Flam. Liq. 2 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 D608-004-00-X2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin200-909-475-86-5 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H400 H410 GHS06 GHS09 Dgr H330 H310 H300 H410 608-005-00-5n-butyronitrile203-700-6109-74-0 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H225 H331 H311 H301 GHS02 GHS06 Dgr H225 H331 H311 H301 608-006-00-0bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol216-882-71689-84-5 Repr. 2 Acute Tox. 2 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H330 H301 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H361d H330 H301 H317 H410 M = 10608-007-00-6ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile216-881-11689-83-4 Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H361d H331 H301 H312 H373 H319 H400 H410 GHS06 GHS08 GHS09 Dgr H361d H331 H301 H312 H373 H319 H410 M = 10608-008-00-1chloroacetonitrile203-467-0107-14-2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H331 H311 H301 H411 GHS06 GHS09 Dgr H331 H311 H301 H411 608-009-00-7malononitrile203-703-2109-77-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 608-010-00-2methacrylonitrile; 2-methyl-2-propene nitrile204-817-5126-98-7 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 H225 H331 H311 H301 H317 GHS02 GHS06 Dgr H225 H331 H311 H301 H317

Skin Sens. 1; H317: C ≥0,2 % D608-011-00-8oxalonitrile; cyanogen207-306-5460-19-5 Press. Gas Flam. Gas 1 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H220 H331 H400 H410 GHS02 GHS04 GHS06 GHS09 Dgr H220 H331 H410 U608-012-00-3benzonitrile202-855-7100-47-0Acute Tox. 4 Acute Tox. 4 H312 H302 GHS07 Wng H312 H302 608-013-00-92-chlorobenzonitrile212-836-5873-32-5 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 H312 H302 H319 GHS07 Wng

H312 H302 H319 608-014-00-4chlorothalonil (ISO); tetrachloroisophthalonitrile217-588-11897-45-6 Carc. 2 Acute Tox. 2 STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H335 H318 H317 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H351 H330 H335 H318 H317 H410 M=10608-015-00-Xdichlobenil (ISO); 2,6-dichlorobenzonitrile214-787-51194-65-6 Acute Tox. 4 Aquatic Chronic 2 H312 H411 GHS07 GHS09 Wng H312 H411 608-016-00-51,4-Dicyano-2,3,5,6-tetra-chloro-benzene401-550-81897-41-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 608-017-00-0bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate216-885-31689-99-2 Repr. 2 Acute Tox. 3 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H331 H302 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H361d H331 H302 H317 H410 M = 10608-018-00-6ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate223-375-43861-47-0 Repr. 2 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H301 H319 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H361d H301 H319 H317 H410 M = 10608-019-00-12,2'-dimethyl-2,2'-azodipropiononitrile; ADZN201-132-378-67-1 Self-react. C Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H242 H332 H302 H412 GHS02 GHS07 Dgr H242 H332 H302 H412 T608-020-00-7diphenoxymethylenecyanamide427-300-879463-77-7 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 608-021-00-23-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile403-710-276823-93-3 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 608-022-00-83,7-dimethyloctanenitrile403-620-340188-41-8 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H315 H317 H411 GHS07 GHS09 Wng H315 H317 H411 608-023-00-3fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile406-140-2114369-43-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410608-024-00-92-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile407-650-897460-76-9Aquatic Chronic 4H413—H413608-025-00-42-nitro-4,5-bis(benzyloxy)phenylacetonitrile410-970-0117568-27-1Aquatic Chronic 4H413—H413608-026-00-X3-cyano-3,5,5-trimethylcyclohexanone411-490-47027-11-4 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H302 H373 H317 H412 GHS08 GHS07 Wng H302 H373 H317 H412 608-027-00-5reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile412-660-0—Aquatic Chronic 2H411GHS09H411608-028-00-04-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate413-510-7147374-67-2 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H373 H317 H411 GHS08 GHS09 Wng H373 H317 H411 608-029-00-61,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile411-990-268612-94-2Skin Sens. 1H317 GHS07 Wng H317608-030-00-1N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide412-340-0147741-93-3

Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410608-031-00-72-benzyl-2-methyl-3-butenitrile407-870-497384-48-0 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 608-032-00-2 acetamiprid (ISO); (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine —135410-20-7 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 608-033-00-8N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide407-970-875511-91-0 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 608-034-00-3chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile—122453-73-0 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H331 H302 H400 H410 GHS06 GHS09 Dgr H331 H302 H410 M=100608-035-00-9(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile419-290-9— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 608-036-00-43-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile419-060-879026-02-1Aquatic Chronic 4H413—H413608-037-00-Xreaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile422-190-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410608-038-00-52,2,4-trimethyl-4-phenyl-butane-nitrile422-580-875490-39-0 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 608-039-00-02-phenylhexanenitrile423-460-83508-98-3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 608-040-00-64,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)423-490-1130755-46-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 608-041-00-14'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile423-500-4138401-24-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 608-043-00-23-(cis-3-hexenyloxy)propanenitril415-220-6142653-61-0 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H331 H302 H400 H410 GHS06 GHS09 Dgr H331 H302 H410 608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 608-046-00-95-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile425-310-777889-90-8Aquatic Chronic 4H413—H413608-047-00-42-piperidin-1-yl-benzonitrile427-330-172752-52-4Aquatic Chronic 2H411GHS09H411608-048-00-X1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile427-450-4152630-47-2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H302 H373 H317 H411 GHS08 GHS07 GHS09 Wng H302 H373 H317 H411 608-049-00-52-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile429-180-2157362-53-3

Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 608-050-00-0 reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile 429-760-5—Aquatic Chronic 4H413—H413608-051-00-6(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile430-760-2219861-18-4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 608-052-00-1(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile430-770-7128173-52-4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 608-053-00-7(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile430-780-1103146-25-4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 608-054-00-2(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)3-(hydroxymethyl)benzonitrile hemisulfate430-790-6— Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 608-056-00-3N-methyl-N-cyanomethylmorpholiniummethylsulfate429-340-1— Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 608-057-00-94-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate431-200-1208538-34-5 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H302 H318 H317 GHS05 GHS07 Dgr H302 H318 H317 608-058-00-4 esfenvalerate (ISO); (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate —66230-04-4 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H317 H400 H410 GHS06 GHS09 Dgr H331 H301 H317 H410 M = 10000608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3Aquatic Chronic 2H411GHS09H411608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4 Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H301 H318 H317 H410 608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2—Aquatic Chronic 3H412—H412 608-065-00-2salts of bromoxynil with the exception of those specified elsewhere in this Annex—— Repr. 2 Acute Tox. 2 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361d H330 H301 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H361d H330 H301 H317 H410 M = 10A608-066-00-8salts of ioxynil with the exception of those specified elsewhere in this Annex—— Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1

H361d H331 H301 H312 H373 H319 H400 H410 GHS06 GHS08 GHS09 Dgr H361d H331 H301 H312 H373 H319 H410 M = 10A609-001-00-61-nitropropane203-544-9108-03-2 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H226 H332 H312 H302 GHS02 GHS07 Wng H 226 H332 H312 H302 609-002-00-12-nitropropane201-209-179-46-9 Flam. Liq. 3 Carc. 1B Acute Tox. 4 Acute Tox. 4 H226 H350 H332 H302 GHS02 GHS08 GHS07 Dgr H226 H350 H332 H302 609-003-00-7nitrobenzene202-716-098-95-3 Carc. 2. Repr. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Aquatic Chronic 3 H351 H360F H301 H331 H311 H372 (blood) H412 GHS06 GHS08 Dgr H351 H360F H301 H331 H311 H372 (blood) H412 609-004-00-2 dinitrobenzene; [1] 1,4-dinitrobenzene; [2] 1,3-dinitrobenzene; [3] 1,2-dinitrobenzene [4] 246-673-6 [1] 202-833-7 [2] 202-776-8 [3] 208-431-8 [4] 25154-54-5 [1] 100-25-4 [2] 99-65-0 [3] 528-29-0 [4] Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H410 609-005-00-81,3,5-trinitrobenzene202-752-799-35-4 Expl. 1.1 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H330 H310 H300 H373 H400 H410 GHS01 GHS06 GHS08 GHS09 Dgr H201 H330 H310 H300 H373 H410 609-006-00-34-nitrotoluene202-808-099-99-0 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H411 609-007-00-9 2,4-dinitrotoluene; [1] dinitrotoluene [2] 204-450-0 [1] 246-836-1 [2] 121-14-2 [1] 25321-14-6 [2] Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H341 H361f H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H341 H361f H331 H311 H301 H373 H410 609-008-00-42,4,6-trinitrotoluene; TNT204-289-6118-96-7 Expl. 1.1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H201 H331 H311 H301 H373 H411 GHS01 GHS06 GHS08 GHS09 Dgr H201 H331 H311 H301 H373 H411 609-009-00-X 2,4,6-trinitrophenol; picric acid 201-865-988-89-1 Expl. 1.1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H201 H331 H311 H301 GHS01 GHS06 Dgr H201 H331 H311 H301 609-010-00-5salts of picric acid—— Unst. Expl Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H201 H331 H311 H301 GHS01 GHS06 Dgr H201 H331 H311 H301 T609-011-00-02,4,6-trinitroanisole—606-35-9 Expl. 1.1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H201 H332 H312 H302 H411 GHS01 GHS07 GHS09 Wng H201 H332 H312 H302 H411 609-012-00-62,4,6-trinitro-m-cresol210-027-1602-99-3 Expl. 1.1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H201 H332 H312 H302 GHS01 GHS07 Wng H201 H332 H312 H302 609-013-00-12,4,6-trinitro-m-xylene211-187-5632-92-8 Expl. 1.1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 H201 H332 H312 H302 H373 GHS01 GHS08 GHS07 Wng H201 H332 H312 H302 H373 609-015-00-2 4-nitrophenol; p-nitrophenol 202-811-7100-02-7 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 H332 H312 H302 H373

GHS08 GHS07 Wng H332 H312 H302 H373 609-016-00-8 dinitrophenol (reaction mass of isomers); [1] 2,4(or 2,6)-dinitrophenol [2] 247-096-2 [1] 275-732-9 [2] 25550-58-7 [1] 71629-74-8 [2] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H410 609-018-00-9 2,4,6-trinitroresorcinol; styphnic acid 201-436-682-71-3 Expl. 1.1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H201 H332 H312 H302 GHS01 GHS07 Dgr H201 H332 H312 H302 609-019-00-4 lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate 239-290-015245-44-0 Unst. Expl Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H200 H360Df H332 H302 H373 H400 H410 GHS01 GHS08 GHS07 GHS09 Dgr H200 H360Df H332 H302 H373 H410 1609-019-01-1 lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser) 239-290-015245-44-0 Expl. 1.1 Repr. 1A Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H360Df H332 H302 H373 H400 H410 GHS01 GHS08 GHS07 GHS09 Dgr H201 H360Df H332 H302 H373 H410 1 609-020-00-X DNOC (ISO); 4,6-dinitro-o-cresol 208-601-1534-52-1 Muta. 2 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H330 H310 H300 H315 H318 H317 H400 H410 GHS06 GHS08 GHS05 GHS07 GHS09 Dgr H341 H330 H310 H300 H315 H318 H317 H410 EUH044609-021-00-5 sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate; [1] potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] 219-007-7 [1] -[2] 2312-76-7 [1] 5787-96-2 [2] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H410 609-022-00-0ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide221-037-02980-64-5 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H300 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H410 609-023-00-6 dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which "octyl" is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups 254-408-039300-45-3 Repr. 1B Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H332 H302 H373 H315 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H360D H332 H302 H373 H315 H317 H410 M=100 609-024-00-1 binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate 207-612-9485-31-4 Repr. 1B Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H360D H312 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H360D H312 H302 H410 609-025-00-7 dinoseb (ISO); 6-sec-butyl-2,4-dinitrophenol 201-861-788-85-7 Repr. 1B Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H311 H301 H319 H400 H410 GHS06 GHS08 GHS09 Dgr H360Df H311 H301

H319 H410 EUH044609-026-00-2salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex—— Repr. 1B Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H311 H301 H319 H400 H410 GHS06 GHS08 GHS09 Dgr H360Df H311 H301 H319 H410 EUH044A609-027-00-8 dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate —63919-26-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 609-028-00-3 dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol 205-042-5131-89-5 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 609-029-00-9salts and esters of dinex—— Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 A609-030-00-4 dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol 215-813-81420-07-1 Repr. 1B Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H360D H300 H311 H400 H410 GHS06 GHS08 GHS09 Dgr H360D H300 H311 H410 EUH044609-031-00-Xsalts and esters of dinoterb—— Repr. 1B Acute Tox. 2 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H360D H300 H311 H400 H410 GHS06 GHS08 GHS09 Dgr H360D H300 H311 H410 A609-032-00-5 bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime 236-129-613181-17-4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 609-033-00-0 dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol —4097-36-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 609-034-00-6salts and esters of dinosam—— Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H410 A 609-035-00-1nitroethane201-188-979-24-3 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 H226 H332 H302 GHS02 GHS07 Wng H226 H332 H302 609-036-00-7nitromethane200-876-675-52-5 Flam. Liq. 3 Acute Tox. 4 H226 H302 GHS02 GHS07 Wng H226 H302 609-037-00-25-nitroacenaphthene210-025-0602-87-9Carc. 1BH350 GHS08 Dgr H350609-038-00-82-nitronaphthalene209-474-5581-89-5 Carc. 1B Aquatic Chronic 2 H350 H411 GHS08 GHS09 Dgr H350 H411 609-039-00-34-nitrobiphenyl202-204-792-93-3 Carc. 1B Aquatic Chronic 2 H350 H411 GHS08 GHS09 Dgr H350 H411 609-040-00-9 nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether 217-406-01836-75-5 Carc. 1B Repr. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H360D H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H360D H302 H410 609-041-00-42,4-dinitrophenol200-087-751-28-5 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 H331 H311 H301 H373 H400 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H400 609-042-00-X pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine 254-938-240487-42-1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1

H317 H400 H410 GHS07 GHS09 Wng H317 H410 609-043-00-5 quintozene (ISO); pentachloronitrobenzene 201-435-082-68-8 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 609-044-00-0 tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene 204-178-2117-18-0 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 609-045-00-6reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6—8069-76-9 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 609-046-00-1 trifluralin (ISO) (containing <0.5 ppm NPDA); α, α, α-trifluoro-2,6-dinitro-N, N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA); 2,6-dinitro-N, N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N, N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA) 216-428-81582-09-8 Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H317 H410 M=10609-047-00-72-nitroanisole202-052-191-23-6 Carc. 1B Acute Tox. 4 H350 H302 GHS08 GHS07 Dgr H350 H302 609-048-00-2sodium 3-nitrobenzenesulphonate204-857-3127-68-4 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 609-049-00-82,6-dinitrotoluene210-106-0606-20-2 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 3 H350 H341 H361f H331 H311 H301 H373 H412 GHS06 GHS08 Dgr H350 H341 H361f H331 H311 H301 H373 H412 609-050-00-32,3-dinitrotoluene210-013-5602-01-7 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H341 H361f H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H341 H361f H331 H311 H301 H373 H410 609-051-00-93,4-dinitrotoluene210-222-1610-39-9 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H350 H341 H361f H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H350 H341 H361f H331 H311 H301 H373 H411 609-052-00-43,5-dinitrotoluene210-566-2618-85-9 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 3 H350 H341 H361f H331 H311 H301 H373 H412 GHS06 GHS08 Dgr H350 H341 H361f H331 H311 H301 H373 H412 609-053-00-Xhydrazine-trinitromethane414-850-9— Expl. 1.1 Self-react. A Carc. 1B Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 H201 H240 H350 H331 H301 H317 GHS01 GHS06 GHS08 Dgr H201 H240 H350 H331 H301 H317 609-054-00-5 2,3-dinitrophenol; [1] 2,5-dinitrophenol; [2] 2,6-dinitrophenol; [3] 3,4-dinitrophenol; [4] salts of dinitrophenol [5] 200-628-7 [1] 206-348-1 [2] 209-357-9 [3] 209-415-3 [4]-[5] 66-56-8 [1] 329-71-5 [2] 573-56-8 [3] 577-71-9 [4]-[5] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H411 609-055-00-02,5-dinitrotoluene210-581-4619-15-8 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3

Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H350 H341 H361f H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H350 H341 H361f H331 H311 H301 H373 H411 609-056-00-62,2-dibromo-2-nitroethanol412-380-969094-18-4 Expl. 1.1 Carc. 2 Acute Tox. 4 STOT RE 2 Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H201 H351 H302 H373 H314 H317 H400 H410 GHS01 GHS08 GHS05 GHS07 GHS09 Dgr H201 H351 H302 H373 H314 H317 H410

STOT SE 3; H335: C ≥ 1 % T609-057-00-13-chloro-2,4-difluoronitrobenzene411-980-83847-58-3 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H317 H410 609-058-00-72-nitro-2-phenyl-1,3-propanediol410-360-45428-02-4 STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H372 H312 H302 H317 H411 GHS08 GHS07 GHS09 Dgr H372 H312 H302 H317 H411 EUH070609-059-00-22-chloro-6-(ethylamino)-4-nitrophenol411-440-1131657-78-8 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 609-060-00-84-[(3-hydroxypropyl)amino]-3-nitrophenol406-305-992952-81-3 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 609-061-00-3(E, Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime406-100-494097-88-8 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 609-062-00-92-bromo-2-nitropropanol407-030-724403-04-1 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H311 H302 H373 H314 H317 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H311 H302 H373 H314 H317 H410 609-063-00-42-[(4-chloro-2-nitrophenyl)amino]ethanol413-280-859320-13-7 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 609-064-00-X mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione —104206-82-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410609-065-00-52-nitrotoluene201-853-388-72-2 Carc. 1B Muta. 1B Repr. 2 Acute Tox. 4 Aquatic Chronic 2 H350 H340 H361f H302 H411 GHS08 GHS07 GHS09 Dgr H350 H340 H361f H302 H411 609-066-00-0lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate418-870-9154212-58-5 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT SE 2 H332 H312 H302 H371 GHS08 GHS07 Dgr H332 H312 H302 H371 609-067-00-6sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3(4-methoxy-2-sulfophenylazo)4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine416-280-6156769-97-0Skin Sens. 1H317 GHS07 Wng H317609-068-00-1 musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene 201-329-481-15-2 Expl. 1.1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H351 H400 H410 GHS01 GHS08 GHS09 Wng H201 H351 H410 T609-069-00-7 musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4'-tert-butyl-2', 6'-dimethyl-3', 5'-dinitroacetophenone 201-328-981-14-1

Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 609-070-00-21,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene415-580-4130841-23-5 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 609-071-00-8 reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol 423-520-3156137-33-6Skin Sens. 1H317 GHS07 Wng H317609-072-00-34-mesyl-2-nitrotoluene430-550-01671-49-4 Repr. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H361f H302 H317 H412 GHS08 GHS07 Wng H361f H302 H317 H412 609-073-00-9lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato}-N'-(2-aminoethyl)piperazine427-850-9—Skin Sens. 1H317 GHS07 Wng H317610-001-00-3 trichloronitromethane; chloropicrin 200-930-976-06-2 Acute Tox. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H330 H302 H319 H335 H315 GHS06 Dgr H330 H302 H319 H335 H315 610-002-00-91,1-dichloro-1-nitroethane209-854-0594-72-9 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 610-003-00-4chlorodinitrobenzene—— Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H410 C610-004-00-X2-chloro-1,3,5-trinitrobenzene201-864-388-88-0 Expl. 1.1 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H330 H310 H300 H400 H410 GHS01 GHS06 GHS09 Dgr H201 H330 H310 H300 H410 610-005-00-51-chloro-4-nitrobenzene202-809-6100-00-5 Carc. 2 Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H351 H341 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H351 H341 H331 H311 H301 H373 H411 610-006-00-0chloronitroanilines with the exception of those specified elsewhere in this Annex—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H330 H310 H300 H373 H411 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H411 A C610-007-00-61-chloro-1-nitropropane209-990-0600-25-9 Acute Tox. 4 Acute Tox. 4 H332 H302 GHS07 Wng H332 H302 610-008-00-12,6-dichloro-4-nitroanisole403-350-617742-69-7 Acute Tox. 3 Aquatic Chronic 2 H301 H411 GHS06 GHS09 Dgr H301 H411 610-009-00-72-chloro-4-nitroaniline204-502-2121-87-9 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 610-010-00-22-bromo-1-(2-furyl)-2-nitroethylene406-110-935950-52-8 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H314 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H302 H373 H314 H317 H410 611-001-00-6azobenzene203-102-5103-33-3 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H350 H341 H332 H302 H373 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H341 H332 H302 H373 H410 611-002-00-1azoxybenzene207-802-1495-48-7 Acute Tox. 4 Acute Tox. 4 H332 H302

GHS07 Wng H332 H302 611-003-00-7 fenaminosulf (ISO); sodium 4-dimethylaminobenzenediazosulphonate 205-419-4140-56-7 Acute Tox. 3 Acute Tox. 4 Aquatic Chronic 3 H301 H312 H412 GHS06 Dgr H301 H312 H412 611-004-00-2 methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate 209-765-7592-62-1Carc. 1B Repr. 1B H350 H360D GHS08 Dgr H350 H360D 611-005-00-8 disodium {5-[(4'-((2,6-hydroxy3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato (4-)}cuprate(2-); CI Direct Brown 95 240-221-116071-86-6Carc. 1BH350 GHS08 Dgr H350 611-006-00-3 4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene 202-591-297-56-3 Carc. 1B Skin Sens. 1 H350 H317 GHS08 Dgr H350 H317 611-007-00-9 tricyclazole (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole; 255-559-541814-78-2Acute Tox. 4 H302 GHS07 Wng H302611-008-00-4 4-aminoazobenzene; 4-phenylazoaniline 200-453-660-09-3 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 611-009-00-Xsodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)401-220-3— Acute Tox. 4 Aquatic Chronic 3 H332 H412 GHS07 Wng H332 H412 611-010-00-52'-(2-cyano-4,6-dinitrophenylazo)-5'-(N, N-dipropylamino)propionanilide403-010-7106359-94-8 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 611-011-00-0N, N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate403-340-1— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dg H318 H411 611-012-00-6reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N, N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate403-410-1114565-65-0Skin Sens. 1H317 GHS07 Wng H317 611-013-00-1trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate403-650-7117409-78-6 Expl. 1.3 Aquatic Chronic 2 H203 H411 GHS01 GHS09 Dgr H203 H411 611-014-00-7(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide404-250-5115099-55-3Skin Sens. 1H317 GHS07 Wng H317611-015-00-2tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate404-320-5116889-78-2Skin Sens. 1H317 GHS07 Wng H317611-016-00-8reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or 2,6 or 3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride404-540-1—Skin Sens. 1H317

GHS07 Wng H317611-017-00-32-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide404-910-2— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-018-00-9tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate405-130-5—Skin Sens. 1H317 GHS07 Wng H317 611-019-00-4tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate405-150-4106028-58-4Skin Sens. 1H317 GHS07 Wng H317611-020-00-X tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-170-3116340-05-7 Acute Tox. 3 Skin Sens. 1 Aquatic Chronic 3 H301 H317 H412 GHS06 Dgr H301 H317 H412 611-021-00-52-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate405-480-9— Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Aquatic Chronic 4 H302 H373 H315 H413 GHS08 GHS07 Wng H302 H373 H315 H413 611-022-00-04-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate404-980-4— Self-react. C Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H242 H331 H301 H312 H373 H318 H317 H400 H410 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H242 H331 H301 H312 H373 H318 H317 H410 T611-023-00-6disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate404-600-7—Skin Sens. 1H317 GHS07 Wng H317 611-024-00-1 benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex ——Carc. 1BH350 GHS08 Dgr H350A611-025-00-7 disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38 217-710-31937-37-7Carc. 1B Repr. 2 H350 H361d GHS08 Dgr H350 H361d 611-026-00-2 tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6 220-012-12602-46-2Carc. 1B Repr. 2 H350 H361d GHS08 Dgr H350 H361d 611-027-00-8disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28209-358-4573-58-0Carc. 1B Repr. 2 H350 H361d GHS08 Dgr H350 H361d 611-028-00-3C,C'-azodi(formamide)204-650-8123-77-3Resp. Sens. 1H334 GHS08 Dgr H334G611-029-00-9 o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex ——Carc. 1BH350 GHS08 Dgr H350A611-030-00-4 o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex ——Carc. 1BH350 GHS08 Dgr H350A 611-031-00-X 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; C.I. Basic Red 9 209-321-2569-61-9Carc. 1BH350 GHS08 Dgr H350611-032-00-5 1,4,5,8-tetraaminoanthra quinone; C.I. Disperse Blue 1 219-603-72475-45-8 Carc. 1B Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1

H350 H315 H318 H317 GHS08 GHS05 GHS07 Dgr H350 H315 H318 H317 611-033-00-0hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'diylazo)]-bis[5'-sulfonatobenzene-2,2'-diolato-O(2), O(2), N(1)]-copper(II)400-020-382027-60-9Aquatic Chronic 2H411GHS09H411611-034-00-6N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide402-430-8105076-77-5Aquatic Chronic 4H413—H413611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0Aquatic Chronic 2H411GHS09H411611-036-00-72-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate405-440-0—Skin Sens. 1H317 GHS07 Wng H317611-037-00-23(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)1,4-dimethyl-1,2,4-triazolium methylsulphate406-055-0124584-00-5 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 611-038-00-8trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate406-820-9—Eye Irrit. 2H319 GHS07 Wng H319 611-039-00-37-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid407-050-6117715-57-8Skin Sens. 1H317 GHS07 Wng H317611-040-00-93-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid407-670-7115099-58-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410611-041-00-42-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide407-680-198809-11-1 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 611-042-00-Xtrisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate411-770-6136213-71-3Aquatic Chronic 3H412—H412611-043-00-5 reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1), O(2'))-chromate; trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''disulfamoyl-3,3''-disulfonato bis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) 402-850-1— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-044-00-0 reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);

tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) 403-720-7117527-94-3Aquatic Chronic 2H411GHS09H411611-045-00-62-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene404-830-8—Aquatic Chronic 4H413—H413611-046-00-14,4'-diamino-2-methylazobenzene407-590-243151-99-1 Acute Tox. 3 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H373 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H373 H317 H410 611-047-00-7reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)407-890-3111381-11-4Aquatic Chronic 4H413—H413611-048-00-2reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)407-900-6111381-12-5Aquatic Chronic 4H413—H413611-049-00-8reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)408-000-6118658-98-3 STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H373 H317 H412 GHS08 Wng H373 H317 H412 611-050-00-3 reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl]azo]-7-sulfonato-1naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonatophenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate 415-350-3— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-051-00-92-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride411-110-7136213-74-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410611-052-00-4monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex400-720-9—Aquatic Chronic 3H412—H412 611-053-00-X2,2'-azobis[2-methylpropionamidine] dihydrochloride221-070-02997-92-4

Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 611-055-00-0 C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide 220-600-82832-40-8 Carc. 2 Skin Sens. 1 H351 H317 GHS08 GHS07 Wng H351 H317 611-056-00-6 C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol 212-668-2842-07-9 Carc. 2 Muta. 2 Skin Sens. 1 Aquatic Chronic 4 H351 H341 H317 H413 GHS08 GHS07 Wng H351 H341 H317 H413 611-057-00-16-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile400-340-385136-74-9 Carc. 1B Aquatic Chronic 4 H350 H413 GHS08 Wng H350 H413 611-058-00-7(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate402-060-7108225-03-2 Carc. 1B Eye Dam. 1 Aquatic Chronic 2 H350 H318 H411 GHS08 GHS05 GHS09 Dgr H350 H318 H411 611-059-00-2octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate412-960-1148878-21-1 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 611-060-00-8 reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy 3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid 413-180-4187285-15-0Eye Dam. 1H318 GHS05 Dgr H318611-061-00-3disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate412-530-3— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-062-00-9octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate413-550-5— Skin Irrit. 2 Eye Dam. 1 H315 H318 GHS05 Dgr H315 H318 611-063-00-4trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato2-naphthylazo)-biphenyl 1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)413-590-3164058-22-4Carc. 1BH350 GHS08 Dgr H350 611-064-00-X4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol410-600-8124719-26-2 STOT RE 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1

H373 H315 H400 H410 GHS08 GHS07 GHS09 Wng H373 H315 H410 611-065-00-54-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol410-610-2111850-24-9 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H319 H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 H319 H315 H317 H410 611-066-00-0tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate411-540-5130201-57-9 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 611-067-00-6reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate406-910-8— Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 611-068-00-1tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate400-690-785665-98-1Aquatic Chronic 2H411GHS09H411 611-069-00-7N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline413-380-1—Aquatic Chronic 2H411GHS09H411611-070-00-2 reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) 405-665-4— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 611-071-00-8tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate406-073-9131013-81-5 Acute Tox. 3 Aquatic Chronic 3 H301 H412 GHS06 Dgr H301 H412 611-072-00-32,4-bis[2,2'-[2-(N, N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride407-010-8118208-02-9 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 611-073-00-9dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate407-310-9122630-55-1Aquatic Chronic 4H413—H413611-074-00-4 reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) 407-100-7—Skin Sens. 1H317 GHS07 Wng H317 611-075-00-X reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)

406-000-0— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 611-076-00-53-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole406-280-4117584-16-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410611-077-00-0dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3, N4-η:N3', N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)407-230-4126637-70-5 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 611-078-00-6(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(-3-(diethylammonio)propylamino)1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate407-240-9159604-94-1 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-079-00-1disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)2-naphthalenesulfonate410-390-8147703-64-8Eye Dam. 1H318 GHS05 Dgr H318611-080-00-7sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate410-150-2147703-65-9Skin Sens. 1H317 GHS07 Wng H317 611-081-00-2tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6)]cuprate(II)411-470-5141048-13-7 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 611-082-00-8reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)407-570-3—Aquatic Chronic 2H411GHS09H411611-083-00-3 reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) 411-560-4— STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 H372 H317 H411 GHS08 GHS07 GHS09 Dgr H372 H317 H411 611-085-00-4 reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine 411-880-4— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-086-00-X monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate 411-360-7—Aquatic Chronic 3H412—H412611-087-00-5 reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)

411-710-9—Aquatic Chronic 4H413—H413611-088-00-0 reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate; trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate 411-890-9— Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 611-089-00-62-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate411-100-2136213-73-5 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 H317 H410 611-090-00-12,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate413-290-293672-52-7 Self-react. C Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H242 H302 H318 H317 H412 GHS02 GHS05 GHS07 Dgr H242 H302 H318 H317 H412 T 611-091-00-7sodium (1,0-1,95)/lithium (0,051) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate413-470-0134595-59-8Skin Sens. 1H317 GHS07 Wng H317611-092-00-2tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)-pyrazol-1-yl)benzenesulfonamidato)chromate413-210-6—Aquatic Chronic 2H411GHS09H411611-093-00-8sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate410-770-3146177-84-6Skin Sens. 1H317 GHS07 Wng H317611-094-00-3 reaction mass of: 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) 411-600-0143145-93-1Aquatic Chronic 4H413—H413611-095-00-9hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide412-240-789797-03-5Aquatic Chronic 2H411GHS09H411611-096-00-4methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate413-040-2149850-30-6Skin Sens. 1H317 GHS07 Wng H317 611-097-00-X reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) 414-150-3— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-098-00-5tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate405-950-3131013-83-7Acute Tox. 3 Aquatic Chronic 3 H301 H412 GHS06 Dgr H301 H412 611-099-00-0(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridinium dichloride dihydrochloride401-500-5118658-99-4

Carc. 1B Aquatic Chronic 2 H350 H411 GHS08 GHS09 Dgr H350 H411 611-100-00-4potassium sodium 3,3'-(3(or 4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate403-810-6140876-13-7Eye Dam. 1H318 GHS05 Dgr H318611-101-00-X2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide405-200-5104366-25-8Skin Sens. 1H317 GHS07 Wng H317611-102-00-5reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid424-500-7—Aquatic Chronic 3H412—H412 611-103-00-0trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)407-110-1— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 611-104-00-6 reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)5-hydroxy-4(or 2 or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-); disodium 3,3'-(2,4-dihydroxy1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate 406-870-1— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-105-00-1sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate407-800-2136213-75-7 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-106-00-7hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate410-180-6157627-99-1Eye Dam. 1H318 GHS05 Dgr H318611-107-00-2potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate412-490-7—Skin Sens. 1H317 GHS07 Wng H317611-108-00-8disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate413-600-66527-62-4Aquatic Chronic 3H412—H412611-109-00-3reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)407-710-3—Aquatic Chronic 2H411GHS09H411611-110-00-9tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene408-210-8124605-82-9

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-111-00-4disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)414-230-8—Skin Sens. 1H317 GHS07 Wng H317611-112-00-Xtetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate413-070-6—Skin Sens. 1H317 GHS07 Wng H317 611-113-00-5lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)414-280-0149626-00-6Aquatic Chronic 2H411GHS09H411611-114-00-0lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)414-250-7149564-66-9 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 611-115-00-6trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)414-290-5149564-65-8 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 611-116-00-1 reaction mass of: trisodium 5{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 414-620-8— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-117-00-71,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt415-100-3149850-29-3Skin Sens. 1H317 GHS07 Wng H317611-118-00-2sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt413-990-8Skin Sens. 1H317 GHS07 Wng H317611-119-00-8tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate415-400-4148878-22-2 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-120-00-35-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt418-340-7157707-94-3

Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-121-00-9 main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol 417-280-930785-74-1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 611-122-00-4hexasodium (diN-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl-phthalocyaninato)nickel417-250-5151436-99-6 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-123-00-X3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate424-310-4178452-66-9Eye Dam. 1H318 GHS05 Dgr H318611-124-00-5 reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate; pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate; tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate 424-320-9 Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 611-125-00-0 reaction mass of: disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex 423-940-7— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 611-126-00-62,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride424-120-1174514-06-8 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 611-127-00-1pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate423-790-2— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 G611-128-00-7N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt419-500-9171599-85-2

Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-129-00-2 reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid 418-230-9163879-69-4 Expl. 1.3 Repr. 2 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H203 H361f H373 H317 H411 GHS01 GHS08 GHS07 GHS09 Dgr H203 H361f H373 H317 H411 611-130-00-8tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate418-520-5183130-96-3 Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 611-131-00-32-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one420-580-2151798-26-4 Repr. 1B Aquatic Chronic 4 H360D H413 GHS08 Dgr H360D H413 611-132-00-9pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)419-210-2178452-71-6 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-133-00-4product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt419-260-5— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 611-134-00-Xtrisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex423-770-3— Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 611-135-00-5reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt424-250-9— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-136-00-02-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate424-260-3— Repr. 2 Eye Dam. 1 Aquatic Chronic 2 H361f H318 H411 GHS05 GHS08 GHS09 Dgr H361f H318 H411 611-137-00-66-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole419-870-1159038-16-1Aquatic Chronic 4H413—H413611-138-00-12-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole415-910-7152828-25-6 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 611-139-00-7reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride424-510-1—

Eye Dam. 1 Aquatic Chronic 2 H318 H411 GHS05 GHS09 Dgr H318 H411 611-140-00-2 azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one —68049-83-2 Repr. 1B STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360Df H373 H400 H410 GHS08 GHS09 Dgr H360Df H373 H410 M = 1000611-141-00-85-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt414-410-6— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-142-00-3 product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride 425-740-5— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-143-00-9reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)428-260-4—Eye Dam. 1H318 GHS05 Dgr H318 611-144-00-4 reaction mas of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt 429-070-4214362-06-8Eye Dam. 1H318 GHS05 Dgr H318611-145-00-X reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino{-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt 429-440-5—Eye Dam. 1H318 GHS05 Dgr H318 611-146-00-5 reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate

430-070-1—Aquatic Chronic 2H411GHS09H411611-147-00-0sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate430-090-0205764-96-1 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-148-00-6 reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol 429-590-1— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 611-149-00-12-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate427-570-7193486-83-8Aquatic Chronic 2H411GHS09H411611-150-00-7tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate440-460-3— Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 611-151-00-2 chrysoidine; 4-(phenylazo)benzene-1,3-diamine 207-803-7495-54-5 Muta. 2 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H341 H302 H315 H400 H410 GHS08 GHS07 GHS09 Wng H341 H302 H315 H410 611-152-00-8 chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate; [3] chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4] chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5] chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6] 208-545-8 [1] 278-290-5 [2] 279-116-0 [3] 264-409-8 [4] 281-549-5 [5] 282-432-1 [6] 532-82-1 [1] 75660-25-2 [2] 79234-33-6 [3] 63681-54-9 [4] 83968-67-6 [5] 84196-22-5 [6] Muta. 2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H302 H315 H318 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H341 H302 H315 H318 H410 611-153-00-3 chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] 286-946-7 [1] 304-236-8 [2] 85407-90-5 [1] 94247-67-3 [2] Muta. 2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 H341 H302 H315 H318 GHS05 GHS08 GHS07 Dgr H341 H302 H315 H318 611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3Aquatic Chronic 3H412—H412611-155-00-44,4'-oxybis(benzenesulfonylazide)431-850-47456-68-0 Expl. 1.1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H201 H373 H400 H410 GHS01 GHS08 GHS09 Dgr H201 H373 H410 611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6

Repr. 2 STOT RE 2 Aquatic Chronic 2 H361f H373 H411 GHS08 GHS09 Wng H361f H373 H411 611-157-00-5 benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo)) bis-, potassium sodium salt; potassium sodium 3-[(E)-(6{3,4-dihydroxy-2-}(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate 432-590-4243869-48-9 Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 611-158-00-0 reaction product of: 2,3,4,2', 3', 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride 421-520-8—

Aquatic Chronic 4 H413 H413 611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-160-00-1 reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naphthalene1''-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) 422-760-6—

Aquatic Chronic 4 H413 H413611-161-00-7trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O,N]chromate(III)423-100-1—Eye Dam. 1H318 GHS05 Dgr H318611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4— Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9— Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 2 H302 H318 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H411 611-164-00-3 reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile; 2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile); 2,2’-dimethyl-2,2’-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile) 429-710-2— Self-react. D Acute Tox. 4 Aquatic Chronic 2 H242 H302 H411 GHS02 GHS07 GHS09 Dgr H242 H302 H411 611-165-00-9reaction mass of: tetrasodium - 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate431-830-5—Aquatic Chronic 3H412—H412 611-166-00-4 reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium - 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-}2-(sulfonatooxy)ethylsulfonyl{phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 432-100-9— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)435-240-9—Aquatic Chronic 3H412—H412611-168-00-5 reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid 435-440-6—Eye Dam. 1H318 GHS05 Dgr H318611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2—Aquatic Chronic 3H412—H412 611-170-00-6 reaction mas of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5))cuprate(II) 435-880-9—Aquatic Chronic 3H412—H412611-171-00-1 reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate 436-890-6— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-172-00-7 reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate 438-310-7— Self-react. C Repr. 2 Acute Tox. 4 STOT RE 2 Aquatic Chronic 3 H242 H361f H302 H373 H412 GHS02 GHS08 GHS07 Dgr H242 H361f H302 H373 H412 611-173-00-2reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2oxo-1-pyridyl]propanoicacid, disodium salt440-510-4— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-174-00-8 reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino[-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt 442-290-5457624-86-1Eye Dam. 1H318 GHS05 Dgr H318611-175-00-3 reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)aniline]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate 444-050-5— Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2—Self-react. C Aquatic Chronic 2 H242 H411 GHS02 GHS09 Dgr H242 H411 611-177-00-4reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)444-290-0508202-43-5 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 611-178-00-X reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate 445-280-9— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 611-179-00-5 reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonatethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8— Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 611-180-00-0 iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotized 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts 417-850-7—Aquatic Chronic 2H411GHS09H411612-001-00-9 mono-methylamine; [1] di-methylamine; [2] tri-methylamine [3] 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] 74-89-5 [1] 124-40-3 [2] 75-50-3 [3] Flam. Gas 1 Press. Gas Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H220 H332 H335 H315 H318 GHS02 GHS04 GHS05 GHS07 Dgr H220 H332 H335 H315 H318

Skin Irrit. 2; H315: C ≥ 5 % Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: C ≥ 5 % U5612-001-01-6 mono-methylamine … %; [1] di-methylamine … %; [2] tri-methylamine … % [3] 200-820-0 [1] 204-697-4 [2] 200-875-0 [3] 74-89-5 [1] 124-40-3 [2] 75-50-3 [3] Flam. Liq. 1 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H224 H332 H302 H314 GHS02 GHS05 GHS07 Dgr H224 H332 H302 H314

STOT SE 3; H335: C ≥ 5 % B 612-002-00-4ethylamine200-834-775-04-7 Flam. Gas 1 Press. Gas Eye Irrit. 2 STOT SE 3 H220 H319 H335 GHS02 GHS04 GHS07 Dgr H220 H319 H335 U612-003-00-Xdiethylamine203-716-3109-89-7 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H225 H332 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H312 H302 H314 STOT SE 3; H335: C ≥ 1 %612-004-00-5triethylamine204-469-4121-44-8 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H225 H332 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H312 H302 H314 STOT SE 3; H335: C ≥ 1 %612-005-00-0butylamine203-699-2109-73-9 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H225 H332 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H312 H302 H314 STOT SE 3; H335: C ≥ 1 %612-006-00-6 ethylenediamine; 1,2-diaminoethane 203-468-6107-15-3 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 H226 H312 H302 H314 H334 H317 GHS02 GHS08 GHS05 GHS07 Dgr H226 H312 H302 H314 H334 H317 612-007-00-1 2-aminopropane; isopropylamine 200-860-975-31-0 Flam. Liq. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H224 H319 H335 H315 GHS02 GHS07 Dgr H224 H319 H335 H315 612-008-00-7niline200-539-362-53-3 Carc. 2 Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H351 H341 H331 H311 H301 H372 H318 H317 H400 GHS06 GHS08 GHS05 GHS09 Dgr H351 H341 H331 H311 H301 H372 H318 H317 H400

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % 612-009-00-2salts of aniline—— Carc. 2 Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H351 H341 H331 H311 H301 H372 H318 H317 H400 GHS06 GHS08 GHS05 GHS09 Dgr H351 H341 H331 H311 H301 H372 H318 H317 H400

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % A612-010-00-8chloroanilines (with exception of those specified elsewhere in this Annex)——

Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H410 C 612-011-00-34-nitrosoaniline211-535-6659-49-4 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H332 H312 H302 GHS07 Wng H332 H312 H302 612-012-00-9o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] 201-855-4 [1] 202-729-1 [2] 202-810-1 [3] 88-74-4 [1] 99-09-2 [2] 100-01-6 [3] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 3 H331 H311 H301 H373 H412 GHS06 GHS08 Dgr H331 H311 H301 H373 H412 C612-013-00-4 3-aminobenzene sulphonic acid; metanilic acid 204-473-6121-47-1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H332 H312 H302 GHS07 Wng H332 H312 H302 612-014-00-X sulphanilic acid; 4-aminobenzenesulphonic acid 204-482-5121-57-3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H319 H315 H317 GHS07 Wng H319 H315 H317 612-015-00-5N-methylaniline202-870-9100-61-8 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H410 612-016-00-0N,N-dimethylaniline204-493-5121-69-7 Carc. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H351 H331 H311 H301 H411 GHS06 GHS08 GHS09 Dgr H351 H331 H311 H301 H411 612-017-00-6N-methyl-N-2,4,6-tetranitroaniline; tetryl207-531-9479-45-8 Expl. 1.1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 H201 H331 H311 H301 H373 GHS01 GHS06 GHS08 Dgr H201 H331 H311 H301 H373 612-018-00-1 bis(2,4,6-trinitrophenyl)amine; hexyl 205-037-8131-73-7 Expl. 1.1 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H201 H330 H310 H300 H373 H411 GHS01 GHS06 GHS08 GHS09 Dgr H201 H330 H310 H300 H373 H411 612-019-00-7dipicrylamine, ammonium salt220-639-02844-92-0 Expl. 1.1 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H201 H330 H310 H300 H373 H411 GHS01 GHS06 GHS08 GHS09 Dgr H201 H330 H310 H300 H373 H411 612-020-00-21-naphthylamine205-138-7134-32-7 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 612-022-00-32-naphthylamine202-080-491-59-8 Carc. 1A Acute Tox. 4 Aquatic Chronic 2 H350 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H411 Carc. 1A; H350: C ≥ 0,01 % 612-023-00-9 phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3] phenylhydrazinium sulphate (2:1) [4] 202-873-5 [1] 200-444-7 [2] 248-259-0 [3] 257-622-2 [4] 100-63-0 [1] 59-88-1 [2] 27140-08-5 [3] 52033-74-6 [4] Carc. 1B Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H350 H341 H331 H311 H301 H372 H319 H315 H317 H400 GHS06 GHS08 GHS09 Dgr H350 H341 H331 H311 H301 H372 H319 H315 H317 H400 612-024-00-4 m-toluidine; 3-aminotoluene 203-583-1108-44-1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 H331 H311 H301 H373 H400 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H400 612-025-00-Xnitrotoluidines, with the exception of those specified elsewhere in this Annex——

Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H411 C612-026-00-5diphenylamine204-539-4122-39-4 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H410 612-027-00-0 xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex —— Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H411 C 612-028-00-6p-phenylenediamine203-404-7106-50-3 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H319 H317 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H319 H317 H410 612-029-00-1 benzene-1,4-diamine dihydrochloride; p-phenylenediamine dihydrochloride 210-834-9624-18-0 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H319 H317 H400 H410 GHS06 GHS09 Dgr H331 H311 H301 H319 H317 H410 612-030-00-72-methyl-p-phenylenediamine sulphate [1] 210-431-8 [1] 228-871-4 [2] 615-50-9 [1] 6369-59-1 [2] Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H301 H332 H312 H317 H411 GHS06 GHS09 Dgr H301 H332 H312 H317 H411 612-031-00-2 N,N-dimethylbenzene-1,3-diamine; [1] 4-amino-N,N-dimethylaniline; 3-amino-N,N'-dimethylaniline [2] 220-623-3 [1] 202-807-5 [2] 2836-04-6 [1] 99-98-9 [2] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H331 H311 H301 GHS06 Dgr H331 H311 H301 C612-032-00-8N, N,N',N'-tetramethyl-p-phenylenediamine202-831-6100-22-1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H332 H312 H302 GHS07 Wng H332 H312 H302 612-033-00-32-aminophenol202-431-195-55-6 Muta. 2 Acute Tox. 4 Acute Tox. 4 H341 H332 H302 GHS08 GHS07 Wng H341 H332 H302 612-034-00-9 2-amino-4,6-dinitrophenol; picramic acid 202-544-696-91-3 Expl. 1.1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H201 H332 H312 H302 H412 GHS01 GHS07 Dgr H201 H332 H312 H302 H412 612-034-01-6 2-amino-4,6-dinitrophenol; picramic acid; [≥ 20 % water] 202-544-696-91-3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H332 H312 H302 H412 GHS07 Wng H332 H312 H302 H412 G612-035-00-4 2-methoxyaniline; o-anisidine 201-963-190-04-0 Carc. 1B Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 H350 H341 H331 H311 H301 GHS06 GHS08 Dgr H350 H341 H331 H311 H301 612-036-00-X 3,3'-dimethoxybenzidine; o-dianisidine 204-355-4119-90-4 Carc. 1B Acute Tox. 4 H350 H302 GHS08 GHS07 Dgr H350 H302 612-037-00-5salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine—— Carc. 1B Acute Tox. 4 H350 H302 GHS08 GHS07 Dgr H350 H302 A 612-038-00-0 2-nitro-p-anisidine; 4-methoxy-2-nitroaniline 202-547-296-96-8 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 3 H330 H310 H300 H373 H412 GHS06 GHS08 Dgr H330

H310 H300 H373 H412 612-039-00-6 2-ethoxyaniline; o-phenetidine 202-356-494-70-2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 H331 H311 H301 H373 GHS06 GHS08 Dgr H331 H311 H301 H373 612-040-00-12,4-dinitroaniline202-553-597-02-9 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Chronic 2 H330 H310 H300 H373 H411 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H411 612-041-00-74,4'-bi-o-toluidine204-358-0119-93-7 Carc. 1B Acute Tox. 4 Aquatic Chronic 2 H350 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H411 612-042-00-2 benzidine; 1,1'-biphenyl-4,4'-diamine; 4,4'-diaminobiphenyl; biphenyl-4,4'-ylenediamine 202-199-192-87-5 Carc. 1A Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 Carc. 1A; H350: C ≥ 0,01 % 612-043-00-8N,N'-dimethylbenzidine—2810-74-4 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H332 H312 H302 GHS07 Wng H332 H312 H302 612-044-00-3N,N'-diacetylbenzidine210-338-2613-35-4 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H350 H341 H332 H312 H302 GHS08 GHS07 Dgr H350 H341 H332 H312 H302 612-046-00-4allylamine203-463-9107-11-9 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H225 H331 H311 H301 H411 GHS02 GHS06 GHS09 Dgr H225 H331 H311 H301 H411 612-047-00-Xbenzylamine202-854-1100-46-9 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 612-048-00-5dipropylamine205-565-9142-84-7 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H225 H332 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H312 H302 H314 STOT SE 3; H335: C ≥ 1 % 612-049-00-0 di-n-butylamine; [1] di-sec-butylamine [2] 203-921-8 [1] 210-937-9 [2] 111-92-2 [1] 626-23-3 [2] Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H226 H332 H312 H302 GHS02 GHS07 Wng H226 H332 H312 H302 612-050-00-6cyclohexylamine203-629-0108-91-8 Flam. Liq. 3 Repr. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H226 H361f H312 H302 H314 GHS02 GHS05 GHS08 GHS07 Dgr H226 H361f H312 H302 H314 612-051-00-1 4,4'-diaminodiphenylmethane; 4,4'-methylenedianiline 202-974-4101-77-9 Carc. 1B Muta. 2 STOT SE 1 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H350 H341 H370 H373 H317 H411 GHS08 GHS07 GHS09 Dgr H350 H341 H370 H373 H317 H411 612-052-00-7 (S)-sec-butylamine; (S)-2-aminobutane; [1] (R)-sec-butylamine; (R)-2-aminobutane; [2] sec-butylamine; 2-aminobutane [3] 208-164-7 [1] 236-232-6 [2] 237-732-7 [3] 513-49-5 [1] 13250-12-9 [2] 13952-84-6 [3] Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A Aquatic Acute 1 H225 H332 H302 H314 H400 GHS02 GHS05 GHS07 GHS09 Dgr H225 H332 H302 H314 H400 C612-053-00-2N-ethylaniline203-135-5103-69-5 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 H331 H311 H301 H373 GHS06 GHS08 Dgr H331 H311 H301 H373 612-054-00-8N,N-diethylaniline202-088-891-66-7 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H411 612-055-00-3N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3]

210-260-9 [1] 211-795-0 [2] 210-769-6 [3] 611-21-2 [1] 696-44-6 [2] 623-08-5 [3] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 3 H331 H311 H301 H373 H412 GHS06 GHS08 Dgr H331 H311 H301 H373 H412 C612-056-00-9N,N-dimethyl-p-toluidine; [1] N,N-dimethyl-m-toluidine; [2] N,N-dimethyl-o-toluidine [3] 202-805-4 [1] 204-495-6 [2] 210-199-8 [3] 99-97-8 [1] 121-72-2 [2] 609-72-3 [3] Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 3 H331 H311 H301 H373 H412 GHS06 GHS08 Dgr H331 H311 H301 H373 H412 C612-057-00-4piperazine; [solid]203-808-3110-85-0 Repr. 2 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 H361fd H314 H334 H317 GHS05 GHS08 Dgr H361fd H314 H334 H317 612-057-01-1piperazine; [liquid]203-808-3110-85-0 Repr. 2 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 H361fd H314 H334 H317 GHS05 GHS08 Dgr H361fd H314 H334 H317 612-058-00-X 2,2'-iminodiethylamine; diethylenetriamine 203-865-4111-40-0 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H312 H302 H314 H317 GHS05 GHS07 Dgr H312 H302 H314 H317 612-059-00-5 3,6-diazaoctanethylenediamin; triethylenetetramine 203-950-6112-24-3 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H312 H314 H317 H412 GHS05 GHS07 Dgr H312 H314 H317 H412 612-060-00-03,6,9-triazaundecamethylenediamine; tetraethylenepentamine203-986-2112-57-2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H312 H302 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H312 H302 H314 H317 H411 612-061-00-63-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane203-680-9109-55-7 Flam. Liq. 3 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H226 H302 H314 H317 GHS02 GHS05 GHS07 Dgr H226 H302 H314 H317 612-062-00-1 3-aminopropyldiethylamine; N,N-diethyl-1,3-diaminopropane 203-236-4104-78-9 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H226 H312 H302 H314 H317 GHS02 GHS05 GHS07 Dgr H226 H312 H302 H314 H317 612-063-00-7 3,3'-iminodi(propylamine); dipropylenetriamine 200-261-256-18-8 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Skin Sens. 1 H330 H311 H302 H314 H317 GHS06 GHS05 Dgr H330 H311 H302 H314 H317 612-064-00-23,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine223-775-94067-16-7 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410 612-065-00-8polyethlyenepolyamines with the exception of those specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H312 H302 H314 H317 H410 612-066-00-3dicyclohexylamine202-980-7101-83-7 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H410 612-067-00-93-aminomethyl-3,5,5-trimethylcyclohexylamine220-666-82855-13-2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H312 H302 H314 H317 H412 GHS05 GHS07 Dgr H312 H302 H314 H317 H412 612-068-00-4 3,3'-dichlorobenzidine;

3,3'-dichlorobiphenyl-4,4'-ylenediamine 202-109-091-94-1 Carc. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H312 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H312 H317 H410 612-069-00-X salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine —— Carc. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H312 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H312 H317 H410 A612-070-00-5salts of benzidine 208-519-6 208-520-1 244-236-4 252-984-8 531-85-1 531-86-2 21136-70-9 36341-27-2 Carc. 1A Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 A612-071-00-0salts of 2-naphthylamine 209-030-0 210-313-6 553-00-4 612-52-2 Carc. 1A Acute Tox. 4 Aquatic Chronic 2 H350 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H411 A612-072-00-6 biphenyl-4-ylamine; xenylamine; 4-aminobiphenyl 202-177-192-67-1 Carc. 1A Acute Tox. 4 H350 H302 GHS08 GHS07 Dgr H350 H302 612-073-00-1 salts of biphenyl-4-ylamine; salts of xenylamine; salts of 4-aminobiphenyl —— Carc. 1A Acute Tox. 4 H350 H302 GHS08 GHS07 Dgr H350 H302 A612-074-00-7benzyldimethylamine203-149-1103-83-3 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 3 H226 H332 H312 H302 H314 H412 GHS02 GHS05 GHS07 Dgr H226 H332 H312 H302 H314 H412 612-075-00-2 2-aminoethyldimethylamine; 2-dimethylaminoethylamine 203-541-2108-00-9 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H225 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H312 H302 H314 612-076-00-8ethyldimethylamine209-940-8598-56-1 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H225 H332 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H302 H314 612-077-00-3 dimethylnitrosoamine; N-nitrosodimethylamine 200-549-862-75-9 Carc. 1B Acute Tox. 2 Acute Tox. 3 STOT RE 1 Aquatic Chronic 2 H350 H330 H301 H372 H411 GHS06 GHS08 GHS09 Dgr H350 H330 H301 H372 H411 Carc. 1B; H350: C ≥ 0,001 % 612-078-00-9 2,2'-dichloro-4,4'-methylenedianiline; 4,4'-methylene bis(2-chloroaniline) 202-918-9101-14-4 Carc. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 612-079-00-4 salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline) —— Carc. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H410 A612-080-00-X 4-amino-N,N-diethylaniline; N,N-diethyl-p-phenylendiamine 202-214-193-05-0 Acute Tox. 3 Skin Corr. 1B H301 H314 GHS06 GHS05 Dgr H301 H314 612-081-00-5 salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine 210-322-5 265-294-7 277-985-0 612-82-8 64969-36-4 74753-18-7 Carc. 1B Acute Tox. 4 Aquatic Chronic 2 H350 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H411 A612-082-00-0 thiourea; thiocarbamide 200-543-562-56-6 Carc. 2 Repr. 2 Acute Tox. 4 Aquatic Chronic 2 H351 H361d H302 H411 GHS08 GHS07 GHS09 Wng H351 H361d H302 H411 612-083-00-61-methyl-3-nitro-1-nitrosoguanidine200-730-170-25-7

Carc. 1B Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H350 H332 H319 H315 H411 GHS08 GHS07 GHS09 Dgr H350 H332 H319 H315 H411 Carc. 1B; H350: C ≥ 0,01 % 612-084-00-1 dapsone; 4,4'-diamino diphenyl sulfone 201-248-480-08-0Acute Tox. 4 H302 GHS07 Wng H302612-085-00-74,4'-methylenedi-o-toluidine212-658-8838-88-0 Carc. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350 H302 H317 H410 612-086-00-2 amitraz (ISO); N,N-bis(2,4-xylyliminomethyl) methylamine 251-375-433089-61-1 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 M = 10612-087-00-8guazatine (ISO)108173-90-6 Acute Tox. 2 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H312 H302 H335 H315 H318 H400 H410 GHS06 GHS05 GHS09 Dgr H330 H312 H302 H335 H315 H318 H410 612-088-00-3 simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 204-535-2122-34-9 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 612-089-00-91,5-naphthylenediamine218-817-82243-62-1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 612-090-00-42,2'-(nitrosoimino)bisethanol214-237-41116-54-7Carc. 1BH350 GHS08 Dgr H350612-091-00-X o-toluidine; 2-aminotoluene 202-429-095-53-4 Carc. 1B Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Aquatic Acute 1 H350 H331 H301 H319 H400 GHS06 GHS08 GHS09 Dgr H350 H331 H301 H319 H400 612-092-00-5N, N'-(2,2-dimethylpropylidene)hexamethylenediamine401-660-61000-78-8 Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 612-093-00-03,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline401-790-3104147-32-2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 612-094-00-64-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride402-190-4113674-95-6 STOT RE 1 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H372 H302 H373 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H372 H302 H373 H318 H317 H410 612-095-00-1 benzyl-2-hydroxydodecyldi methylammonium benzoate 402-610-6113694-52-3 Skin Corr. 1B Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H314 H302 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H302 H410 612-096-00-74,4'-carbonimidoylbis[N, N-dimethylaniline]207-762-5492-80-8 Carc. 2 Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 2 H351 H302 H319 H411 GHS08 GHS07 GHS09 Wng H351 H302 H319 H411 612-097-00-2salts of 4,4'-carbonimidoylbis[N, N-dimethylaniline]—— Carc. 2 Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 2 H351 H302 H319 H411 GHS08 GHS07 GHS09 Wng H351 H302 H319 H411 A612-098-00-8nitrosodipropylamine210-698-0621-64-7 Carc. 1B Acute Tox. 4 Aquatic Chronic 2 H350 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H411 Carc. 1B; H350: C ≥ 0,001 %612-099-00-3 4-methyl-m-phenylenediamine; 2,4-toluenediamine 202-453-195-80-7 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4

STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H350 H341 H361f H301 H312 H373 H317 H411 GHS06 GHS08 GHS09 Dgr H350 H341 H361f H301 H312 H373 H317 H411 612-100-00-7propylenediamine201-155-978-90-0 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A H226 H312 H302 H314 GHS02 GHS05 GHS07 Dgr H226 H312 H302 H314 612-101-00-2 methenamine; hexamethylenetetramine 202-905-8100-97-0 Flam. Sol. 2 Skin Sens. 1 H228 H317 GHS02 GHS07 Wng H228 H317 612-102-00-8N, N-bis(3-aminopropyl)methylamine203-336-8105-83-9 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B H331 H311 H302 H314 GHS06 GHS05 Dgr H331 H311 H302 H314 612-103-00-3N, N,N',N'-tetramethylethylenediamine203-744-6110-18-9 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H225 H332 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H302 H314 612-104-00-9hexamethylenediamine204-679-6124-09-4 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Corr. 1B H312 H302 H335 H314 GHS05 GHS07 Dgr H312 H302 H335 H314 612-105-00-42-piperazin-1-ylethylamine205-411-0140-31-8 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H312 H302 H314 H317 H412 GHS05 GHS07 Dgr H312 H302 H314 H317 H412 612-106-00-X2,6-diethylaniline209-445-7579-66-8Acute Tox. 4 H302—H302612-107-00-5 1-phenylethylamine; [1] DL-α-methylbenzylamine [2] 202-706-6 [1] 210-545-8 [2] 98-84-0 [1] 618-36-0 [2] Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 612-108-00-03-aminopropyltriethoxysilane213-048-4919-30-2 Acute Tox. 4 Skin Corr. 1B H302 H314 GHS05 GHS07 Dgr H302 H314 612-109-00-6bis(2-dimethylaminoethyl)(methyl)amine221-201-13030-47-5 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B H311 H302 H314 GHS06 GHS05 Dgr H311 H302 H314 612-110-00-12,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)229-962-16864-37-5 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Aquatic Chronic 2 H331 H311 H302 H314 H411 GHS06 GHS05 GHS09 Dgr H331 H311 H302 H314 H411 612-111-00-7 2-methyl-m-phenylenediamine; 2,6-toluenediamine 212-513-9823-40-5 Muta. 2 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H341 H312 H302 H317 H411 GHS08 GHS07 GHS09 Wng H341 H312 H302 H317 H411 612-112-00-2 p-anisidine; 4-methoxyaniline 203-254-2104-94-9 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 STOT RE 2 Aquatic Acute 1 H330 H310 H300 H373 H400 GHS06 GHS08 GHS09 Dgr H330 H310 H300 H373 H400 612-113-00-86-methyl-2,4-bis(methylthio)phenylene-1,3-diamine403-240-8106264-79-3 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 612-114-00-3R, R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate404-390-7— Flam. Sol. 1 Skin Sens. 1 Aquatic Chronic 3 H228 H317 H412 GHS02 GHS07 Wng H228 H317 H412 612-115-00-9dimethyldioctadecylammonium hydrogen sulfate404-050-8123312-54-9 Eye Irrit. 2 Aquatic Chronic 4 H319 H413 GHS07 Wng H319 H413 612-116-00-4C8-18 alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate404-690-868132-19-4 Acute Tox. 3

Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H314 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H331 H314 H317 H410 612-117-00-XC12-14-tert-alkylamine, methylphosphonic acid salt404-750-3119415-07-5 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H302 H314 H411 GHS05 GHS07 GHS09 Dgr H302 H314 H411 612-118-00-5A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide405-080-4— Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 612-119-00-0benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate405-330-2— Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H400 H410 GHS05 GHS09 Dgr H315 H318 H410 612-120-00-6 aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline 277-704-174070-46-5 Carc. 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H351 H317 H400 H410 GHS08 GHS07 GH09 Wng H351 H317 H410 M = 100 M = 10 612-121-00-1amines, polyethylenepoly-; HEPA268-626-968131-73-7 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H312 H302 H314 H317 H410 612-122-00-7 hydroxylamine … % [> 55 % in aqueous solution] 232-259-27803-49-8 Unst. Expl. Met. Corr. 1 Carc. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H200 H290 H351 H312 H302 H373 H335 H315 H318 H317 H400 GHS01 GHS05 GHS08 GHS07 GHS09 Dgr H200 H290 H351 H312 H302 H373 H335 H315 H318 H317 H400 B 612-122-01-4hydroxylamine …% [≤ 55 % in aqueous solution]232-259-27803-49-8 Met. Corr. 1 Carc. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H290 H351 H312 H302 H373 H335 H315 H318 H317 H400 GHS05 GHS08 GHS07 GHS09 Dgr H290 H351 H312 H302 H373 H335 H315 H318 H317 H400 B612-123-00-2 hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2] 226-798-2 [1] 233-118-8 [2] 5470-11-1 [1] 10039-54-0 [2] Met. Corr. 1 Carc. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H290 H351 H312 H302 H373 H319 H315 H317 H400 GHS05 GHS08 GHS07 GHS09 Wng H290 H351 H312 H302 H373 H319 H315 H317 H400 612-124-00-8N,N,N-trimethylanilinium chloride205-319-0138-24-9 Acute Tox. 3 Acute Tox. 3 H311 H301 GHS06 Dgr H311 H301 612-125-00-3 2-methyl-p-phenylenediamine; 2,5-toluenediamine 202-442-195-70-5 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H301 H332 H312 H317 H411 GHS06 GHS09 Dgr H301 H332 H312 H317 H411 612-126-00-9 toluene-2,4-diammonium sulphate; 4-methyl-m-phenylenediamine sulfate 265-697-865321-67-7 Carc. 1B Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H350 H301 H312 H319 H317 H411 GHS06 GHS08 GHS09 Dgr H350 H301 H312 H319 H317 H411 612-127-00-43-aminophenol209-711-2591-27-5 Acute Tox. 4

Acute Tox. 4 Aquatic Chronic 2 H332 H302 H411 GHS07 GHS09 Wng H332 H302 H411 612-128-00-X4-aminophenol204-616-2123-30-8 Muta. 2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H341 H332 H302 H400 H410 GHS08 GHS07 GHS09 Wng H341 H332 H302 H410 612-129-00-5diisopropylamine203-558-5108-18-9 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H225 H332 H302 H314 GHS02 GHS05 GHS07 Dgr H225 H332 H302 H314 STOT SE 3; H335: C ≥ 5 %612-130-00-0 2,6-diamino-3,5-diethyltoluene; 4,6-diethyl-2-methyl-1,3-benzenediamine; [1] 2,4-diamino-3,5-diethyltoluene; 2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3] 218-255-3 [1] 218-256-9 [2] 270-877-4 [3] 2095-01-4 [1] 2095-02-5 [2] 68479-98-1 [3] Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373 H319 H400 H410 GHS08 GHS07 GHS09 Wng H312 H302 H373 H319 H410 C612-131-00-6didecyldimethylammonium chloride230-525-27173-51-5 Acute Tox. 4 Skin Corr. 1B H302 H314 GHS05 GHS07 Dgr H302 H314 612-132-00-1 N, N'-diphenyl-p-phenylenediamine; N, N'-diphenyl-1,4-benzenediamine 200-806-474-31-7 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 612-133-00-7 (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate 247-162-025646-77-9 Acute Tox. 3 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H373 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H373 H317 H410 612-134-00-2 N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate 247-161-525646-71-3 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 612-135-00-8 N-2-naphthylaniline; N-phenyl-2-naphthylamine 205-223-9135-88-6 Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H351 H319 H315 H317 H411 GHS08 GHS07 GHS09 Wng H351 H319 H315 H317 H411 612-136-00-3N-isopropyl-N'-phenyl-p-phenylenediamine202-969-7101-72-4 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 Skin Sens. 1; H317:C ≥0,1 %612-137-00-94-chloroaniline203-401-0106-47-8 Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H331 H311 H301 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H331 H311 H301 H317 H410 612-138-00-4 furalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate 260-875-157646-30-7 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 612-139-00-X mefenacet (ISO); 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide 277-328-873250-68-7Aquatic Chronic 2H411GHS09H411612-140-00-5quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides264-151-663449-41-2 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 H312 H302 H314 H400 GHS05 GHS07 GHS09 Dgr H312 H302 H314 H400 612-141-00-0 4,4'-methylenebis(2-ethylaniline);

4,4'-methylenebis(2-ethylbenzeneamine) 243-420-119900-65-3 Carc. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H410 612-142-00-6biphenyl-2-ylamine201-990-990-41-5 Carc. 2 Acute Tox. 4 Aquatic Chronic 3 H351 H302 H412 GHS08 GHS07 Wng H351 H302 H412 612-143-00-1 N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride 218-130-32051-79-8 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H319 H317 H400 H410 GHS06 GHS09 Dgr H301 H319 H317 H410 612-144-00-7 flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine —62924-70-3 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H317 H400 H410 GHS07 GHS09 Wng H319 H315 H317 H410 612-145-00-2o-phenylenediamine202-430-695-54-5 Carc. 2 Muta. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H341 H301 H332 H312 H319 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H341 H301 H332 H312 H319 H317 H410 612-146-00-8o-phenylenediamine dihydrochloride210-418-7615-28-1 Carc. 2 Muta. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H341 H301 H332 H312 H319 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H351 H341 H301 H332 H312 H319 H317 H410 612-147-00-3m-phenylenediamine203-584-7108-45-2 Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H331 H311 H301 H319 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H341 H331 H311 H301 H319 H317 H410 612-148-00-9m-phenylenediamine dihydrochloride208-790-0541-69-5 Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H331 H311 H301 H319 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H341 H331 H311 H301 H319 H317 H410 612-149-00-41,3-diphenylguanidine203-002-1102-06-7 Repr. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H361f H302 H319 H335 H315 H411 GHS08 GHS07 GHS09 Wng H361f H302 H319 H335 H315 H411 612-151-00-5 methyl-phenylene diamine; diaminotoluene; [technical product — reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] —— Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H350 H341 H361f H301 H312 H373 H319 H317 H411 GHS06 GHS08 GHS09 Dgr H350 H341 H361f H301 H312 H373 H319 H317 H411 612-152-00-0N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine406-610-762478-82-4 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1A Aquatic Chronic 3 H226 H332 H302 H373 H314 H412 GHS02 GHS08 GHS05 GHS07 Dgr H226 H332 H302 H373 H314 H412 612-153-00-64-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride407-020-2132885-85-9 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302

H317 H412 612-154-00-16'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]410-890-695235-29-3Aquatic Chronic 4H413—H413612-155-00-72'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene411-730-893071-94-4Aquatic Chronic 4H413—H413612-156-00-2reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride405-620-9— Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 612-157-00-8(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride410-780-8— Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H373 H318 H317 H411 GHS08 GHS05 GHS07 GHS09 Dgr H302 H373 H318 H317 H411 612-158-00-3 reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; 4-dodecylsalicylaldoxime 410-820-4—Aquatic Chronic 4H413—H413 612-159-00-9reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid410-880-1— Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H410 612-160-00-4 p-toluidine; 4-aminotoluene; [1] toluidinium chloride; [2] toluidine sulphate (1:1) [3] 203-403-1 [1] 208-740-8 [2] 208-741-3 [3] 106-49-0 [1] 540-23-8 [2] 540-25-0 [3] Carc. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H351 H331 H311 H301 H319 H317 H400 GHS06 GHS08 GHS09 Dgr H351 H331 H311 H301 H319 H317 H400 612-161-00-X 2,6-xylidine; 2,6-dimethylaniline 201-758-787-62-7 Carc. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 H351 H332 H312 H302 H335 H315 H411 GHS08 GHS07 GHS09 Wng H351 H332 H312 H302 H335 H315 H411 612-162-00-5 dimethyldioctadecylammonium chloride; DODMAC 203-508-2107-64-2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 612-163-00-0 metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester —70630-17-0 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 612-164-00-62-butyl-2-ethyl-1,5-diaminopentane412-700-7137605-95-9 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H312 H302 H373 H314 H317 H412 GHS08 GHS05 GHS07 Dgr H312 H302 H373 H314 H317 H412 612-165-00-1N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine413-810-865181-78-4Aquatic Chronic 2H411GHS09H411612-166-00-7 reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) 411-830-1114765-88-7 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 612-167-00-25-acetyl-3-amino-10,11-dihydro-5H-dibenz[b, f]azepine-hydrochloride410-490-1—

Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H373 H318 H317 H411 GHS08 GHS05 GHS07 GHS09 Dgr H302 H373 H318 H317 H411 612-168-00-83,5-dichloro-2,6-difluoropyrdine-4-amine220-630-12840-00-8 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H312 H302 H411 GHS07 GHS09 Wng H312 H302 H411 612-169-00-3bis(N-methyl-N-phenylhydrazine)sulfate423-170-1618-26-8 Flam. Liq. 2 STOT RE 1 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H225 H372 H302 H318 H317 H400 H410 GHS02 GHS05 GHS08 GHS07 GHS09 Dgr H225 H372 H302 H318 H317 H410 612-170-00-94-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime405-260-2— Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 612-171-00-4N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane410-060-3130728-76-6 Muta. 2 Skin Sens. 1 Aquatic Chronic 2 H341 H317 H411 GHS08 GHS09 Wng H341 H317 H411 612-172-00-X4,4'-methylenebis(N,N'-dimethylcyclohexanamine412-840-913474-64-1 Acute Tox. 4 STOT RE 2 Skin Corr. 1A Aquatic Chronic 3 H302 H373 H314 H412 GHS08 GHS05 GHS07 Dgr H302 H373 H314 H412 612-173-00-5lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate411-140-0125328-86-1 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 612-174-00-04,4-dimethoxybutylamine407-690-619060-15-2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 H302 H314 H317 H412 GHS05 GHS07 Dgr H302 H314 H317 H412 612-175-00-62-(O-aminooxy)ethylamine dihydrochloride412-310-737866-45-8 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 612-176-00-1polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine410-570-6143747-73-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410612-177-00-72-naphthylamino-6-sulfomethylamide412-120-4104295-55-8 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H373 H317 H411 GHS08 GHS09 Wng H373 H317 H411 612-178-00-21,4,7,10-tetraazacyclododecane disulfate412-080-8112193-77-8 Acute Tox. 4 STOT SE 3 Eye Dam. 1 Aquatic Chronic 3 H302 H335 H318 H412 GHS05 GHS07 Dgr H302 H335 H318 H412 612-179-00-81-(2-propenyl)pyridinium chloride412-740-525965-81-5 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 612-180-00-33-aminobenzylamine412-230-24403-70-7 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 2 H302 H314 H411 GHS05 GHS07 GHS09 Dgr H302 H314 H411 612-181-00-92-phenylthioaniline413-030-81134-94-7 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 612-182-00-41-ethyl-1-methylmorpholinium bromide418-210-165756-41-4Muta. 2H341 GHS08 Wng H341612-183-00-X1-ethyl-1-methylpyrrolidinium bromide418-200-569227-51-6Muta. 2H341 GHS08 Wng H341 612-184-00-56'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one403-830-589331-94-2Aquatic Chronic 3H412—H412612-185-00-01-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N, N,N-trimethylammonium iodide407-400-859493-72-0 Eye Dam. 1 Aquatic Acute 1

Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 612-186-00-6bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate406-770-8149057-64-7 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H318 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H373 H318 H317 H410 612-187-00-12,3,4-trifluoroaniline407-170-93862-73-5 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H312 H302 H373 H315 H318 H411 GHS08 GHS05 GHS07 GHS09 Dgr H312 H302 H373 H315 H318 H411 612-188-00-74,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)407-560-9107934-68-9Aquatic Chronic 2H411GHS09H411612-189-00-24-amino-2-(aminomethyl)phenol dihydrochloride412-510-4135043-64-0 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 612-190-00-84,4'-methylenebis(2-isopropyl-6-methylaniline)415-150-616298-38-7 STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411 612-191-00-3polymer of allylamine hydrochloride415-050-271550-12-4 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 612-192-00-92-isopropyl-4-(N-methyl)aminomethylthiazole414-800-6154212-60-9 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H312 H302 H315 H318 H411 GHS05 GHS07 GHS09 Dgr H312 H302 H315 H318 H411 612-193-00-43-methylaminomethylphenylamine414-570-718759-96-1 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H312 H302 H314 H317 H410 612-194-00-X2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride414-670-0141890-30-4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410 612-195-00-5bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate415-210-1160236-81-7 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H332 H302 H318 H410 612-196-00-0 4-chloro-o-toluidine; [1] 4-chloro-o-toluidine hydrochloride [2] 202-441-6[1] 221-627-8[2] 95-69-2[1] 3165-93-3[2] Carc. 1B Muta. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H350 H341 H331 H311 H301 H400 H410 GHS06 GHS08 GHS09 Dgr H350 H341 H331 H311 H301 H410 612-197-00-6 2,4,5-trimethylaniline; [1] 2,4,5-trimethylaniline hydrochloride [2] 205-282-0[1]-[2] 137-17-7 [1] 21436-97-5[2] Carc. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H350 H331 H311 H301 H411 GHS06 GHS08 GHS09 Dgr H350 H331 H311 H301 H411 612-198-00-14,4'-thiodianiline and its salts205-370-9139-65-1 Carc. 1B Acute Tox. 4 Aquatic Chronic 2 H350 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H302 H411 612-199-00-7 4,4'-oxydianiline and its salts; p-aminophenyl ether 202-977-0101-80-4 Carc. 1B Muta. 1B Repr. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 2 H350 H340 H361f H331 H311 H301 H411 GHS06 GHS08 GHS09

Dgr H350 H340 H361f H331 H311 H301 H411 612-200-00-0 2,4-diaminoanisole; 4-methoxy-m-phenylenediamine; [1] 2,4-diaminoanisole sulphate [2] 210-406-1 [1] 254-323-9 [2] 615-05-4 [1] 39156-41-7 [2] Carc. 1B Muta. 2 Acute Tox. 4 Aquatic Chronic 2 H350 H341 H302 H411 GHS08 GHS07 GHS09 Dgr H350 H341 H302 H411 612-201-00-6N,N,N',N'-tetramethyl-4,4'-methylendianiline202-959-2101-61-1 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410 612-202-00-13,4-dichloroaniline202-448-495-76-1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H331 H311 H301 H318 H317 H410 612-203-00-7C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %- 85 %, chain > C10: <3 %)417-360-3— Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 H312 H302 H315 GHS07 Wng H312 H302 H315 612-204-00-2 C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride 208-953-6548-62-9 Carc. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H318 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H351 H302 H318 H410 612-205-00-8C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5)208-953-6548-62-9 Carc. 1B Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H350 H302 H318 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H350 H302 H318 H410 612-206-00-3 famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione —131807-57-3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410 612-207-00-9 4-ethoxyaniline; p-phenetidine 205-855-5156-43-4 Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H341 H332 H312 H302 H319 H317 GHS08 GHS07 Wng H341 H332 H312 H302 H319 H317 612-208-00-4N-methylbenzene-1,2-diammonium hydrogen phosphate424-460-0— Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 612-209-00-X 6-methoxy-m-toluidine; p-cresidine 204-419-1120-71-8 Carc. 1B Acute Tox. 4 H350 H302 GHS08 GHS07 Dgr H350 H302 612-210-00-5 5-nitro-o-toluidine; [1] 5-nitro-o-toluidine hydrochloride [2] 202-765-8 [1] 256-960-8 [2] 99-55-8 [1] 51085-52-0 [2] Carc. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Aquatic Chronic 3 H351 H331 H311 H301 H412 GHS06 GHS08 Dgr H351 H331 H311 H301 H412 612-211-00-0N-[(benzotriazole-1-yl)methyl)]4-carboxy-benzenesulfonamide416-470-9170292-97-4 Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 612-212-00-62,6-dichloro-4-trifluoromethylaniline416-430-024279-39-8 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H315 H317 H400 H410 GHS07 GHS09 Wng H332 H302 H315 H317 H410 612-213-00-1isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine419-850-2148348-13-4 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412

612-214-00-74-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine421-390-289114-90-9Aquatic Chronic 4H413—H413612-215-00-23-chloro-2-(isopropylthio)aniline421-700-6179104-32-6 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 612-216-00-81-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt425-870-219450-38-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 612-217-00-31-methoxy-2-propylamine422-550-437143-54-7 Flam. Liq. 2 Skin Corr. 1B Acute Tox. 4 Aquatic Chronic 3 H225 H314 H302 H412 GHS02 GHS05 GHS07 Dgr H225 H314 H302 H412 612-219-00-4(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride402-200-7—Aquatic Chronic 3H412—H412612-220-00-XN-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine431-060-1153719-38-1 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 612-221-00-52-amino-4-(trifluoromethyl)benzenethiol hydrochloride429-560-84274-38-8 Skin Corr. 1B Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 H314 H332 H312 H302 H373 H317 H400 GHS05 GHS08 GHS07 GHS09 Dgr H314 H332 H312 H302 H373 H317 H400 612-222-00-0cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine425-080-8104860-26-6 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H373 H318 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H312 H302 H373 H318 H410 612-223-00-6N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine425-300-2186450-73-7 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 612-224-00-1N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine426-150-0121246-28-4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 612-225-00-71,4,7,10-tetraazacyclododecane425-450-9294-90-6 Skin Corr. 1B Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H314 H312 H302 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H312 H302 H410 612-226-00-23-(2'-phenoxyethoxy)propylamine427-870-86903-18-0 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H302 H315 H318 H412 GHS05 GHS07 Dgr H302 H315 H318 H412 612-227-00-8benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride428-290-8120606-08-8 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410 612-228-00-3 reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine 414-340-6— Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT SE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H226 H332 H312 H302 H371 H318 H317 H412 GHS02 GHS05 GHS08 GHS07 Dgr H226 H332 H312 H302 H371 H318 H317 H412 612-229-00-9 mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine

—110235-47-7 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 612-230-00-4N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide431-530-4— Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410 612-231-00-X3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride427-370-1164288-56-6 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 612-232-00-5reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid430-410-9186148-38-9Aquatic Chronic 3H412—H412 612-237-00-2 hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphos phate; [3] hydroxylamine 4-methylben zenesulfonate [4] 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] Expl. 1.1 Carc. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H201 H351 H312 H302 H373 H319 H315 H317 H400 GHS01 GHS08 GHS07 GHS09 Dgr H201 H351 H312 H302 H373 H319 H315 H317 H400 T612-238-00-8 (3-chloro-2-hydroxypropyl) trimethylammonium chloride …% 222-048-33327-22-8 Carc. 2 Aquatic Chronic 3 H351 H412 GHS08 Wng H351 H412 B612-239-00-3 biphenyl-3,3', 4,4'-tetrayltetraamine; diaminobenzidine 202-110-691-95-2Carc. 1B Muta. 2 H350 H341 GHS08 Dgr H350 H341 612-240-00-9 pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline —53112-28-0Aquatic Chronic 2H411GHS09H411612-241-00-4piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] Repr. 2 Eye Irrit. 2 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H361fd H319 H315 H334 H317 H412 GHS08 Dgr H361fd H319 H315 H334 H317 H412 612-242-00-X cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine —121552-61-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10 612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 M=10612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1 Repr. 2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H302 H319 H317 H400 H410 GHS08 GHS07 GHS09 Wng H361f H302 H319 H317 H410 612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2 Carc. 2 STOT RE 1 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H372 H302 H318 H317 H400 H410 GHS05 GHS08 GHS07 GHS09 Dgr H351 H372 H302 H318 H317 H410 M=10612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chloride429-740-640722-80-3

Carc. 1B Muta. 1B STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H350 H340 H373 H317 H412 GHS08 GHS07 Dgr H350 H340 H373 H317 H412 612-247-00-7N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4 STOT RE 1 Acute Tox. 4 Aquatic Chronic 3 H372 H302 H412 GHS08 GHS07 Dgr H372 H302 H412 612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0— Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 H315 H317 H413 GHS07 Wng H315 H317 H413 612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2 Repr. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H361f H302 H314 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H361f H302 H314 H317 H411 612-250-00-3chloro-N, N-dimethylformiminium chloride425-970-63724-43-4 Repr. 1B Acute Tox. 4 Skin Corr. 1A H360D H302 H314 GHS05 GHS08 GHS07 Dgr H360D H302 H314 EUH014612-251-00-9cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8 Flam. Sol. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H228 H361d H302 H315 H317 H411 GHS02 GHS08 GHS07 GHS09 Wng H228 H361d H302 H315 H317 H411 612-252-00-4 imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine 428-040-8138261-41-3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 612-253-00-X7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)]429-400-7199327-61-2Aquatic Chronic 3H412—H412 612-253-01-77-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)]429-400-7199327-61-2 Repr. 1B Aquatic Chronic 3 H360D H412 GHS08 Dgr H360D H412 612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5 Carc. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H351 H302 H314 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H351 H302 H314 H317 H411 612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B Aquatic Chronic 3 H312 H302 H314 H412 GHS05 GHS07 Dgr H312 H302 H314 H412 612-256-00-6benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Acute Tox. 4 H302 GHS07 Wng H302612-259-00-2N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Eye Dam. 1H318 GHS05 Dgr H318612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M=10612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7Aquatic Chronic 3H412—H412 612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0 Muta. 2 Acute Tox. 4

STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H341 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H341 H302 H373 H410 612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 612-269-00-7 reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1yl)methyl]-4-octyl-N-(4-octylphenyl)aniline 420-720-2—Aquatic Chronic 4H413—H413612-270-00-2 (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride 433-010-2— Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H302 H317 H412 GHS07 Wng H302 H317 H412 612-271-00-8 reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate 434-970-5160987-57-5Aquatic Chronic 4H413—H413 612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4))iron(3+) monohydrate435-210-5—Aquatic Chronic 2H411GHS09H411612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8— Acute Tox. 4 Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H410 612-274-00-4(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3— Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412 612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 M=10612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 612-277-00-0 reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium 451-440-9586372-44-3Eye Dam. 1H318 GHS05 Dgr H318612-278-00-6 ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide 214-984-61239-45-8 Muta. 2 Acute Tox. 2 Acute Tox. 4 H341 H330 H302 GHS06 GHS08 Dgr H341 H330 H302 612-279-00-1(R, S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8 Repr. 2 STOT RE 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1

H361f H373 H319 H315 H317 GHS08 GHS07 Wng H361f H373 H319 H315 H317 612-280-00-7 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine 205-057-7132-32-1Carc. 1BH350 GHS08 Dgr H350612-281-00-2leucomalachite green; N, N,N',N'-tetramethyl-4,4'-benzylidenedianiline204-961-9129-73-7 Carc. 2 Muta. 2 H351 H341 GHS08 Wng H351 H341 612-282-00-8octadecylamine204-695-3124-30-1 Asp. Tox. 1 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H304 H373 (gastrointestinal tract, liver, immune system) H315 H318 H400 H410 GHS05 GHS08 GHS09 Dgr H304 H373 (gastrointestinal tract, liver, immune system) H315 H318 H410 M = 10 M = 10 612-283-00-3(Z)-octadec-9-enylamine204-015-5112-90-3 Acute Tox. 4 Asp Tox. 1 STOT SE 3 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H304 H335 H373 (gastro-intestinal tract, liver, immune system) H314 H400 H410 GHS05 GHS07 GHS08 GHS09 Dgr H302 H304 H335 H373 (gastro-intestinal tract, liver, immune system) H314 H410 M = 10 M = 10 612-284-00-9amines, hydrogenated tallow alkyl262-976-661788-45-2 Asp Tox. 1 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H304 H373 (gastro-intestinal tract, liver, immune system) H315 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H304 H373 (gastro-intestinal tract, liver, immune system) H315 H318 H410 M = 10 M = 10 612-285-00-4amines, coco alkyl262-977-161788-46-3 Acute Tox. 4 Asp. Tox. 1 STOT SE 3 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H304 H335 H373 (gastro-intestinal tract, liver, immune system) H314 H400 H410 GHS05 GHS07 GHS08 GHS09 Dgr H302 H304 H335 H373 (gastro-intestinal tract, liver, immune system) H314 H410 M = 10 M = 10 612-286-00-Xamines, tallow alkyl263-125-161790-33-8 Acute Tox. 4 Asp. Tox. 1 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H302 H304 H373 (gastro-intestinal tract, liver, immune system) H314 H400 H410 GHS05 GHS07 GHS08 GHS09 Dgr H302 H304 H373 (gastro-intestinal tract, liver, immune system) H314 H410 M = 10 M = 10 612-287-00-5fluazinam (ISO); 3-chloro-N-[3- chloro-2,6-dinitro-4-(trifluor omethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine—79622-59-6 Repr. 2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H361d H332 H318 H317 H400 H410 GHS08 GHS07 GHS05 GHS09 Dgr H361d H332 H318 H317 H410 M = 10 M = 10 613-001-00-1ethyleneimine; aziridine205-793-9151-56-4 Flam. Liq. 2 Carc. 1B Muta. 1B Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Skin Corr. 1B Aquatic Chronic 2 H225 H350 H340 H330 H310 H300 H314 H411 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H225 H350 H340 H330 H310 H300 H314 H411 D613-002-00-7pyridine203-809-9110-86-1 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H225 H332 H312 H302 GHS02 GHS07 Dgr H225 H332 H312 H302 613-003-00-21,2,3,4-tetranitrocarbazole—6202-15-9 Expl. 1.1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 H201 H332 H312 H302 GHS01 GHS07 Dgr H201 H332 H312 H302 613-004-00-8crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine208-622-6535-89-7Acute Tox. 2 H300 GHS06 Dgr

H300613-007-00-4desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine213-800-11014-69-3 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 613-008-00-Xdazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thione208-576-7533-74-4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H400 H410 GHS07 GHS09 Wng H302 H319 H410 613-009-00-52,4,6-trichloro-1,3,5-triazine; cyanuric chloride203-614-9108-77-0 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 H330 H302 H314 H317 GHS06 GHS05 Dgr H330 H302 H314 H317 EUH014STOT SE 3; H335: C ≥ 5 %613-010-00-0ametryn (ISO);N-ethyl-N'-isopropyl-6-(methyl-thio)-1,3,5-triazine-2,4-diamine212-634-7834-12-8 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M = 100613-011-00-6amitrole (ISO);1,2,4-triazol-3-ylamine200-521-561-82-5 Repr. 2 STOT RE 2 Aquatic Chronic 2 H361d H373 H411 GHS08 GHS09 Wng H361d H373 H411 613-012-00-1bentazone (ISO);3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide246-585-825057-89-0 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H302 H319 H317 H412 GHS07 Wng H302 H319 H317 H412 613-013-00-7cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile244-544-921725-46-2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-014-00-2ethoxyquin (ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline202-075-791-53-2Acute Tox. 4H302 GHS07 Wng H302613-015-00-8fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluor-omethylbenzimidazole-1-carboxylate238-134-914255-88-0 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 613-016-00-3fuberidazole (ISO);2-(2-furyl-)-1H-benzimidazole223-404-03878-19-1 Carc. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H373 (heart) H317 H400 H410 GHS07 GHS08 GHS09 Wng H351 H302 H373 (heart) H317 H410 M = 1613-017-00-9bis(8-hydroxyquinolinium) sulphate205-137-1134-31-6Acute Tox. 4H302 GHS07 Wng H302613-018-00-4morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion7411-47-4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 H302 H319 H335 H315 H412 GHS07 Wng H302 H319 H335 H315 H412 613-019-00-Xthioquinox(ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline202-272-893-75-4Acute Tox. 4 H302 GHS07 Wng H302613-020-00-5tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine246-347-324602-86-6 Repr. 1B Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H360D H332 H302 H315 H400 H410 GHS08 GHS07 GHS09 Dgr H360D H332 H302 H315 H410 613-021-00-0dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3- dicarbonitrile222-098-63347-22-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-022-00-6pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex——

Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 A613-023-00-12-methyl-4-oxo-3-(penta-2,4- dienyl)cyclopent-2-enyl [1R- [1α[S(Z)],3β]]-chrysanthemate; pyrethrin I204-455-8121-21-1 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 613-024-00-72-methyl-4-oxo-3-(penta-2,4- dienyl)cyclopent-2-enyl[1R- [1αS(Z)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2- dimethylcyclopropanecar boxylate; pyrethrin II204-462-6121-29-9 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 613-025-00-2cinerin I; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate246-948-025402-06-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-026-00-8cinerin II; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate204-454-2121-20-0 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-027-00-3piperidine203-813-0110-89-4 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B H225 H331 H311 H314 GHS02 GHS06 GHS05 Dgr H225 H331 H311 H314

613-028-00-9morpholine203-815-1110-91-8 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H226 H332 H312 H302 H314 GHS02 GHS05 GHS07 Dg H226 H332 H312 H302 H314 613-029-00-4dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid220-487-52782-57-2 Ox. Sol. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H272 H302 H319 H335 H400 H410 GHS03 GHS07 GHS09 Dgr H272 H302 H319 H335 H410 EUH031T613-030-00-Xtroclosene potassium; [1] troclosene sodium [2] 218-828-8 [1] 220-767-7 [2] 2244-21-5 [1] 2893-78-9 [2] Ox. Sol. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H272 H302 H319 H335 H400 H410 GHS03 GHS07 GHS09 Dgr H272 H302 H319 H335 H410 EUH031

STOT SE 3; H335: C ≥ 10 % EUH031: C ≥10 % G613-030-01-7troclosene sodium, dihydrate220-767-751580-86-0 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H335 H400 H410 GHS07 GHS09 Wng H302 H319 H335 H410 EUH031613-031-00-5symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion201-782-887-90-1 Ox. Sol. 2 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H272 H302 H319 H335 H400 H410 GHS03 GHS07 GHS09 Dgr H272 H302 H319 H335 H410 EUH031 613-032-00-0methyl-2,3,5,6-tetrachloro-4- pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine236-035-513108-52-6 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 H312 H302 H319 H317 GHS07 Wng H312 H302 H319 H317 613-033-00-62-methylaziridine; propyleneimine200-878-775-55-8 Flam. Liq. 2 Carc. 1B Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Eye Dam. 1 Aquatic Chronic 2 H225 H350 H330

H310 H300 H318 H411 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H225 H350 H330 H310 H300 H318 H411 Carc. 1B; H350: C ≥ 0,01 % 613-034-00-11,2-dimethylimidazole217-101-21739-84-0 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 H302 H315 H318 GHS05 GHS07 Dgr H302 H315 H318 613-035-00-71-methylimidazole210-484-7616-47-7 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1B H312 H302 H314 GHS05 GHS07 Dgr H312 H302 H314 613-036-00-22-methylpyridine; 2-picoline203-643-7109-06-8 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 H226 H332 H312 H302 H319 H335 GHS02 GHS07 Wng H226 H332 H312 H302 H319 H335 613-037-00-84-methylpyridine; 4-picoline203-626-4108-89-4 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H226 H311 H332 H302 H319 H335 H315 GHS02 GHS06 Dgr H226 H311 H332 H302 H319 H335 H315 613-038-00-36-phenyl-1,3,5-triazine-2,4- diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine202-095-691-76-9 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 613-039-00-9ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol202-506-996-45-7 Repr. 1B Acute Tox. 4 H360D H302 GHS08 GHS07 Dgr H360D H302613-040-00-4azaconazole (ISO);1-{[2-(2,4-dichlorophenyl)-1,3- dioxolan-2-yl]methyl}-1H-1,2.4- triazole262-102-360207-31-0Acute Tox. 4 H302 GHS07 Wng H302613-041-00-Xmorpholine-4-carbonyl chloride239-213-015159-40-7 Carc. 2 Eye Irrit. 2 Skin Irrit. 2 H351 H319 H315 GHS08 Wng H351 H319 H315 EUH014613-043-00-0imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate; 1-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] 261-351-5 [1] 281-291-3 [2] 58594-72-2 [1] 83918-57-4 [2] Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 613-043-01-8imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] 261-351-5 [1] 281-291-3 [2] 58594-72-2 [1] 83918-57-4 [2] Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Wng H302 H314 H317 H410 Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % Eye Dam. 1; H318: 15 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % 613-044-00-6captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide205-087-0133-06-2 Carc. 2 Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H351 H331 H318 H317 H400 GHS06 GHS05 GHS08 GHS09 Dgr H351 H331 H318 H317 H400 M=10613-045-00-1folpet (ISO);N-(trichloromethylthio)phthalimide205-088-6133-07-3 Carc. 2 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H351 H332 H319 H317 H400 GHS08 GHS07 GHS09 Wng H351 H332 H319 H317 H400 M=10613-046-00-7captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2- tetrachloroethylthio)phthalimide219-363-32425-06-1 Carc. 1B Skin Sens. 1

Aquatic Acute 1 Aquatic Chronic 1 H350 H317 H400 H410 GHS08 GHS09 Dgr H350 H317 H410 613-047-00-21-dimethylcarbamoyl-5-methyl pyrazol-3-yl dimethylcarbamate; dimetilan (ISO)211-420-0644-64-4 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H400 H410 GHS06 GHS09 Dgr H301 H312 H410 613-048-00-8carbendazim (ISO);methyl benzimidazol-2-ylcarbamate234-232-010605-21-7 Muta. 1B Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H340 H360FD H400 H410 GHS08 GHS09 Dgr H340 H360FD H410 613-049-00-3benomyl (ISO);methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate241-775-717804-35-2 Muta. 1B Repr. 1B STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H340 H360FD H335 H315 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H340 H360FD H335 H315 H317 H410 M = 10613-050-00-9carbadox (INN);methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl) quinoxaline 1,4-dioxide229-879-06804-07-5 Flam. Sol. 1 Carc. 1B Acute Tox. 4 H228 H350 H302 GHS02 GHS08 GHS07 Dgr H228 H350 H302 T613-051-00-4molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate218-661-02212-67-1 Carc. 2 Repr. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361f H332 H302 H373 H317 H410 M = 100613-052-00-Xtrifenmorph (ISO);4-tritylmorpholine215-812-21420-06-0 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-053-00-5anilazine (ISO);2-chloro-N-(4,6-dichloro-1,3,5- triazin-2-yl)aniline202-910-5101-05-3 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H315 H400 H410 GHS07 GHS09 Wng H319 H315 H410 613-054-00-0thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole205-725-8148-79-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 613-056-00-11,2-dimethyl-3,5-diphenylpyra zolium methylsulphate; difenzoquat methyl sulfate256-152-543222-48-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS09 Wng H302 H410 613-058-00-2permethrin (ISO);m-phenoxybenzyl 3-(2,2-dichorovinyl)-2,2-dimethylcyclopro panecarboxylate258-067-952645-53-1 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H317 H400 H410 GHS07 GHS09 Wng H332 H302 H317 H410 M = 1000613-059-00-8profluralin (ISO);N-(cyclopropylmethyl)-α, α,α- trifluoro-2,6-dinitro-N-propyl-p-toluidine247-656-626399-36-0 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H400 H410 GHS07 GHS09 Wng H319 H410 613-060-00-3resmethrin (ISO);5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate233-940-710453-86-8 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=1000613-061-00-96-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania239-732-215662-33-6 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09

Wng H312 H302 H410 613-062-00-4sabadilla (ISO);veratrine—8051-02-3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H319 H335 H315 GHS07 Wng H319 H335 H315 613-063-00-Xsecbumeton (ISO);2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine247-554-126259-45-0 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H400 H410 GHS07 GHS09 Wng H302 H319 H410 613-064-00-55-(3,6,9-trioxa-2-undecy loxy)benzo(d)-1,3-dioxolane; sesamex—51-14-9Acute Tox. 4 H302 GHS07 Wng H302613-065-00-0simetryn (ISO);2,4-bis(ethylamino)-6- methylthio-1,3,5-triazine213-801-71014-70-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-066-00-6terbumeton (ISO);2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine251-637-833693-04-8 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-067-00-1propazine (ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine205-359-9139-40-2 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 613-068-00-7atrazine (ISO);2-chloro-4-ethylamine-6- isopropylamine-1,3,5-triazine217-617-81912-24-9 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H317 H400 H410 GHS08 GHS09 Wng H373 H317 H410 613-069-00-2ε-caprolactam203-313-2105-60-2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 H332 H302 H319 H335 H315 GHS07 Wng H332 H302 H319 H335 H315 613-070-00-8propylenethiourea—2122-19-2 Repr. 2 Acute Tox. 4 Aquatic Chronic 3 H361d H302 H412 GHS08 GHS07 Wng H361d H302 H412 613-071-00-32-fluoro-5-trifluoromethylpyridine400-290-269045-82-5 Flam. Liq. 3 Skin Sens. 1 Aquatic Chronic 3 H226 H317 H412 GHS02 GHS07 Wng H226 H317 H412 613-072-00-9N, N-bis(2-ethylhexyl)-((1,2,4- triazol-1-yl)methyl)amine401-280-091273-04-0 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H314 H317 H411 613-073-00-4N, N-dimethyl-2-(3-(4-chloro phenyl)-4,5-dihydropyrazol-1- ylphenylsulphonyl)ethylamine401-410-610357-99-0 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H373 H317 H411 GHS08 GHS09 Wng H373 H317 H411 613-074-00-X3-(3-methylpent-3-yl)isoxazol-5- ylamine401-460-982560-06-3 Acute Tox. 3 Acute Tox. 3 Eye Dam. 1 Aquatic Chronic 3 H331 H301 H318 H412 GHS06 GHS05 Dgr H331 H301 H318 H412 613-075-00-51,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione401-570-789415-87-2 Ox. Sol. 1 Acute Tox. 3 Skin Corr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 H271 H331 H314 H302 H317 H400 GHS03 GHS06 GHS05 GHS09 Dgr H271 H331 H314 H302 H317 H400 613-076-00-03-chloro-5-trifluoromethyl-2- pyridylamine401-670-079456-26-1 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 613-077-00-6reaction mass of 5-heptyl-1,2,4- triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine401-940-8— Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 2 H302 H319 H411 GHS07 GHS09 Wng H302 H319 H411 613-078-00-1N,N,N,N-tetrakis(4,6-bis(butyl- (N-methyl-2,2,6,6-tetramethyl piperidin-4-yl)amino)triazin-2- yl)-4,7-diazadecane-1,10- diamine401-990-0106990-43-6

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 613-079-00-74-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2- yl)pyridine, reaction mass of isomers402-520-7— Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H315 H317 H400 H410 GHS07 GHS09 Wng H312 H302 H315 H317 H410 613-080-00-23-(bis(2-ethylhexyl)amino methyl)benzothiazole-2(3H)- thione402-540-6105254-85-1 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410 613-081-00-81-butyl-2-methylpyridinium bromide402-680-826576-84-1 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 613-082-00-32-methyl-1-pentylpyridinium bromide402-690-2— Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H312 H302 H412 GHS07 Wng H312 H302 H412 613-083-00-92-(4-(3-(4-chlorophenyl)-2-pyra zolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate402-120-2— Skin Corr. 1B STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H373 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H314 H373 H317 H410 613-084-00-42-(4-(3-(4-chlorophenyl)-4,5- dihydropyrazolyl)phenylsulphonyl) ethyldimethylammonium hydrogen phosphonate402-490-5106359-93-7 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H400 H410 GHS07 GHS09 Wng H319 H410 613-085-00-Xreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5- oxo-2H-2-furylide namino)benzyl)phenyl)pyrrole-2,5-dione401-970-1— Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 613-086-00-5caffeine200-362-158-08-2Acute Tox. 4 H302 GHS07 Wng H302613-087-00-0tetrahydrothiophene203-728-9110-01-0 Flam. Liq. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 H225 H332 H312 H302 H319 H315 H412 GHS02 GHS07 Dgr H225 H332 H312 H302 H319 H315 H412 613-088-00-61,2-benzisothiazol-3(2H)-one;1,2-benzisothiazolin-3-one220-120-92634-33-5 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H302 H315 H318 H317 H400 GHS05 GHS07 GHS09 Dgr H302 H315 H318 H317 H400 Skin Sens. 1; H317: C≥0,05 % 613-089-00-1diquat dibromide; [1]diquat dichloride; [2]6,7-dihydrodipyrido[1,2-α:2',1'- c]pyrazinediylium dihydroxide [3] 201-579-4 [1] 223-714-6 [2] 301-467-6 [3] 85-00-7 [1] 4032-26-2 [2] 94021-76-8 [3] Acute Tox. 2 STOT RE 1 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H372 H302 H319 H335 H315 H317 H400 H410 GHS06 GHS08 GHS09 Dgr H330 H372 H302 H319 H335 H315 H317 H410 613-090-00-7paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride; [1]paraquat dimethylsulfate;1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] 217-615-7 [1] 218-196-3 [2] 1910-42-5 [1] 2074-50-2 [2] Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H311 H301 H372 H319 H335 H315 H400 H410 GHS06 GHS08

GHS09 Dgr H330 H311 H301 H372 H319 H335 H315 H410 613-091-00-2morfamquat dichloride; [1]morfamquat sulfate [2]225-062-8 [1] [2] 4636-83-3 [1] 29873-36-7 [2] Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 H302 H319 H335 H315 H412 GHS07 Wng H302 H319 H335 H315 H412 613-092-00-81,10-phenanthroline200-629-266-71-7 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H410 613-093-00-3hexasodium 6,13-dichloro-3,10- bis((4-(2,5-disulfonatoanilino)-6- fluoro-1,3,5-triazin-2- ylamino)prop-3-ylamino)-5,12- dioxa-7,14-diazapentacene-4,11- disulfonate400-050-785153-92-0 Resp. Sens. 1 Skin Sens. 1 H334 H317 GHS08 Dgr H334 H317 613-094-00-94-methoxy-N,6-dimethyl-1,3,5- triazin-2-ylamine401-360-55248-39-5Acute Tox. 4 STOT RE 2 H302 H373 GHS08 GHS07 Wng H302 H373 613-095-00-4sodium 3-(2H-benzotriazol-2- yl)-5-sec-butyl-4-hydroxyben zenesulfonate403-080-992484-48-5Eye Dam. 1H318 GHS05 Dgr H318613-096-00-X2-amino-6-ethoxy-4-methylamino-1,3,5-triazine403-580-762096-63-3Acute Tox. 4 H302 GHS07 Wng H302613-097-00-57-amino-3-((5-carboxymethyl-4- methyl-1,3-thiazol-2- ylthio)methyl)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid403-690-5111298-82-9 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H334 H317 H412 GHS08 Dgr H334 H317 H412 613-098-00-0N-(n-octyl)-2-pyrrolidone403-700-82687-94-7Skin Corr. 1B Aquatic Chronic 2 H314 H411 GHS05 GHS09 Dgr H314 H411 613-099-00-61-dodecyl-2-pyrrolidone403-730-12687-96-9 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H317 H410 613-100-00-X2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione404-230-6— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 613-101-00-5N—tert-pentyl-2-benzothiazolesulfenamide404-380-2110799-28-5 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-102-00-0dimethomorph (ISO);4-(3-(4-chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine404-200-2110488-70-5Aquatic Chronic 2H411GHS09H411613-103-00-6sodium 5-n-butylbenzotriazole404-450-2118685-34-0 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H302 H314 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H314 H317 H411 613-104-00-15-tert-butyl-3-isoxazolylamine hydrochloride404-840-2— Acute Tox. 4 STOT RE 2 Eye Dam. 1 Aquatic Chronic 3 H302 H373 H318 H412 GHS08 GHS05 GHS07 Dgr H302 H373 H318 H412 613-105-00-7hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6- morpholino-1,3,5-triazine-4,2- diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7- disulfonate)405-160-9124537-30-0 Acute Tox. 3 Skin Sens. 1 Aquatic Chronic 3 H301 H317 H412 GHS06 Dgr H301 H317 H412 613-106-00-2tetrapotassium 2-(4-(5-(1-(2,5- disulfonatophenyl)-3-ethoxycar bonyl-5-hydroxypyrazol-4- yl)penta-2,4-dienylidene)-3- ethoxycarbonyl-5-oxo-2-pyra zolin-1-yl)benzene-1,4- disulfonate405-240-3—Skin Sens. 1H317 GHS07 Wng H317613-107-00-8hexasodium 2,2'-vinylenebis((3- sulfonato-4,1-pheny lene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate405-280-176508-02-6Eye Irrit. 2H319

GHS07 Wng H319 613-108-00-3benzothiazole-2-thiol205-736-8149-30-4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 613-109-00-9bis(piperidinothiocarbonyl) disulphide202-328-194-37-1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 H319 H335 H315 H317 GHS07 Wng H319 H335 H315 H317 613-110-00-4dimepiperate (ISO);S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate262-784-261432-55-1 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 613-111-00-X1,2,4-triazole206-022-9288-88-0 Repr. 2 Acute Tox. 4 Eye Irrit. 2 H361d H302 H319 GHS08 GHS07 Wng H361d H302 H319 613-112-00-5octhilinone (ISO);2-octyl-2H-isothiazol-3-one247-761-726530-20-1 Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H302 H314 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H331 H311 H302 H314 H317 H410 Skin Sens. 1; H317: C≥0,05 %613-113-00-02-(morpholinothio)benzothiazole203-052-4102-77-2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H319 H315 H317 H411 GHS07 GHS09 Wng H319 H315 H317 H411 613-114-00-62,2',2''-(hexahydro-1,3,5- triazine-1,3,5-triyl)triethanol;1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine225-208-04719-04-4 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 Skin Sens. 1; H317: C ≥ 0,1 % 613-115-00-1hymexazol (ISO);3-hydroxy-5-methylisoxazole233-000-610004-44-1 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 613-116-00-7tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing ≥0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]211-986-9731-27-1 Acute Tox. 2 STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H330 H372 H319 H335 H315 H317 H400 GHS06 GHS08 GHS09 Dgr H330 H372 H319 H335 H315 H317 H400 M=10613-116-01-4tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]211-986-9731-27-1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 H319 H335 H315 H317 H400 GHS07 GHS09 Wng H319 H335 H315 H317 H400 M=10613-117-00-2diniconazole (ISO);(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1- ethanol;(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4- triazol-1-yl)pent-1-en-3-ol—76714-88-0 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-118-00-8flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2- ylidene]aniline253-703-137893-02-0 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H400 H410 GHS07 GHS09 Wng H319 H410 613-119-00-3(benzothiazol-2-ylthio)methyl thiocyanate; TCMTB244-445-021564-17-0 Acute Tox. 2 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H302 H319 H315 H317 H400 H410 GHS06 GHS09 Dgr H330 H302 H319 H315 H317 H410 613-120-00-9bioresmethrin (ISO);(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1- en-1-yl)cyclopropanecarboxylate249-014-028434-01-7

Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M = 1000613-122-00-Xdiclobutrazole (ISO);(R, R)-(±)-β-[(2,4-dichlorop henyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2- (1H—1,2,4-triazol-1yl)pentan-3-ol—75736-33-3 Eye Irrit. 2 Aquatic Chronic 2 H319 H411 GHS07 GHS09 Wng H319 H411 613-123-00-55,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem251-684-433813-20-6 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-124-00-0fenpropimorph (ISO);cis-4-[3-(p-tert-butylphenyl)-2- methylpropyl]-2,6-dimethylmorpholine266-719-967564-91-4 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H361d H302 H315 H411 GHS08 GHS07 GHS09 Wng H361d H302 H315 H411 613-125-00-6hexythiazox(ISO);trans-5-(4-chlorophenyl)-N- cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide—78587-05-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-126-00-1imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1- methylethyl)-5-oxo-1H- imidazol-2-yl]-3-pyridine carboxylate—81334-34-1 Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 613-127-00-71,1-dimethylpiperidinium chloride; mepiquat chloride246-147-624307-26-4 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 613-128-00-2prochloraz (ISO);N-propyl-N-[2-(2,4,6-trichlorop henoxy)ethyl]-1H-imidazole-1- carboxamide266-994-567747-09-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-129-00-8metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one255-349-341394-05-2 Acute Tox. 4 Aquatic Acute 1 H302 H400 GHS07 GHS09 Wng H302 H400 613-131-00-9pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1- ij]quinolin-4-one—57369-32-1 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 613-132-00-4hexazinone (ISO);3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione257-074-451235-04-2 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H400 H410 GHS07 GHS09 Wng H302 H319 H410 613-134-00-5myclobutanil(ISO);2-(4-chlorophenyl)-2-(1H-1,2,4- triazol-1-ylmethyl)hexanenitrile—88671-89-0 Repr. 2 Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 2 H361d H302 H319 H411 GHS08 GHS07 GHS09 Wng H361d H302 H319 H411 613-135-00-0di(benzothiazol-2-yl) disulphide204-424-9120-78-5 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 EUH031613-136-00-6N-cyclohexylbenzothiazole-2- sulphenamide202-411-295-33-0 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 613-137-00-1methabenzthiazuron (ISO);1-(1,3-benzothiazol-2-yl)1,3- dimethylurea242-505-018691-97-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-138-00-7quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline—124495-18-7 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 613-139-00-2metsulfuron-methyl (ISO); methyl-2-{[(4-methoxy-6- methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate—74223-64-6

Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M = 1000613-140-00-8cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione200-636-066-81-9 Muta. 2 Repr. 1B Acute Tox. 2 Aquatic Chronic 2 H341 H360D H300 H411 GHS06 GHS08 GHS09 Dgr H341 H360D H300 H411 613-141-00-31,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone401-470-393686-63-6Aquatic Chronic 4H413—H413613-142-00-9trans—N-methyl-2-styryl-[4'- aminomethine-(1-acetyl-1-(2- methoxyphenyl)acetamido)]py ridinium acetate405-860-4— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 613-143-00-41-(3-phenylpropyl)-2-methylpyridinium bromide405-930-410551-42-5 Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 3 H302 H319 H412 GHS07 Wng H302 H319 H412 613-144-00-Xreaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4- dimethylthiazoliummethylsulfate406-460-2125139-08-4Aquatic Chronic 3H412—H412613-145-00-5(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate406-960-077497-97-3Aquatic Chronic 2H411GHS09H411613-146-00-0N-ethyl-N-methylpiperidinium iodide407-780-54186-71-4 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 613-147-00-64-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine407-940-4111681-72-2Eye Dam. 1H318 GHS05 Dgr H318613-148-00-1tetrasodium 1,2-bis(4-fluoro-6- [5-(1-amino-2-sulfonatoanthra chinon-4-ylamino)-2,4,6- trimethyl-3-sulfonatopheny lamino]-1,3,5-triazin-2- ylamino)ethane411-240-4143683-23-2 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-150-00-22,2'-[3,3'-(piperazine-1,4-diyl)di propyl]bis(1H-benzimidazo[2,1—b]benzo[l, m,n][3,8]phenanthroline-1,3,6-trione406-295-6—Aquatic Chronic 4H413—H413613-151-00-81-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine406-360-9104218-44-2Aquatic Chronic 4H413—H413613-152-00-3phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate406-600-289392-03-0 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 613-153-00-92,3,5-trichloropyridine407-270-216063-70-0Aquatic Chronic 3H412—H412613-154-00-42-amino-4-chloro-6-methoxypyrimidine410-050-95734-64-5Acute Tox. 4 H302 GHS07 Wng H302613-155-00-X5-chloro-2,3-difluoropyridine410-090-789402-43-7 Flam. Liq. 3 Acute Tox. 4 Aquatic Chronic 3 H226 H302 H412 GHS02 GHS07 Wng H226 H302 H412 613-156-00-52-butyl-4-chloro-5-formylimidazole410-260-083857-96-9 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 613-157-00-02,4-diamino-5-methoxymethylpyrimidine410-330-054236-98-5 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 H302 H373 H319 GHS08 GHS07 Wng H302 H373 H319 613-158-00-62,3-dichloro-5-trifluoromethyl- pyridine410-340-569045-84-7 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H332 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H332 H302 H318 H317 H411 613-159-00-1fenazaquin (ISO);4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline410-580-0120928-09-8 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1

Aquatic Chronic 1 H301 H332 H400 H410 GHS06 GHS09 Dgr H301 H332 H410 613-160-00-7(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptanes dihydrobromide411-000-9125224-62-6Skin Sens. 1H317 GHS07 Wng H317 613-161-00-2(2,4-diaminopteridin-6-yl)methanol hydrobromide430-620-076145-91-0 STOT RE 2 Skin Sens. 1 Aquatic Chronic 3 H373 H317 H412 GHS08 GHS07 Wng H373 H317 H412 613-162-00-8(6R-trans)-1-((7-ammonio-2- carboxylato-8-oxo-5-thia-1- azabicyclo-[4.2.0]oct-2-en-3- yl)methyl)pyridinium iodide423-260-0100988-63-4 Muta. 2 Skin Sens. 1 Aquatic Chronic 2 H341 H317 H411 GHS08 GHS07 GHS09 Wng H341 H317 H411 613-163-00-3azimsulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H- tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea—120162-55-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=1000613-164-00-9flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide—142459-58-3 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 M=100613-165-00-4flupyrsulfuron-methyl-sodium(ISO);methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt—144740-54-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=100613-167-00-5reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H -isothiazol-3- one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3- one [EC no. 220-239-6] (3:1)—55965-84-9 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H311 H301 H314 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H331 H311 H301 H314 H317 H410 Skin Corr. 1B; H314: C ≥0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1; H317: C ≥ 0,0015 % 613-168-00-01-vinyl-2-pyrrolidone201-800-488-12-0 Carc. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 STOT SE 3 Eye Dam. 1 H351 H332 H312 H302 H373 H335 H318 GHS06 GHS05 GHS09 Dgr H351 H332 H312 H302 H373 H335 H318 D613-169-00-69-vinylcarbazole216-055-01484-13-5 Muta. 2 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H341 H312 H302 H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H341 H312 H302 H315 H317 H410 M=100613-170-00-12,2-ethylmethylthiazolidine404-500-3694-64-4 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 613-171-00-7hexaconazole (ISO);(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2- ol413-050-779983-71-4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 613-172-00-25-chloro-1,3-dihydro-2H-indol-2-one412-200-917630-75-0 Repr. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 H361f H302 H317 H412 GHS08 GHS07 Wng H361f H302 H317 H412 613-173-00-8fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one411-960-9136426-54-5

Acute Tox. 3 Acute Tox. 3 STOT RE 1 Acute Tox. 4 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H372 H312 H315 H400 H410 GHS06 GHS08 GHS09 Dgr H331 H301 H372 H312 H315 H410 613-174-00-3 tetraconazole (ISO); (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether 407-760-6112281-77-3 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 2 H332 H302 H411 GHS07 GHS09 Wng H332 H302 H411 613-175-00-9epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane406-850-2133855-98-8 Carc. 2 Repr. 1B Aquatic Chronic 2 H351 H360Df H411 GHS08 GHS09 Dgr H351 H360Df H411 613-176-00-42-methyl-2-azabicyclo[2.2.1]heptane404-810-94524-95-2 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B H226 H312 H302 H373 H314 GHS02 GHS08 GHS05 GHS07 Dgr H226 H312 H302 H373 H314 613-177-00-X8-amino-7-methylquinoline412-760-45470-82-6 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H312 H302 H317 H411 GHS07 GHS09 Wng H312 H302 H317 H411 613-178-00-54-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine410-470-2137796-06-6 Skin Corr. 1B Skin Sens. 1 H314 H317 GHS05 GHS07 Dgr H314 H317 STOT SE 3; H335: C ≥ 5 %613-179-00-0lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide411-690-1111337-53-2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H302 H314 H317 H411 GHS05 GHS07 Dgr H302 H314 H317 H411 613-180-00-6N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide407-430-13741-80-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-181-00-15,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone405-090-967485-29-4 STOT RE 1 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H372 H302 H319 H400 H410 GHS08 GHS07 GHS09 Dgr H372 H302 H319 H410 613-182-00-71-(1-naphthylmethyl)quinolinium chloride406-220-765322-65-8 Carc. 2 Muta. 2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H351 H341 H302 H315 H318 H412 GHS08 GHS05 GHS07 Dgr H351 H341 H302 H315 H318 H412 613-183-00-2reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one413-640-4— STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410 613-184-00-8nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate413-670-8— Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 613-185-00-32,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one407-630-982633-79-2 Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H301 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H301 H318 H317 H410 613-186-00-9(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate408-050-976855-69-1 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H319 H317 H411 GHS07 GHS09 Wng H319 H317 H411 613-187-00-45-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene410-530-8—Skin Sens. 1H317

GHS07 Wng H317613-188-00-X1-(3-(4-fluorophenoxy)propyl)3-methoxy-4-piperidinone411-500-7116256-11-2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 613-189-00-51,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane414-030-052667-88-6 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 613-190-00-0disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate414-040-5149530-93-8 Acute Tox. 4 Skin Sens. 1 H302 H317 GHS07 Wng H302 H317 613-191-00-63-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine421-150-7143860-04-2 Repr. 1B Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360F H314 H400 H410 GHS08 GHS05 GHS09 Dgr H360F H314 H410 613-192-00-13-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane426-750-2151860-15-0 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-193-00-7pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate414-930-3—Aquatic Chronic 2H411GHS09H411613-194-00-26,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt418-000-8163062-28-0Eye Dam. 1H318 GHS05 Dgr H318613-195-00-82,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)418-280-118600-59-4 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 613-196-00-35-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt418-380-5168113-78-8Eye Dam. 1H318 GHS05 Dgr H318613-197-00-9 reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine 420-390-1187547-46-2 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 613-198-00-42-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine415-500-8145963-84-4 Acute Tox. 4 STOT RE 2 Aquatic Chronic 3 H302 H373 H412 GHS08 GHS07 Wng H302 H373 H412 613-199-00-X reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6 trione; reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trione 421-550-1— Carc. 1B Repr. 1B Skin Sens. 1 Aquatic Chronic 3 H350 H360D H317 H412 GHS08 Dgr H350 H360D H317 H412 613-200-00-3reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts420-980-7—Eye Dam. 1H318 GHS05 Dgr H318613-201-00-9(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole422-390-5143322-57-0

Repr. 2 STOT RE 1 Acute Tox. 4 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H372 H332 H302 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H361f H372 H332 H302 H317 H410 EUH070613-202-00-4 pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one —123312-89-0 Carc. 2 Aquatic Chronic 3 H351 H412 GHS08 Wng H351 H412 613-203-00-X pyraflufen-ethyl (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2] -[1] -[2] 129630-19-9 [1] 129630-17-7 [2] Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=1000613-204-00-5 oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 254-637-639807-15-3 Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H361d H373 H400 H410 GHS08 GHS09 Wng H361d H373 H410 M = 1000613-205-00-0 propiconazole(ISO); (±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole 262-104-460207-90-1 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 613-206-00-6 fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one —161326-34-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-208-00-7 imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid —114311-32-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-209-00-2cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride417-430-363645-17-0 Acute Tox. 3 STOT RE 2 Skin Sens. 1 Aquatic Chronic 2 H301 H373 H317 H411 GHS06 GHS08 GHS09 Dgr H301 H373 H317 H411 613-210-00-82-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane417-650-188128-57-8 STOT RE 2 Aquatic Chronic 3 H373 H412 GHS08 Wng H373 H412 613-211-00-3N-methyl-4-(p-formylstyryl)pyridinium methylsulfate418-240-374401-04-0 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-212-00-94-4-(2-ethylhexyloxy)phenyl418-320-8133467-41-1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-213-00-4cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline416-040-0120807-02-5Aquatic Chronic 3H412—H412613-214-00-XN, N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide416-260-7147613-95-4Aquatic Chronic 4H413—H413613-215-00-52-chloromethyl-3,4-dimethoxypyridinium chloride416-440-572830-09-2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H312 H302 H373 H315 H318 H317 H411 GHS08 GHS05 GHS07 GHS09 Dgr H312 H302 H373 H315 H318 H317 H411 613-216-00-06-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole416-490-8162208-01-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-217-00-64-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine416-770-173754-27-5Aquatic Chronic 4H413—H413

613-218-00-16-hydroxyindole417-020-42380-86-1 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H302 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H302 H318 H317 H411 613-219-00-77a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole417-140-779185-77-6 Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 613-220-00-2trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide417-290-3147086-81-5Acute Tox. 4 H302 GHS07 Wng H302613-221-00-82-chloro-5-methyl-pyridine418-050-018368-64-4 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 3 H312 H302 H315 H412 GHS07 Wng H312 H302 H315 H412 613-222-00-34-(1-oxo-2-propenyl)-morpholine418-140-15117-12-4 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H302 H373 H318 H317 GHS08 GHS05 GHS07 Dgr H302 H373 H318 H317 613-223-00-9N-isopropyl-3-(4-fluorophenyl)-1H-indole418-790-493957-49-4Aquatic Chronic 4H413—H413613-224-00-42,5-dimercaptomethyl-1,4-dithiane419-770-8136122-15-1 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H317 H410 613-225-00-X reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. 421-290-9— STOT RE 2 Aquatic Chronic 4 H373 H413 GHS08 Wng H373 H413 613-226-00-51-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride420-950-3163831-67-2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 613-227-00-0(±)-[(R,R) and (R,S)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran419-600-299199-90-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 613-228-00-6(±)-(R,S)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran419-630-6793669-26-8Aquatic Chronic 2H411GHS09H411613-229-00-11-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine411-930-5106917-31-1 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 613-230-00-7 florasulam (ISO); 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; pyrimidine-2-sulfonanilide —145701-23-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 613-231-00-22,6-diamino-3-((pyridine-3-yl)azo)pyridine421-430-928365-08-4 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H302 H373 H411 GHS08 GHS07 GHS09 Wng H302 H373 H411 613-232-00-83-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide431-030-6163269-30-5 Acute Tox. 3 STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H373 H318 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H331 H373 H318 H410 613-233-00-34,4'-(oxy-(bismethylene))-bis-1,3-dioxolane423-230-756552-15-9Eye Dam. 1H318 GHS05 Dgr H318613-234-00-9imidazo[1,2-b]pyridazin hydrochloride431-510-518087-70-2 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319

613-235-00-42,3-dihydro-2,2-dimethyl-1H-perimidine424-060-66364-17-6 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 613-236-00-X2-chloro-3-trifluoromethylpyridine424-520-665753-47-1 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B Aquatic Chronic 3 H311 H301 H372 H314 H412 GHS06 GHS05 GHS08 Dgr H311 H301 H372 H314 H412 613-237-00-56-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine424-950-4133949-92-5Aquatic Chronic 4H413—H413 613-238-00-0sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate430-890-181992-66-7 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 613-239-00-62-[3-(methylamino)propyl]-1H-benzimidazole425-760-464137-52-6 Eye Dam. 1 Aquatic Chronic 3 H318 H412 GHS05 Dgr H318 H412 613-241-00-73-(2H-tetrazol-5-yl)pyridine426-810-83250-74-6Eye Dam. 1H318 GHS05 Dgr H318613-242-00-2reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts426-860-0191877-09-5Eye Dam. 1H318 GHS05 Dgr H318613-243-00-84,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)427-350-0182235-14-9Aquatic Chronic 2H411GHS09H411613-244-00-35,7-dichloro-4-hydroxyquinoline427-420-021873-52-9Aquatic Chronic 2H411GHS09H411613-245-00-92-fluoro-6-trifluoromethylpyridine428-100-394239-04-0 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H226 H332 H302 H412 GHS02 GHS07 Wng H226 H332 H302 H412 613-246-00-42-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine428-200-7103577-66-8Aquatic Chronic 3H412—H412613-247-00-X3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole428-910-7107786-36-7Aquatic Chronic 4H413—H413 613-248-00-53,4-dimethyl-1H-pyrazole429-130-12820-37-3 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 613-249-00-01-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate429-300-3155601-30-2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 613-250-00-6 reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine 429-990-6— Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H318 H317 H412 GHS05 GHS07 Dgr H318 H317 H412 613-251-00-1(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole430-560-5180637-89-2 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H302 H373 H318 H317 GHS05 GHS08 GHS07 Dgr H302 H373 H318 H317 613-253-00-2 2,2-dialkyl-4-hydroxymethyl1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5) 430-580-4— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 EUH019613-254-00-8

forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea —68157-60-8 Carc. 2 Aquatic Chronic 2 H351 H411 GHS08 GHS09 Wng H351 H411 613-255-00-3reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl]2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{[}(sulfonatophthalocyaninato)]copper(II)424-270-8—Eye Dam. 1H318 GHS05 Dgr H318613-256-00-93'5'-anhydro thymidine425-810-538313-48-3Aquatic Chronic 3H412—H412613-257-00-42-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate426-400-9170222-39-6 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 613-258-00-X reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt 427-730-6202420-04-0 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412 613-259-00-5 reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate 428-790-672963-72-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 613-260-00-0(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin430-730-9— Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H400 H410 GHS05 GHS09 Dgr H318 H410 613-261-00-6pyrazole-1-carboxamidine monohydrochloride429-520-14023-02-3 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H373 H318 H317 H412 GHS05 GHS08 GHS07 Dgr H302 H373 H318 H317 H412 613-262-00-1disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene427-310-2180850-95-7Eye Dam. 1H318 GHS05 Dgr H318613-263-00-7monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate429-570-2—Skin Sens. 1H317 GHS07 Wng H317613-266-00-32-chloro-5-chloromethylthiazole429-830-5105827-91-6 Acute Tox. 3 Skin Corr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H311 H314 H302 H317 H411 GHS06 GHS05 GHS09 Dgr H311 H314 H302 H317 H411 613-267-00-9 thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine 428-650-4153719-23-4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=10613-268-00-4(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine425-930-8151213-39-7 Skin Corr. 1B Acute Tox. 4 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H314 H332 H302 H373 H411 GHS05 GHS08 GHS07 GHS09 Dgr H314 H332 H302 H373 H411 613-269-00-X2-thiazolidinylidenecyanamide427-720-126364-65-8 Acute Tox. 4 STOT RE 2 Aquatic Chronic 3 H302 H373 H412 GHS08 GHS07 Wng H302 H373 H412 613-270-00-55-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide428-150-6113171-13-4Aquatic Chronic 3H412—H412 613-271-00-0 tritosulfuron (ISO) (containing ≤0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)

—142469-14-5 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10613-272-00-6 pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate —— Acute Tox. 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H331 H315 H400 H410 GHS06 GHS09 Dgr H331 H315 H410 M=100613-273-00-1tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine427-600-9192439-46-6Aquatic Chronic 2H411GHS09H411613-274-00-72,6-dichloro-1-fluoropyridiniumtetrafluoroborate427-400-1140623-89-8 Skin Corr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H302 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H314 H302 H317 H410 613-275-00-23-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride424-530-093076-03-0 Acute Tox. 3 STOT SE 2 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H301 H371 H373 H318 H317 H411 GHS06 GHS05 GHS08 GHS09 Dgr H301 H371 H373 H318 H317 H411 613-276-00-81-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one426-110-298377-35-6 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-277-00-3(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one427-070-9—Aquatic Chronic 4H413—H413 613-278-00-9(3-aminophenyl)pyridin-3-ylmethanone428-230-079568-06-2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410 613-279-00-42-ethyl-2,3-dihydro-2-methyl-1H-perimidine424-380-643057-68-7 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H410 613-280-00-X tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea 230-625-67226-23-5 Repr. 2 Acute Tox. 4 Eye Dam. 1 H361f H302 H318 GHS05 GHS08 GHS07 Dgr H361f H302 H318 613-281-00-5quinoline202-051-691-22-5 Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H350 H341 H312 H302 H319 H315 H411 GHS08 GHS07 GHS09 Dgr H350 H341 H312 H302 H319 H315 H411 613-282-00-0 triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol —131983-72-7Aquatic Chronic 2H411GHS09H411 613-283-00-6 ketoconazole; 1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone 265-667-465277-42-1 Repr. 1B Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H360F H301 H373 H400 H410 GHS06 GHS08 GHS09 Dgr H360F H301 H373 H410 613-284-00-1 metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol —125116-23-6 Repr. 2 Acute Tox. 4 Aquatic Chronic 2 H361d H302 H411 GHS08 GHS07 GHS09 Wng H361d H302 H411 613-285-00-7 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] 219-989-7 [1] 219-989-7 [2] 2592-95-2 [1] 123333-53-9 [2] Expl. 1.3H203 GHS01 Dgr H203613-286-00-2 potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing < 0,5 % N, N-dimethylformamide (EC no 200-679-5)] 418-260-2183196-57-8Skin Sens. 1H317 GHS07 Wng H317613-286-01-X potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N, N-dimethylformamide (EC No 200-679-5)] 418-260-2183196-57-8 Repr. 1B Skin Sens. 1 H360D H317 GHS08 GHS07 Dgr H360D H317613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410 613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one434-820-9106461-41-0 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410 613-292-00-5N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3 Muta. 2 Aquatic Chronic 3 H341 H412 GHS08 Wng H341 H412 613-293-00-0 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonyl methyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester 448-050-6444065-11-6Aquatic Chronic 4H413—H413613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9Aquatic Chronic 4H413—H413613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride448-720-8363138-44-7 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1yl)benzene-1,4-disulfonate418-270-7— Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6— Flam. Liq. 3 Acute Tox. 4 Aquatic Chronic 2 H226 H302 H411 GHS02 GHS07 GHS09 Wng H226 H302 H411 613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate421-560-6— STOT RE 2 Eye Dam. 1 Aquatic Chronic 2 H373 H318 H411 GHS05 GHS08 GHS09 Dgr H373 H318 H411 613-299-00-3 main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfophenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt 422-610-1—Eye Dam. 1H318 GHS05 Dgr H318 613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate443-910-7—Aquatic Chronic 4H413—H413613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Eye Dam. 1H318 GHS05 Dgr H318613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1Aquatic Chronic 4H413—H413613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1 Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 2 H302 H317 H411 GHS07 GHS09 Wng H302 H317 H411 613-307-00-5 clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine —210880-92-5 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 M=10 613-308-00-02-amino-5-methylthiazole423-800-57305-71-7 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H410 613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2 Acute Tox. 4 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 H312 H302 H315 H318 H412 GHS05 GHS07 Dgr H312 H302 H315 H318 H412 613-310-00-1(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride432-360-3105813-13-6 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H302 H319 H317 H412 GHS07 Wng H302 H319 H317 H412 613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5— Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412 613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione442-780-9173838-67-0Aquatic Chronic 3H412—H412613-314-00-3

4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one 443-770-77693-82-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1— Acute Tox. 4 Aquatic Chronic 3 H332 H412 GHS07 Wng H332 H412 613-316-00-4 trimethylopropane tri(3-aziridinylpropanoate); (TAZ) 257-765-052234-82-9 Muta. 2 Eye Dam. 1 Skin Sens. 1 H341 H318 H317 GHS05 GHS08 GHS07 Dgr H341 H318 H317 613-317-00-Xpenconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole266-275-666246-88-6 Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H361d H302 H400 H410 GHS08 GHS07 GHS09 Wng H361d H302 H410 M = 1 M = 1 614-002-00-Xsalts of nicotine—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 A614-003-00-5strychnine200-319-757-24-9 Acute Tox. 1 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H310 H300 H400 H410 GHS06 GHS09 Dgr H310 H300 H410 614-004-00-0salts of strychnine—— Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 H330 H300 H400 H410 GHS06 GHS09 Dgr H330 H300 H410 A 614-005-00-6colchicine200-598-564-86-8 Muta. 1B Acute Tox. 2 H340 H300 GHS06 GHS08 Dgr H340 H300 614-006-00-1 brucine; 2,3-dimethoxystrychnine 206-614-7357-57-3 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 3 H330 H300 H412 GHS06 Dgr H330 H300 H412 614-007-00-7 brucine sulphate; [1] brucine nitrate; [2] strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3] strychnidin-10-one, 2,3-dimethoxy-, compd.with (S) mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] 225-432-9 [1] 227-317-9 [2] 269-439-5 [3] 269-710-8 [4] 4845-99-2 [1] 5786-97-0 [2] 68239-26-9 [3] 68310-42-9 [4] Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 3 H330 H300 H412 GHS06 Dgr H330 H300 H412 A614-008-00-2aconitine206-121-7302-27-2 Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 614-009-00-8salts of aconitine—— Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 A614-010-00-3atropine200-104-851-55-8 Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 614-011-00-9salts of atropine—— Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 A 614-012-00-4hyoscyamine202-933-0101-31-5 Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 614-013-00-Xsalts of hyoscyamine—— Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 A614-014-00-5hyoscine200-090-351-34-3 Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 H330 H310 H300 GHS06 Dgr H330 H310 H300 614-015-00-0salts of hyoscine—— Acute Tox. 2 Acute Tox. 1 Acute Tox. 2 H330 H310 H300 GHS06 Dgr H330 H310 H300 A614-016-00-6pilocarpine202-128-492-13-7 Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 614-017-00-1salts of pilocarpine—— Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 A614-018-00-7papaverine200-397-258-74-2Acute Tox. 4 H302

GHS07 Wng H302614-019-00-2salts of papaverine——Acute Tox. 4 H302 GHS07 Wng H302A614-020-00-8physostigmine200-332-857-47-6 Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 614-021-00-3salts of physostigmine—— Acute Tox. 2 Acute Tox. 2 H330 H300 GHS06 Dgr H330 H300 A614-022-00-9digitoxin200-760-571-63-6 Acute Tox. 3 Acute Tox. 3 STOT RE 2 H331 H301 H373 GHS06 GHS08 Dgr H331 H301 H373 614-023-00-4ephedrine206-080-5299-42-3Acute Tox. 4 H302 GHS07 Wng H302614-024-00-Xsalts of ephedrine——Acute Tox. 4 H302 GHS07 Wng H302A614-025-00-5ouabain211-139-3630-60-4 Acute Tox. 3 Acute Tox. 3 STOT RE 2 H331 H301 H373 GHS06 GHS08 Dgr H331 H301 H373 614-026-00-0strophantin-K234-239-911005-63-3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 H331 H301 H373 GHS06 GHS08 Dgr H331 H301 H373 614-027-00-6 bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-; red squill; scilliroside 208-077-4507-60-8Acute Tox. 2 H300 GHS06 Dgr H300 614-028-00-1 reaction mass of: 2-ethylhexyl mono-D-glucopyranoside; 2-ethylhexyl di-D-glucopyranoside 414-420-0—Eye Dam. 1H318 GHS05 Dgr H318614-029-00-7 constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside 419-640-068784-14-5Acute Tox. 4 H302 GHS07 Wng H302615-001-00-7methyl isocyanate210-866-3624-83-9 Flam. Liq. 2 Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Resp. Sens. 1 Skin Sens. 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 H225 H361d H330 H311 H301 H334 H317 H335 H315 H318 GHS02 GHS06 GHS05 GHS08 Dgr H225 H361d H330 H311 H301 H334 H317 H335 H315 H318 615-002-00-2methyl isothiocyanate209-132-5556-61-6 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H301 H314 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H331 H301 H314 H317 H410 615-003-00-8thiocyanic acid207-337-4463-56-9 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H332 H312 H302 H412 GHS07 Wng H332 H312 H302 H412 EUH032615-004-00-3salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H332 H312 H302 H412 GHS07 Wng H332 H312 H302 H412 EUH032A615-005-00-9 4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate; [1] 2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate; [2] o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4'-diisocyanate; [3] methylenediphenyl diisocyanate [4] 202-966-0 [1] 219-799-4 [2] 227-534-9 [3] 247-714-0 [4] 101-68-8 [1] 2536-05-2 [2] 5873-54-1 [3] 26447-40-5 [4] Carc. 2 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 H351 H332 H373 H319 H335 H315 H334 H317 GHS08 GHS07 Dgr H351 H332 H373 H319 H335 H315 H334 H317 Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1 % STOT SE 3; H335: C ≥ 5 %

C2615-006-00-4 2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate; [1] 4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate; [2] m-tolylidene diisocyanate; toluene-diisocyanate [3] 202-039-0 [1] 209-544-5 [2] 247-722-4 [3] 91-08-7 [1] 584-84-9 [2] 26471-62-5 [3] Carc. 2 Acute Tox. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H351 H330 H319 H335 H315 H334 H317 H412 GHS06 GHS08 Dgr H351 H330 H319 H335 H315 H334 H317 H412 Resp. Sens. 1; H334: C ≥ 0,1 % C 615-007-00-X1,5-naphthylene diisocyanate221-641-43173-72-6 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Aquatic Chronic 3 H332 H319 H335 H315 H334 H412 GHS08 GHS07 Dgr H332 H319 H335 H315 H334 H412 615-008-00-53-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate223-861-64098-71-9 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 2 H331 H319 H335 H315 H334 H317 H411 GHS06 GHS08 GHS09 Dgr H331 H319 H335 H315 H334 H317 H411

Resp. Sens. 1; H334: C ≥0,5 % Skin Sens.1; H317: C ≥0,5 % 2615-009-00-04,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate225-863-25124-30-1 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 H331 H319 H335 H315 H334 H317 GHS06 GHS08 Dgr H331 H319 H335 H315 H334 H317

Resp. Sens. 1; H334: C ≥0,5 % Skin Sens. 1; H317: C ≥0,5 % 2615-010-00-6 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1] 2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] 241-001-8 [1] 239-714-4 [2] 16938-22-0 [1] 15646-96-5 [2] Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H331 H319 H335 H315 H334 GHS06 GHS08 Dgr H331 H319 H335 H315 H334

Resp. Sens. 1; H334: C ≥0,5 % Skin Sens. 1; H317: C ≥0,5 % C2 615-011-00-1hexamethylene-di-isocyanate212-485-8822-06-0 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 H331 H319 H335 H315 H334 H317 GHS06 GHS08 Dgr H331 H319 H335 H315 H334 H317

Resp. Sens. 1; H334: C ≥ 0,5 % Skin Sens. 1; H317: C ≥0,5 % 2615-012-00-7 4-isocyanatosulphonyltoluene; tosyl isocyanate 223-810-84083-64-1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 EUH014 Eye Irrit.; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % 615-014-00-8tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate—7276-58-6Acute Tox. 4 H302 GHS07 Wng H302615-015-00-3 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; isobornyl thiocyanoacetate 204-081-5115-31-1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 615-016-00-9potassium cyanate209-676-3590-28-3Acute Tox. 4 H302 GHS07 Wng H302615-017-00-4calcium cyanamide205-861-8156-62-7 Acute Tox. 4 STOT SE 3 Eye Dam. 1 H302 H335 H318 GHS05 GHS07 Dgr H302 H335 H318 615-018-00-X2-(2-butoxyethoxy)ethyl thiocyanate203-985-7112-56-1 Flam. Liq. 3 Acute Tox. 3 Acute Tox. 3 H226 H311 H301 GHS02 GHS06 Dgr H226

H311 H301 615-019-00-5dicyclohexylcarbodiimide208-704-1538-75-0 Acute Tox. 3 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H311 H302 H318 H317 GHS06 GHS05 Dgr H311 H302 H38 H317 615-020-00-0methylene dithiocyanate228-652-36317-18-6 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 H330 H301 H314 H317 H400 GHS06 GHS05 GHS09 Dgr H330 H301 H314 H317 H400 615-021-00-6 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; TGIC 219-514-32451-62-9 Muta. 1B Acute Tox. 3 Acute Tox. 3 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H340 H331 H301 H373 H318 H317 H412 GHS06 GHS08 GHS05 Dgr H340 H331 H301 H373 H318 H317 H412 615-022-00-1methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate410-550-779277-18-2 STOT RE 2 Resp. Sens. 1 Skin Sens. 1 H373 H334 H317 GHS08 Dgr H373 H334 H317 EUH014615-023-00-72-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate410-900-983056-32-0 Flam. Liq. 3 Muta. 2 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Resp. Sens. 1 H226 H341 H332 H373 H318 H334 GHS02 GHS08 GHS05 GHS07 Dgr H226 H341 H332 H373 H318 H334 EUH014 615-024-00-22-phenylethylisocyanate413-080-01943-82-4 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 2 H331 H302 H314 H334 H317 H411 GHS06 GHS08 GHS05 GHS09 Dgr H331 H302 H314 H334 H317 H411 615-025-00-84,4'-ethylidenediphenyl dicyanate405-740-147073-92-7 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H373 H318 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H332 H302 H373 H318 H410 615-026-00-34,4'-methylenebis(2,6-dimethylphenyl cyanate)405-790-4101657-77-6 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H302 H373 H318 H334 H317 GHS05 GHS08 GHS07 Dgr H302 H373 H318 H334 H317 EUH014615-029-00-X2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane411-280-2— Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 H330 H302 H314 H334 H317 H412 GHS06 GHS08 GHS05 Dgr H330 H302 H314 H334 H317 H412 615-030-00-5alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Chronic 3 H332 H312 H302 H412 GHS07 Wng H332 H312 H302 H412 A615-031-00-0thallium thiocyanate222-571-73535-84-0 Acute Tox. 2 Acute Tox. 2 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H330 H300 H312 H373 H411 GHS06 GHS08 GHS09 Dgr H330 H300 H312 H373 H411 615-032-00-6metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex—— Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H332 H312 H302 H400 H410 GHS07 GHS09 Wng H332 H312 H302 H410 A615-033-00-1reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)430-980-9—Aquatic Chronic 4H413—H413615-034-00-7

reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) 430-750-8—Aquatic Chronic 4H413—H413615-035-00-2 reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14) 430-930-6122886-55-9Aquatic Chronic 4H413—H413 615-036-00-8 reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) 430-940-0—Aquatic Chronic 4H413—H413615-037-00-3reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)430-950-5—Aquatic Chronic 4H413—H413615-038-00-9 reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2) 430-960-1—Aquatic Chronic 4H413—H413615-039-00-4reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)430-970-4—Aquatic Chronic 4H413—H413615-044-00-14-chlorophenylisocyanate203-176-9104-12-1 Acute Tox. 2 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H330 H302 H335 H315 H318 H334 H400 H410 GHS06 GHS05 GHS08 GHS09 Dgr H330 H302 H335 H315 H318 H334 H410 615-045-00-74,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1— Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 H334 H317 H413 GHS08 Dgr H334 H317 H413 616-001-00-X N, N-dimethylformamide; dimethyl formamide 200-679-568-12-2 Repr. 1B Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 H360D H332 H312 H319 GHS08 GHS07 Dgr H360D H332 H312 H319 616-002-00-52-fluoroacetamide211-363-1640-19-7 Acute Tox. 2 Acute Tox. 3 H300 H311 GHS06 Dgr H300 H311 616-003-00-0 acrylamide; prop-2-enamide 201-173-779-06-1 Carc. 1B Muta. 1B Repr. 2 Acute Tox. 3 STOT RE 1 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 H350 H340 H361f H301 H372 H332 H312 H319 H315 H317 GHS06 GHS08 Dgr H350 H340 H361f H301 H372 H332 H312 H319 H315 H317 D616-004-00-6 allidochlor (ISO); N,N-diallylchloroacetamide 202-270-793-71-0 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H312 H302 H319 H315 H411 GHS07 GHS09 Wng H312 H302 H319 H315 H411 616-005-00-1 chlorthiamid (ISO); 2,6-dichloro (thiobenzamide) 217-637-71918-13-4Acute Tox. 4 H302 GHS07 Wng H302 616-007-00-2 diphenamid (ISO); N, N-dimethyl-2,2-diphenylacetamide 213-482-4957-51-7 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 616-008-00-8 propachlor (ISO); 2-chloro-N-isopropylacetanilide; α-chloro-N-isopropylacetanilide 217-638-21918-16-7 Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H319 H317 H400 H410 GHS07 GHS09 Wng H302 H319 H317 H410 616-009-00-3 propanil (ISO); 3',4'-dichloropropionanilide

211-914-6709-98-8 Acute Tox. 4 Aquatic Acute 1 H302 H400 GHS07 GHS09 Wng H302 H400 M=10616-010-00-9tosylchloramide sodium204-854-7127-65-1 Acute Tox. 4 Skin Corr. 1B Resp. Sens. 1 H302 H314 H334 GHS08 GHS05 GHS07 Dg H302 H314 H334 EUH031616-012-00-X N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide 211-952-3719-96-0Skin Irrit. 2H315 GHS07 Wng H315616-013-00-5butyraldehyde oxime203-792-8110-69-0 Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 H311 H302 H319 GHS06 Dgr H311 H302 H319 616-014-00-0 2-butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime 202-496-696-29-7 Carc. 2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 H351 H312 H318 H317 GHS08 GHS05 GHS07 Dgr H351 H312 H318 H317 616-015-00-6 alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide 240-110-815972-60-8 Carc. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H317 H410 M=10616-016-00-1 1-(3,4-dichlorophenylimino) thiosemicarbazide —5836-73-7Acute Tox. 2 H300 GHS06 Dgr H300616-017-00-7cartap hydrochloride239-309-215263-52-2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H312 H302 H400 H410 GHS07 GHS09 Wng H312 H302 H410 616-018-00-2 N,N-diethyl-m-toluamide; deet 205-149-7134-62-3 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 H302 H319 H315 H412 GHS07 Wng H302 H319 H315 H412 616-019-00-8 perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; 253-718-337924-13-3 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 616-020-00-3 tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 251-793-734014-18-1 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 616-021-00-9 thiazafluron (ISO); 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea 246-901-425366-23-8 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 616-022-00-4acetamide200-473-560-35-5Carc. 2H351 GHS08 Wng H351 616-023-00-XN-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide401-980-6— Skin Irrit. 2 Skin Sens. 1 H315 H317 GHS07 Wng H315 H317 616-024-00-52-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide402-260-454942-74-4Aquatic Chronic 4H413—H413616-025-00-0valinamide402-840-720108-78-5 Repr. 2 Eye Irrit. 2 Skin Sens. 1 H361f H319 H317 GHS08 Wng H361f H319 H317 616-026-00-6thioacetamide200-541-462-55-5 Carc. 1B Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 H350 H302 H319 H315 H412 GHS08 GHS07 Dgr H350 H302 H319 H315 H412 616-027-00-1tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate403-760-5—Skin Sens. 1H317 GHS07 Wng H317616-028-00-7N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide403-790-9108673-51-4 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-029-00-2N, N'-ethylenebis(vinylsulfonylacetamide)404-790-166710-66-5

Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 616-030-00-8 ethidimuron (ISO); 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 250-010-630043-49-3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 616-031-00-3 dimethachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; 256-625-650563-36-5 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 616-032-00-9 diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide —83164-33-4Aquatic Chronic 3H412—H412616-033-00-4 cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide 274-050-969581-33-5 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H301 H312 H400 H410 GHS06 GHS09 Dgr H301 H312 H410 616-034-00-X pyracarbolid; (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide 246-419-424691-76-7Aquatic Chronic 3H412—H412616-035-00-5 cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-057966-95-7 Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361fd H302 H373 (blood, thymus) H317 H400 H410 GHS08 GHS07 GHS09 Wng H361fd H302 H373 (blood, thymus) H317 H410 M = 1 M = 1 616-036-00-02-chloracetamide201-174-279-07-2 Repr. 2 Acute Tox. 3 Skin Sens. 1 H361f H301 H317 GHS06 GHS08 Dgr H361f H301 H317 Skin Sens. 1; H317: C ≥ 0,1 % 616-038-00-1(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride406-010-588918-84-7 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H318 H317 H411 GHS05 GHS07 GHS09 Dgr H318 H317 H411 616-039-00-73',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide406-200-8117827-06-2Skin Sens. 1H317 GHS07 Wng H317616-040-00-2potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide406-650-597888-41-0Eye Dam. 1H318 GHS05 Dgr H318616-041-00-83',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide406-840-8101664-25-9Aquatic Chronic 4H413—H413616-042-00-3N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide407-070-5142859-67-4 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-043-00-9 isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide 407-190-882558-50-7Aquatic Chronic 4H413—H413616-044-00-4N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide402-510-2—Aquatic Chronic 2H411GHS09H411616-045-00-X2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide405-190-2122371-93-1 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-046-00-5N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide406-390-2— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 616-047-00-0 reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N, N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N, N-di(C18)alkylacetamide 406-640-0—Skin Sens. 1H317

GHS07 Wng H317616-048-00-63'-trifluoromethylisobutyranilide406-740-41939-27-1 STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411 616-049-00-12-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide408-150-299141-89-6Aquatic Chronic 4H413—H413616-050-00-7 lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide 410-690-9103055-07-8 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 616-051-00-2 reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene 411-070-0—Aquatic Chronic 4H413—H413616-052-00-8formamide200-842-075-12-7Repr. 1BH360D GHS08 Dgr H360D 616-053-00-3N-methylacetamide201-182-679-16-3Repr. 1BH360D GHS08 Dgr H360D 616-054-00-9 iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide 253-178-936734-19-7 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 616-055-00-4 propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide 245-951-423950-58-5 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 616-056-00-XN-methylformamide204-624-6123-39-7 Repr. 1B Acute Tox. 4 H360D H312 GHS08 GHS07 Dg H360D H312616-057-00-5 reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide 412-790-8— Carc. 1B Muta. 2 STOT RE 2 H350 H341 H373 GHS08 Dgr H350 H341 H373 616-058-00-01,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene412-570-1119462-56-5 STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 H318 H317 H400 H410 GHS08 GHS05 GHS07 GHS09 Dgr H373 H318 H317 H410 616-059-00-64-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide412-650-6121487-83-0Aquatic Chronic 4H413—H413616-060-00-1 condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) 413-770-1— Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H314 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H314 H317 H410 616-061-00-7N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide413-610-0124172-53-8 Eye Irrit. 2 Aquatic Chronic 3 H319 H412 GHS07 Wng H319 H412 616-062-00-2N-[3-(2-acetyloxy)ethylamino]-4-methoxyphenylacetamide411-590-870693-57-1 Skin Corr. 1B Aquatic Chronic 3 H314 H412 GHS05 Dgr H314 H412 616-063-00-83-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione411-920-0106917-30-0 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 H331 H302 H373 H314 H400 H410 GHS06 GHS08 GHS05

GHS09 Dgr H331 H302 H373 H314 H410 616-064-00-3N—tert-butyl-3-methylpicolinamide406-720-532998-95-1Aquatic Chronic 3H412—H412616-065-00-93'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea411-970-379881-89-3 Acute Tox. 4 STOT RE 2 H302 H373 GHS08 GHS07 Wng H302 H373 616-066-00-45,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone405-100-1115662-06-1Repr. 2H361f GHS08 Wng H361f 616-067-00-Xdodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate407-300-492683-20-0Aquatic Chronic 4H413—H413616-068-00-5potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate406-500-9174393-75-0Skin Sens. 1H317 GHS07 Wng H317616-069-00-01-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide406-210-2110560-22-0Aquatic Chronic 4H413—H413 616-070-00-6 reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-530-2—Aquatic Chronic 4H413—H413616-071-00-1 reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; bis(N-octadecyl-N'-phenyleneureido)methylene; bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) 406-550-1— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-072-00-71-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine407-120-655612-11-8Aquatic Chronic 4H413—H413616-073-00-24'-ethoxy-2-benzimidazoleanilide407-600-5120187-29-3 Muta. 2 Aquatic Chronic 4 H341 H413 GHS08 Wng H341 H413 616-074-00-8N-butyl-2-(4-morpholinylcarbonyl)benzamide407-730-2104958-67-0 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H317 H412 GHS07 Wng H319 H317 H412 616-075-00-3D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)408-120-965197-96-8 Acute Tox. 4 Eye Dam. 1 H302 H318 GHS05 GHS07 Dgr H302 H318 616-076-00-9 tebufenozide (ISO); N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide 412-850-3112410-23-8Aquatic Chronic 2H411GHS09H411616-077-00-4 reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate 411-310-4—Eye Dam. 1H318 GHS05 Dgr H318616-078-00-X2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide411-330-3104541-33-5Aquatic Chronic 4H413—H413616-079-00-51,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate411-700-4140921-24-0Skin Sens. 1H317 GHS07 Wng H317616-080-00-04-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)411-850-0119018-29-0Aquatic Chronic 3H412—H412616-081-00-65-bromo-8-naphtholactam413-480-524856-00-6 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 616-082-00-1N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide413-200-1129604-78-0Skin Sens. 1H317

GHS07 Wng H317616-083-00-7[2-[(4-nitrophenyl)amino]ethyl]urea410-700-127080-42-8 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 616-084-00-22,4-bis[N'-(4-methylphenyl)ureido]toluene411-790-5— Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-085-00-83-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione412-190-6168900-02-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-086-00-32-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene412-250-1102387-48-4Aquatic Chronic 4H413—H413616-087-00-9 reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate; 7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate 412-260-652658-19-2 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H319 H317 H411 GHS07 GHS09 Wng H319 H317 H411 616-088-00-42-aminosulfonyl-N, N-dimethylnicotinamide413-440-7112006-75-4 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 616-089-00-X5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran415-360-841107-56-6Muta. 2H341 GHS08 Wng H341616-090-00-51-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride415-660-970918-74-0 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Aquatic Chronic 2 H331 H311 H301 H373 H411 GHS06 GHS08 GHS09 Dgr H331 H311 H301 H373 H411 616-091-00-01,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione423-400-059653-74-6 Muta. 1B Acute Tox. 3 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Skin Sens. 1 H340 H331 H302 H373 H318 H317 GHS06 GHS08 GHS05 Dgr H340 H331 H302 H373 H318 H317 616-092-00-6polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N, N-di-2-propenylformamide404-035-6— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-093-00-1reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride406-620-1129217-90-9 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-095-00-2 3,3'-dioctadecyl-1,1'-methylene bis(4,1-phenylene)diurea 406-690-343136-14-7Aquatic Chronic 4H413—H413616-096-00-8N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide408-110-4110483-07-3Aquatic Chronic 4H413—H413616-097-00-3N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide411-840-683372-55-8Aquatic Chronic 4H413—H413616-098-00-91-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide411-750-7119126-15-7Aquatic Chronic 2H411GHS09H411616-099-00-42-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide414-170-2135937-20-1Aquatic Chronic 4H413—H413616-100-00-81,3-dimethyl-1,3-bis(trimethylsilyl)urea414-180-710218-17-4 Acute Tox. 4 Skin Irrit. 2 H302 H315 GHS07 Wng H302 H315 616-101-00-3(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide414-600-9149182-72-9

Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 616-102-00-9 reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene); 1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol; 1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] 415-870-0— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-103-00-4(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide415-030-3120298-38-6 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 616-104-00-X benalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate 275-728-771626-11-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-105-00-5 chlorotoluron (ISO); 3-(3-chloro-p-tolyl)-1,1-dimethylurea 239-592-215545-48-9 Carc. 2 Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H361d H400 H410 GHS08 GHS09 Wng H351 H361d H410 616-106-00-0 phenmedipham (ISO); methyl 3-(3-methylcarbaniloyloxy)carbanilate 237-199-013684-63-4 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 616-107-00-6 cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate —142891-20-1 Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H317 H410 616-108-00-1iodosulfuron-methyl-sodium; sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide—144550-36-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-109-00-7 sulfosulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea —141776-32-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-110-00-2 cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid 419-150-7113136-77-9Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H411 616-111-00-8 fenhexamid (ISO); N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid 422-530-5126833-17-8Aquatic Chronic 2H411GHS09H411616-112-00-3 oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate —144651-06-9 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H373 H400 H410 GHS08 GHS09 Wng H373 H410 616-113-00-9 desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate 237-198-513684-56-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=10 616-114-00-4dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-418-010-2136897-58-0Aquatic Chronic 4H413—H413616-115-00-XN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide416-150-9136450-06-1Aquatic Chronic 4H413—H413616-116-00-5N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate416-790-9143052-96-4Aquatic Chronic 4H413—H413616-117-00-0N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide416-860-9777891-21-1

Repr. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H317 H400 H410 GHS08 GHS09 Wng H361f H317 H410 616-118-00-6N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride417-950-065797-42-4 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 616-119-00-12-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide418-060-5118020-93-2Aquatic Chronic 4H413—H413616-120-00-7 reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide; N-(3-dimethylamino-2-methyl-phenyl)-benzamide; N-(3-dimethylamino-3-methyl-phenyl)-benzamide 420-600-1— STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411 616-121-00-22,4-dihydroxy-N-(2-methoxyphenyl)benzamide419-090-1129205-19-2 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-122-00-8methyl neodecanamide414-460-9105726-67-8Acute Tox. 4 H302 GHS07 Wng H302616-123-00-3N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide414-740-096141-86-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Corr. 1B Aquatic Chronic 3 H311 H301 H373 H314 H412 GHS06 GHS05 GHS08 Dgr H311 H301 H373 H314 H412 616-125-00-43-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide415-730-9151338-11-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng 410616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7 Acute Tox. 4 STOT RE 2 Aquatic Chronic 3 H302 H373 H412 GHS08 GHS07 Wng H302 H373 H412 616-127-00-5 reaction mass of: N, N'-Ethane-1,2-diylbis(decanamide); 12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide; N, N'-Ethane-1,2-diylbis(12hydroxyoctadecanamide) 430-050-2— Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-128-00-0N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide417-530-7123590-00-1Aquatic Chronic 4H413—H413616-129-00-6N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide419-710-042774-15-2 Acute Tox. 4 Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 616-130-00-1N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide421-780-2150919-56-5Aquatic Chronic 4H413—H413616-131-00-71-aminocyclopentanecarboxamide422-950-917193-28-1 STOT RE 1 Acute Tox. 4 Eye Dam. 1 H372 H302 H318 GHS05 GHS08 GHS07 Dgr H372 H302 H318 616-132-00-2N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide423-250-6130016-98-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-133-00-8 N-cyclohexyl-S, S-dioxo benzo[b]tiophene-2-carboxamide 423-990-1149118-66-1 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410 616-134-00-33,3'-bis(dioctyloxyphosphinothioylthio)-N, N'-oxybis(methylene)dipropionamide401-820-5793710-14-2Aquatic Chronic 3H412—H412

616-135-00-9(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide430-230-0136522-17-3 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 616-136-00-4reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)430-380-7—Aquatic Chronic 2H411GHS09H411616-137-00-X4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane401-130-471526-07-3 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-138-00-5benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide431-600-4112226-61-6 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-139-00-0(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide420-380-5136465-81-1 Acute Tox. 4 Eye Dam. 1 Aquatic Chronic 3 H302 H318 H412 GHS05 GHS07 Dgr H302 H318 H412 616-140-00-6N, N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]429-380-1133336-92-2 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-141-00-1 zoxamide (ISO); (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide —156052-68-5 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M=10616-142-00-71,3-bis(vinylsulfonylacetamido)propane428-350-393629-90-4 Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H341 H318 H317 H412 GHS08 GHS05 GHS07 Dgr H341 H318 H317 H412 616-143-00-2N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide422-560-9149591-38-8 Repr. 2 Eye Irrit. 2 Aquatic Chronic 4 H361f H319 H413 GHS08 Wng H361f H319 H413 616-144-00-83,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide431-130-1—Aquatic Chronic 4H413—H413616-145-00-3 pethoxamide (ISO); 2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1enyl)acetamide —106700-29-2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H317 H400 H410 GHS07 GHS09 Wng H302 H317 H410 M=100616-146-00-9N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide431-330-7142776-95-2Aquatic Chronic 4H413—H413616-147-00-41-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide424-160-1139481-22-4 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 616-148-00-XN-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide424-550-184245-12-5 Carc. 1B Muta. 1B Repr. 1B H350 H340 H360FD GHS08 Dgr H350 H340 H360FD 616-150-00-0(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride425-260-6— STOT RE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H373 H318 H317 H411 GHS05 GHS08 GHS07 GHS09 Dgr H373 H318 H317 H411 616-151-00-6N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide425-650-6171887-03-9 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 H302 H318 H317 H412 GHS05 GHS07 Dgr H302 H318 H317 H412 616-152-00-14-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide425-850-3125971-96-2Aquatic Chronic 4H413—H413616-153-00-74-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide425-860-8125971-57-5

Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-154-00-23,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide431-110-0—Aquatic Chronic 4H413—H413616-155-00-8N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide431-040-0104560-40-9 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-156-00-36-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide430-500-8204277-61-2Aquatic Chronic 4H413—H413616-157-00-93-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride427-780-9114565-70-7 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H318 H400 H410 GHS05 GHS07 GHS09 Dgr H302 H318 H410 616-158-00-4N-[4-cyano-3-trifluoromethylphenyl]methacrylamide427-880-290357-53-2 STOT RE 2 Aquatic Chronic 2 H373 H411 GHS08 GHS09 Wng H373 H411 616-160-00-52,2'-azobis[N-(2-hydroxyethyl)2-methylpropionamide]429-090-361551-69-7 Skin Sens. 1 Aquatic Chronic 3 H317 H412 GHS07 Wng H317 H412 616-161-00-02,4-dichloro-5-hydroxyacetanilide429-110-067669-19-6Aquatic Chronic 3H412—H412616-162-00-6isostearic acid monoisopropanolamide431-540-9— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 616-163-00-14,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]430-350-3192463-88-0Aquatic Chronic 4H413—H413616-164-00-7 dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide —149961-52-4 Carc. 2 Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H361d H332 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361d H332 H410 M=10616-165-00-2 beflubutamid (ISO); (RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide —113614-08-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=100616-166-00-8 cyazofamid (ISO); 4-chloro-2-cyano-N, N-dimethyl-5-p-tolylimidazole-1-sulfonamide —120116-88-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410M=10616-167-00-3N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2Skin Sens. 1H317 GHS07 Wng H317 616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2 Eye Irrit. 2 Skin Sens. 1 H319 H317 GHS07 Wng H319 H317 616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5 Eye Dam. 1 Skin Sens. 1 H318 H317 GHS05 GHS07 Dgr H318 H317 616-172-00-0 N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetra methyl-1-piperidinyl)oxidanyl 423-840-314691-89-5Acute Tox. 4 H302 GHS07 Wng H302616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1 Acute Tox. 4

Eye Irrit. 2 H302 H319 GHS07 Wng H302 H319 616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3Aquatic Chronic 4H413—H413616-176-00-23-N, N-bis(methoxyethyl)aminoacetanilide432-530-724294-01-7 Acute Tox. 4 Aquatic Chronic 3 H302 H412 GHS07 Wng H302 H412 616-177-00-8 (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; N-[3-({4-[(2-{]butyl[}(4methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3yl[}amino)-4-chlorophenyl]tetradecanamide 432-970-1217324-98-6Aquatic Chronic 4H413—H413 616-178-00-3N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4Aquatic Chronic 4H413—H413616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H318 H317 H410 616-180-00-4N, N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410616-181-00-X4'-methyldodecane-1-sulfonanilide435-490-917417-32-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-182-00-5N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1 Skin Sens. 1 Aquatic Chronic 2 H317 H411 GHS07 GHS09 Wng H317 H411 616-183-00-0N-dodecyl-4-methoxybenzamide442-340-61854-15-5Aquatic Chronic 4H413—H413616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8Aquatic Chronic 4H413—H413616-186-00-7N, N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4Aquatic Chronic 3H412—H412616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9 Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-189-00-3N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9Aquatic Chronic 4H413—H413616-190-00-9N-decyl-4-nitrobenzamide445-880-064026-19-3Aquatic Chronic 4H413—H413616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0 Acute Tox. 4 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H302 H319 H315 H317 H411 GHS07 GHS09 Wng H302 H319 H315 H317 H411 616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9Aquatic Chronic 4H413—H413616-193-00-5N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9Aquatic Chronic 4H413—H413616-194-00-02,2-diethoxy-N, N-dimethylacetamide449-950-134640-92-1Eye Irrit. 2H319 GHS07 Wng H319616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide419-990-4—

Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410616-197-00-7 reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide 422-500-1—STOT RE 2 H373 GHS08 Wng H373 616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7— Skin Sens. 1 Aquatic Chronic 4 H317 H413 GHS07 Wng H317 H413 616-200-00-1reaction mass of N, N’-ethane1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N, N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)432-430-3Aquatic Chronic 4H413H413616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6 Acute Tox. 4 Aquatic Chronic 4 H332 H413 GHS07 Wng H332 H413 616-202-00-2 reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide 434-330-5— Carc. 2 Skin Sens. 1 Aquatic Chronic 4 H351 H317 H413 GHS08 GHS07 Wng H351 H317 H413 616-203-00-8 reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol5-ylazo)5-diethylaminophenyl]acetamide 442-280-0—Aquatic Chronic 4H413—H413 616-204-00-3N, N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]451-060-3122886-55-9Aquatic Chronic 4H413—H413616-205-00-9 metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)-acetamide 266-583-067129-08-2 Skin Sens. 1B Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H317 H351 H400 H410 GHS07 GHS08 GHS09 Wng H317 H351 H410 M = 100 M = 100 616-206-00-4 flufenoxuron (ISO); 1-(4-(2-cloro-α, α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea 417-680-3101463-69-8 Lact. Aquatic Acute 1 Aquatic Chronic 1 H362 H400 H410 GHS09 Wng H362 H410 M = 10000 M = 10000 616-208-00-5 N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one 220-250-62687-91-4Repr. 1BH360D GHS08 Dgr H360D616-209-00-0 amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea 407-380-0120923-37-7 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 100 M = 100 616-210-00-6 tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide 119168-77-3 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H301 H332 H373 (gastro-intestinal tract) (Oral) H317 H400 H410 GHS06 GHS08 GHS09 Dgr H301 H332 H373 (gastro-intestinal tract) (Oral) H317 H410 M = 10 M = 10 616-211-00-1 proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H400 H410 GHS08 GHS09 Wng H351 H410 M = 1 M = 10 616-212-00-73-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate259-627-555406-53-6 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H331 H302 H372 (larynx) H318 H317 H400 H410 GHS06 GHS08 GHS05 GHS09 Dgr H331 H302 H372 (larynx) H318 H317 H410 M = 10 M = 1 617-001-00-2di-tert-butyl peroxide203-733-6110-05-4Org. Perox. E Flam. Liq. 2 Muta. 2 H242 H225 H341 GHS02 GHS08 Dgr H242 H225 H341 617-002-00-8 α, α-dimethylbenzyl hydroperoxide; cumene hydroperoxide 201-254-780-15-9 Org. Perox. E Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Aquatic Chronic 2 H242 H331 H312 H302 H373 H314 H411 GHS02 GHS06 GHS08 GHS05 GHS09 Dgr H242 H331 H312 H302 H373 H314 H411 Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Dam. 1; H318: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 3 % STOT SE 3; H335: C < 10 % 617-003-00-3dilauroyl peroxide203-326-3105-74-8Org. Perox. DH242 GHS02 Dgr H242617-004-00-91,2,3,4-tetrahydro-1-naphthyl hydroperoxide212-230-0771-29-9 Org. Perox. D Acute Tox. 4 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 H242 H302 H314 H400 H410 GHS02 GHS05 GHS07 GHS09 Dgr H242 H302 H314 H410 STOT SE 3; H335: C ≥ 5 %617-006-00-X bis(α, α-dimethylbenzyl) peroxide 201-279-380-43-3 Org. Perox. F Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 H242 H319 H315 H411 GHS02 GHS07 GHS09 Wng H242 H319 H315 H411 617-007-00-5tert-butyl α, α-dimethylbenzyl peroxide222-389-83457-61-2 Org. Perox. E Skin Irrit. 2 Aquatic Chronic 2 H242 H315 H411 GHS02 GHS07 GHS09 Wng H242 H315 H411 617-008-00-0 dibenzoyl peroxide; benzoyl peroxide 202-327-694-36-0 Org. Perox. B Eye Irrit. 2 Skin Sens. 1 H241 H319 H317 GHS01 GHS02 GHS07 Dgr H241 H319 H317 617-010-00-1 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1] 1,1’-dioxybiscyclohexan-1-ol; [2] cyclohexylidene hydroperoxide; [3] cyclohexanone, peroxide [4] 201-091-1 [1] 219-306-2 [2] 220-279-4 [3] 235-527-7 [4] 78-18-2 [1] 2407-94-5 [2] 2699-11-8 [3] 12262-58-7 [4] Org. Perox. A Skin Corr. 1B Acute Tox. 4 H240 H314 H302 GHS01 GHS05 GHS07 Dgr H240 H314 H302 STOT SE 3; H335: C ≥ 5 %C617-010-01-9 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1] 1,1'-dioxybiscyclohexan-1-ol; [2] cyclohexylidene hydroperoxide; [3] cyclohexanone, peroxide [4] [≤ 91 % solution] 201-091-1 [1] 219-306-2 [2] 220-279-4 [3] 235-527-7 [4] 78-18-2 [1] 2407-94-5 [2] 2699-11-8 [3] 12262-58-7 [4] Org. Perox. C Acute Tox. 4 Skin Corr. 1B H242 H302 H314 GHS02 GHS05 GHS07 Dgr H242 H302 H314 STOT SE 3; H335: C ≥ 5 %C T617-012-00-2 8-p-menthyl hydroperoxide; p-menthane hydroperoxide 201-281-480-47-7 Org. Perox. D Skin Corr. 1B Acute Tox. 4 H242 H314 H332 GHS02 GHS05 GHS07 Dgr H242 H314 H332 STOT SE 3; H335: C ≥ 5 %617-013-00-8O, O-tert-butyl O-docosyl monoperoxyoxalate404-300-6116753-76-5 Org. Perox. C Aquatic Acute 1 Aquatic Chronic 1 H242 H400 H410

GHS02 GHS09 Dgr H242 H410 617-014-00-36-(nonylamino)-6-oxo-peroxyhexanoic acid406-680-9104788-63-8 Org. Perox. C Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 H242 H318 H317 H400 GHS02 GHS05 GHS07 GHS09 Dgr H242 H318 H317 H400 617-015-00-9bis(4-methylbenzoyl)peroxide407-950-9895-85-2 Org. Perox. B Aquatic Acute 1 Aquatic Chronic 1 H241 H400 H410 GHS01 GHS02 GHS09 Dgr H241 H410 617-016-00-43-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate413-910-1— Org. Perox. C Flam. Liq. 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H242 H226 H315 H400 H410 GHS02 GHS07 GHS09 Dgr H242 H226 H315 H410 617-017-00-X reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene; 2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene 412-140-332144-25-5 Org. Perox. D Aquatic Chronic 4 H242 H413 GHS02 Dgr H242 H413 T617-018-00-5 reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight; 1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight 410-840-371566-50-2Org. Perox. C Aquatic Chronic 2 H242 H411 GHS02 GHS09 Dgr H242 H411 T617-019-00-06-(phthalimido)peroxyhexanoic acid410-850-8128275-31-0 Org. Perox. D Eye Dam. 1 Aquatic Acute 1 H242 H318 H400 GHS02 GHS05 GHS09 DgDgr H242 H318 H400 T617-020-00-61,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)420-060-5117663-11-3 Flam. Liq. 3 Org. Perox. D Aquatic Chronic 2 H226 H242 H411 GHS02 GHS09 Dgr H226 H242 H411 617-021-00-1methylethylketone peroxide trimer429-320-2— Org. Perox. B Asp. Tox. 1 Skin Irrit. 2 Skin Sens. 1 H241 H304 H315 H317 GHS01 GHS02 GHS08 GHS07 Dgr H241 H304 H315 H317 617-022-00-7reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate442-480-8— Org. Perox. C Acute Tox. 4 Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 H242 H302 H314 H317 H411 GHS02 GHS05 GHS07 GHS09 Dgr H242 H302 H314 H317 H411 647-001-00-8glucosidase, β-232-589-79001-22-3Resp. Sens. 1H334 GHS08 Dgr H334647-002-00-3cellulase232-734-49012-54-8Resp. Sens. 1H334 GHS08 Dgr H334647-003-00-9cellobiohydrolase, exo-253-465-937329-65-0Resp. Sens. 1H334 GHS08 Dgr H334647-004-00-4cellulases with the exception of those specified elsewhere in this Annex——Resp. Sens. 1H334 GHS08 Dgr H334A647-005-00-Xbromelain, juice232-572-49001-00-7 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-006-00-5ficin232-599-19001-33-6 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-007-00-0papain232-627-29001-73-4 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-008-00-6pepsin A232-629-39001-75-6 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-009-00-1rennin232-645-09001-98-3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-010-00-7trypsin232-650-89002-07-7

Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-011-00-2chymotrypsin232-671-29004-07-3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-012-00-8subtilisin232-752-29014-01-1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 H335 H315 H318 H334 GHS08 GHS05 GHS07 Dgr H335 H315 H318 H334 647-013-00-3proteinase, microbial neutral232-966-69068-59-1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-014-00-9proteases with the exception of those specified elsewhere in this Annex—— Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 H319 H335 H315 H334 GHS08 GHS07 Dgr H319 H335 H315 H334 647-015-00-4amylase, α-232-565-69000-90-2Resp. Sens. 1H334 GHS08 Dgr H334647-016-00-Xamylases with the exception of those specified elsewhere in this Annex——Resp. Sens. 1H334 GHS08 Dgr H334647-017-00-5laccase420-150-480498-15-3Resp. Sens. 1H334 GHS08 Dgr H334 648-001-00-0 Distillates (coal tar), benzole fraction; Light Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80oC to 160 oC (175oF to 320oF).] 283-482-784650-02-2Carc. 1BH350 GHS08 Dgr H350648-002-00-6 Tar oils, brown-coal; Light Oil; [The distillate from lignite tar boiling in the range of approximately 80 o C to 250 o C (176oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] 302-674-494114-40-6 Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-003-00-1 Benzol forerunnings (coal); Light Oil Redistillate, low boiling; [The distillate from coke oven light oil having an approximate distillation range below 100 o C (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.] 266-023-565996-88-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-004-00-7 Distillates (coal tar), benzole fraction, BTX-rich; Light Oil Redistillate, low boiling; [A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).] 309-984-9101896-26-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-005-00-2Aromatic hydrocarbons, C6-10, C8-rich; Light Oil Redistillate, low boiling292-697-590989-41-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-006-00-8Solvent naphtha (coal), light; Light Oil Redistillate, low boiling287-498-585536-17-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-007-00-3Solvent naphtha (coal), xylene-styrene cut; Light Oil Redistillate, intermediate boiling287-502-585536-20-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-008-00-9Solvent naphtha (coal), coumarone-styrene contg.; Light Oil Redistillate, intermediate boiling287-500-485536-19-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr

H350 H340 J648-009-00-4 Naphtha (coal), distn. residues; Light Oil Redistillate, high boiling; [The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] 292-636-290641-12-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-010-00-XAromatic hydrocarbons, C8; Light Oil Redistillate, high boiling292-694-990989-38-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-012-00-0 Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product; Light Oil Redistillate, high boiling; [A complex combination of hydrocarbons obtained from the evaporation of solven under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 o C to 215 o C (248 oF to 419 oF).] 295-281-191995-20-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-013-00-6 Aromatic hydrocarbons, C9-12, benzene distn.; Light Oil Redistillate, high boiling 295-551-992062-36-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-014-00-1 Extract residues (coal), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; [The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90o C to 160 o C (194oF to 320 oF). It consists predomi nantly of benzene, toluene and xylenes.] 295-323-991995-61-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-015-00-7 Extract residues (coal tar), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; [A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC to 195o C (185oF to 383oF).] 309-868-8101316-63-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-016-00-2 Extract residues (coal), benzole fraction acid; Light Oil Extract Residues, low boiling; [An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] 298-725-293821-38-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-017-00-8 Extract residues (coal), light oil alk., distn. overheads; Light Oil Extract Residues, low boiling; [The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145o C (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.] 292-625-290641-02-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-018-00-3 Extract residues (coal), light oil alk., acid ext., indene fraction; Light Oil Extract Residues, intermediate boiling 309-867-2101316-62-5Carc. 1B Muta. 1B H350 H340 GHS08

Dgr H350 H340 J648-019-00-9 Extract residues (coal), light oil alk., indene naphtha fraction; Light Oil Extract Residues, high boiling; [The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed Carbolic oils, having an approximate boiling range of 155o C to 180o C (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.] 292-626-890641-03-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-020-00-4 Solvent naphtha (coal); Light Oil Extract Residues, high boiling; [The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130o C to 210o C (266oF to 410oF). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] 266-013-065996-79-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-021-00-XDistillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135o C to 210o C (275oF to 410oF). May also include unsaturated hydrocarbons such as indene and coumarone.]309-971-8101794-90-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-022-00-5 Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling; [This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m-and p-cresol and boiling in the range of 140o C to 215o C (284 oF to 419 oF).] 292-609-590640-87-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-023-00-0 Distillates (coal tar), light oils; Carbolic Oil; [A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 o C to 210 o C (302 oF to 410 oF).] 283-483-284650-03-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-024-00-6 Tar oils, coal; Carbolic Oil; [The distillate from high temperature coal tar having an approximate distillation range of 130 o C to 250 o C (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] 266-016-765996-82-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-026-00-7 Extract residues (coal), light oil alk., acid ext.; Carbolic Oil Extract Residue; [The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.] 292-624-790641-01-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-027-00-2 Extract residues (coal), tar oil alk.; Carbolic Oil Extract Residue; [The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]

266-021-465996-87-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-028-00-8 Extract oils (coal), light oil; Acid Extract; [The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-622-690640-99-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-029-00-3 Pyridine, alkyl derivs.; Crude Tar Bases; [The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approxi mately above 150o C (302oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] 269-929-968391-11-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-030-00-9 Tar bases, coal, picoline fraction; Distillate Bases; [Pyridine bases boiling in the range of approximately 125o C to 160o C (257oF 320oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] 295-548-292062-33-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-031-00-4 Tar bases, coal, lutidine fraction; Distillate Bases 293-766-291082-52-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-032-00-X Extract oils (coal), tar base, collidine fraction; Distillate Bases; [The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] 273-077-368937-63-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-033-00-5 Tar bases, coal, collidine fraction; Distillate Bases; [The distillation fraction boiling in the range of approximately 181 o C to 186 o C (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] 295-543-592062-28-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-034-00-0 Tar bases, coal, aniline fraction; Distillate Bases; [The distillation fraction boiling in the range of approximately 180o C to 200o C (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.] 295-541-492062-27-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-035-00-6 Tar bases, coal, toluidine fraction; Distillate Bases 293-767-891082-53-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-036-00-1 Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction; Redistillates; [A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately160 o C to 190 o C (320 oF to 374 oF).]

295-292-191995-31-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-037-00-7 Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils; Redistillates; [The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190o C to 270o C (374oF to 518oF). Composed primarily of substituted dinuclear aromatics.] 295-295-891995-35-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-038-00-2 Extract oils (coal), coal tar-residual pyrolysis oils, naph thalene oil, redistillate; Redistillates; [The redistillate from the fractional distillation of dephe nolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220o C to 230o C (428oF to 446oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] 295-329-191995-66-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-039-00-8 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils; Redistillates; [A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225o C to 255o C (437oF to 491oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.] 310-170-0122070-79-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-040-00-3 Extract oils (coal), coal tar residual pyrolysis oils, naph thalene oil, distn. residues; Redistillates; [Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 o C to 260o C (464oF to 500oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] 310-171-6122070-80-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-041-00-9 Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500oF to 554oF).] 309-851-5101316-45-4Carc. 1BH350 GHS08 Dgr H350M648-042-00-4 Distillates (coal tar), upper, fluorene-rich; Wash Oil Redistillate; [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] 284-900-084989-11-7Carc. 1BH350 GHS08 Dgr H350M648-043-00-X Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate; [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] 292-606-990640-85-0Carc. 1BH350 GHS08 Dgr H350M648-044-00-5Distillates (coal tar), heavy oils; Heavy Anthracene Oil; [Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240oC to 400oC (464oF to 752 oF). Composed primarily of tri-and polynuclear hydrocarbons and heterocyclic compounds.]292-607-490640-86-1Carc. 1BH350

GHS08 Dgr H350 648-045-00-0 Distillates (coal tar), upper; Heavy Anthracene Oil; [The distillate from coal tar having an approximate distillation range of 220oC to 450oC (428oF to 842oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] 266-026-165996-91-0Carc. 1BH350 GHS08 Dgr H350M648-046-00-6Anthracene oil, acid ext.; Anthracene Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approxi mately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]295-274-391995-14-1Carc. 1BH350 GHS08 Dgr H350M648-047-00-1 Distillates (coal tar); Heavy Anthracene Oil; [The distillate from coal tar having an approximate distil lationrange of 100oC to 450oC (212oF to 842oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] 266-027-765996-92-1Carc. 1BH350 GHS08 Dgr H350M648-048-00-7 Distillates (coal tar), pitch, heavy oils; Heavy Anthracene Oil; [The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri-and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.] 295-312-991995-51-6Carc. 1BH350 GHS08 Dgr H350M 648-049-00-2 Distillates (coal tar), pitch; Heavy Anthracene Oil; [The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two-to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).] 309-855-7101316-49-8Carc. 1BH350 GHS08 Dgr H350M648-050-00-8 Distillates (coal tar), heavy oils, pyrene fraction; Heavy Anthracene Oil Redistillate; [The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri-and polynuclear aromatics and heterocyclic hydrocarbons.] 295-304-591995-42-5Carc. 1BH350 GHS08 Dgr H350M648-051-00-3 Distillates (coal tar), pitch, pyrene fraction; Heavy Anthracene Oil Redistillate; [The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri-and polynuclear aromatic hydrocarbons and heterocyclic compounds.] 295-313-491995-52-7Carc. 1BH350 GHS08 Dgr H350M648-052-00-9 Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated; Coal Tar Extract; [A complet combination of hydrocarbons obtained by the treatment of lignite carbon ization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]

308-296-697926-76-6Carc. 1BH350 GHS08 Dgr H350M 648-053-00-4 Paraffin waxes (coal), brown-coal high-temp tar, clay-treated; Coal Tar Extract; [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-297-197926-77-7Carc. 1BH350 GHS08 Dgr H350M648-054-00-XPitch; Pitch263-072-461789-60-4Carc. 1BH350 GHS08 Dgr H350M648-055-00-5Pitch, coal tar, high-temp.; Pitch; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86oF to 356oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]266-028-265996-93-2Carc. 1BH350 GHS08 Dgr H350648-056-00-0Pitch, coal tar, high-temp., heat-treated; Pitch; [The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80oC to180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]310-162-7121575-60-8Carc. 1BH350 GHS08 Dgr H350M 648-057-00-6 Pitch, coal tar, high-temp., secondary; Pitch Redistillate; [The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri-and polynuclear aromatic compounds which also contain heteroatoms.] 302-650-394114-13-3Carc. 1BH350 GHS08 Dgr H350M648-058-00-1 Residues (coal tar), pitch distn.; Pitch Redistillate; [Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400oC to 470oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] 295-507-992061-94-4Carc. 1BH350 GHS08 Dgr H350M648-059-00-7 Tar, coal, high-temp., distn. and storage residues; Coal Tar Solids Residue; [Coke-and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] 295-535-192062-20-9Carc. 1BH350 GHS08 Dgr H350M648-060-00-2 Tar, coal, storage residues; Coal Tar Solids Residue; [The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] 293-764-191082-50-7Carc. 1BH350 GHS08 Dgr H350M 648-061-00-8 Tar, coal, high-temp., residues; Coal Tar Solids Residue; [Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]

309-726-5100684-51-3Carc. 1BH350 GHS08 Dgr H350M648-062-00-3 Tar, coal, high-temp., high-solids; Coal Tar Solids Residue; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] 273-615-768990-61-4Carc. 1BH350 GHS08 Dgr H350M648-063-00-9 Waste solids, coal-tar pitch coking; Coal Tar Solids Residue; [The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] 295-549-892062-34-5Carc. 1BH350 GHS08 Dgr H350M648-064-00-4 Extract residues (coal), brown; Coal Tar Extract; [The residue from extraction of dried coal.] 294-285-091697-23-3Carc. 1BH350 GHS08 Dgr H350M 648-065-00-X Paraffin waxes (coal), brown-coal-high-temp. tar; Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-454-192045-71-1Carc. 1BH350 GHS08 Dgr H350M648-066-00-5 Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated; Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predomi nantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-455-792045-72-2Carc. 1BH350 GHS08 Dgr H350M648-067-00-0 Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated; Coal Tar Extract; [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-298-797926-78-8Carc. 1BH350 GHS08 Dgr H350M 648-068-00-6 Tar, coal, low-temp, distn. residues; Tar Oil, intermediate boiling; [Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.] 309-887-1101316-85-2Carc. 1BH350 GHS08 Dgr H350M648-069-00-1 Pitch, coal tar, low-temp; Pitch Residue; [A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-651-490669-57-1Carc. 1BH350 GHS08 Dgr H350M648-070-00-7 Pitch, coal tar, low-temp., oxidized; Pitch Residue, oxidised; [The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]

292-654-090669-59-3Carc. 1BH350 GHS08 Dgr H350M648-071-00-2 Pitch, coal tar, low-temp., heat-treated; Pitch Residue, oxidised; Pitch Residue, heat-treated; [A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122oF to 284oF). Composed primarily of a complex mixture of aromatic compounds.] 292-653-590669-58-2Carc. 1BH350 GHS08 Dgr H350M 648-072-00-8 Distillates (coal-petroleum), condensed-ring arom; Distillates; [The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428oF to 842oF). Composed primarily of 3-to 4-membered condensed ring aromatic hydrocarbons.] 269-159-368188-48-7Carc. 1BH350 GHS08 Dgr H350M648-073-00-3 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived; Pyrolysis Products; [A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212oF to 428oF) according to DIN 52025.]; 309-956-6101794-74-5Carc. 1BH350 GHS08 Dgr H350M648-074-00-9 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived; Pyrolysis Products; [A complex combination of hydrocarbonsobtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numberspredominantly in the range of C20 through C28 and having a softening pointof 100oC to 220oC (212oF to 428oF) according to DIN 52025.] 309-957-1101794-75-6Carc. 1BH350 GHS08 Dgr H350M 648-075-00-4 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived; Pyrolysis Products; [A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100oC to 220oC (212oF to 428oF) according to DIN 52025.] 309-958-7101794-76-7Carc. 1BH350 GHS08 Dgr H350M648-076-00-X Pitch, coal tar-petroleum; Pitch Residues; [The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40oC to 180oC (140oF to 356oF). Composed; primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] 269-109-068187-57-5Carc. 1BH350 GHS08 Dgr H350M648-077-00-5 Phenanthrene, distn. residues; Heavy Anthracene Oi Redistillate; [Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644oF to 788oF). It consists predominantly of phenanthrene, anthracene and carbazole.] 310-169-5122070-78-4Carc. 1BH350 GHS08 Dgr H350M 648-078-00-0 Distillates (coal tar), upper, fluorene-free; Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] 284-899-784989-10-6Carc. 1BH350 GHS08 Dgr H350M648-079-00-6 Anthracene oil; Anthracene oil; [A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC to 400 oC (572oF to 752oF). Composed primarily of phenanthrene, anthracene and carbazole.] 292-602-790640-80-5Carc. 1BH350 GHS08 Dgr H350M648-080-00-1 Residues (coal tar), creosote oil distn.; Wash Oil Redistillate; [The residue from the fractional distillation of wash oil boiling in the approximate range of 270 o C to 330 o C (518 oF to 626 oF). It consists predomi nantly of dinuclear aromatic and heterocyclic hydrocarbons.] 295-506-392061-93-3Carc. 1BH350 GHS08 Dgr H350M648-081-00-7 Tar, coal; Coal tar; [The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydrocarbons, phenolic compounds, nitrogen bases and thiophene.] 232-361-78007-45-2Carc. 1AH350 GHS08 Dgr H350 648-082-00-2Tar, coal, high-temp.; Coal tar; [The condensation product obtained by cooling, to approxi mately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]266-024-065996-89-6Carc. 1AH350 GHS08 Dgr H350648-083-00-8 Tar, coal, low-temp.; Coal oil; [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] 266-025-665996-90-9Carc. 1AH350 GHS08 Dgr H350648-084-00-3 Distillates (coal), coke-oven light oil, naphthalene cut; Naphthalene Oil; [The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298oF).] 285-076-585029-51-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-085-00-9 Distillates (coal tar), naphthalene oils; Naphthalene Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compound and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392oF to 482oF).]- 283-484-884650-04-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-086-00-4Distillates (coal tar), naph thalene oils, naphthalene-low; Naphthalene Oil Redistillate; [A complex combination of hydrocarbons obtained by crys tallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]284-898-184989-09-3Carc. 1B Muta. 1B

H350 H340 GHS08 Dgr H350 H340 JM648-087-00-X Distillates (coal tar), naphthalene oil crystn. mother liquor; Naphthalene Oil Redistillate; [A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] 295-310-891995-49-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-088-00-5 Extract residues (coal), naphthalene oil, alk.; Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] 310-166-9121620-47-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-089-00-0 Extract residues (coal), naphthalene oil, alk., naphthalene-low; Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] 310-167-4121620-48-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-090-00-6 Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.; Naphthalene Oil Extract Residue; [The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] 292-612-190640-90-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-091-00-1 Extract residues (coal), naphthalene oil alk., distn. overheads; Naphthalene Oil Extract Residue; [The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] 292-627-390641-04-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-092-00-7 Distillates (coal tar), naphthalene oils, methylnaphthalene fraction; Methylnaphthalene Oil; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437oF to 491 oF).] 309-985-4101896-27-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-093-00-2 Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction; Methylnaphthalene Oil; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).] 309-972-3101794-91-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-094-00-8 Distillates (coal tar), naphthalene oils, acid exts.; Methylnaphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446oF to 491oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]

295-309-291995-48-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-095-00-3Extract residues (coal), naphthalene oil alk., distn. residues; Methylnaphthalene Oil Extract Residue; [The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428oF to 572oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]292-628-990641-05-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-096-00-9 Extract oils (coal), acidic, tar-base free; Methylnaphthalene Oil Extract Residue; [The extract oil boiling in the range of approximately 220 oC to 265 oC (428oF to 509oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] 284-901-684989-12-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-097-00-4 Distillates (coal tar), benzole fraction, distn. residues; Wash Oil; [A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150o C to 300 oC (302oF to 572oF) or a semi-solid or solid with a melting point up to 70 oC (158oF). It is composed primarily of naphthalene and alkyl naphthalenes.] 310-165-3121620-46-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-098-00-X Creosote oil, acenaphthene fraction; Wash Oil; [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] 292-605-390640-84-9Carc. 1BH350 GHS08 Dgr H350M648-099-00-5 Creosote oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392oF to 617oF).] 263-047-861789-28-4Carc. 1BH350 GHS08 Dgr H350M648-100-00-9 Creosote oil, high-boiling distillate; Wash Oil; [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41oF).] 274-565-970321-79-8Carc. 1BH350 GHS08 Dgr H350M 648-101-00-4 Creosote; [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] 232-287-58001-58-9Carc. 1BH350 GHS08 Dgr H350648-102-00-X Extract residues (coal), creosote oil acid; Wash Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482oF to 536oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]

310-189-4122384-77-4Carc. 1BH350 GHS08 Dgr H350M648-103-00-5 Anthracene oil, anthracene paste; Anthracene Oil Fraction; [The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] 292-603-290640-81-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-104-00-0 Anthracene oil, anthracene-low; Anthracene Oil Fraction; [The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] 292-604-890640-82-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-105-00-6 Residues (coal tar), anthracene oil distn.; Anthracene Oil Fraction; [The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644oF to 752oF). It consists predominantly of tri-and polynuclear aromatic and heterocyclic hydrocarbons.] 295-505-892061-92-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-106-00-1 Anthracene oil, anthracene paste, anthracene fraction; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626oF to 662oF). It contains chiefly anthracene, carbazole and phenanthrene.] 295-275-991995-15-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-107-00-7 Anthracene oil, anthracene paste, carbazole fraction; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distil lation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662oF to 680 oF). It contains chiefly anthracene, carbazole and phenanthrene.] 295-276-491995-16-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-108-00-2 Anthracene oil, anthracene paste, distn. lights; Anthracene Oil Fraction; [A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 oC to 340 oC (554oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.] 295-278-591995-17-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-109-00-8 Tar oils, coal, low-temp.; Tar Oil, high boiling; [A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320oF to 644oF).] 309-889-2101316-87-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-110-00-3 Extract residues (coal), low temp. coal atar alk.; [The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]

310-191-5122384-78-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-111-00-9 Phenols, ammonia liquor ext.; Alkaline Extract; [The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292oF)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.] 284-881-984988-93-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-112-00-4 Distillates (coal tar), light oils, alk. exts.; Alkaline Extract; [The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 292-610-090640-88-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-113-00-X Extracts, coal tar oil alk.; Alkaline Extract; [The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 266-017-265996-83-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-114-00-5 Distillates (coal tar), naphthalene oils, alk. exts.; Alkaline Extract; [The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 292-611-690640-89-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-115-00-0 Extract residues (coal), tar oil alk., carbonated, limed; Crude Phenols; [The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] 292-629-490641-06-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-116-00-6 Tar acids, coal, crude; Crude Phenols; [The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] 266-019-365996-85-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-117-00-1 Tar acids, brown-coal, crude; Crude Phenols; [An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.] 309-888-7101316-86-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-118-00-7 Tar acids, browncoal gasification; Crude Phenols; [A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] 295-536-792062-22-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-119-00-2 Tar acids, distn. residues; Distillate Phenols; [A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140oF to 176oF).] 306-251-596690-55-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340

JM648-120-00-8 Tar acids, methylphenol fraction; Distillate Phenols; [The fraction of tar acid rich in 3-and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-892-984989-04-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-121-00-3 Tar acids, polyalkylphenol fraction; Distillate Phenols; [The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437oF to 608oF). Composed primarily of polyalkylphenols.] 284-893-484989-05-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-122-00-9 Tar acids, xylenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 2,4-and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-895-584989-06-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-123-00-4 Tar acids, ethylphenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 3-and 4-ethylphenol, recovered by distillation of low-temperature coal tar rude tar acids.] 284-891-384989-03-7Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-124-00-X Tar acids, 3,5-xylenol fraction; Distillate Phenols; [The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] 284-896-084989-07-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-125-00-5 Tar acids, residues, distillates, first-cut; Distillate Phenols; [The residue from the distillation in the range of 235 oC to 355 oC (481oF to 697oF) of light carbolic oil.] 270-713-168477-23-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-126-00-0 Tar acids, cresylic, residues; Distillate Phenols; [The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176oF). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.] 271-418-068555-24-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-127-00-6Phenols, C9-11; Distillate Phenols293-435-291079-47-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-128-00-1 Tar acids, cresylic; Distillate Phenols; [A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). It contains chiefly phenols and pyridine bases.] 295-540-992062-26-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-129-00-7 Tar acids, brown-coal, C2-alkylphenol fraction; Distillate Phenols; [The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). Composed primarily of m-and p-ethylphenol as well as cresols and xylenols.] 302-662-994114-29-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-130-00-2 Extract oils (coal), naphthalene oils; Acid Extract; [The aqueous extract produced by an acidic wash of alkali- washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]

292-623-190641-00-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-131-00-8Tar bases, quinoline derivs.; Distillate Bases271-020-768513-87-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-132-00-3 Tar bases, coal, quinoline derivs. fraction; Distillate Bases 274-560-170321-67-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-133-00-9 Tar bases, coal, distn. residues; Distillate Bases; [The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of oal tars. I contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] 295-544-092062-29-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-134-00-4 Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of a polyethylene/ polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).] 309-745-9100801-63-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-135-00-X Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158oF to 248oF).] 309-748-5100801-65-8Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM 648-136-00-5 Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction; Heat Treatment Products; [The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410oF).] 309-749-0100801-66-9Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-137-00-0 Extract residues (coal), tar oil alk., naphthalene distn. residues; Naphthalene Oil Extract Residue; [The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] 277-567-873665-18-6Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-138-00-6 Creosote oil, low-boiling distillate; Wash Oil; [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).] 274-566-470321-80-1Carc. 1BH350 GHS08 Dgr H350M 648-139-00-1Tar acids, cresylic, sodium salts, caustic solns.; Alkaline Extract272-361-468815-21-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr

H350 H340 JM648-140-00-7 Extract oils (coal), tar base; Acid Extract; [The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] 266-020-965996-86-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-141-00-2 Tar bases, coal, crude; Crude Tar Bases; [The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] 266-018-865996-84-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 JM648-142-00-8 Residues (coal), liq. solvent extn.; [A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] 302-681-294114-46-2Carc. 1BH350 GHS08 Dgr H350M 648-143-00-3 Coal liquids, liq. solvent extn. soln.; [The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] 302-682-894114-47-3Carc. 1BH350 GHS08 Dgr H350M648-144-00-9Coal liquids, liq. solvent extn.; [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]302-683-394114-48-4Carc. 1BH350 GHS08 Dgr H350M648-145-00-4 Tar brown-coal; [An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one-to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one-and two-ring phenols boiling in the range of approximately 150oC to 360 oC (302oF to 680oF).] 309-885-0101316-83-0Carc. 1AH350 GHS08 Dgr H350 648-146-00-X Tar, brown-coal, low-temp.; [A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] 309-886-6101316-84-1Carc. 1AH350 GHS08 Dgr H350648-147-00-5 Light oil (coal), coke-oven; Crude benzole; [The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]

266-012-565996-78-3Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-148-00-0 Distillates (coal), liq. solvent extn., primary; [The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC 86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] 302-688-094114-52-0Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-149-00-6 Distillates (coal), solvent extn., hydrocracked; [Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 300o C (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-689-694114-53-1Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-150-00-1 Naphtha (coal), solvent extn., hydrocracked; [Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86oF to 356oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-690-194114-54-2Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-151-00-7 Gasoline, coal solvent extn., hydrocracked naphtha; [Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] 302-691-794114-55-3Carc. 1BH350 GHS08 Dgr H350648-152-00-2 Distillates (coal), solvent extn., hydrocracked middle; [Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 o C to 300 oC (356oF to 572oF. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]

302-692-294114-56-4Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J648-153-00-8 Distillates (coal), solvent extn., hydrocracked hydrogenated middle; [Distillate from the hydroge nation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 F to 536oF). Composed primarily of hydrogenated two-ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] 302-693-894114-57-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J 648-154-00-3 Fuels, jet aircraft, coal solvent extn.,hydrocracked hydro genated; [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180oC to 225oC (356oF to 473oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-394114-58-6Carc. 2H351 GHS08 Wng H350648-155-00-9Fuels, diesel, coal solvent extn., hydrocracked hydrogenated; [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200oC to 280oC (392oF to 536oF). Composed primarily of hydrogenated two-ring hydrocarbons andtheir alkylderivatives having carbon numbers predominantly in the range of C11 through C14.]302-695-994114-59-7Carc. 2H351 GHS08 Wng H350648-156-00-4Light oil (coal), semi-coking process; Fresh oil; [The volatile organic liquid condensed from the gasevolved in the low-temperature (less than 700 oC (1292oF)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]292-635-790641-11-5Carc. 1B Muta. 1B H350 H340 GHS08 Dgr H350 H340 J649-001-00-3Extracts (petroleum), light naphthenic distillate solvent265-102-164742-03-6Carc. 1BH350 GHS08 Dgr H350 649-002-00-9Extracts (petroleum), heavy paraffinic distillate solvent265-103-764742-04-7Carc. 1BH350 GHS08 Dgr H350649-003-00-4Extracts (petroleum), light paraffinic distillate solvent265-104-264742-05-8Carc. 1BH350 GHS08 Dgr H350649-004-00-XExtracts (petroleum), heavy naphthenic distillate solvent265-111-064742-11-6Carc. 1BH350 GHS08 Dgr H350649-005-00-5Extracts (petroleum), light vacuum gas oil solvent295-341-791995-78-7Carc. 1BH350 GHS08 Dgr H350649-006-00-0hydrocarbons C26-55, arom-rich307-753-797722-04-8Carc. 1BH350 GHS08 Dgr H350649-007-00-6fatty acids, tall-oil, reaction products with iminodiethanol and boric acid400-160-5— Skin Irrit. 2 Aquatic Chronic 2 H315 H411 GHS07 GHS09 Wng H315 H411 649-008-00-1 Residues (petroleum), atm. tower; Heavy Fuel oil; [A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approxi mately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]

265-045-264741-45-3Carc. 1BH350 GHS08 Dgr H350 649-009-00-7 Gas oils (petroleum), heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-058-364741-57-7Carc. 1BH350 GHS08 Dgr H350649-010-00-2 Distillates (petroleum), heavy catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260oC to 500oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-063-064741-61-3Carc. 1BH350 GHS08 Dgr H350 649-011-00-8 Clarified oils (petroleum), catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350oC (662oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-064-664741-62-4Carc. 1BH350 GHS08 Dgr H350649-012-00-3 Residues (petroleum), hydrocracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approxi mately 350oC (662 oF).] 265-076-164741-75-9Carc. 1BH350 GHS08 Dgr H350649-013-00-9 Residues (petroleum), thermal cracked; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-081-964741-80-6Carc. 1BH350 GHS08 Dgr H350 649-014-00-4 Distillates (petroleum), heavy thermal cracked; Heavy Fuel oil; [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-082-464741-81-7Carc. 1BH350

GHS08 Dgr H350649-015-00-X Gas oils (petroleum), hydro-treated vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230oC to 600oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-162-964742-59-2Carc. 1BH350 GHS08 Dgr H350 649-016-00-5 Residues (petroleum), hydrodesulfurized atmospheric tower; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-181-264742-78-5Carc. 1BH350 GHS08 Dgr H350649-017-00-0Gas oils (petroleum), hydrodesulfurized heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]265-189-664742-86-5Carc. 1BH350 GHS08 Dgr H350649-018-00-6 Residues (petroleum), steam-cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-memberedcondensed ring aromatic hydrocarbons.] 265-193-864742-90-1Carc. 1BH350 GHS08 Dgr H350 649-019-00-1 Residues (petroleum), atmospheric; Heavy Fuel oil; [A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approxi mately 200oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-777-368333-22-2Carc. 1BH350 GHS08 Dgr H350649-020-00-7 Clarified oils (petroleum), hydrodesulfurized catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]

269-782-068333-26-6Carc. 1BH350 GHS08 Dgr H350 649-021-00-2 Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 269-783-668333-27-7Carc. 1BH350 GHS08 Dgr H350649-022-00-8 Distillates (petroleum), hydrodesulfurized heavy catalytic cracked; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260oC to 500 oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-784-168333-28-8Carc. 1BH350 GHS08 Dgr H350649-023-00-3 Fuel oil, residues-straight-run gas oils, high-sulfur; Heavy Fuel oil 270-674-068476-32-4Carc. 1BH350 HS08 Dgr H350 649-024-00-9 Fuel oil, residual; Heavy Fuel oil; [The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] 270-675-668476-33-5Carc. 1BH350 GHS08 Dgr H350649-025-00-4 Residues (petroleum), catalytic reformer fractionator residue distn.; Heavy Fuel oil; [A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399oC (750oF).] 270-792-268478-13-7Carc. 1BH350 GHS08 Dgr H350649-026-00-X Residues,(petroleum), heavy coker gas oil and vacuum gas oil; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predomi nantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-796-468478-17-1Carc. 1BH350 GHS08 Dgr H350649-027-00-5 Residues (petroleum), heavy coker and light vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-983-068512-61-8Carc. 1BH350 GHS08 Dgr H350 649-028-00-0 Residues(petroleum), light vacuum; Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]

270-984-668512-62-9Carc. 1BH350 GHS08 Dgr H350649-029-00-6 Residues (petroleum), steam-cracked light; Heavy Fuel oil; [A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101oC to 555 oC (214 oF to 1030oF).] 271-013-968513-69-9Carc. 1BH350 GHS08 Dgr H350649-030-00-1 Fuel oil, No 6; Heavy Fuel oil; [A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).] 271-384-768553-00-4Carc. 1BH350 GHS08 Dgr H350649-031-00-7 Residues (petroleum), topping plant, low-sulfur; Heavy Fuel oil; [A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] 271-763-768607-30-7Carc. 1BH350 GHS08 Dgr H350 649-032-00-2 Gas oils (petroleum), heavy atmospheric; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121oC to 510 oC (250 oF to 950oF).] 272-184-268783-08-4Carc. 1BH350 GHS08 Dgr H350649-033-00-8Residues(petroleum), coker scrubber, Condensed-ring-arom.-contg.; Heavy Fuel oil; [A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed rind aromatic hydrocarbons.]272-187-968783-13-1Carc. 1BH350 GHS08 Dgr H350649-034-00-3 Distillates (petroleum), petroleum residues vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] 273-263-468955-27-1Carc. 1BH350 GHS08 Dgr H350649-035-00-9 Residues (petroleum), steam-cracked, resinous; Heavy Fuel oil; [A complex residuum from the distillation of steam-cracked petroleum residues.] 273-272-368955-36-2Carc. 1BH350 GHS08 Dgr H350 649-036-00-4 Distillates (petroleum), intermediate vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250oC to 545oC (482oF to 1013oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 274-683-070592-76-6Carc. 1BH350 GHS08 Dgr H350649-037-00-X Distillates (petroleum), light vacuum;

Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545oC (482oF to 1013 oF).] 274-684-670592-77-7Carc. 1BH350 GHS08 Dgr H350649-038-00-5 Distillates (petroleum), vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 274-685-170592-78-8Carc. 1BH350 GHS08 Dgr H350 649-039-00-0 Gas oils (petroleum), hydrodesulfurized coker heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304oC to 548oC (579oF to 1018oF). Likely to contain 5 % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 285-555-985117-03-9Carc. 1BH350 GHS08 Dgr H350649-040-00-6 Residues (petroleum), steam-cracked, distillates; Heavy Fuel oil; [A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] 292-657-790669-75-3Carc. 1BH350 GHS08 Dgr H350649-041-00-1 Residues (petroleum), vacuum, light; Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).] 292-658-290669-76-4Carc. 1BH350 GHS08 Dgr H350 649-042-00-7 Fuel oil, heavy, high-sulfur; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 295-396-792045-14-2Carc. 1BH350 GHS08 Dgr H350649-043-00-2 Residues (petroleum), catalytic cracking; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200oC (392oF).] 295-511-092061-97-7Carc. 1BH350 GHS08 Dgr H350649-044-00-8 Distillates (petroleum), intermediate catalytic cracked, thermally degraded; Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 C (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.] 295-990-692201-59-7Carc. 1BH350 GHS08 Dgr H350 649-045-00-3 Residual oils (petroleum); Heavy Fuel oil; [A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] 298-754-093821-66-0Carc. 1BH350 GHS08 Dgr H350649-046-00-9 Residues, steam cracked, thermally treated; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180oC (356oF).] 308-733-098219-64-8Carc. 1BH350 GHS08 Dgr H350649-047-00-4 Distillates (petroleum), hydrodesulfurized full-range middle; Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150oC to 400oC (302 oF to 752 oF).] 309-863-0101316-57-8Carc. 1BH350 GHS08 Dgr H350 649-048-00-X Residues (petroleum), catalytic reformer fractionator; Heavy Fuel oil; [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4-or 6-membered condensed ring aromatic hydrocarbons.] 265-069-364741-67-9Carc. 1BH350 GHS08 Dgr H350649-049-00-5 Petroleum; Crude oil; [A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-58002-05-9Carc. 1BH350 GHS08 Dgr H350 649-050-00-0 Distillates (petroleum), light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]

265-051-564741-50-0Carc. 1AH350 GHS08 Dgr H350649-051-00-6 Distillates(petroleum), heavy paraffinic; Unrefined ormildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] 265-052-064741-51-1Carc. 1AH350 GHS08 Dgr H350649-052-00-1 Distillates (petroleum), light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-053-664741-52-2Carc. 1AH350 GHS08 Dgr H350 649-053-00-7 Distillates (petroleum), heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-054-164741-53-3Carc. 1AH350 GHS08 Dgr H350649-054-00-2 Distillates (petroleum), acid-treated heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-117-364742-18-3Carc. 1AH350 GHS08 Dgr H350649-055-00-8 Distillates (petroleum), acid-treated light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-118-964742-19-4Carc. 1AH350 GHS08 Dgr H350 649-056-00-3 Distillates (petroleum), acid-treated heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons btained as a raffinate from a sulfuric acid process. It consists predomi nantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100oF (19cSt at 40 oC).] 265-119-464742-20-7Carc. 1AH350

GHS08 Dgr H350649-057-00-9 Distillates (petroleum), acid-treated light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oi having aviscosity of less than 100 SUS at 100 oF (19cSt at 40oC).] 265-121-564742-21-8Carc. 1AH350 GHS08 Dgr H350649-058-00-4 Distillates (petroleum), chemically neutralized heavy paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons obtained from a treating proces to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] 265-127-864742-27-4Carc. 1AH350 GHS08 Dgr H350 649-059-00-X Distillates (petroleum), chemically neutralized light paraffinic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-128-364742-28-5Carc. 1AH350 GHS08 Dgr H350649-060-00-5 Distillates (petroleum), chemically neutralized heavy naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-135-164742-34-3Carc. 1AH350 GHS08 Dgr H350649-061-00-0 Distillates (petroleum), chemically neutralized light naphthenic; Unrefined or mildly refined baseoil; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-136-764742-35-4Carc. 1AH350 GHS08 Dgr H350 649-062-00-6 Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] 270-755-068477-73-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-063-00-1 Gases (petroleum), catalytic cracker; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]

270-756-668477-74-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-064-00-7 Gases (petroleum), catalytic cracker, C1-5-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydro carbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] 270-757-168477-75-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-065-00-2 Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] 270-758-768477-76-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-066-00-8 Gases (petroleum), catalytic reformer, C1-4-rich; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] 270-760-868477-79-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-067-00-3 Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed; Petroleum gas; [A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] 270-765-568477-83-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-068-00-9 Gases (petroleum), C4-rich; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-767-668477-85-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-069-00-4 Gases (petroleum), deethanizer overheads; Petroleum gas; [A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] 270-768-168477-86-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-070-00-X Gasespetroleum),deisobutanizer tower overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C3 through C4.] 270-769-768477-87-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340

GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-071-00-5 Gases (petroleum), depropanizer dry, propene-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene withsome ethane and propane.] 270-772-368477-90-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-072-00-0 Gases (petroleum), depropanizer overheads; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-773-968477-91-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-073-00-6 Gases (petroleum), gas recovery plant depropanizer overheads; Petroleum gas; [A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] 270-777-068477-94-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-074-00-1 Gases (petroleum), Girbotol unit feed; Petroleum gas; [A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C2 through C4.] 270-778-668477-95-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-075-00-7 Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free; Petroleum gas 270-782-868477-99-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-076-00-2 Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-802-568478-21-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-077-00-8 Tail gas (petroleum), catalytic cracked naphtha stabilization absorber; Petroleum gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-803-068478-22-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-078-00-3 Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater; Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.] 270-804-668478-24-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-079-00-9 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-806-768478-26-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-080-00-4 Tail gas (petroleum), saturate gas plant mixed stream, C4-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] 270-813-568478-32-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-081-00-X Tail gas (petroleum), saturate gas recovery plant, C1-2-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, Predominantly methane and ethane.] 270-814-068478-33-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-082-00-5 Tail gas (petroleum), vacuum residues thermal cracker; Petroleum gas; [A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-815-668478-34-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-083-00-0 Hydrocarbons, C3-4-rich, petroleum distillate; Petroleum gas; [A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] 270-990-968512-91-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-084-00-6Gases (petroleum), full-range straight-run naphtha dehexanizer off; petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]271-000-868513-15-5 Press. Gas Flam. Gas 1

Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-085-00-1 Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich; Petroleum gas; [A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] 271-001-368513-16-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-086-00-7 Gases (petroleum), light straight-run naphtha stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-002-968513-17-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-087-00-2 Residues (petroleum), alkylation splitter, C4-rich; Petroleum gas; [A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 o C to 27.8 o C (11 oF to 82 oF).] 271-010-268513-66-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-088-00-8 Hydrocarbons, C1-4; Petroleum gas; [A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus164 o C to minus 0.5 o C (– 263 oF to 31 oF).] 271-032-268514-31-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-089-00-3 Hydrocarbons, C1-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtaine by subjectin hydrocarbon gases to a sweetening process to convert mercaptans o to remove acidc impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164o C to - 0.5 oC (– 263 oF to 31 oF).] 271-038-568514-36-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-090-00-9 Hydrocarbons, C1-3; Petroleum gas; [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approxi mately minus 164 o C to minus 42 oC (– 263 oF to - 44 oF).] 271-259-768527-16-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-091-00-4 Hydrocarbons, C1-4, debutanizer fraction; Petroleum gas 271-261-868527-19-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-092-00-X

Gases (petroleum), C1-5, wet; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 271-624-068602-83-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-093-00-5Hydrocarbons, C2-4; Petroleum gas271-734-968606-25-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-094-00-0Hydrocarbons, C3; Petroleum gas271-735-468606-26-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-095-00-6 Gases (petroleum), alkylation feed; Petroleum gas; [A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 271-737-568606-27-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-096-00-1 Gases (petroleum), depropanizer bottoms fractionation off; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] 271-742-268606-34-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-097-00-7 Gases (petroleum), refinery blend; Petroleum gas; [A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-183-768783-07-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-098-00-2 Gases (petroleum), catalytic cracking; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 272-203-468783-64-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-099-00-8 Gases (petroleum), C2-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (– 60oF to - 30oF).] 272-205-568783-65-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-100-00-1 Gases (petroleum), crude oil fractionation off; Petroleum gas; [A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]

272-871-768918-99-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-101-00-7 Gases (petroleum), dehexanizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the Fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-872-268919-00-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-102-00-2 Gases (petroleum), light straight run gasoline fractionation stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-878-568919-05-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-103-00-8 Gases (petroleum), naphtha unifiner desulfurization stripper off; Petroleum gas; [A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-879-068919-06-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-104-00-3 Gases (petroleum), straight-run naphtha catalytic reforming off; Petroleum gas; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] 272-882-768919-09-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-105-00-9 Gases(petroleum), fluidized catalytic cracker splitter overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.] 272-893-768919-20-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-106-00-4 Gases (petroleum), straight-run stabilizer off; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-883-268919-10-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-107-00-X Gases (petroleum), catalytic cracked naphtha debutanizer; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-169-368952-76-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350

H340 K U 649-108-00-5 Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-170-968952-77-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-109-00-0 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber; petroleum gas; [A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-668952-81-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-110-00-6 Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-176-168952-82-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-111-00-1 Gases (petroleum, light steam-cracked, butadiene conc.; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.] 273-265-568955-28-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-112-00-7 Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead; Petroleum gas; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the frac tionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 273-270-268955-34-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-113-00-2Hydrocarbons, C4; Petroleum gas289-339-587741-01-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-114-00-8Alkanes, C1-4, C3-rich; Petroleum gas292-456-490622-55-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-115-00-3 Gases (petroleum), steam-cracker C3-rich; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (– 94oF to 32oF).] 295-404-992045-22-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220

H350 H340 K U649-116-00-9 Hydrocarbons, C4, steam-cracker distillate; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 o C to 5 o C (10.4 oF to 41oF).] 295-405-492045-23-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-117-00-4 Petroleum gases, liquefied, sweetened, C4 fraction; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] 295-463-092045-80-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K S U649-118-00-XHydrocarbons, C4, 1,3-butadiene-and isobutene-free; Petroleum gas306-004-195465-89-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-119-00-5Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free; Petroleum gas307-769-497722-19-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-120-00-0 Gases (petroleum), amine system feed; Refinery gas; [The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.] 270-746-168477-65-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-121-00-6 Gases (petroleum), benzene unit hydrodesulfurizer off; Refinery gas; [Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] 270-747-768477-66-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-122-00-1 Gases (petroleum), benzene unit recycle, hydrogen-rich; Refinery gas; [A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydro carbons having carbon numbers in the range of C1 through C6.] 270-748-268477-67-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-123-00-7 Gases (petroleum), blend oil, hydrogen-nitrogen-rich; Refinery gas; [A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]

270-749-868477-68-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-124-00-2 Gases (petroleum), catalytic reformed naphtha stripper overheads; Refinery gas; [A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-759-268477-77-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-125-00-8 Gases (petroleum), C6-8 catalytic reformer recycle; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-761-368477-80-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-126-00-3 Gases (petroleum), C6-8 catalytic reformer; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] 270-762-968477-81-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-127-00-9Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich; Refinery gas270-763-468477-82-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-128-00-4 Gases (petroleum), C2-return stream; Refinery gas; [A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydroge with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contain predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] 270-766-068477-84-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-129-00-X Gases (petroleum), dry sour, gas-concn.-unit-off; Refinery gas; [The complex combination of dry gase from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-774-468477-92-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-130-00-5 Gases (petroleum), gas concn. reabsorber distn.; Refinery gas; [A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]

270-776-568477-93-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-131-00-0 Gases (petroleum), hydrogen absorber off; Refinery gas; [A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] 270-779-168477-96-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-132-00-6 Gases (petroleum), hydrogen-rich; Refinery gas; [A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] 270-780-768477-97-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-133-00-1 Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich; Refinery gas; [A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-781-268477-98-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-134-00-7 Gases (petroleum), recycle, hydrogen-rich; Refinery gas; [A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 270-783-368478-00-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-135-00-2 Gases (petroleum), reformer make-up, hydrogen-rich; Refinery gas; [Acomplex combination obtained from the reformers. It consists primarily of hydrogen with variou smal amount of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-784-968478-01-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-136-00-8 Gases (petroleum), reforming hydrotreater; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 270-785-468478-02-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-137-00-3 Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich; Refinery gas; [A complex combination obtained fromthe reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]

270-787-568478-03-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-138-00-9 Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich; Refinery gas; [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-788-068478-04-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-139-00-4 Gases (petroleum), thermal cracking distn.; Refinery gas; [A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-789-668478-05-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-140-00-X Tail gas (petroleum), catalytic cracker refractionation absorber; Refinery gas; [A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-168478-25-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-141-00-5 Tail gas (petroleum), catalytic reformed naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-807-268478-27-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-142-00-0 Tail gas (petroleum), catalytic reformed naphtha stabilizer; Refinery gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-808-868478-28-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-143-00-6Tail gas (petroleum), cracked distillate hydrotreater separator; Refinery gas; [A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]270-809-368478-29-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-144-00-1 Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]

270-810-968478-30-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-145-00-7 Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads; Refinery gas; [A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] 270-999-868513-14-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-146-00-2 Gases (petroleum), reformer effluent high-pressure flash drum off; Refinery gas; [A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-003-468513-18-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-147-00-8 Gases (petroleum), reformer effluent low-pressure flash drum off; Refinery gas; [A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-005-568513-19-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-148-00-3 Gases (petroleum), oil refinery gas distn. off; Refinery gas; [A complex combination separatedby distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] 271-258-168527-15-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-149-00-9 Gases (petroleum), benzene unit hydrotreater depentanizer overheads; Refinery gas; [A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] 271-623-568602-82-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-150-00-4 Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator; Refinery gas; [A complex combination produced by the fractionation of the overhead products from the catalyticcracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 271-625-668602-84-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04

GHS02 GHS08 Dgr H220 H350 H340 K U649-151-00-X Petroleum products, refinery gases; Refinery gas; [A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-750-668607-11-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-152-00-5 Gases (petroleum), hydrocracking low-pressure separator; Refinery gas; [A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-182-168783-06-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-153-00-0 Gases (petroleum), refinery; Refinery gas; [A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-338-968814-67-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-154-00-6 Gases (petroleum), platformer products separator off; Refinery gas; [A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 272-343-668814-90-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-155-00-1 Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off; Refinery gas; [The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] 272-775-568911-58-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-156-00-7 Gases (petroleum), hydrotreated sour kerosine flash drum; Refinery gas; [A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] 272-776-068911-59-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-157-00-2 Gases (petroleum), distillate unifiner desulfurization stripper off; Refinery gas; [A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] 272-873-868919-01-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-158-00-8 Gases (petroleum), fluidized catalytic cracker fractionation off;

Refinery gas; [A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-874-368919-02-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-159-00-3 Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off; Refinery gas; [A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] 272-875-968919-03-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-160-00-9 Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off; Refinery gas; [A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-876-468919-04-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-161-00-4 Gases (petroleum), platformer stabilizer off, light ends fractionation; Refinery gas; [A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.] 272-880-668919-07-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-162-00-X Gases (petroleum), preflash tower off, crude distn.; Refinery gas; [A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-881-168919-08-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-163-00-5 Gases (petroleum), tar stripper off; Refinery gas; [A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-884-868919-11-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-164-00-0 Gases (petroleum), unifiner stripper off; Refinery gas; [A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] 272-885-368919-12-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-165-00-6 Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator; Refinery gas; [A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] 273-173-568952-79-4 Press. Gas

Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-166-00-1 Tail gas (petroleum), straight-run naphtha hydrodesulfurizer; Refinery gas; [A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 273-174-068952-80-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-167-00-7 Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation; Refinery gas; [A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-269-768955-33-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-168-00-2 Gases (petroleum), crude distn. and catalytic cracking; Refinery gas; [A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-568989-88-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-169-00-8 Gases (petroleum), gas oil diethanolamine scrubber off; Refinery gas; [A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 295-397-292045-15-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-170-00-3 Gases (petroleum), gas oil hydrodesulfurization effluent; Refinery gas; [A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydro carbons having carbon numbers predominantly in the range of C1 through C3.] 295-398-892045-16-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-171-00-9 Gases (petroleum), gas oil hydrodesulfurization purge; Refinery gas; [A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 295-399-392045-17-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-172-00-4 Gases (petroleum), hydrogenator effluent flash drum off; Refinery gas; [A complex combination of gases obtained from flash of the effluents after the hydroge nation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]

295-400-792045-18-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-173-00-X Gases (petroleum), naphtha steam cracking high-pressure residual; Refinery gas; [A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] 295-401-292045-19-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-174-00-5 Gases (petroleum), residue visbaking off; Refinery gas; [A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 295-402-892045-20-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-175-00-0 Foots oil (petroleum), acid-treated; Foots oil; [A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-225-793924-31-3 Flam. Gas 1 Press. Gas Carc. 1B H220 H350 H340 GHS02 GHS04 GHS08 Dgr H220 H350 H340 K U 649-176-00-6 Foots oil (petroleum), clay-treated; Foots oil; [A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predomi nantly of branched chain hydro carbons with carbon numbers predominantly in the range of C20 through C50.] 300-226-293924-32-4 Flam. Gas 1 Press. Gas Carc. 1B H220 H350 H340 GHS02 GHS04 GHS08 Dgr H220 H350 H340 K U649-177-00-1Gases (petroleum), C3-4; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (– 60 oF to 30 oF.)]268-629-568131-75-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-178-00-7 Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber; Petroleum gas; [The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-617-268307-98-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08

Dgr H220 H350 H340 K U 649-179-00-2 Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-618-868307-99-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-180-00-8 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-619-368308-00-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-181-00-3 Tail gas (petroleum), cracked distillate hydrotreater stripper; Petroleum gas; [A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-620-968308-01-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-182-00-9 Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-630-368308-10-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-183-00-4 Tail gas (petroleum), gas oil catalytic cracking absorber; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-623-568308-03-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-184-00-X Tail gas (petroleum), gas recovery plant; Petroleum gas; [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-624-068308-04-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-185-00-5 Tail gas (petroleum), gas recovery plant deethanizer; Petroleum gas; [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]

269-625-668308-05-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-186-00-0 Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of hydrodesul furized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-626-168308-06-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-187-00-6 Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-627-768308-07-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-188-00-1 Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-629-868308-09-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-189-00-7 Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-631-968308-11-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-190-00-2 Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-632-468308-12-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-191-00-8 Gases (petroleum), catalytic cracked overheads; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately –48 oC to 32 oC (– 54 oF to 90oF).]

270-071-268409-99-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-193-00-9Alkanes, C1-2; Petroleum gas270-651-568475-57-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-194-00-4Alkanes, C2-3; Petroleum gas270-652-068475-58-1 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-195-00-X Alkanes, C3-4; petroleum gas 270-653-668475-59-2 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-196-00-5Alkanes, C4-5; Petroleum gas270-654-168475-60-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-197-00-0 Fuel gases; Petroleum gas; [A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] 270-667-268476-26-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-198-00-6 Fuel gases, crude oil of distillates; Petroleum gas; [A complex combination of light gases produced by distil lation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217o C to - 12 o C (– 423 oF to 10 oF).] 270-670-968476-29-9 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-199-00-1Hydrocarbons, C3-4; Petroleum gas270-681-968476-40-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-200-00-5Hydrocarbons, C4-5; Petroleum gas270-682-468476-42-6 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-201-00-0Hydrocarbons, C2-4, C3-rich; Petroleum gas270-689-268476-49-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-202-00-6 Petroleum gases, liquefied; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 oC to 80 oC (– 40oF to 176oF).] 270-704-268476-85-7 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K S U649-203-00-1 Petroleum gases, liquefied, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately–40 o C to 80 o C (– 40 oF to176 oF).] 270-705-868476-86-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K S U 649-204-00-7 Gases (petroleum), C3-4, isobutane-rich;

Petroleum gas; [A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] 270-724-168477-33-8 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-205-00-2 Distillates (petroleum), C3-6, piperylene-rich; Petroleum gas; [A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] 270-726-268477-35-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-206-00-8 Gases (petroleum), butane splitter overheads; Petroleum gas; [A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-750-368477-69-0 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-207-00-3 Gases (petroleum), C2-3-; Petroleum gas; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] 270-751-968477-70-3 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-208-00-9 Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free; Petroleum gas; [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-752-468477-71-4 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-209-00-4 Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich; Petroleum gas; [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 270-754-568477-72-5 Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U 649-210-00-X Tail gas (petroleum), isomerized naphtha fractionation stabilizer; Petroleum gas; [A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-628-268308-08-7 Press. Gas Flam. Gas 1

Carc. 1A Muta. 1B H220 H350 H340 GHS04 GHS02 GHS08 Dgr H220 H350 H340 K U649-211-00-5 Foots oil (petroleum), carbon-treated; Foots oil; [A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-126-097862-76-5Carc. 1BH350 GHS08 Dgr H350L649-212-00-0 Distillates (petroleum), sweetened middle; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302 o F to 653oF).] 265-088-764741-86-2Carc. 1BH350 GHS08 Dgr H350N 649-213-00-6 Gas oils (petroleum), solvent-refined; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401oF to 752oF).] 265-092-964741-90-8Carc. 1BH350 GHS08 Dgr H350N649-214-00-1 Distillates (petroleum), solvent-refined middle; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302oF to 653 oF).] 265-093-464741-91-9Carc. 1BH350 GHS08 Dgr H350N649-215-00-7 Gas oils (petroleum), acid-treated; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230oC to 400oC (446oF to 752 oF).] 265-112-664742-12-7Carc. 1BH350 GHS08 Dgr H350N 649-216-00-2 Distillates (petroleum), acid-treated middle; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-113-164742-13-8Carc. 1BH350 GHS08 Dgr H350N649-217-00-8 Distillates (petroleum), acid-treated light; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150oC to 290oC (302oF to 554oF).] 265-114-764742-14-9Carc. 1BH350 GHS08 Dgr H350N649-218-00-3 Gas oils (petroleum), chemically neutralized;

Gasoil — unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446oF to 752 oF).] 265-129-964742-29-6Carc. 1BH350 GHS08 Dgr H350N 649-219-00-9 Distillates (petroleum), chemically neutralized middle; Gasoil — unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205oC to 345oC (401oF to 653oF).] 265-130-464742-30-9Carc. 1BH350 GHS08 Dgr H350N649-220-00-4 Distillates (petroleum), clay-treated middle; Gasoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302oF to 653oF).] 265-139-364742-38-7Carc. 1BH350 GHS08 Dgr H350N649-221-00-X Distillates (petroleum), hydrotreated middle; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401 oF to 752 oF).] 265-148-264742-46-7Carc. 1BH350 GHS08 Dgr H350N 649-222-00-5 Gas oils (petroleum), hydrodesulfurized; Gasoil — unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230oC to 400oC (446oF to 752 oF).] 265-182-864742-79-6Carc. 1BH350 GHS08 Dgr H350N649-223-00-0 Distillates (petroleum), hydrodesulfurized middle; Gasoil — unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401oF to 752oF).] 265-183-364742-80-9Carc. 1BH350 GHS08 Dgr H350N649-224-00-6 Fuels, diesel; Gasoil — unspecified; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163oC to 357oC (325oF to 675oF).] 269-822-768334-30-5Carc. 2H351 GHS08 Wng H351N 649-225-00-1

Fuel oil, No 2; Gasoil — unspecified; [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7oC (100oF) to a maximum of 37,9 SUS at 37,7oC (100 oF).] 270-671-468476-30-2Carc. 2H351 GHS08 Wng H351649-226-00-7 Fuel oil, No 4; Gasoil — unspecified; [A distillate oil having a minimum viscosity of 45 SUS at 37,7oC (100oF) to a maximum of 125 SUS at 37,7 oC (100 oF).] 270-673-568476-31-3Carc. 2H351 GHS08 Wng H351649-227-00-2 Fuels, diesel, No 2; Gasoil — unspecified; [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).] 270-676-168476-34-6Carc. 2H351 GHS08 Wng H351649-228-00-8 Distillates (petroleum), catalytic reformer fractionator residue, high-boiling; Gasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 99oC (650oF to 750 oF).] 270-719-468477-29-2Carc. 1BH350 GHS08 Dgr H350N649-229-00-3 Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling; Gasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288oC to 371oC (550oF to 700oF).] 270-721-568477-30-5Carc. 1BH350 GHS08 Dgr H350N 649-230-00-9 Distillates (petroleum), catalytic reformer fractionator residue, low-boiling; Gasoil — unspecified; [The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550oF).] 270-722-068477-31-6Carc. 1BH350 GHS08 Dgr H350N649-231-00-4 Distillates (petroleum), highly refined middle; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] 292-615-890640-93-0Carc. 1BH350 GHS08 Dgr H350N649-232-00-XDistillates (petroleum) catalytic reformer, heavy arom. conc.; Gasoil — unspecified; [A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200oC to 300oC (392 oF to 572 oF).]295-294-291995-34-5Carc. 1BH350 GHS08 Dgr H350N 649-233-00-5 Gas oils, paraffinic; Gasoil — unspecified; [A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190oC to 330oC (374oF to 594oF).] 300-227-893924-33-5Carc. 1BH350 GHS08 Dgr H350N649-234-00-0 Naphtha (petroleum), solvent-refined hydrodesulfurized heavy; Gasoil — unspecified

307-035-397488-96-5Carc. 1BH350 GHS08 Dgr H350N649-235-00-6 Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-659-697675-85-9Carc. 1BH350 GHS08 Dgr H350N 649-236-00-1 Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights; Gasoil — unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluent from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having viscosity of 2cSt at 100oC (212oF).] 307-660-197675-86-0Carc. 1BH350 GHS08 Dgr H350N649-237-00-7 Hydrocarbons, C11-17, solvent-extd. light naphthenic; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200oC to 300oC (392oF to 572 oF).] 307-757-997722-08-2Carc. 1BH350 GHS08 Dgr H350N649-238-00-2 Gas oils, hydrotreated; Gasoil — unspecified; [A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330oC to 340oC (626oF to 644oF).] 308-128-197862-78-7Carc. 1BH350 GHS08 Dgr H350N 649-239-00-8 Distillates (petroleum), carbon-treated light paraffinic; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impur ities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] 309-667-5100683-97-4Carc. 1BH350 GHS08 Dgr H350N649-240-00-3 Distillates (petroleum), intermediate paraffinic, carbon-treated; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar consti tuents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-668-0100683-98-5Carc. 1BH350

GHS08 Dgr H350N649-241-00-9Distillates (petroleum), intermediate paraffinic, clay-treated; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]309-669-6100683-99-6Carc. 1BH350 GHS08 Dgr H350N649-242-00-4Alkanes, C12-26-branched and linear292-454-390622-53-0Carc. 1BH350 GHS08 Dgr H350N 649-243-00-X Lubricating greases; Grease; [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] 278-011-774869-21-9Carc. 1BH350 GHS08 Dgr H350N649-244-00-5 Slack wax (petroleum); Slack wax; [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 265-165-564742-61-6Carc. 1BH350 GHS08 Dgr H350N649-245-00-0 Slack wax (petroleum), acid-treated; Slack wax; [A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 292-659-890669-77-5Carc. 1BH350 GHS08 Dgr H350N649-246-00-6 Slack wax (petroleum), clay-treated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predomi nantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] 292-660-390669-78-6Carc. 1BH350 GHS08 Dgr H350N 649-247-00-1 Slack wax (petroleum), hydrotreated; Slack wax; [A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 295-523-692062-09-4Carc. 1BH350 GHS08 Dgr H350N649-248-00-7 Slack wax (petroleum), low-melting; Slack wax; [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-524-192062-10-7Carc. 1BH350 GHS08 Dgr H350N649-249-00-2 Slack wax (petroleum), low-melting, hydrotreated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predomi nantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]

295-525-792062-11-8Carc. 1BH350 GHS08 Dgr H350N 649-250-00-8 Slack wax (petroleum), low-melting, carbon-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-155-997863-04-2Carc. 1BH350 GHS08 Dgr H350N649-251-00-3 Slack wax (petroleum), low-melting, clay-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impur ities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-156-497863-05-3Carc. 1BH350 GHS08 Dgr H350N649-252-00-9Slack wax (petroleum), low-melting, silicic acid-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]308-158-597863-06-4Carc. 1BH350 GHS08 Dgr H350N 649-253-00-4 Slack wax (petroleum), carbon-treated; Slack wax; [A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] 309-723-9100684-49-9Carc. 1BH350 GHS08 Dgr H350N649-254-00-X Petrolatum; Petrolatum; [A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 232-373-28009-03-8Carc. 1BH350 GHS08 Dgr H350N649-255-00-5 Petrolatum (petroleum), oxidized; Petrolatum; [A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] 265-206-764743-01-7Carc. 1BH350 GHS08 Dgr H350N649-256-00-0 Petrolatum (petroleum), alumina-treated; Petrolatum; [A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 285-098-585029-74-9Carc. 1BH350 GHS08 Dgr H350N 649-257-00-6 Petrolatum (petroleum), hydrotreated; Petrolatum; [A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] 295-459-992045-77-7Carc. 1BH350 GHS08 Dgr H350N649-258-00-1 Petrolatum (petroleum), carbon-treated;

Petrolatum; [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impur ities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-149-697862-97-0Carc. 1BH350 GHS08 Dgr H350N649-259-00-7 Petrolatum (petroleum), silicic acid-treated; Petrolatum; [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-150-197862-98-1Carc. 1BH350 GHS08 Dgr H350N 649-260-00-2 Petrolatum (petroleum), clay-treated; Petrolatum; [A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] 309-706-6100684-33-1Carc. 1BH350 GHS08 Dgr H350N649-261-00-8 Gasoline, natural; Low boiling point naphtha; [A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (– 4oF to 248oF).] 232-349-18006-61-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-262-00-3 Naphtha; Low boiling point naphtha; [Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100o C to 200o C (212oF to 392oF).] 232-443-28030-30-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-263-00-9 Ligroine; Low boiling point naphtha; [A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58oF to 275oF).] 232-453-78032-32-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-264-00-4Naphtha (petroleum), heavy straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149oF to 446oF).]265-041-064741-41-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-265-00-X Naphtha (petroleum), full-range straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (– 4 oF to 428oF).]

265-042-664741-42-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-266-00-5 Naphtha (petroleum), light straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately - 20 oC to 180 oC (– 4oF to 356oF).] 265-046-864741-46-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-267-00-0 Solvent naphtha (petroleum), light aliph.; Low boiling point naphtha; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35o C to 160o C (95oF to 320oF).] 265-192-264742-89-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-268-00-6 Distillates (petroleum), straight-run light; Low boiling point naphtha; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately– 88 oC to 99o C (– 127oF to 210oF).] 270-077-568410-05-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-269-00-1 Gasoline, vapor-recovery; Low boiling point naphtha; [A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (– 4oF to 384oF).] 271-025-468514-15-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-270-00-7 Gasoline, straight-run, topping-plant; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97oF to 380oF).] 271-727-068606-11-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-271-00-2Naphtha (petroleum), unsweetened; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25oF to 446oF).]272-186-368783-12-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-272-00-8 Distillates (petroleum), light straight-run gasoline frac tionation stabilizer overheads; Low boiling point naphtha; [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in he range of C3 through C6.]

272-931-268921-08-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-273-00-3 Naphtha (petroleum), heavy straight run, arom.-contg.; Low boiling point naphtha; [A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266oF to 410oF).] 309-945-6101631-20-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-274-00-9 Naphtha (petroleum), full-range alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194oF to 428oF).] 265-066-764741-64-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-275-00-4 Naphtha (petroleum), heavy alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302oF to 428oF).] 265-067-264741-65-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-276-00-X Naphtha (petroleum), light alkylate; Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 oC to 160 oC (194oF to 320 oF).] 265-068-864741-66-8Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-277-00-5 Naphtha (petroleum), isomerization; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] 265-073-564741-70-4Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-278-00-0 Naphtha (petroleum), solvent-refined light; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approxi mately 35 oC to 190 oC (95oF to 374oF).]

265-086-664741-84-0Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-279-00-6 Naphtha (petroleum), solvent-refined heavy; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194oF to 446oF).] 265-095-564741-92-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-280-00-1 Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] 270-088-568410-71-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-281-00-7 Raffinates (petroleum), reformer, Lurgi unit-sepd.; Low boiling point modified naphtha; [The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] 270-349-368425-35-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-28-00-2 Naphtha (petroleum), full-range alkylate, butane-contg.; Low boiling point modified naphta; [A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).] 271-267-068527-27-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-283-00-8 Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] 295-315-591995-53-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-284-00-3 Naphtha (petroleum),C4-12, butane-alkylate, isooctane-rich; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95oF to 410oF).] 295-430-092045-49-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-285-00-9

Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha; [A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 o C to 99 o C (201 oF to 210 oF).] 295-436-392045-55-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-286-00-4 Naphtha (petroleum), isomerisation, C6-fraction; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalyticall isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140oF to 151oF).] 295-440-592045-58-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-287-00-X Hydrocarbons, C6-7, naphtha-cracking, solvent-refined; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predomi nantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158oF to 212oF).] 295-446-892045-64-2 Carc. 1B muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-288-00-5 Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha; [A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65o C to 70o C (149oF to 158oF).] 309-871-4101316-67-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-289-00-0 Naphtha (petroleum), heavy catalytic cracked; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-055-764741-54-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-290-00-6 Naphtha (petroleum), light catalytic cracked; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 190 oC (– 4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-056-264741-55-5

Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-291-00-1 Hydrocarbons, C3-11, catalytic cracker distillates; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400oF).] 270-686-668476-46-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-292-00-7 Naphtha (petroleum), catalytic cracked light distd.; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-185-868783-09-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-293-00-2 Distillates (petroleum), naphtha steam cracking-derived, hydro-treated light arom.; Low boiling point cat-cracked naphtha.; [A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.] 295-311-391995-50-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-294-00-8 Naphtha (petroleum), heavy catalytic cracked, sweetened; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to200 oC (140oF to 392oF).] 295-431-692045-50-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-295-00-3 Naphtha (petroleum), light catalytic cracked sweetened; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predomi nantly of hydrocarbons boiling in a range of approximately 35 oC to 210 oC (95oF to 410oF).] 295-441-092045-59-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-296-00-9 Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized; Low boiling point cat-cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predomi nantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266oF to 410oF).] 295-794-092128-94-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-297-00-4 Hydrocarbons, C8-12, catalytic cracker distillates; Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approxi mately 140 oC to 210 oC (284oF to 410oF).] 309-974-4101794-97-2 Carc. 1B Muta. 1B A Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-298-00-XHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened; Low boiling point cat-cracked naphtha309-987-5101896-28-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-299-00-5 Naphtha (petroleum), light catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190o C (95oF to 374oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol.% or more benzene.] 265-065-164741-63-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-300-00-9 Naphtha (petroleum), heavy catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194oF to 446oF).] 265-070-964741-68-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-301-00-4 Distillates (petroleum), catalytic reformed depentanizer; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC (–57oF to 145oF).] 270-660-468475-79-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-302-00-X Hydrocarbons, C2-6, C6-8 catalytic reformer; Low boiling point cat-reformed naphtha 270-687-168476-47-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-303-00-5 Residues (petroleum), C6-8 catalytic reformer; Low boiling point cat-reformed naphtha; [A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 270-794-368478-15-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-304-00-0 Naphtha (petroleum), light catalytic reformed, arom.-free; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approxi mately 35o C to 120o C (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]

270-993-568513-03-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-305-00-6 Distillates (petroleum), catalytic reformed straight-run naphtha overheads; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-008-168513-63-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-306-00-1 Petroleum products, hydrofiner-powerformer reformates; Low boiling point cat-reformed naphtha; [The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80oF to 410oF).] 271-058-468514-79-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-307-00-7 Naphtha (petroleum), full-range reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35o C to 230 oC (95oF to 446oF).] 272-895-868919-37-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-308-00-2 Naphtha (petroleum), catalytic reformed; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90oF to 430oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] 273-271-868955-35-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-309-00-8 Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;-Low boiling point cat-reformed naphtha; [A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320oF to 356oF).] 285-509-885116-58-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-310-00-3 Aromatic hydrocarbons, C8, catalytic reforming-derived; Low boiling point cat-reformed naphtha 295-279-091995-18-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-311-00-9 Aromatic hydrocarbons, C7-12, C8-rich; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266oF to 392oF).]

297-401-893571-75-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-312-00-4 Gasoline, C5-11, high-octane stabilised reformed; Low boiling point cat-reformed naphtha; - [A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approxi mately 45 oC to 185 oC (113oF to 365 oF).] 297-458-993572-29-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-313-00-X Hydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248oF to380oF) and C9 and higher aromatic hydrocarbons.] 297-465-793572-35-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-314-00-5 Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction; Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 125 oC (94oF to 257oF), benzene and toluene.] 297-466-293572-36-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-315-00-0 Foots oil (petroleum), silicic acid-treated; Foots oil; [A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-127-697862-77-6Carc. 1B H350 H304 GHS08 Dgr H350 H304 L649-316-00-6 Naphtha (petroleum), light thermal cracked; Low boiling point thermally cracked naphtha; [A complexcombination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately - 10 oC to 130 oC (14oF to 266oF).] 265-075-664741-74-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-317-00-1 Naphtha (petroleum), heavy thermal cracked; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65o C to 220 oC (148oF to 428oF).] 265-085-064741-83-9

Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-318-00-7 Distillates (petroleum), heavy arom.; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] 267-563-467891-79-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-319-00-2 Distillates (petroleum), light arom.; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] 267-565-567891-80-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 HS08 Dgr H350 H340 H304 P649-320-00-8 Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending; Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816o C (1500oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400oF).] 270-344-668425-29-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-321-00-3Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 o C (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]270-658-368475-70-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-322-00-9 Distillates (petroleum), thermal cracked naphtha and gas oil; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approxi mately 33 o C to 60 o C (91 oF to 140 oF).] 271-631-968603-00-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-323-00-4 Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33o C to 184 o C (91oF to 363 oF).] 271-632-468603-01-0 Carc. 1B

Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-324-00-X Distillates (petroleum), thermal cracked naphtha and gas oil, extractive; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predomi nantly isoamylenes such as 2-methyl-1-buteneand 2-methyl-2-butene and boiling in the rangeof approximately 31o C to 40o C (88oF to 104oF).] 271-634-568603-03-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-325-00-5 Distillates (petroleum), light thermal cracked, debutanized arom.; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] 273-266-068955-29-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-326-00-0 Naphtha (petroleum), light thermal cracked, sweetened; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate From the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 o C (68 oF to 212 oF).] 295-447-392045-65-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-327-00-6 Naphtha (petroleum), hydrotreated heavy; Low boiling point ydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65o C to 230o C (149oF to 446oF).] 265-150-364742-48-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-328-00-1 Naphtha (petroleum), hydrotreated light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction With hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20o C to 190o C (– 4oF to 374oF).] 265-151-964742-49-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-329-00-7 Naphtha (petroleum), hydrodesulfurized light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in The range of approximately - 20o C to 190o C (– 4oF to 374oF).] 265-178-664742-73-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304

P 649-330-00-2 naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90o C to 230o C (194oF to 446 oF).] 265-185-464742-82-1 Carc. 1B Muta. 1B STOT RE 1 Asp. Tox. 1 H350 H340 H372 (central nervous system) H304 GHS08 Dgr H350 H340 H372 (central nervous system) H304 P649-331-00-8 Distillates (petroleum), hydrotreated middle, intermediate boiling; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127o C to 188o C (262oF to 370oF).] 270-092-768410-96-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-332-00-3 Distillates (petroleum), light distillate hydrotreating process, low-boiling; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 o C to 194 o C (37 oF to 382 oF).] 270-093-268410-97-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-333-00-9 Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (– 57oF to 155oF).] 270-094-868410-98-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-334-00-4 Solvent naphtha (petroleum), light arom., hydrotreated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approxi mately 135 oC to 210 oC (275oF to 410oF).] 270-988-868512-78-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-335-00-X Naphtha (petroleum), hydrodesulfurized thermal cracked light; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73oF to 383oF).]

285-511-985116-60-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-336-00-5 Naphtha (petroleum), hydrotreated light, cycloalkane-contg.; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately - 20o C to 190 oC (– 4oF to 374oF).] 285-512-485116-61-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-337-00-0Naphtha (petroleum),heavy steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha295-432-192045-51-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-338-00-6 Naphtha (petroleum), hydrodesulfurized full-range; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86oF to 482oF).] 295-433-792045-52-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-339-00-1 Naphtha (petroleum), hydrotreated light steam-cracked; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35o C to 190 oC (95oF to 374oF).] 295-438-492045-57-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-340-00-7 Hydrocarbons, C4-12, naphtha-cracking, hydrotreated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by distallation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230o C (86oF to 446oF).] 295-443-192045-61-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-341-00-2 Solvent naphtha (petroleum), hydrotreated light naphthenic; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approxi mately 73o C to 85o C (163 oF to 185 oF).] 295-529-992062-15-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-342-00-8 Naphtha (petroleum), light steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons produced from the separation and subsequent Hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50o C to 200o C (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts ofsulfur and oxygenated compounds.]

296-942-793165-55-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-343-00-3 Hydrocarbons, C6-11, hydrotreated, dearomatized; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-852-093763-33-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-344-00-9 Hydrocarbons, C9-12, hydrotreated, dearomatized; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-853-693763-34-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-345-00-4 stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 oC to 204,4 o C (300oF to 400oF).] 232-489-38052-41-3 Carc. 1B Muta. 1B STOT RE 1 Asp. Tox. 1 H350 H340 H372 (central nervous system) H304 GHS08 Dgr H350 H340 H372 (central nervous system) H304 P649-346-00-X Natural gas condensates (petroleum); Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] 265-047-364741-47-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-347-00-5 Natural gas (petroleum), raw liq. mix; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] 265-048-964741-48-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-348-00-0 Naphtha (petroleum), light hydrocracked; Low boiling naphtha — unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approxi mately - 20 o C to 180 o C (– 4 oF to 356 oF).] 265-071-464741-69-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-349-00-6 Naphtha (petroleum), heavy hydrocracked; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148oF to 446oF).]

265-079-864741-78-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-350-00-1 Naphtha (petroleum) sweetened; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately - 10o C to 230o C (14oF to 446oF).] 265-089-264741-87-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-351-00-7 Naphtha(petroleum), acid-treated; Low boilingpoint naphtha -unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 o C to 230 o C (194 oF to 446 oF).] 265-115-264742-15-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-352-00-2 Naphtha (petroleum), chemically neutralized heavy; Low boilingpoint naphtha — unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65o C to 230o C (149oF to 446oF).] 265-122-064742-22-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-353-00-8 Naphtha (petroleum), chemically neutralized light; Low boilingpoint naphtha -unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 190o C (–4 oF to 374 oF).] 265-123-664742-23-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-354-00-3 Naphtha (petroleum), catalytic dewaxed; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35o C to 230 oC (95oF to 446oF).] 265-170-264742-66-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-355-00-9 Naphtha (petroleum), light steam-cracked; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (– 4oF to 374oF). This stream is likely to contain 10 vol.% or more benzene.] 265-187-564742-83-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08

Dgr H350 H340 H304 P649-356-00-4 Solvent naphtha (petroleum), light arom.; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275oF to 410oF).] 265-199-064742-95-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-357-00-X Aromatic hydrocarbons, C6-10, acid-treated, neutralized; Low boiling point naphtha — unspecified 268-618-568131-49-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-358-00-5 Distillates (petroleum), C3-5, 2-methyl-2-butene-rich; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons from the distil lation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] 270-725-768477-34-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-359-00-0 Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction; Low boiling point naphtha- unspecified; [A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-735-168477-50-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-360-00-6 Distillates (petroleum), steam-cracked, C5-12 fraction; Low boiling point naphtha -unspecified; [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-736-768477-53-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-361-00-1Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction; Low boiling point naphtha -unspecified270-738-868477-55-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-362-00-7Extracts (petroleum), cold-acid, C4-6; Low boiling point naphtha — unspecified; [A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]270-741-468477-61-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-363-00-2 Distillates (petroleum), depentanizer overheads; Low boiling point naphtha -unspecified;

[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C4 through C6.] 270-771-868477-89-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-364-00-8 Residues (petroleum), butane splitter bottoms; Low boiling point naphtha -unspecified; [A complex residuum from the distillation of butane stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C4 through C6.] 270-791-768478-12-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-365-00-3 Residual oils (petroleum), deisobutanizer tower; Low boiling point naphtha -unspecified; [A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-795-968478-16-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-366-00-9 Naphtha (petroleum), full-range coker; Low boiling point naphtha — unspecified; [A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43o C to 250o C (110oF-500oF).] 270-991-468513-02-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-367-00-4 Naphtha (petroleum), steam-cracked middle arom.; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130o C to 220o C (266oF to 428oF).] 271-138-968516-20-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-368-00-X Naphtha (petroleum), clay-treated full-range straight-run; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons resulting from treatment of full-range straight- run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20o C to 220o C (– 4oF to 429oF).] 271-262-368527-21-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-369-00-5 Naphtha (petroleum), clay-treated light straight-run; Low boiling point naphtha — unspecified; [A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200oF to 356oF).]

271-263-968527-22-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-370-00-0 Naphtha (petroleum), light steam-cracked arom.; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110o C to 165 o C (230 oF to 329 oF).] 271-264-468527-23-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-371-00-6 Naphtha (petroleum),light steam-cracked, debenzenized; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80o C to 218o C (176oF to 424oF).] 271-266-568527-26-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-372-00-1 Naphtha (petroleum), arom.-contg.; Low boilingpoint naphtha — unspecified 271-635-068603-08-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-373-00-7 Gasoline, pyrolysis, debutanizer bottoms; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] 271-726-568606-10-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-374-00-2 Naphtha (petroleum), light, sweetened; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydro carbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20o C to 100o C (– 4oF to 212 oF).] 272-206-068783-66-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-375-00-8 Natural gas condensates; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] 272-896-368919-39-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-376-00-3 Distillates (petroleum), naphtha unifiner stripper; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]

272-932-868921-09-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-377-00-9 Naphtha (petroleum), catalytic reformed light, arom.-free fraction; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66o C to 121o C (151oF to250oF).] 285-510-385116-59-2 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-378-00-4 Gasoline; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260o C (86oF to 500oF).] 289-220-886290-81-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-379-00-X Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues; Low boiling point naphtha — unspecified 292-698-090989-42-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-380-00-5 Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes and boiling in the range of approximately 25 oC to 40 o C (77oF to 104oF).] 295-298-491995-38-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-381-00-0 Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich; Low boiling point naphtha — unspecified; [A complex combination of hydrocarbons obtained by distillation of heat-soaked steam- cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 295-302-491995-41-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-382-00-6 Extracts (petroleum), catalytic reformed light naphtha solvent; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212oF to 392oF).] 295-331-291995-68-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-383-00-1 Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90o C to 100o C (194oF to 212oF).]

295-434-292045-53-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-384-00-7 Naphtha (petroleum), light, C5-rich, sweetened; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35o C (14oF to 95oF).] 295-442-692045-60-8 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-385-00-2 Hydrocarbons, C8-11, naphtha-cracking, toluene cut; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130o C to 205o C (266oF to 401oF).] 295-444-792045-62-0 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-386-00-8 Hydrocarbons, C4-11, naphtha-cracking, arom.-free; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene-and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 o C to 205 o C (86 oF to 401 oF).] 295-445-292045-63-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-387-00-3 Naphtha (petroleum), light heat-soaked, steam-cracked; Low boiling point naphtha — unspecified; [A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approxi mately 0o C to 80o C (32oF to 176oF).] 296-028-892201-97-3 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-388-00-9 Distillates (petroleum), C6-rich; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60o C to70o C (140 oF to 158 oF).] 296-903-493165-19-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-389-00-4 Gasoline, pyrolysis, hydrogenated; Low boiling point naphtha-unspecified; [A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20o C to 200o C (68oF to 392oF).] 302-639-394114-03-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-390-00-X

Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 305-750-595009-23-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-391-00-5 Extracts (petroleum) heavy naphtha solvent, clay-treated; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 o C to 180 o C (175 oF to 356 oF).] 308-261-597926-43-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-392-00-0 Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200o C (203oF to 392oF).] 308-713-198219-46-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-393-00-6 Naphtha (petroleum), light steam-cracked, thermally treated; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 o C to 80 o C (95 oF to 176 oF).] 308-714-798219-47-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-394-00-1 Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 o C to 130 o C (248 oF to 266 oF).] 309-862-5101316-56-7 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-395-00-7 Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination; Low boiling point naphtha — unspecified; [A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80o C to 135o C (176oF to 275oF).]

309-870-9101316-66-9 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-396-00-2 Naphtha (petroleum), hydrodesulfurised full-range coker; Low boiling point naphtha -unspecified; [A complex ombination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 o C (73 oF to 385 oF).] 309-879-8101316-76-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-397-00-8 Naphtha (petroleum), sweetened light; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 o C to 130 o C (68 oF to 266 oF).] 309-976-5101795-01-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-398-00-3 Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] 310-012-0102110-14-5 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-399-00-9 Hydrocarbons, C5-rich, dicyclopentadiene-contg.; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30o C to 170o C (86oF to 338oF).] 310-013-6102110-15-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-400-00-2 Residues (petroleum), steam-cracked light, arom.; Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products of steamcracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40o C (104oF).] 310-057-6102110-55-4 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P 649-401-00-8Hydrocarbons, C≥5, C5-6-rich; Low boiling point naphtha -unspecified270-690-868476-50-6 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-402-00-3 Hydrocarbons, C5-rich; Low boiling point naphtha — unspecified 270-695-568476-55-1 Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-403-00-9Aromatic hydrocarbons, C8-10; Low boiling point naphtha -unspecified292-695-490989-39-2

Carc. 1B Muta. 1B Asp. Tox. 1 H350 H340 H304 GHS08 Dgr H350 H340 H304 P649-404-00-4 Kerosine (petroleum); Straight run kerosine; [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150oC to 290oC (320oF to 554oF).] 232-366-48008-20-6Asp. Tox. 1H304 GHS08 Dgr H304649-405-00-X solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140o C to 220o C (284oF to 428oF).] 265-191-764742-88-7 STOT RE 1 Asp. Tox. 1 H372 (central nervous system) H304 GHS08 Dgr H372 (central nervous system) H304 649-406-00-5 Solvent naphtha (petroleum) heavy aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).] 265-200-464742-96-7Asp. Tox. 1H304 GHS08 Dgr H304649-407-00-0 Kerosine (petroleum), straight-run wide-cut; Straight run kerosine; [A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).] 295-418-592045-37-9Asp. Tox. 1H304 GHS08 Dgr H304649-408-00-6 Distillates (petroleum), steam-cracked; Cracked kerosine; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).] 265-194-364742-91-2Asp. Tox. 1H304 GHS08 Dgr H304 649-409-00-1 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction; Cracked kerosine; [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydrocarbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129oC to 194oC (264 oF to 382 oF).] 270-728-368477-39-4Asp. Tox. 1H304 GHS08 Dgr H304649-410-00-7 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction; Cracked kerosine; [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] 270-729-968477-40-7Asp. Tox. 1H304 GHS08 Dgr H304649-411-00-2 Distillates (petroleum), steam-cracked, C8-12 fraction;

Cracked kerosine; [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 270-737-268477-54-3Asp. Tox. 1H304 GHS08 Dgr H304 649-412-00-8 Kerosine (petroleum), hydrodesulfurized thermal cracked; Cracked kerosine; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predomi nantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120oC to 283oC (284oF to 541oF).] 285-507-785116-55-8Asp. Tox. 1H304 GHS08 Dgr H304649-413-00-3 Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated; Cracked kerosine; [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).] 292-621-090640-98-5Asp. Tox. 1H304 GHS08 Dgr H304649-414-00-9 Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich; Cracked kerosine; [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140oC to 200oC (284oF to 392oF).] 292-637-890641-13-7Asp. Tox. 1H304 GHS08 Dgr H304 649-415-00-4 Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250oC (212oF to 482oF.] 309-866-7101316-61-4Asp. Tox. 1H304 GHS08 Dgr H304649-416-00-X Distillates (petroleum), catalytic cracked heavy tar light; Cracked kerosine; [A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predomi nantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-938-8101631-13-4Asp. Tox. 1H304 GHS08 Dgr H304649-417-00-5 Solvent naphtha (petroleum), hydrocracked heavy arom.; Cracked kerosine; [A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).] 309-881-9101316-80-7Asp. Tox. 1H304 GHS08 Dgr H304 649-418-00-0 Distillates (petroleum), steam-cracked heavy tar light; Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-940-9101631-15-6Asp. Tox. 1H304 GHS08 Dgr H304649-419-00-6 Distillates (petroleum), alkylate; Kerosine — unspecified; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205oC to 320oC (401oF to 608oF).] 265-074-064741-73-7Asp. Tox. 1H304 GHS08 Dgr H304649-420-00-1 Extracts (petroleum), heavy naphtha solvent; Kerosine — unspecified; [A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90oC to 220oC (194 oF to 428 oF).] 265-099-764741-98-6Asp. Tox. 1H304 GHS08 Dgr H304 649-421-00-7 Distillates (petroleum), chemically neutralized light; Kerosine — unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-132-564742-31-0Asp. Tox. 1H304 GHS08 Dgr H304649-422-00-2 Distillates (petroleum), hydro- treated light; Kerosine — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approxi mately 150 oC to 290 oC (302 oF to 554 oF).] 265-149-864742-47-8Asp. Tox. 1H304 GHS08 Dgr H304649-423-00-8 Kerosine (petroleum), hydrodesulfurized; Kerosine — unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-184-964742-81-0Asp. Tox. 1H304 GHS08 Dgr H304 649-424-00-3 Solvent naphtha (petroleum), heavy arom.; Kerosine — unspecified; [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).] 265-198-564742-94-5Asp. Tox. 1H304 GHS08 Dgr H304649-425-00-9 Naphtha (petroleum), heavy coker;

Kerosine — unspecified; [A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).] 269-778-968333-23-3Asp. Tox. 1H304 GHS08 Dgr H304649-426-00-4 Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction; Kerosine — unspecified; [A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98oC to 218oC (208oF to 424oF).] 285-508-285116-57-0Asp. Tox. 1H304GHS08-DgrH304 649-427-00-X Kerosine (petroleum), sweetened; Kerosine — unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).] 294-799-591770-15-9Asp. Tox. 1H304 GHS08 Dgr H304649-428-00-5 Kerosine (petroleum), solvent-refined sweetened; Kerosine — unspecified; [A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).] 295-416-492045-36-8Asp. Tox. 1H304 GHS08 Dgr H304649-429-00-0 Hydrocarbons, C9-16, hydrotreated, dearomatized; Kerosine — unspecified; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-854-193763-35-0Asp. Tox. 1H304 GHS08 Dgr H304 649-430-00-6Kerosine (petroleum), solvent-refined hydrodesulfurized; Kerosine — unspecified307-033-297488-94-3Asp. Tox. 1H304 GHS08 Dgr H304649-431-00-1 Distillates (petroleum), hydrodesulfurized full-range middle coker; Kerosine — unspecified; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).] 309-864-6101316-58-9Asp. Tox. 1H304 GHS08 Dgr H304649-432-00-7 Solvent naphtha (petroleum), hydrodesulfurized heavy arom.; Kerosine — unspecified; [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).] 309-882-4101316-81-8Asp. Tox. 1H304 GHS08 Dgr H304649-433-00-2 Solvent naphtha (petroleum), hydrodesulfurized medium; Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).] 309-884-5101316-82-9Asp. Tox. 1H304 GHS08 Dgr H304 649-434-00-8 Kerosine (petroleum), hydrotreated; Kerosine — unspecified; [A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).] 309-944-0101631-19-0Asp. Tox. 1H304 GHS08 Dgr H304649-435-00-3 Distillates (petroleum), light catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 265-060-464741-59-9Carc. 1BH350 GHS08 Dgr H350649-436-00-9 Distillates (petroleum), intermediate catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 265-062-564741-60-2Carc. 1BH350 GHS08 Dgr H350 649-437-00-4 Distillates (petroleum), light hydrocracked; Cracked gasoil; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approxi mately 160oC to 320oC (320 oF to 608 oF).] 265-078-264741-77-1Carc. 2H351 GHS08 Wng H351649-438-00-X Distillates (petroleum), light thermal cracked; Cracked gasoil; [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160oC to 370 oC (320oF to 698oF).] 265-084-564741-82-8Carc. 1BH350 GHS08 Dgr H350649-439-00-5 Distillates (petroleum), hydrodesulfurized light catalytic cracked; Cracked gasoil; [A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]

269-781-568333-25-5Carc. 1BH350 GHS08 Dgr H350 649-440-00-0 Distillates (petroleum),light steam-cracked naphtha; Cracked gasoil; [A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] 270-662-568475-80-9Carc. 1BH350 GHS08 Dgr H350649-441-00-6 Distillates (petroleum), cracked steam-cracked petroleum distillates; Cracked gasoil; [A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] 270-727-868477-38-3Carc. 1BH350 GHS08 Dgr H350649-442-00-1 Gas oils (petroleum), steam-cracked; Cracked gasoil; [A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).] 271-260-268527-18-4Carc. 1BH350 GHS08 Dgr H350649-443-00-7 Distillates (petroleum), hydrodesulfurized thermal cracked middle; Cracked gasoil; [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400ooC (401oF to 752oF).] 285-505-685116-53-6Carc. 1BH350 GHS08 Dgr H350 649-444-00-2Gas oils (petroleum), thermal-cracked, hydrodesulfurized; Cracked gasoil295-411-792045-29-9Carc. 1BH350 GHS08 Dgr H350649-445-00-8 Residues (petroleum), hydrogenated steam-cracked naphtha; Cracked gasoil; [A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200oC to 350oC (32 oF to 662 oF).] 295-514-792062-00-5Carc. 1BH350 GHS08 Dgr H350649-446-00-3 Residues (petroleum), steam-cracked naphtha distn.; Cracked gasoil; [A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] 295-517-392062-04-9Carc. 1BH350 GHS08 Dgr H350649-447-00-9 Distillates (petroleum), light catalytic cracked, thermally degraded; Cracked gasoil; [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190oC to 340oC (374oF to 644oF). This stream is likely to contain organic sulfur compounds.] 295-991-192201-60-0Carc. 1BH350

GHS08 Dgr H350 649-448-00-4 Residues (petroleum), steam-cracked heat-soaked naphtha; Cracked gasoil; [A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).] 297-905-893763-85-0Carc. 1BH350 GHS08 Dgr H350649-449-00-X Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue; Cracked gasoil; [A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] 307-662-297675-88-2Carc. 2H351 GHS08 Wng H351649-450-00-5 Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized; Cracked gasoil; [A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).] 308-278-897926-59-5Carc. 1BH350 GHS08 Dgr H350 649-451-00-0 Distillates (petroleum), hydrodesulfurized middle coker; Cracked gasoil; [A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydrocarbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).] 309-865-1101316-59-0Carc. 1BH350 GHS08 Dgr H350649-452-00-6 Distillates (petroleum), heavy steam-cracked; Cracked gasoil; [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).] 309-939-3101631-14-5Carc. 1BH350 GHS08 Dgr H350649-453-00-1 Distillates (petroleum), heavy hydrocracked; Baseoil — unspecified; [A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).] 265-077-764741-76-0Carc. 1BH350 GHS08 Dgr H350L 649-454-00-7 Distillates (petroleum), solvent-refined heavy paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-090-864741-88-4Carc. 1BH350

GHS08 Dgr H350L649-455-00-2 Distillates (petroleum), solvent-refined light paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-091-364741-89-5Carc. 1BH350 GHS08 Dgr H350L649-456-00-8 Residual oils (petroleum), solvent deasphalted; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-096-064741-95-3Carc. 1BH350 GHS08 Dgr H350L 649-457-00-3 Distillates (petroleum), solvent-refined heavy naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.] 265-097-664741-96-4Carc. 1BH350 GHS08 Dgr H350L649-458-00-9 Distillates (petroleum), solvent-refined light naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-098-164741-97-5Carc. 1BH350 GHS08 Dgr H350L649-459-00-4 Residual oils (petroleum,) solvent-refined; Baseoil — unspecified; [A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400oC (752oF).] 265-101-664742-01-4Carc. 1BH350 GHS08 Dgr H350L 649-460-00-X Distillates (petroleum), clay-treated paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-137-264742-36-5Carc. 1BH350 GHS08 Dgr H350L649-461-00-5 Distillates (petroleum), clay-treated light paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]

265-138-864742-37-6Carc. 1BH350 GHS08 Dgr H350L 649-462-00-0 Residual oils (petroleum), clay-treated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400oC (752 oF).] 265-143-564742-41-2Carc. 1BH350 GHS08 Dgr H350L649-463-00-6Distillates (petroleum), clay-treated heavy naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]265-146-164742-44-5Carc. 1BH350 GHS08 Dgr H350L 649-464-00-1 Distillates (petroleum), clay-treated light naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-147-764742-45-6Carc. 1BH350 GHS08 Dgr H350L649-465-00-7 Distillates (petroleum), hydrotreated heavy naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-155-064742-52-5Carc. 1BH350 GHS08 Dgr H350L649-466-00-2 Distillates (petroleum), hydrotreated light naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-156-664742-53-6Carc. 1BH350 GHS08 Dgr H350L 649-467-00-8 Distillates (petroleum), hydrotreated heavy paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]

265-157-164742-54-7Carc. 1BH350 GHS08 Dgr H350L649-468-00-3 Distillates (petroleum), hydrotreated light paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-158-764742-55-8Carc. 1BH350 GHS08 Dgr H350L649-469-00-9 Distillates (petroleum), solvent-dewaxed light paraffinic; Baseoil — unspecified; [A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-159-264742-56-9Carc. 1BH350 GHS08 Dgr H350L 649-470-00-4 Residual oils (petroleum), hydrotreated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-160-864742-57-0Carc. 1BH350 GHS08 Dgr H350L649-471-00-X Residual oils (petroleum), solvent-dewaxed; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by removal of ong, branched chain hydrocarbons from a residual oil by solvent crystalli zation. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approxi mately 400 oC (752 oF).] 265-166-064742-62-7Carc. 1BH350 GHS08 Dgr H350L649-472-00-5 Distillates (petroleum), solvent-dewaxed heavy naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-167-664742-63-8Carc. 1BH350 GHS08 Dgr H350L 649-473-00-0 Distillates (petroleum), solvent-dewaxed light naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-168-164742-64-9Carc. 1BH350 GHS08 Dgr H350L649-474-00-6 Distillates (petroleum), solvent-dewaxed heavy paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]

265-169-764742-65-0Carc. 1BH350 GHS08 Dgr H350L649-475-00-1 Naphthenic oils (petroleum), catalytic dewaxed heavy; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-172-364742-68-3Carc. 1BH350 GHS08 Dgr H350L 649-476-00-7 Naphthenic oils (petroleum), catalytic dewaxed light; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-173-964742-69-4Carc. 1BH350 GHS08 Dgr H350L649-477-00-2 Paraffin oils (petroleum), catalytic dewaxed heavy; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-174-464742-70-7Carc. 1BH350 GHS08 Dgr H350L649-478-00-8 Paraffin oils (petroleum), catalytic dewaxed light; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-176-564742-71-8Carc. 1BH350 GHS08 Dgr H350L 649-479-00-3 Naphthenic oils (petroleum), complex dewaxed heavy; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-179-164742-75-2Carc. 1BH350 GHS08 Dgr H350L649-480-00-9 Naphthenic oils (petroleum), complex dewaxed light; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-180-764742-76-3Carc. 1BH350 GHS08 Dgr H350L 649-481-00-4 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and

solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-736-372623-85-9Carc. 1BH350 GHS08 Dgr H350L649-482-00-X Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] 276-737-972623-86-0Carc. 1BH350 GHS08 Dgr H350L 649-483-00-5 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-738-472623-87-1Carc. 1BH350 GHS08 Dgr H350L649-484-00-0 Lubricating oils; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] 278-012-274869-22-0Carc. 1BH350 GHS08 Dgr H350L649-485-00-6 Distillates (petroleum), complex dewaxed heavy paraffinci; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-613-790640-91-8Carc. 1BH350 GHS08 Dgr H350L 649-486-00-1 Distillates (petroleum), complex dewaxed light paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]

292-614-290640-92-9Carc. 1BH350 GHS08 Dgr H350L649-487-00-7 Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-616-390640-94-1Carc. 1BH350 GHS08 Dgr H350L649-488-00-2 Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated; Baseoil — unspecified; [A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-617-990640-95-2Carc. 1BH350 GHS08 Dgr H350L 649-489-00-8 Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-618-490640-96-3Carc. 1BH350 GHS08 Dgr H350L649-490-00-3 Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated; Baseoil — unspecified; [A complex combination of hydrocarbons produced by Treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-620-590640-97-4Carc. 1BH350 GHS08 Dgr H350L649-491-00-9Residual oils (petroleum), hydrotreated solvent dewaxed; Baseoil — unspecified292-656-190669-74-2Carc. 1BH350 GHS08 Dgr H350L649-492-00-4 Residual oils (petroleum), catalytic dewaxed; Baseoil — unspecified 294-843-391770-57-9Carc. 1BH350 GHS08 Dgr H350L 649-493-00-X Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] 295-300-391995-39-0Carc. 1BH350 GHS08 Dgr H350L649-494-00-5 Distillates (petroleum), dewaxed light paraffinic, hydrotreated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] 295-301-991995-40-3Carc. 1BH350 GHS08 Dgr

H350L649-495-00-0 Distillates (petroleum), hydrocracked solvent-refined, dewaxed; Baseoil — unspecified; [A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] 295-306-691995-45-8Carc. 1BH350 GHS08 Dgr H350L 649-496-00-6 Distillates (petroleum), solvent-refined light naphthenic, hydrotreated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] 295-316-091995-54-9Carc. 1BH350 GHS08 Dgr H350L649-497-00-1 Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated; Baseoil — unspecified 295-423-292045-42-6Carc. 1BH350 GHS08 Dgr H350L649-498-00-7 Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined; Baseoil — unspecified 295-424-892045-43-7Carc. 1BH350 GHS08 Dgr H350L649-499-00-2 Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed; Baseoil — unspecified; [A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distil lation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).] 295-499-792061-86-4Carc. 1BH350 GHS08 Dgr H350L 649-500-00-6 Paraffin oils (petroleum), solvent-refined dewaxed heavy; Baseoil — unspecified; [A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] 295-810-692129-09-4Carc. 1BH350 GHS08 Dgr H350L649-501-00-1 Lubricating oils (petroleum), base oils, paraffinic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).] 297-474-693572-43-1Carc. 1BH350 GHS08 Dgr H350L649-502-00-7 Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed; Baseoil — unspecified 297-857-893763-38-3Carc. 1BH350 GHS08 Dgr H350L649-503-00-2 Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate; Baseoil — unspecified 300-257-193924-61-9Carc. 1BH350 GHS08 Dgr H350L649-504-00-8 Distillates (petroleum), solvent-refined hydrotreated heavy; hydrogenated; Baseoil — unspecified 305-588-594733-08-1Carc. 1BH350 GHS08 Dgr H350L 649-505-00-3 Distillates (petroleum), solvent-refined hydrocracked light; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370oC to 450oC (698oF to 842oF).]

305-589-094733-09-2Carc. 1BH350 GHS08 Dgr H350L649-506-00-9 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370oC to 550 oC (698 oF to 1022oF).] 305-594-894733-15-0Carc. 1BH350 GHS08 Dgr H350L649-507-00-4 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-595-394733-16-1Carc. 1BH350 GHS08 Dgr H350L 649-508-00-X Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate; Baseoil — unspecified 305-971-795371-04-3Carc. 1BH350 GHS08 Dgr H350L649-509-00-5 Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate; Baseoil — unspecified 305-972-295371-05-4Carc. 1BH350 GHS08 Dgr H350L649-510-00-0 Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues; Baseoil — unspecified 305-974-395371-07-6Carc. 1BH350 GHS08 Dgr H350L649-511-00-6 Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues; Baseoil — unspecified 305-975-995371-08-7Carc. 1BH350 GHS08 Dgr H350L649-512-00-1 Distillates (petroleum), hydrocracked solvent-refined light; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predomiantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450oC (698 oF to 842 oF.] 307-010-797488-73-8Carc. 1BH350 GHS08 Dgr H350L649-513-00-7Distillates (petroleum), solvent-refined hydrogenated heavy; Baseoil — unspecified; [A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]307-011-297488-74-9Carc. 1BH350 GHS08 Dgr H350L 649-514-00-2 Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed; Baseoil — unspecified 307-034-897488-95-4Carc. 1BH350 GHS08 Dgr H350L649-515-00-8 Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]

307-661-797675-87-1Carc. 1BH350 GHS08 Dgr H350L649-516-00-3 Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights; Baseoil — unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).] 307-755-897722-06-0Carc. 1BH350 GHS08 Dgr H350L 649-517-00-9 Hydrocarbons, C13-27, solvent-extd. light naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).] 307-758-497722-09-3Carc. 1BH350 GHS08 Dgr H350L649-518-00-4 Hydrocarbons, C14-29, solvent-extd. light naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40oC (104oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).] 307-760-597722-10-6Carc. 1BH350 GHS08 Dgr H350L649-519-00-X Hydrocarbons, C27-42, dearomatized; Baseoil — unspecified 308-131-897862-81-2Carc. 1BH350 GHS08 Dgr H350L649-520-00-5Hydrocarbons, C17-30, hydrotreated distillates, distn. lights; Baseoil — unspecified308-132-397862-82-3Carc. 1BH350 GHS08 Dgr H350L 649-521-00-0 Hydrocarbons, C27-45, naphthenic vacuum distn.; Baseoil — unspecified 308-133-997862-83-4Carc. 1BH350 GHS08 Dgr H350L649-522-00-6 Hydrocarbons, C27-45, dearomatized; Baseoil — unspecified 308-287-797926-68-6Carc. 1BH350 GHS08 Dgr H350L649-523-00-1 Hydrocarbons, C20-58, hydrotreated; Baseoil — unspecified 308-289-897926-70-0Carc. 1BH350 GHS08 Dgr H350L649-524-00-7 Hydrocarbons, C27-42, naphthenic; Baseoil — unspecified 308-290-397926-71-1Carc. 1BH350 GHS08 Dgr H350L649-525-00-2 Residual oils (petroleum), carbon-treated solvent-dewaxed; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] 309-710-8100684-37-5Carc. 1BH350 GHS08 Dgr H350L649-526-00-8 Residual oils (petroleum), clay-treated solvent-dewaxed; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] 309-711-3100684-38-6Carc. 1BH350

GHS08 Dgr H350L 649-527-00-3 Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).] 309-874-0101316-69-2Carc. 1BH350 GHS08 Dgr H350L649-528-00-9 Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.] 309-875-6101316-70-5Carc. 1BH350 GHS08 Dgr H350L649-529-00-4 Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).] 309-876-1101316-71-6Carc. 1BH350 GHS08 Dgr H350L 649-530-00-X Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated; Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).] 309-877-7101316-72-7Carc. 1BH350 GHS08 Dgr H350L649-531-00-5 Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.; Distillate aromatic extract (treated); [An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] 272-175-368783-00-6Carc. 1BH350 GHS08 Dgr H350L649-532-00-0 Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent; Distillate aromaticextract (treated); [A complex combination of hydrocarbons obtained as the extractfrom the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 272-180-068783-04-0Carc. 1BH350 GHS08 Dgr H350L 649-533-00-6 Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] 272-342-068814-89-1Carc. 1BH350 GHS08 Dgr H350L649-534-00-1

Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).] 292-631-590641-07-9Carc. 1BH350 GHS08 Dgr H350L649-535-00-7 Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350oC to 480oC (662oF to 896oF). 292-632-090641-08-0Carc. 1BH350 GHS08 Dgr H350L 649-536-00-2 Extracts (petroleum), light paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons produced by treating a lightparaffinic distillate solvent extract with hydrogen in the presence of acatalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280oC to 400oC (536 oF to 752 oF).] 292-633-690641-09-1Carc. 1BH350 GHS08 Dgr H350L649-537-00-8 Extracts (petroleum), hydrotreated light paraffinic distillate solvent; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 295-335-491995-73-2Carc. 1BH350 GHS08 Dgr H350L 649-538-00-3 Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 295-338-091995-75-4Carc. 1BH350 GHS08 Dgr H350L649-539-00-9 Extracts(petroleum), light paraffinic distillate solvent, acid-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]

295-339-691995-76-5Carc. 1BH350 GHS08 Dgr H350L 649-540-00-4 Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] 295-340-191995-77-6Carc. 1BH350 GHS08 Dgr H350L649-541-00-X Extracts (petroleum), light vacuum gas oil solvent, hydrotreated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 295-342-291995-79-8Carc. 1BH350 GHS08 Dgr H350L 649-542-00-5 Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] 296-437-192704-08-0Carc. 1BH350 GHS08 Dgr H350L649-543-00-0 Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-827-493763-10-1Carc. 1BH350 GHS08 Dgr H350L 649-544-00-6 Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-829-593763-11-2Carc. 1BH350 GHS08 Dgr H350L649-545-00-1 Extracts (petroleum), light paraffinic distillate solvent, carbon-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]

309-672-2100684-02-4Carc. 1BH350 GHS08 Dgr H350L 649-546-00-7 Extracts (petroleum), light paraffinic distillate solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-673-8100684-03-5Carc. 1BH350 GHS08 Dgr H350L649-547-00-2 Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-674-3100684-04-6Carc. 1BH350 GHS08 Dgr H350L 649-548-00-8 Extracts (petroleum), light vacuum gas oil solvent, clay-treated; Distillate aromatic extract (treated); [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-675-9100684-05-7Carc. 1BH350 GHS08 Dgr H350L649-549-00-3 Foots oil (petroleum); Foots oil; [A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predomi nantly of branched chain hydro carbons having carbon numbers predominantly in the range of C20 through C50.] 265-171-864742-67-2Carc. 1BH350 GHS08 Dgr H350L649-550-00-9Foots oil (petroleum), hydrotreated; Foots oil295-394-692045-12-0Carc. 1BH350 GHS08 Dgr H350L650-002-00-6turpentine, oil232-350-78006-64-2 Flam. Liq. 3 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 H226 H332 H312 H302 H304 H319 H315 H317 H411 GHS02 GHS08 GHS07 GHS09 Dgr H226 H332 H312 H302 H304 H319 H315 H317 H411 650-003-00-1 fenson (ISO); 4-chlorophenyl benzenesulphonate; 201-274-680-38-6 Acute Tox. 4 Eye Irrit. 2 Aquatic Chronic 2 H302 H319 H411 GHS07 GHS09 Wng H302 H319 H411 650-004-00-7 norbormide (ISO); 5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicycle [2.2.1] hept-5-ene-2,3-dicarboximide 213-589-6991-42-4Acute Tox. 4 H302 GHS07 Wng H302650-005-00-2(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone201-501-983-79-4 Acute Tox. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H301 H319 H335 H315 H400 H410 GHS06 GHS09 Dgr H301 H319 H335 H315 H410 650-006-00-8 benquinox (ISO); p-benzoquinone 1-benzoylhydrazone 4-oxime

207-807-9495-73-8Acute Tox. 3 Acute Tox. 4 H301 H312 GHS06 Dgr H301 H312 650-007-00-3 chlordimeform (ISO); N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine 228-200-56164-98-3 Carc. 2 Acute Tox. 4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H312 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H312 H302 H410 650-008-00-9 drazoxolon (ISO); 4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone 227-197-85707-69-7 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 H301 H400 H410 GHS06 GHS09 Dgr H301 H410 650-009-00-4 chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride; N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride 243-269-119750-95-9 Carc. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H410 650-010-00-X benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonato benzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate 216-901-91694-09-3Carc. 2H351 GHS08 Wng H351650-012-00-0erionite—12510-42-8Carc. 1AH350 GHS08 Dgr H350650-013-00-6asbestos — — — — — — — 12001-28-4 132207-32-0 12172-73-5 77536-66-4 77536-68-6 77536-67-5 12001-29-5 Carc. 1A STOT RE 1 H350 H372 GHS08 Dgr H350 H372 650-014-00-1diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate401-770-4— Skin Corr. 1B Acute Tox. 4 H314 H302 GHS05 GHS07 Dgr H314 H302 650-015-00-7 rosin; colophony 232-475-7 232-484-6 277-299-1 8050-09-7 8052-10-6 73138-82-6 Skin Sens. 1H317 GHS07 Wng H317 650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] ——Carc. 2H351 GHS08 Wng H351AQR650-017-00-8 Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] ——Carc. 1BH350i GHS08 Dgr H350iAR650-018-00-3Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid406-230-1— Flam. Liq. 3 Carc. 2 Skin Corr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H226 H351 H314 H332 H317 H400 H410 GHS02 GHS08 GHS05 GHS07 GHS09 Dgr H226 H351 H314 H332 H317 H410 650-031-00-4bis(4-hydroxy-N-methylanilinium) sulphate200-237-155-55-0 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 H317 H400 H410 GHS08 GHS07 GHS09 Wng H302 H373 H317 H410 650-041-00-9 triasulfuron (ISO); 1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea —82097-50-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410650-042-00-4Reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates417-450-2—

Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 H319 H315 H317 H412 GHS07 Wng H319 H315 H317 H412 650-043-00-Xreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate420-310-3— Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 650-044-00-5mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin420-480-9158570-99-1 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H317 H400 H410 GHS07 GHS09 Wng H315 H317 H410 650-045-00-0Reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate417-110-3— Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 H225 H315 H318 H411 GHS02 GHS05 GHS09 Dgr H225 H315 H318 H411 650-046-00-6di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates416-180-212222-04-7 Acute Tox. 4 STOT RE 2 Aquatic Chronic 2 H302 H373 H411 GHS08 GHS07 GHS09 Wng H302 H373 H411 650-047-00-1dibenzylphenylsulfonium hexafluoroantimonate417-760-8134164-24-2 STOT RE 1 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 H372 H302 H318 H317 H411 GHS08 GHS05 GHS07 GHS09 Dgr H372 H302 H318 H317 H411 650-048-00-7reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid420-070-1— Org. Perox. D Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1A Aquatic Acute 1 H242 H332 H312 H302 H314 H400 GHS02 GHS05 GHS07 GHS09 Dgr H242 H332 H312 H302 H314 H400 650-049-00-22-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl417-960-5— Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 H318 H317 H400 H410 GHS05 GHS07 GHS09 Dgr H315 H318 H317 H410 650-050-00-8 reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate; 1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers; 1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers 423-600-8—Aquatic Chronic 2H411GHS09H411 650-055-00-5silver sodium zirconium hydrogenphosphate422-570-3155925-27-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410